SeqName	ortholog_cluster_id	Gene.Name	EggNOG.Description	E.Value	Bit.Score	Best.Tax.Level	EC.Codes	n_GO	GOs	GO.Names	KEGG.KO	KEGG.Pathway	Description	Length	e.Value	GO.IDs	GO.mes	Enzyme.Codes	Enzyme.mes	InterPro.IDs	InterPro.GO.IDs	InterPro.GO.mes	baseMean	log2FoldChange	lfcSE	stat	pvalue	padj
Avas.s001.g47.i1	paralog_cluster_00107	NA	cysteine-type endopeptidase activity	6.8e-91	340.9	Metazoa	NA	NA	NA	NA	NA	NA	CATL1_RAT | Procathepsin L OS=Rattus norvegicus OX=10116 GN=Ctsl PE=1 SV=2	337	4.4e-85	P:GO:0002250; P:GO:0006590; P:GO:0007283; P:GO:0009267; P:GO:0009749; P:GO:0010259; P:GO:0010839; P:GO:0016540; P:GO:0019064; P:GO:0019065; P:GO:0021675; P:GO:0030574; P:GO:0031069; P:GO:0031638; P:GO:0034698; P:GO:0039654; P:GO:0043373; P:GO:0046697; P:GO:0048002; P:GO:0048102; P:GO:0051384; P:GO:0051603; P:GO:0060008; P:GO:0060309; P:GO:0097067; P:GO:1990834; F:GO:0001968; F:GO:0004177; F:GO:0004197; F:GO:0005518; F:GO:0016807; F:GO:0030984; F:GO:0042277; F:GO:0042393; F:GO:0043394; F:GO:0097655; C:GO:0005615; C:GO:0005730; C:GO:0005768; C:GO:0005794; C:GO:0005902; C:GO:0009897; C:GO:0030141; C:GO:0043005; C:GO:0043202; C:GO:0043204; C:GO:0045169; C:GO:0045177	P:adaptive immune response; P:thyroid hormone generation; P:spermatogenesis; P:cellular response to starvation; P:response to glucose; P:multicellular organism aging; P:negative regulation of keratinocyte proliferation; P:protein autoprocessing; P:fusion of virus membrane with host plasma membrane; P:receptor-mediated endocytosis of virus by host cell; P:nerve development; P:collagen catabolic process; P:hair follicle morphogenesis; P:zymogen activation; P:response to godotropin; P:fusion of virus membrane with host endosome membrane; P:CD4-positive, alpha-beta T cell lineage commitment; P:decidualization; P:antigen processing and presentation of peptide antigen; P:autophagic cell death; P:response to glucocorticoid; P:proteolysis involved in cellular protein catabolic process; P:Sertoli cell differentiation; P:elastin catabolic process; P:cellular response to thyroid hormone stimulus; P:response to odorant; F:fibronectin binding; F:aminopeptidase activity; F:cysteine-type endopeptidase activity; F:collagen binding; F:cysteine-type carboxypeptidase activity; F:kininogen binding; F:peptide binding; F:histone binding; F:proteoglycan binding; F:serpin family protein binding; C:extracellular space; C:nucleolus; C:endosome; C:Golgi apparatus; C:microvillus; C:exterl side of plasma membrane; C:secretory granule; C:neuron projection; C:lysosomal lumen; C:perikaryon; C:fusome; C:apical part of cell	EC:3.4.22; EC:3.4.11; EC:3.4.18	Acting on peptide bonds (peptidases); Acting on peptide bonds (peptidases); Acting on peptide bonds (peptidases)	IPR013201 (PFAM); IPR000668 (PFAM); IPR000169 (PROSITE_PATTERNS); IPR025660 (PROSITE_PATTERNS); IPR025661 (PROSITE_PATTERNS)	P:GO:0006508; F:GO:0008234	P:proteolysis; F:cysteine-type peptidase activity	7076.75865718436	-1.68396551672539	0.314919307012477	-5.34729208158289	8.92798788688382e-08	4.6336257132927e-06
Avas.s001.g199.i1	paralog_cluster_01633	NA	Methyltransferase	8.9e-14	84	Bacteroidetes	NA	NA	NA	NA	NA	NA	------	199	NA					IPR007318 (PFAM)	no GO terms	no GO terms	966.728453858428	3.94328299975385	0.363758519392108	10.8403866563555	2.21532761936082e-27	7.74834914519484e-25
Avas.s001.g198.i1	paralog_cluster_18173	NA	Isoprenylcysteine carboxyl methyltransferase (ICMT) family	0.0014	48.5	Alphaproteobacteria	NA	NA	NA	NA	NA	NA	------	69	NA					no IPS match	no IPS match	no IPS match	727.002723041192	4.76092829865168	0.468243433318351	10.167634951999	2.76541710949366e-24	7.80575366221815e-22
Avas.s001.g200.i1	paralog_cluster_01633	NA	Methyltransferase	1.2e-14	87	Bacteroidetes	NA	NA	NA	NA	NA	NA	------	234	NA					IPR007269 (PFAM)	P:GO:0006481; F:GO:0004671; C:GO:0016021	P:C-termil protein methylation; F:protein C-termil S-isoprenylcysteine carboxyl O-methyltransferase activity; C:integral component of membrane	1052.42481648834	4.99503497750266	0.649146457525683	7.69477352852232	1.41745008621997e-14	1.88474003613166e-12
Avas.s001.g201.i1	paralog_cluster_01633	NA	Isoprenylcysteine carboxyl methyltransferase (ICMT) family	5.7e-08	64.7	Halanaerobiales	NA	NA	NA	NA	NA	NA	------	203	NA					IPR007318 (PFAM)	no GO terms	no GO terms	244.578617644447	3.89482074019977	0.62160209860062	6.26577797753253	3.70968582451678e-10	2.94015444485963e-08
Avas.s001.g226.i1	paralog_cluster_00247	NA	Belongs to the G-protein coupled receptor 2 family	7.3e-28	132.5	Metazoa	NA	NA	NA	NA	NA	NA	AGRD1_MOUSE | Adhesion G-protein coupled receptor D1 OS=Mus musculus OX=10090 GN=Adgrd1 PE=2 SV=2	669	3.8e-24	P:GO:0007165; P:GO:0007399; F:GO:0004888; F:GO:0005515; C:GO:0005886; C:GO:0016021; C:GO:0043005; C:GO:0045202	P:sigl transduction; P:nervous system development; F:transmembrane sigling receptor activity; F:protein binding; C:plasma membrane; C:integral component of membrane; C:neuron projection; C:sypse			IPR000203 (PFAM); IPR000832 (PFAM); IPR017981 (PROSITE_PROFILES)	P:GO:0007166; P:GO:0007186; F:GO:0004888; F:GO:0004930; C:GO:0016021	P:cell surface receptor sigling pathway; P:G protein-coupled receptor sigling pathway; F:transmembrane sigling receptor activity; F:G protein-coupled receptor activity; C:integral component of membrane	57.5263617837586	2.9511568543866	0.612899164991127	4.81507729649023	1.47142922492491e-06	6.00858497457283e-05
Avas.s001.g603.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	38	NA					no IPS match	no IPS match	no IPS match	355.922851040707	1.53728290496827	0.251939027072914	6.10180535675151	1.04877045365899e-09	7.56666718785628e-08
Avas.s001.g732.i1	homolog_cluster_10838	NA	Golgi organization	1.9e-22	112.5	Chordata	NA	NA	NA	NA	NA	NA	EFC4B_HUMAN | EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens OX=9606 GN=CRACR2A PE=1 SV=2	166	2e-22	P:GO:0001881; P:GO:0002115; P:GO:0017157; P:GO:0032237; P:GO:0032456; P:GO:0034776; P:GO:0046330; P:GO:0048488; P:GO:0080092; P:GO:0099641; P:GO:1902647; P:GO:1904951; F:GO:0003924; F:GO:0005509; F:GO:0005525; F:GO:0019900; F:GO:0032794; F:GO:0071532; C:GO:0000139; C:GO:0000331; C:GO:0001772; C:GO:0005769; C:GO:0005770; C:GO:0005797; C:GO:0005815; C:GO:0016324; C:GO:0030424; C:GO:0031045; C:GO:0033093; C:GO:0042589; C:GO:0043025; C:GO:0055038; C:GO:0090404; C:GO:0098993; C:GO:0140220	P:receptor recycling; P:store-operated calcium entry; P:regulation of exocytosis; P:activation of store-operated calcium channel activity; P:endocytic recycling; P:response to histamine; P:positive regulation of JNK cascade; P:syptic vesicle endocytosis; P:regulation of pollen tube growth; P:anterograde axol protein transport; P:negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:positive regulation of establishment of protein localization; F:GTPase activity; F:calcium ion binding; F:GTP binding; F:kise binding; F:GTPase activating protein binding; F:ankyrin repeat binding; C:Golgi membrane; C:contractile vacuole; C:immunological sypse; C:early endosome; C:late endosome; C:Golgi medial cister; C:microtubule organizing center; C:apical plasma membrane; C:axon; C:dense core granule; C:Weibel-Palade body; C:zymogen granule membrane; C:neurol cell body; C:recycling endosome membrane; C:pollen tube tip; C:anchored component of syptic vesicle membrane; C:pathogen-containing vacuole	EC:3.6.1	Acting on acid anhydrides	IPR001806 (PFAM); IPR001806 (PROSITE_PROFILES); PS51419 (PROSITE_PROFILES)	F:GO:0003924; F:GO:0005525	F:GTPase activity; F:GTP binding	634.373339895233	2.49596647290699	0.234224746277065	10.6562885116951	1.62971997495247e-26	5.24411293540206e-24
Avas.s001.g761.i1	paralog_cluster_01634	NA	N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity	9e-49	201.8	Metazoa	NA	NA	NA	NA	NA	NA	B4GN4_MOUSE | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1	609	4.4e-43	F:GO:0008376; C:GO:0005794	F:acetylgalactosaminyltransferase activity; C:Golgi apparatus	EC:2.4.1	Glycosyltransferases	IPR008428 (PFAM); IPR037524 (PROSITE_PROFILES)	F:GO:0008376; C:GO:0032580	F:acetylgalactosaminyltransferase activity; C:Golgi cister membrane	53.2548855160612	2.23377757753501	0.43157617032509	5.17585939893853	2.26864260744846e-07	1.08631520569162e-05
Avas.s001.g790.i1	paralog_cluster_01884	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	104	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	177.411820389341	4.22217704050944	0.691282816419806	6.10774192591151	1.01050572611799e-09	7.32343541779832e-08
Avas.s001.g791.i1	paralog_cluster_01884	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	104	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	164.991730905332	3.2714162114595	0.56569370417626	5.78301682926312	7.3372719508438e-09	4.70316208833171e-07
Avas.s001.g794.i1	paralog_cluster_01884	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	111	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	1079.70094817842	5.59113456198983	0.66659357353489	8.38762145926567	4.96076546719144e-17	8.6754082175699e-15
Avas.s001.g816.i1	paralog_cluster_18192	NA	D-arabinono-1,4-lactone oxidase	1.1e-83	317.4	Fungi	NA	NA	NA	NA	NA	NA	------	472	NA					IPR007173 (PFAM); IPR001025 (PROSITE_PROFILES); IPR016166 (PROSITE_PROFILES)	F:GO:0003682; F:GO:0003885; F:GO:0071949; C:GO:0016020	F:chromatin binding; F:D-arabinono-1,4-lactone oxidase activity; F:FAD binding; C:membrane	85.405244991035	-6.05983737845334	0.684138935487915	-8.85761219558652	8.17465232677786e-19	1.584602184163e-16
Avas.s001.g831.i1	paralog_cluster_18192	NA	D-arabinono-1,4-lactone oxidase	3.4e-74	286.6	Fungi	NA	NA	NA	NA	NA	NA	AOFA_PIG | Amine oxidase	748	1.3e-09	P:GO:0009410; P:GO:0009636; P:GO:0010044; P:GO:0010269; P:GO:0014063; P:GO:0032496; P:GO:0042135; P:GO:0042424; P:GO:0042428; P:GO:0042443; P:GO:0045471; P:GO:0045964; P:GO:0051412; F:GO:0008131; F:GO:0042802; F:GO:0050660; F:GO:0051378; C:GO:0005741; C:GO:0005829	P:response to xenobiotic stimulus; P:response to toxic substance; P:response to aluminum ion; P:response to selenium ion; P:negative regulation of serotonin secretion; P:response to lipopolysaccharide; P:neurotransmitter catabolic process; P:catecholamine catabolic process; P:serotonin metabolic process; P:phenylethylamine metabolic process; P:response to ethanol; P:positive regulation of dopamine metabolic process; P:response to corticosterone; F:primary amine oxidase activity; F:identical protein binding; F:flavin adenine dinucleotide binding; F:serotonin binding; C:mitochondrial outer membrane; C:cytosol	EC:1.4.3.21	Primary-amine oxidase	IPR007173 (PFAM); IPR002937 (PFAM); IPR001025 (PROSITE_PROFILES)	F:GO:0003682; F:GO:0003885; F:GO:0016491; C:GO:0016020	F:chromatin binding; F:D-arabinono-1,4-lactone oxidase activity; F:oxidoreductase activity; C:membrane	222.091194813612	-5.72234890880323	0.712780541181734	-8.02820584764565	9.89084258760931e-16	1.5755818454658e-13
Avas.s001.g868.i1	paralog_cluster_01884	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	104	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	1299.7310964202	7.5434775283611	0.368417328639403	20.4753602557725	3.57097997956316e-93	1.91511656303972e-89
Avas.s001.g874.i1	paralog_cluster_00028	CALML3	Ca2+ insensitive EF hand	1.4e-35	156	Chordata	NA	NA	NA	NA	K02183	map04014, map04015, map04016, map04020, map04022, map04024, map04070, map04114, map04218, map04261, map04270, map04371, map04626, map04713, map04720, map04722, map04728, map04740, map04744, map04745, map04750, map04910, map04912, map04915, map04916, map04921, map04922, map04924, map04925, map04970, map04971, map05010, map05031, map05034, map05133, map05152, map05167, map05200, map05214, map05418	CALM_HALOK | Calmodulin OS=Halichondria okadai OX=163232 PE=2 SV=3	153	1.1e-56	P:GO:0000086; P:GO:0001975; P:GO:0002027; P:GO:0002834; P:GO:0005513; P:GO:0007186; P:GO:0007190; P:GO:0010800; P:GO:0010801; P:GO:0010881; P:GO:0016240; P:GO:0031279; P:GO:0031954; P:GO:0032465; P:GO:0032516; P:GO:0043065; P:GO:0043388; P:GO:0050848; P:GO:0051000; P:GO:0051343; P:GO:0051412; P:GO:0060315; P:GO:0060316; P:GO:0071805; P:GO:0071902; P:GO:0090151; P:GO:0098901; P:GO:1900242; P:GO:1901339; P:GO:1901842; P:GO:1901844; P:GO:1904094; P:GO:1905913; P:GO:1990456; P:GO:2000300; F:GO:0005509; F:GO:0008179; F:GO:0010856; F:GO:0019855; F:GO:0019901; F:GO:0030235; F:GO:0031432; F:GO:0031800; F:GO:0031997; F:GO:0043539; F:GO:0043548; F:GO:0044325; F:GO:0048306; F:GO:0050998; F:GO:0072542; F:GO:0097718; C:GO:0000922; C:GO:0005576; C:GO:0005654; C:GO:0005813; C:GO:0005829; C:GO:0005876; C:GO:0008076; C:GO:0030017; C:GO:0030426; C:GO:0030672; C:GO:0031966; C:GO:0034704; C:GO:0043209; C:GO:1990722	P:G2/M transition of mitotic cell cycle; P:response to amphetamine; P:regulation of heart rate; P:regulation of response to tumor cell; P:detection of calcium ion; P:G protein-coupled receptor sigling pathway; P:activation of adenylate cyclase activity; P:positive regulation of peptidyl-threonine phosphorylation; P:negative regulation of peptidyl-threonine phosphorylation; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; P:autophagosome membrane docking; P:regulation of cyclase activity; P:positive regulation of protein autophosphorylation; P:regulation of cytokinesis; P:positive regulation of phosphoprotein phosphatase activity; P:positive regulation of apoptotic process; P:positive regulation of D binding; P:regulation of calcium-mediated sigling; P:positive regulation of nitric-oxide synthase activity; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; P:response to corticosterone; P:negative regulation of ryanodine-sensitive calcium-release channel activity; P:positive regulation of ryanodine-sensitive calcium-release channel activity; P:potassium ion transmembrane transport; P:positive regulation of protein serine/threonine kise activity; P:establishment of protein localization to mitochondrial membrane; P:regulation of cardiac muscle cell action potential; P:regulation of syptic vesicle endocytosis; P:regulation of store-operated calcium channel activity; P:negative regulation of high voltage-gated calcium channel activity; P:regulation of cell communication by electrical coupling involved in cardiac conduction; P:positive regulation of autophagic cell death; P:negative regulation of calcium ion export across plasma membrane; P:mitochondrion-endoplasmic reticulum membrane tethering; P:regulation of syptic vesicle exocytosis; F:calcium ion binding; F:adenylate cyclase binding; F:adenylate cyclase activator activity; F:calcium channel inhibitor activity; F:protein kise binding; F:nitric-oxide synthase regulator activity; F:titin binding; F:type 3 metabotropic glutamate receptor binding; F:N-termil myristoylation domain binding; F:protein serine/threonine kise activator activity; F:phosphatidylinositol 3-kise binding; F:transmembrane transporter binding; F:calcium-dependent protein binding; F:nitric-oxide synthase binding; F:protein phosphatase activator activity; F:disordered domain specific binding; C:spindle pole; C:extracellular region; C:nucleoplasm; C:centrosome; C:cytosol; C:spindle microtubule; C:voltage-gated potassium channel complex; C:sarcomere; C:growth cone; C:syptic vesicle membrane; C:mitochondrial membrane; C:calcium channel complex; C:myelin sheath; C:DAPK1-calmodulin complex			IPR002048 (PFAM); IPR018247 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES)	F:GO:0005509	F:calcium ion binding	1824.08537248354	1.60335804394291	0.222450868553424	7.20769513901827	5.6906856579143e-13	6.73216481986641e-11
Avas.s001.g887.i1	paralog_cluster_08423	NA	glutamic-type peptidase activity	4.2e-51	209.5	Metazoa	NA	NA	NA	NA	NA	NA	NAS39_CAEEL | Zinc metalloproteinase nas-39 OS=Caenorhabditis elegans OX=6239 GN=s-39 PE=2 SV=3	590	8.9e-17	F:GO:0005488; F:GO:0016787; C:GO:0016020	F:binding; F:hydrolase activity; C:membrane	EC:3	Hydrolases	IPR000884 (PFAM); IPR001506 (PFAM); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR001506 (PROSITE_PROFILES)	P:GO:0006508; F:GO:0004222	P:proteolysis; F:metalloendopeptidase activity	724.072374710876	3.62134106217877	0.258561446539735	14.0057271130028	1.43800387817858e-44	1.7796957227704e-41
Avas.s001.g969.i1	NA	probable collagen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	1638	NA					IPR008160 (PFAM)	no GO terms	no GO terms	10802.8657001521	7.31924353277778	0.733767179023707	9.97488541599283	1.96327930925162e-23	5.17822964041792e-21
Avas.s001.g970.i1	NA	COL3A1	Collagen alpha-1(III)	5.9e-23	117.5	Euarchontoglires	NA	28	F:GO:0005201; P:GO:0001501; P:GO:0071230; P:GO:0007507; P:GO:0007229; P:GO:0060414; P:GO:0043933; C:GO:0005576; P:GO:0048565; P:GO:0042060; P:GO:2001223; F:GO:0046332; P:GO:0050777; P:GO:0009612; P:GO:0030199; P:GO:0009314; P:GO:0007179; P:GO:0034097; P:GO:0021987; P:GO:0018149; P:GO:0043588; C:GO:0005586; F:GO:0048407; P:GO:0035025; F:GO:0005178; F:GO:0002020; P:GO:0007160; P:GO:0050768	P:response to radiation; P:negative regulation of immune response; P:cell-matrix adhesion; P:response to cytokine; F:integrin binding; P:negative regulation of neurogenesis; C:extracellular region; P:positive regulation of Rho protein signal transduction; P:peptide cross-linking; P:heart development; P:response to mechanical stimulus; P:cellular response to amino acid stimulus; C:collagen type III trimer; P:skeletal system development; F:extracellular matrix structural constituent; P:skin development; P:wound healing; P:digestive tract development; P:integrin-mediated signaling pathway; P:cerebral cortex development; P:collagen fibril organization; F:SMAD binding; F:protease binding; P:protein-containing complex organization; P:transforming growth factor beta receptor signaling pathway; F:platelet-derived growth factor binding; P:negative regulation of neuron migration; P:aorta smooth muscle tissue morphogenesis	K19720	map04611, map04926, map04933, map04974, map05146	CO5A2_MOUSE | Collagen alpha-2(V) chain OS=Mus musculus OX=10090 GN=Col5a2 PE=1 SV=1	1614	3.2e-16	P:GO:0009605; P:GO:0009628; P:GO:0030199; P:GO:0032870; P:GO:0048839; P:GO:0051216; P:GO:0060350; P:GO:0071417; P:GO:1901701; F:GO:0005515; C:GO:0005581; C:GO:0062023	P:response to exterl stimulus; P:response to abiotic stimulus; P:collagen fibril organization; P:cellular response to hormone stimulus; P:inner ear development; P:cartilage development; P:endochondral bone morphogenesis; P:cellular response to organonitrogen compound; P:cellular response to oxygen-containing compound; F:protein binding; C:collagen trimer; C:collagen-containing extracellular matrix			IPR000885 (PFAM); IPR008160 (PFAM); IPR000885 (PROSITE_PROFILES)	F:GO:0005201	F:extracellular matrix structural constituent	6787.97725504935	5.91166362343688	0.39107348329845	15.1165033578238	1.26060919941992e-51	2.66209464518538e-48
Avas.s001.g979.i1	paralog_cluster_08428	pyx	Ion transport protein	4.4e-10	74.3	Lepidoptera	NA	7	P:GO:0048060; P:GO:0070588; C:GO:0034703; P:GO:0006813; P:GO:0009408; F:GO:0005262; P:GO:0051290	F:calcium channel activity; P:protein heterotetramerization; P:potassium ion transport; P:calcium ion transmembrane transport; C:cation channel complex; P:response to heat; P:negative gravitaxis	K16772	NA	ANR28_MOUSE | Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1	1235	1.4e-27	P:GO:0009987; P:GO:0051179; P:GO:0065007; F:GO:0005515; C:GO:0005737; C:GO:0005886; C:GO:0043232	P:cellular process; P:localization; P:biological regulation; F:protein binding; C:cytoplasm; C:plasma membrane; C:intracellular non-membrane-bounded organelle			IPR002110 (PFAM); IPR005821 (PFAM); PS50297 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES)	P:GO:0006811; P:GO:0055085; F:GO:0005216; F:GO:0005515; C:GO:0016020	P:ion transport; P:transmembrane transport; F:ion channel activity; F:protein binding; C:membrane	123.097074391858	1.87434077665576	0.387302541772698	4.83947450506479	1.30182889550716e-06	5.4001840008018e-05
Avas.s001.g1102.i1	paralog_cluster_00385	NA	NA	5.1e-203	714.1	Metazoa	NA	NA	NA	NA	NA	NA	------	573	NA					IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES)	F:GO:0005509	F:calcium ion binding	137.529317133821	-2.66209675291334	0.409636804252987	-6.4986757177933	8.10301125658644e-11	7.20272641476349e-09
Avas.s001.g1117.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	99	NA					no IPS match	no IPS match	no IPS match	1440.30495541603	2.72615065216118	0.439947714968771	6.19653326840141	5.77203339832836e-10	4.38048327102382e-08
Avas.s001.g1141.i1	paralog_cluster_03080	NA	transitional stage B cell differentiation	2.9e-167	595.9	Metazoa	EC:2.7.10.2	45	P:GO:0007303; P:GO:0010977; P:GO:0007268; P:GO:0007169; F:GO:0005102; P:GO:0003382; P:GO:0001764; P:GO:0043518; P:GO:0000077; F:GO:0004715; P:GO:0042127; P:GO:0046827; P:GO:0003401; P:GO:0048749; P:GO:0016199; P:GO:0010592; P:GO:0008064; P:GO:0007391; P:GO:0008360; C:GO:0005912; P:GO:0007370; P:GO:0010212; P:GO:0050832; P:GO:0007611; P:GO:0007419; P:GO:0021785; P:GO:0038083; C:GO:0045179; P:GO:0048813; P:GO:0045665; P:GO:0090087; P:GO:0045886; C:GO:0031234; P:GO:0043066; C:GO:0030424; P:GO:0050829; P:GO:0072499; P:GO:1901075; P:GO:0007283; P:GO:0045087; P:GO:0050768; P:GO:0030336; P:GO:0031647; C:GO:0005927; C:GO:0005829	P:chemical synaptic transmission; P:learning or memory; P:regulation of cell shape; C:extrinsic component of cytoplasmic side of plasma membrane; P:positive regulation of lamellipodium assembly; P:compound eye development; P:negative regulation of neurogenesis; F:signaling receptor binding; C:muscle tendon junction; C:cytosol; C:adherens junction; P:negative regulation of engulfment of apoptotic cell; P:regulation of cell population proliferation; P:dendrite morphogenesis; P:response to ionizing radiation; P:regulation of actin polymerization or depolymerization; F:non-membrane spanning protein tyrosine kinase activity; P:ventral furrow formation; P:negative regulation of synaptic assembly at neuromuscular junction; P:spermatogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:cytoplasmic transport, nurse cell to oocyte; C:axon; P:peptidyl-tyrosine autophosphorylation; P:DNA damage checkpoint signaling; P:negative regulation of cell migration; P:branchiomotor neuron axon guidance; P:positive regulation of protein export from nucleus; C:apical cortex; P:negative regulation of neuron differentiation; P:axon midline choice point recognition; P:ventral cord development; P:defense response to fungus; P:dorsal closure; P:regulation of protein stability; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:photoreceptor cell axon guidance; P:defense response to Gram-negative bacterium; P:epithelial cell morphogenesis; P:regulation of peptide transport; P:negative regulation of apoptotic process; P:innate immune response; P:axis elongation; P:neuron migration; P:negative regulation of neuron projection development	K06619	map04012, map04014, map04110, map04360, map04722, map05130, map05131, map05200, map05206, map05220, map05416	ABL1_MOUSE | Tyrosine-protein kinase ABL1 OS=Mus musculus OX=10090 GN=Abl1 PE=1 SV=3	817	6.1e-165	P:GO:0000077; P:GO:0001843; P:GO:0001922; P:GO:0002118; P:GO:0002322; P:GO:0002333; P:GO:0003382; P:GO:0006298; P:GO:0006930; P:GO:0006975; P:GO:0007229; P:GO:0007283; P:GO:0007391; P:GO:0007424; P:GO:0007435; P:GO:0007628; P:GO:0008064; P:GO:0008542; P:GO:0008630; P:GO:0010212; P:GO:0010506; P:GO:0010592; P:GO:0010863; P:GO:0016199; P:GO:0016322; P:GO:0021587; P:GO:0021785; P:GO:0022408; P:GO:0030035; P:GO:0030041; P:GO:0030336; P:GO:0030514; P:GO:0030516; P:GO:0031113; P:GO:0031223; P:GO:0032489; P:GO:0032729; P:GO:0032743; P:GO:0033690; P:GO:0034976; P:GO:0035024; P:GO:0035264; P:GO:0035640; P:GO:0035791; P:GO:0036335; P:GO:0038083; P:GO:0038096; P:GO:0038189; P:GO:0043123; P:GO:0043124; P:GO:0043518; P:GO:0043525; P:GO:0045580; P:GO:0045742; P:GO:0045874; P:GO:0045886; P:GO:0045907; P:GO:0045930; P:GO:0045931; P:GO:0045944; P:GO:0046529; P:GO:0046632; P:GO:0046827; P:GO:0048146; P:GO:0048536; P:GO:0048538; P:GO:0048668; P:GO:0048813; P:GO:0050731; P:GO:0050798; P:GO:0050829; P:GO:0050832; P:GO:0050852; P:GO:0050853; P:GO:0050885; P:GO:0051281; P:GO:0051353; P:GO:0051444; P:GO:0051496; P:GO:0051882; P:GO:0051894; P:GO:0060020; P:GO:0060074; P:GO:0060563; P:GO:0070373; P:GO:0070374; P:GO:0071103; P:GO:0071222; P:GO:0071300; P:GO:0071588; P:GO:0071901; P:GO:0090050; P:GO:0090135; P:GO:0090136; P:GO:0097062; P:GO:1900006; P:GO:1900026; P:GO:1900272; P:GO:1900275; P:GO:1901075; P:GO:1901300; P:GO:1902036; P:GO:1903055; P:GO:1903210; P:GO:1903351; P:GO:1904528; P:GO:1904531; P:GO:1905244; P:GO:1905555; P:GO:1990051; P:GO:2000096; P:GO:2000251; P:GO:2000352; P:GO:2000773; F:GO:0000287; F:GO:0000400; F:GO:0000405; F:GO:0001784; F:GO:0003713; F:GO:0003785; F:GO:0004515; F:GO:0004712; F:GO:0004715; F:GO:0005080; F:GO:0005524; F:GO:0008022; F:GO:0017124; F:GO:0019905; F:GO:0030145; F:GO:0038191; F:GO:0042169; F:GO:0046875; F:GO:0051015; F:GO:0051019; F:GO:0070064; F:GO:0070097; F:GO:1990837; C:GO:0001726; C:GO:0001891; C:GO:0005730; C:GO:0005739; C:GO:0005783; C:GO:0005829; C:GO:0005927; C:GO:0015629; C:GO:0016604; C:GO:0030027; C:GO:0030426; C:GO:0031410; C:GO:0032991; C:GO:0043025; C:GO:0043197; C:GO:0045179; C:GO:0048471; C:GO:0098978	P:D damage checkpoint sigling; P:neural tube closure; P:B-1 B cell homeostasis; P:aggressive behavior; P:B cell proliferation involved in immune response; P:transitiol one stage B cell differentiation; P:epithelial cell morphogenesis; P:mismatch repair; P:substrate-dependent cell migration, cell extension; P:D damage induced protein phosphorylation; P:integrin-mediated sigling pathway; P:spermatogenesis; P:dorsal closure; P:open tracheal system development; P:salivary gland morphogenesis; P:adult walking behavior; P:regulation of actin polymerization or depolymerization; P:visual learning; P:intrinsic apoptotic sigling pathway in response to D damage; P:response to ionizing radiation; P:regulation of autophagy; P:positive regulation of lamellipodium assembly; P:positive regulation of phospholipase C activity; P:axon midline choice point recognition; P:neuron remodeling; P:cerebellum morphogenesis; P:branchiomotor neuron axon guidance; P:negative regulation of cell-cell adhesion; P:microspike assembly; P:actin filament polymerization; P:negative regulation of cell migration; P:negative regulation of BMP sigling pathway; P:regulation of axon extension; P:regulation of microtubule polymerization; P:auditory behavior; P:regulation of Cdc42 protein sigl transduction; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of osteoblast proliferation; P:response to endoplasmic reticulum stress; P:negative regulation of Rho protein sigl transduction; P:multicellular organism growth; P:exploration behavior; P:platelet-derived growth factor receptor-beta sigling pathway; P:intestil stem cell homeostasis; P:peptidyl-tyrosine autophosphorylation; P:Fc-gamma receptor sigling pathway involved in phagocytosis; P:neuropilin sigling pathway; P:positive regulation of I-kappaB kise/NF-kappaB sigling; P:negative regulation of I-kappaB kise/NF-kappaB sigling; P:negative regulation of D damage response, sigl transduction by p53 class mediator; P:positive regulation of neuron apoptotic process; P:regulation of T cell differentiation; P:positive regulation of epidermal growth factor receptor sigling pathway; P:positive regulation of sevenless sigling pathway; P:negative regulation of syptic assembly at neuromuscular junction; P:positive regulation of vasoconstriction; P:negative regulation of mitotic cell cycle; P:positive regulation of mitotic cell cycle; P:positive regulation of transcription by R polymerase II; P:imagil disc fusion, thorax closure; P:alpha-beta T cell differentiation; P:positive regulation of protein export from nucleus; P:positive regulation of fibroblast proliferation; P:spleen development; P:thymus development; P:collateral sprouting; P:dendrite morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; P:activated T cell proliferation; P:defense response to Gram-negative bacterium; P:defense response to fungus; P:T cell receptor sigling pathway; P:B cell receptor sigling pathway; P:neuromuscular process controlling balance; P:positive regulation of release of sequestered calcium ion into cytosol; P:positive regulation of oxidoreductase activity; P:negative regulation of ubiquitin-protein transferase activity; P:positive regulation of stress fiber assembly; P:mitochondrial depolarization; P:positive regulation of focal adhesion assembly; P:Bergmann glial cell differentiation; P:sypse maturation; P:neuroepithelial cell differentiation; P:negative regulation of ERK1 and ERK2 cascade; P:positive regulation of ERK1 and ERK2 cascade; P:D conformation change; P:cellular response to lipopolysaccharide; P:cellular response to retinoic acid; P:hydrogen peroxide mediated sigling pathway; P:negative regulation of protein serine/threonine kise activity; P:positive regulation of cell migration involved in sprouting angiogenesis; P:actin filament branching; P:epithelial cell-cell adhesion; P:dendritic spine maintence; P:positive regulation of dendrite development; P:positive regulation of substrate adhesion-dependent cell spreading; P:negative regulation of long-term syptic potentiation; P:negative regulation of phospholipase C activity; P:negative regulation of engulfment of apoptotic cell; P:positive regulation of hydrogen peroxide-mediated programmed cell death; P:regulation of hematopoietic stem cell differentiation; P:positive regulation of extracellular matrix organization; P:glomerular visceral epithelial cell apoptotic process; P:cellular response to dopamine; P:positive regulation of microtubule binding; P:positive regulation of actin filament binding; P:regulation of modification of syptic structure; P:positive regulation of blood vessel branching; P:activation of protein kise C activity; P:positive regulation of Wnt sigling pathway, plar cell polarity pathway; P:positive regulation of actin cytoskeleton reorganization; P:negative regulation of endothelial cell apoptotic process; P:negative regulation of cellular senescence; F:magnesium ion binding; F:four-way junction D binding; F:bubble D binding; F:phosphotyrosine residue binding; F:transcription coactivator activity; F:actin monomer binding; F:nicotite-nucleotide adenylyltransferase activity; F:protein serine/threonine/tyrosine kise activity; F:non-membrane spanning protein tyrosine kise activity; F:protein kise C binding; F:ATP binding; F:protein C-terminus binding; F:SH3 domain binding; F:syntaxin binding; F:manganese ion binding; F:neuropilin binding; F:SH2 domain binding; F:ephrin receptor binding; F:actin filament binding; F:mitogen-activated protein kise binding; F:proline-rich region binding; F:delta-catenin binding; F:sequence-specific double-stranded D binding; C:ruffle; C:phagocytic cup; C:nucleolus; C:mitochondrion; C:endoplasmic reticulum; C:cytosol; C:muscle tendon junction; C:actin cytoskeleton; C:nuclear body; C:lamellipodium; C:growth cone; C:cytoplasmic vesicle; C:protein-containing complex; C:neurol cell body; C:dendritic spine; C:apical cortex; C:perinuclear region of cytoplasm; C:glutamatergic sypse	EC:2.7.12.1; EC:2.7.10.2; EC:2.7.7.18	Dual-specificity kise; Non-specific protein-tyrosine kise; Nicotite-nucleotide adenylyltransferase	IPR001452 (PFAM); IPR001245 (PFAM); IPR000980 (PFAM); IPR017441 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005515; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:protein binding; F:ATP binding	156.331777352943	1.37700133448296	0.260306026518067	5.28993259549979	1.22361445381133e-07	6.19079652433035e-06
Avas.s001.g1193.i1	paralog_cluster_03137	SLC47A1	antiporter activity	3.8e-81	309.3	Primates	NA	9	F:GO:0042910; P:GO:0015695; P:GO:1902600; C:GO:0031982; P:GO:0009410; C:GO:0005886; F:GO:0005451; P:GO:0006855; P:GO:0046618	P:xenobiotic export; P:response to xenobiotic stimulus; P:organic cation transport; P:proton transmembrane transport; C:vesicle; F:xenobiotic transmembrane transporter activity; P:xenobiotic transmembrane transport; F:monovalent cation:proton antiporter activity; C:plasma membrane	K03327	NA	S47A1_HUMAN | Multidrug and toxin extrusion protein 1 OS=Homo sapiens OX=9606 GN=SLC47A1 PE=1 SV=1	581	3.9e-81	P:GO:0015695; P:GO:0042908; P:GO:0097638; F:GO:0005515; F:GO:0015297; F:GO:0042887; F:GO:0042910; F:GO:0061459; C:GO:0016323; C:GO:0016324; C:GO:0031982	P:organic cation transport; P:xenobiotic transport; P:L-arginine import across plasma membrane; F:protein binding; F:antiporter activity; F:amide transmembrane transporter activity; F:xenobiotic transmembrane transporter activity; F:L-arginine transmembrane transporter activity; C:basolateral plasma membrane; C:apical plasma membrane; C:vesicle	EC:7	Translocases	IPR002528 (PFAM)	P:GO:0055085; F:GO:0015297; F:GO:0042910; C:GO:0016020	P:transmembrane transport; F:antiporter activity; F:xenobiotic transmembrane transporter activity; C:membrane	57.9462523717732	2.86125397178539	0.576607761240573	4.96221897122819	6.96923611996291e-07	3.02231913568957e-05
Avas.s001.g1257.i1	homolog_cluster_17499	NA	Collagenase NC10 and Endostatin	4e-05	57.4	Vertebrata	NA	NA	NA	NA	NA	NA	------	890	NA					IPR008160 (PFAM)	no GO terms	no GO terms	444.372112173517	2.52611189952838	0.471025351301299	5.36300624276273	8.18481763288039e-08	4.30997083841092e-06
Avas.s001.g1345.i1	paralog_cluster_03142	PHKG1	phosphorylase kinase activity	4e-47	195.3	Metazoa	EC:2.7.11.19	8	F:GO:0004689; P:GO:0018105; C:GO:0005964; P:GO:0048598; P:GO:0005977; P:GO:0035556; P:GO:0018107; P:GO:0006007	F:phosphorylase kinase activity; P:intracellular signal transduction; P:embryonic morphogenesis; P:glucose catabolic process; P:glycogen metabolic process; P:peptidyl-threonine phosphorylation; C:phosphorylase kinase complex; P:peptidyl-serine phosphorylation	K00871	map04020, map04910, map04922	PHKG2_RAT | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Rattus norvegicus OX=10116 GN=Phkg2 PE=1 SV=1	291	3.2e-44	P:GO:0005977; P:GO:0006468; F:GO:0004689; F:GO:0005516; F:GO:0005524; F:GO:0019899; C:GO:0005829; C:GO:0005964; C:GO:0098723	P:glycogen metabolic process; P:protein phosphorylation; F:phosphorylase kise activity; F:calmodulin binding; F:ATP binding; F:enzyme binding; C:cytosol; C:phosphorylase kise complex; C:skeletal muscle myofibril	EC:2.7.11.19; EC:2.7.11.17	Phosphorylase kise; Calcium/calmodulin-dependent protein kise	IPR000719 (PFAM); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	228.647561802224	2.20901276537231	0.355218662445977	6.21874073327514	5.01160598997963e-10	3.89525259771895e-08
Avas.s001.g1391.i1	homolog_cluster_11026	SYNGR1	synaptogyrin 1	1.9e-13	83.2	Bilateria	NA	13	C:GO:0016021; P:GO:1990830; P:GO:0006605; C:GO:0043195; P:GO:0043312; C:GO:0030672; C:GO:0035577; C:GO:0005886; P:GO:0048499; P:GO:0048169; P:GO:0015833; C:GO:0031594; P:GO:0048172	C:neuromuscular junction; P:peptide transport; C:azurophil granule membrane; C:plasma membrane; P:regulation of short-term neuronal synaptic plasticity; C:terminal bouton; P:protein targeting; P:cellular response to leukemia inhibitory factor; C:synaptic vesicle membrane; P:neutrophil degranulation; C:integral component of membrane; P:regulation of long-term neuronal synaptic plasticity; P:synaptic vesicle membrane organization	NA	NA	SNG1_RAT | Syptogyrin-1 OS=Rattus norvegicus OX=10116 GN=Syngr1 PE=1 SV=1	244	8.3e-09	P:GO:0006810; P:GO:0048168; C:GO:0016021; C:GO:0030672	P:transport; P:regulation of neurol syptic plasticity; C:integral component of membrane; C:syptic vesicle membrane			IPR008253 (PFAM); IPR008253 (PROSITE_PROFILES)	C:GO:0016020	C:membrane	178.045913762231	4.76131694416326	0.680507258476954	6.99671735290462	2.62029144880338e-12	2.82938718924816e-10
Avas.s001.g1418.i1	paralog_cluster_02141	NA	Citrate transporter	9e-93	347.8	Opisthokonta	NA	NA	NA	NA	NA	NA	LSI2_ORYSJ | Silicon efflux transporter LSI2 OS=Oryza sativa subsp. japonica OX=39947 GN=LSI2 PE=1 SV=1	539	1.3e-38	P:GO:0015700; P:GO:0055085; P:GO:0071722; F:GO:0015105; F:GO:0015446; C:GO:0005886; C:GO:0005887; C:GO:0016020; C:GO:0016021	P:arsenite transport; P:transmembrane transport; P:detoxification of arsenic-containing substance; F:arsenite transmembrane transporter activity; F:ATPase-coupled arsenite transmembrane transporter activity; C:plasma membrane; C:integral component of plasma membrane; C:membrane; C:integral component of membrane			IPR004680 (PFAM)	P:GO:0055085; C:GO:0016021	P:transmembrane transport; C:integral component of membrane	1323.45043372864	5.54939922279012	0.713015116878486	7.78300360178179	7.08226163848017e-15	1.00837617257971e-12
Avas.s001.g1468.i1	paralog_cluster_04994	FAM78A	NA	1.9e-69	269.6	Metazoa	NA	NA	NA	NA	NA	NA	FA78A_HUMAN | Protein FAM78A OS=Homo sapiens OX=9606 GN=FAM78A PE=1 SV=1	323	6.1e-52	F:GO:0005515	F:protein binding			no IPS match	no IPS match	no IPS match	270.781736726017	2.08675106814835	0.435838489359652	4.78789991956486	1.68535653558246e-06	6.76202027456016e-05
Avas.s001.g1475.i1	homolog_cluster_18217	NA	Eukaryotic-type carbonic anhydrase	1.1e-33	150.6	Testudines	EC:4.2.1.1	NA	NA	NA	K01672	map00910	CAH3_BOVIN | Carbonic anhydrase 3 OS=Bos taurus OX=9913 GN=CA3 PE=2 SV=3	275	1.7e-34	P:GO:0009987; P:GO:0050896; P:GO:0065007; F:GO:0003824; F:GO:0046872; C:GO:0110165	P:cellular process; P:response to stimulus; P:biological regulation; F:catalytic activity; F:metal ion binding; C:cellular atomical entity			IPR001148 (PFAM); IPR001148 (PROSITE_PROFILES)	no GO terms	no GO terms	140.924561040982	-1.71784115656304	0.300546685089305	-5.71572152277305	1.09239508895e-08	6.78592455062413e-07
Avas.s001.g1481.i1	paralog_cluster_07142	NA	Alpha-carbonic anhydrase	3.3e-26	125.9	Arthropoda	NA	NA	NA	NA	NA	NA	CAH10_BOVIN | Carbonic anhydrase-related protein 10 OS=Bos taurus OX=9913 GN=CA10 PE=2 SV=1	317	1.1e-26	P:GO:0009987; P:GO:0010033; P:GO:0050789; P:GO:1901700; F:GO:0005488; F:GO:0016829; C:GO:0110165	P:cellular process; P:response to organic substance; P:regulation of biological process; P:response to oxygen-containing compound; F:binding; F:lyase activity; C:cellular atomical entity	EC:4	Lyases	IPR001148 (PFAM); IPR018338 (PROSITE_PATTERNS); IPR001148 (PROSITE_PROFILES)	F:GO:0004089; F:GO:0008270	F:carbote dehydratase activity; F:zinc ion binding	1326.79020715657	-2.96312767016591	0.381332096626291	-7.77046489498575	7.81985837896994e-15	1.08460087464868e-12
Avas.s001.g1539.i1	homolog_cluster_11086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	387	NA					IPR032008 (PFAM); IPR032010 (PFAM)	no GO terms	no GO terms	717.795151261909	-1.23590766189299	0.213996162681349	-5.77537300859603	7.67827927939736e-09	4.90221568754858e-07
Avas.s001.g1614.i1	homolog_cluster_11115	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	652	NA					no IPS match	no IPS match	no IPS match	7075.07753924651	2.80896167066893	0.238115439715277	11.796638109766	4.06218291181658e-32	2.42060966178581e-29
Avas.s001.g1688.i1	paralog_cluster_02480	NA	dopamine beta-monooxygenase activity	2.9e-95	356.3	Chordata	NA	NA	NA	NA	NA	NA	MOXD1_CHICK | DBH-like monooxygese protein 1 OS=Gallus gallus OX=9031 GN=MOXD1 PE=2 SV=1	618	1.1e-78	P:GO:0006950; P:GO:0007275; P:GO:0007610; P:GO:0010038; P:GO:0010243; P:GO:0014070; P:GO:0042136; P:GO:0042423; P:GO:0042592; P:GO:0045471; P:GO:0046333; P:GO:0050789; P:GO:0050877; P:GO:0070887; F:GO:0016715; F:GO:0046872; C:GO:0030141; C:GO:0030424; C:GO:0031090; C:GO:0036477; C:GO:0045202	P:response to stress; P:multicellular organism development; P:behavior; P:response to metal ion; P:response to organonitrogen compound; P:response to organic cyclic compound; P:neurotransmitter biosynthetic process; P:catecholamine biosynthetic process; P:homeostatic process; P:response to ethanol; P:octopamine metabolic process; P:regulation of biological process; P:nervous system process; P:cellular response to chemical stimulus; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; F:metal ion binding; C:secretory granule; C:axon; C:organelle membrane; C:somatodendritic compartment; C:sypse	EC:1.14.17	Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2)	IPR000323 (PFAM); IPR024548 (PFAM); PF03351 (PFAM); IPR005018 (PROSITE_PROFILES)	F:GO:0004497; F:GO:0005507; F:GO:0016715	F:monooxygese activity; F:copper ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen	727.63107344423	-1.3517576048873	0.173883068928934	-7.77394609615368	7.60781236367996e-15	1.06436602712389e-12
Avas.s001.g1717.i1	paralog_cluster_04178	ADAM12	ADAM Cysteine-Rich Domain	1.5e-106	394	Primates	NA	9	P:GO:0045766; P:GO:0007520; C:GO:0005576; C:GO:0005654; P:GO:0030198; C:GO:0005886; F:GO:0008237; P:GO:0006508; F:GO:0017124	P:myoblast fusion; P:extracellular matrix organization; F:metallopeptidase activity; P:proteolysis; P:positive regulation of angiogenesis; C:extracellular region; F:SH3 domain binding; C:plasma membrane; C:nucleoplasm	K06835	NA	ADA12_HUMAN | Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ADAM12 PE=1 SV=3	718	6.6e-107	P:GO:0002687; P:GO:0003006; P:GO:0006508; P:GO:0006952; P:GO:0007507; P:GO:0009653; P:GO:0010033; P:GO:0010468; P:GO:0022407; P:GO:0032270; P:GO:0048584; P:GO:0051094; P:GO:0051240; P:GO:0070887; P:GO:2000026; F:GO:0004222; F:GO:0005515; C:GO:0005576; C:GO:0005634; C:GO:0005886; C:GO:0030667; C:GO:0031224; C:GO:0070820	P:positive regulation of leukocyte migration; P:developmental process involved in reproduction; P:proteolysis; P:defense response; P:heart development; P:atomical structure morphogenesis; P:response to organic substance; P:regulation of gene expression; P:regulation of cell-cell adhesion; P:positive regulation of cellular protein metabolic process; P:positive regulation of response to stimulus; P:positive regulation of developmental process; P:positive regulation of multicellular organismal process; P:cellular response to chemical stimulus; P:regulation of multicellular organismal development; F:metalloendopeptidase activity; F:protein binding; C:extracellular region; C:nucleus; C:plasma membrane; C:secretory granule membrane; C:intrinsic component of membrane; C:tertiary granule	EC:3.4.24	Acting on peptide bonds (peptidases)	IPR002870 (PFAM); IPR006586 (PFAM); IPR001590 (PFAM); IPR001762 (PFAM); IPR000742 (PROSITE_PATTERNS); IPR018358 (PROSITE_PATTERNS); IPR001590 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR001762 (PROSITE_PROFILES)	P:GO:0006508; F:GO:0004222	P:proteolysis; F:metalloendopeptidase activity	79.4794271962976	2.68188016271692	0.549327520293093	4.88211506550046	1.04953979992836e-06	4.39740777110608e-05
Avas.s001.g1811.i1	homolog_cluster_11165	Pk17E	ATP binding. It is involved in the biological process described with protein phosphorylation	2e-43	183.3	Arthropoda	EC:2.7.11.1	5	F:GO:0004674; C:GO:0005634; C:GO:0005737; P:GO:0035556; P:GO:0006468	P:intracellular signal transduction; C:cytoplasm; C:nucleus; P:protein phosphorylation; F:protein serine/threonine kinase activity	K17529	NA	KS6R_HUMAN | Ribosomal protein S6 kinase-related protein OS=Homo sapiens OX=9606 GN=RSKR PE=1 SV=2	371	3.6e-40	P:GO:0002119; P:GO:0003008; P:GO:0008340; P:GO:0010033; P:GO:0010628; P:GO:0018105; P:GO:0031288; P:GO:0032060; P:GO:0033554; P:GO:0043327; P:GO:0046580; P:GO:0050920; P:GO:0051171; P:GO:0051602; P:GO:0065009; P:GO:0080090; P:GO:0110094; P:GO:1904145; P:GO:1905303; P:GO:2000786; F:GO:0004691; F:GO:0019904; F:GO:0043167; F:GO:0099106; C:GO:0005654; C:GO:0005737; C:GO:0005886; C:GO:0012505; C:GO:0031514; C:GO:0042585	P:nematode larval development; P:system process; P:determition of adult lifespan; P:response to organic substance; P:positive regulation of gene expression; P:peptidyl-serine phosphorylation; P:sorocarp morphogenesis; P:bleb assembly; P:cellular response to stress; P:chemotaxis to cAMP; P:negative regulation of Ras protein sigl transduction; P:regulation of chemotaxis; P:regulation of nitrogen compound metabolic process; P:response to electrical stimulus; P:regulation of molecular function; P:regulation of primary metabolic process; P:polyphosphate-mediated sigling; P:negative regulation of meiotic cell cycle process involved in oocyte maturation; P:positive regulation of macropinocytosis; P:positive regulation of autophagosome assembly; F:cAMP-dependent protein kise activity; F:protein domain specific binding; F:ion binding; F:ion channel regulator activity; C:nucleoplasm; C:cytoplasm; C:plasma membrane; C:endomembrane system; C:motile cilium; C:germil vesicle	EC:2.7.11.11	cAMP-dependent protein kise	IPR000719 (PFAM); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	106.837154358678	2.38324871644461	0.375368084328598	6.34909790135037	2.16581176062773e-10	1.77784415391528e-08
Avas.s001.g1812.i1	paralog_cluster_01887	NA	Sterile alpha motif.	4.1e-58	231.5	Metazoa	NA	NA	NA	NA	NA	NA	------	234	NA					IPR001660 (PFAM); IPR001660 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	567.966754356553	3.13361857122287	0.357866776302214	8.75638304176235	2.01615733421756e-18	3.72850061496854e-16
Avas.s001.g1841.i1	homolog_cluster_11177	NA	metanephric glomerular basement membrane development	2.2e-37	165.2	Metazoa	NA	NA	NA	NA	NA	NA	LAMC3_HUMAN | Laminin subunit gamma-3 OS=Homo sapiens OX=9606 GN=LAMC3 PE=1 SV=3	1460	1.6e-30	P:GO:0007423; P:GO:0009653; P:GO:0009888; P:GO:0016043; P:GO:0030182; P:GO:0048468; P:GO:0050789; P:GO:0050896; P:GO:0051179; F:GO:0005515; C:GO:0002141; C:GO:0005604; C:GO:0005622; C:GO:0005929; C:GO:0032991; C:GO:0043005; C:GO:0098590	P:sensory organ development; P:atomical structure morphogenesis; P:tissue development; P:cellular component organization; P:neuron differentiation; P:cell development; P:regulation of biological process; P:response to stimulus; P:localization; F:protein binding; C:stereocilia ankle link; C:basement membrane; C:intracellular atomical structure; C:cilium; C:protein-containing complex; C:neuron projection; C:plasma membrane region			IPR002049 (PFAM); IPR003961 (PFAM); IPR002049 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); IPR002049 (PROSITE_PATTERNS); IPR003961 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES); IPR002049 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	497.819828968865	1.98701869916273	0.31652227962632	6.27765824733906	3.43710368746696e-10	2.73760204097306e-08
Avas.s001.g2253.i1	paralog_cluster_08477	NA	Sulfotransferase family	4.6e-34	152.5	Cyanobacteria	NA	NA	NA	NA	NA	NA	------	453	NA					PF13469 (PFAM)	no GO terms	no GO terms	179.293253627292	1.77727676312559	0.255412211855546	6.95846432014286	3.44001836466753e-12	3.64121417560104e-10
Avas.s001.g1844.i1	homolog_cluster_18237	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	276	NA					no IPS match	no IPS match	no IPS match	308.483765814166	1.85526691321339	0.349949438664469	5.30152847306671	1.14837132990369e-07	5.84688174899384e-06
Avas.s001.g1877.i1	homolog_cluster_11186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	492	NA					no IPS match	no IPS match	no IPS match	90.2122714874568	1.72291907260542	0.29423603938128	5.85556778234365	4.75383080825014e-09	3.12181158669128e-07
Avas.s001.g1909.i1	homolog_cluster_11197	NA	osteoclast differentiation	7e-27	128.3	Chordata	NA	NA	NA	NA	NA	NA	OSTM1_MOUSE | Osteopetrosis-associated transmembrane protein 1 OS=Mus musculus OX=10090 GN=Ostm1 PE=1 SV=1	336	8.1e-23	C:GO:0005737; C:GO:0016020	C:cytoplasm; C:membrane			IPR019172 (PFAM)	no GO terms	no GO terms	267.787458498242	3.08433728920722	0.289210927334646	10.6646637374055	1.48936809505879e-26	4.89029454722468e-24
Avas.s001.g1941.i1	homolog_cluster_11212	LACTB2	endoribonuclease activity	8.5e-63	249.2	Chordata	NA	5	F:GO:0008270; F:GO:0004521; P:GO:0090502; C:GO:0005759; F:GO:0003727	C:mitochondrial matrix; F:zinc ion binding; F:single-stranded RNA binding; F:endoribonuclease activity; P:RNA phosphodiester bond hydrolysis, endonucleolytic	NA	NA	LACB2_RAT | Endoribonuclease LACTB2 OS=Rattus norvegicus OX=10116 GN=Lactb2 PE=2 SV=1	1057	3.6e-61	P:GO:0090502; F:GO:0003727; F:GO:0004521; F:GO:0005515; F:GO:0008270; C:GO:0005759	P:R phosphodiester bond hydrolysis, endonucleolytic; F:single-stranded R binding; F:endoribonuclease activity; F:protein binding; F:zinc ion binding; C:mitochondrial matrix	EC:3.1	Acting on ester bonds	IPR001279 (PFAM); IPR001507 (PFAM)	no GO terms	no GO terms	498.375769905762	2.04510139055246	0.316315421958827	6.46538628400691	1.01040363321128e-10	8.83499133409581e-09
Avas.s001.g1949.i1	homolog_cluster_11214	GATA4	GATA-binding protein 4	3.4e-38	166	Actinopterygii	NA	76	P:GO:0035914; P:GO:0003281; P:GO:0055002; P:GO:1900408; P:GO:0071372; P:GO:0061049; P:GO:0001701; P:GO:0003289; P:GO:0001101; P:GO:0023019; P:GO:0001706; F:GO:0008270; P:GO:0001702; P:GO:0072148; P:GO:0060395; P:GO:0071333; P:GO:0001947; P:GO:0003290; P:GO:0032526; P:GO:2000112; P:GO:0010575; P:GO:0014898; P:GO:0060070; P:GO:0003197; P:GO:0009612; P:GO:0007596; P:GO:0009410; P:GO:0033189; P:GO:1905204; P:GO:0003151; P:GO:0003195; P:GO:0060464; P:GO:0043627; P:GO:0070374; P:GO:0045766; F:GO:0019901; P:GO:0048557; P:GO:0001934; P:GO:0060540; P:GO:0007283; P:GO:0030513; P:GO:2001234; P:GO:0060979; F:GO:0051525; P:GO:0055025; P:GO:0060575; P:GO:0061026; F:GO:0001228; P:GO:0003229; F:GO:0000978; C:GO:0016604; P:GO:0035054; P:GO:0072520; P:GO:0086004; P:GO:0003192; P:GO:0036302; F:GO:0003682; P:GO:0060290; P:GO:0010667; C:GO:0000228; P:GO:0010507; P:GO:0051891; P:GO:1903202; C:GO:0000785; P:GO:0010629; F:GO:0070410; F:GO:0003713; P:GO:0060008; P:GO:0003215; P:GO:0045944; P:GO:0048617; P:GO:0045787; P:GO:0060045; P:GO:0003180; P:GO:0051896; C:GO:0090575	P:response to retinoic acid; P:signal transduction involved in regulation of gene expression; P:in utero embryonic development; P:ventricular cardiac muscle tissue development; P:cardiac right ventricle morphogenesis; P:negative regulation of gene expression; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; C:nuclear body; C:RNA polymerase II transcription regulator complex; P:spermatogenesis; F:co-SMAD binding; P:positive regulation of cardioblast differentiation; P:negative regulation of autophagy; P:positive regulation of transcription by RNA polymerase II; P:negative regulation of connective tissue replacement; P:embryonic digestive tract morphogenesis; P:negative regulation of cellular response to oxidative stress; P:atrioventricular canal development; P:regulation of cardiac muscle cell contraction; P:atrial septum primum morphogenesis; P:endoderm formation; P:vasculogenesis involved in coronary vascular morphogenesis; P:skeletal muscle cell differentiation; P:ventricular septum development; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of vascular endothelial growth factor production; P:negative regulation of cardiac muscle cell apoptotic process; P:response to vitamin A; P:lung lobe formation; P:canonical Wnt signaling pathway; P:response to acid chemical; P:striated muscle cell development; P:intestinal epithelial cell differentiation; P:transdifferentiation; C:nuclear chromosome; P:negative regulation of oxidative stress-induced cell death; P:endocardial cushion development; P:gastrulation with mouth forming second; P:positive regulation of cardiac muscle cell proliferation; P:atrial septum secundum morphogenesis; P:heart looping; P:regulation of cellular macromolecule biosynthetic process; P:positive regulation of cell cycle; P:positive regulation of protein phosphorylation; F:NFAT protein binding; P:Sertoli cell differentiation; P:cellular response to glucose stimulus; P:mitral valve formation; P:outflow tract morphogenesis; P:positive regulation of angiogenesis; P:cardiac muscle tissue regeneration; P:response to mechanical stimulus; P:epithelial cell fate commitment; P:SMAD protein signal transduction; C:chromatin; P:response to xenobiotic stimulus; F:protein kinase binding; P:diaphragm morphogenesis; P:positive regulation of BMP signaling pathway; P:response to estrogen; P:embryonic foregut morphogenesis; F:transcription coactivator activity; F:zinc ion binding; P:negative regulation of apoptotic signaling pathway; P:cardiac muscle hypertrophy in response to stress; P:tricuspid valve formation; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:blood coagulation; P:embryonic heart tube anterior/posterior pattern specification; P:aortic valve morphogenesis; P:positive regulation of cardiac muscle tissue development; P:cellular response to follicle-stimulating hormone stimulus; P:regulation of protein kinase B signaling; P:cell growth involved in cardiac muscle cell development; P:seminiferous tubule development; F:chromatin binding	K09183	map04022, map04218, map04530, map04919	GATA6_MOUSE | Transcription factor GATA-6 OS=Mus musculus OX=10090 GN=Gata6 PE=1 SV=3	385	1.2e-35	P:GO:0000122; P:GO:0001701; P:GO:0001889; P:GO:0001947; P:GO:0001949; P:GO:0002759; P:GO:0003148; P:GO:0003162; P:GO:0003163; P:GO:0003180; P:GO:0003190; P:GO:0003197; P:GO:0003215; P:GO:0003281; P:GO:0003289; P:GO:0003290; P:GO:0003309; P:GO:0003310; P:GO:0006644; P:GO:0007267; P:GO:0007493; P:GO:0008584; P:GO:0009410; P:GO:0009636; P:GO:0010575; P:GO:0010666; P:GO:0010667; P:GO:0014898; P:GO:0030218; P:GO:0030513; P:GO:0032526; P:GO:0032911; P:GO:0032912; P:GO:0035054; P:GO:0036302; P:GO:0042060; P:GO:0042475; P:GO:0043627; P:GO:0045766; P:GO:0045944; P:GO:0048617; P:GO:0048645; P:GO:0051591; P:GO:0051891; P:GO:0051896; P:GO:0055007; P:GO:0060045; P:GO:0060047; P:GO:0060430; P:GO:0060486; P:GO:0060510; P:GO:0060575; P:GO:0060947; P:GO:0061026; P:GO:0070315; P:GO:0070374; P:GO:0071371; P:GO:0071456; P:GO:0098773; P:GO:0110024; P:GO:1901390; P:GO:1902894; P:GO:1903202; P:GO:1904003; P:GO:2001234; F:GO:0000978; F:GO:0001223; F:GO:0001228; F:GO:0003682; F:GO:0019901; F:GO:0046872; F:GO:0051525; F:GO:0070410; C:GO:0000785; C:GO:0016604; C:GO:0031965; C:GO:0090575	P:negative regulation of transcription by R polymerase II; P:in utero embryonic development; P:liver development; P:heart looping; P:sebaceous gland cell differentiation; P:regulation of antimicrobial humoral response; P:outflow tract septum morphogenesis; P:atrioventricular node development; P:sinoatrial node development; P:aortic valve morphogenesis; P:atrioventricular valve formation; P:endocardial cushion development; P:cardiac right ventricle morphogenesis; P:ventricular septum development; P:atrial septum primum morphogenesis; P:atrial septum secundum morphogenesis; P:type B pancreatic cell differentiation; P:pancreatic A cell differentiation; P:phospholipid metabolic process; P:cell-cell sigling; P:endodermal cell fate determition; P:male god development; P:response to xenobiotic stimulus; P:response to toxic substance; P:positive regulation of vascular endothelial growth factor production; P:positive regulation of cardiac muscle cell apoptotic process; P:negative regulation of cardiac muscle cell apoptotic process; P:cardiac muscle hypertrophy in response to stress; P:erythrocyte differentiation; P:positive regulation of BMP sigling pathway; P:response to retinoic acid; P:negative regulation of transforming growth factor beta1 production; P:negative regulation of transforming growth factor beta2 production; P:embryonic heart tube anterior/posterior pattern specification; P:atrioventricular cal development; P:wound healing; P:odontogenesis of dentin-containing tooth; P:response to estrogen; P:positive regulation of angiogenesis; P:positive regulation of transcription by R polymerase II; P:embryonic foregut morphogenesis; P:animal organ formation; P:response to cAMP; P:positive regulation of cardioblast differentiation; P:regulation of protein kise B sigling; P:cardiac muscle cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:heart contraction; P:lung saccule development; P:club cell differentiation; P:type II pneumocyte differentiation; P:intestil epithelial cell differentiation; P:cardiac vascular smooth muscle cell differentiation; P:cardiac muscle tissue regeneration; P:G1 to G0 transition involved in cell differentiation; P:positive regulation of ERK1 and ERK2 cascade; P:cellular response to godotropin stimulus; P:cellular response to hypoxia; P:skin epidermis development; P:positive regulation of cardiac muscle myoblast proliferation; P:positive regulation of transforming growth factor beta activation; P:negative regulation of miR transcription; P:negative regulation of oxidative stress-induced cell death; P:negative regulation of sebum secreting cell proliferation; P:negative regulation of apoptotic sigling pathway; F:R polymerase II cis-regulatory region sequence-specific D binding; F:transcription coactivator binding; F:D-binding transcription activator activity, R polymerase II-specific; F:chromatin binding; F:protein kise binding; F:metal ion binding; F:NFAT protein binding; F:co-SMAD binding; C:chromatin; C:nuclear body; C:nuclear membrane; C:R polymerase II transcription regulator complex			IPR000679 (PFAM); IPR000679 (PROSITE_PROFILES); IPR000679 (PROSITE_PROFILES)	P:GO:0006355; F:GO:0043565	P:regulation of transcription, D-templated; F:sequence-specific D binding	511.491139604207	2.53003204094038	0.362499228451826	6.97941358867363	2.9641467704369e-12	3.15828856884499e-10
Avas.s001.g1968.i2	NA	ARNTL2	aryl hydrocarbon receptor nuclear translocator-like	3e-21	110.2	Euarchontoglires	NA	8	P:GO:0042753; P:GO:0010628; C:GO:0005730; F:GO:0070888; F:GO:0000981; P:GO:2000112; P:GO:0009649; P:GO:0045944	P:positive regulation of circadian rhythm; F:E-box binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; P:entrainment of circadian clock; P:regulation of cellular macromolecule biosynthetic process; P:positive regulation of transcription by RNA polymerase II; C:nucleolus; P:positive regulation of gene expression	K09099	NA	BMAL1_POB | Aryl hydrocarbon receptor nuclear translocator-like protein 1 OS=Pongo abelii OX=9601 GN=ARNTL PE=2 SV=1	513	7e-18	P:GO:0006355; P:GO:0007623; P:GO:0010646; P:GO:0023051; P:GO:0045595; P:GO:0048522; P:GO:0048523; P:GO:0048583; P:GO:0051239; F:GO:0000976; F:GO:0005515; C:GO:0005634	P:regulation of transcription, D-templated; P:circadian rhythm; P:regulation of cell communication; P:regulation of sigling; P:regulation of cell differentiation; P:positive regulation of cellular process; P:negative regulation of cellular process; P:regulation of response to stimulus; P:regulation of multicellular organismal process; F:transcription cis-regulatory region binding; F:protein binding; C:nucleus			IPR013655 (PFAM); IPR011598 (PFAM); IPR000014 (PROSITE_PROFILES); IPR011598 (PROSITE_PROFILES); IPR000014 (PROSITE_PROFILES)	F:GO:0005515; F:GO:0046983	F:protein binding; F:protein dimerization activity	100.287358002341	1.79075930860816	0.353500028120966	5.0657967925122	4.06695583770399e-07	1.84319021050196e-05
Avas.s001.g2083.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	580	NA					no IPS match	no IPS match	no IPS match	61.311887365624	2.28291169273932	0.355562836743785	6.42055765345455	1.35776035042918e-10	1.14973717252922e-08
Avas.s001.g2087.i1	NA	SIDT1	SID1 transmembrane family, member 1	1.2e-58	235	Afrotheria	NA	1	F:GO:0003725	F:double-stranded RNA binding	NA	NA	SIDT1_RAT | SI|D1 transmembrane family member 1 OS=Rattus norvegicus OX=10116 GN=Sidt1 PE=1 SV=2	764	1e-57	P:GO:0000902; P:GO:0003323; P:GO:0006401; P:GO:0044342; P:GO:0050658; P:GO:0061178; F:GO:0003725; F:GO:0005496; F:GO:0005515; F:GO:0035612; F:GO:0035650; F:GO:0051032; C:GO:0005765; C:GO:0005886	P:cell morphogenesis; P:type B pancreatic cell development; P:R catabolic process; P:type B pancreatic cell proliferation; P:R transport; P:regulation of insulin secretion involved in cellular response to glucose stimulus; F:double-stranded R binding; F:steroid binding; F:protein binding; F:AP-2 adaptor complex binding; F:AP-1 adaptor complex binding; F:nucleic acid transmembrane transporter activity; C:lysosomal membrane; C:plasma membrane	EC:7	Translocases	IPR025958 (PFAM)	C:GO:0016021	C:integral component of membrane	20.0038229917641	2.80883678403622	0.577496632558688	4.86381500025591	1.15144541987965e-06	4.8118455481672e-05
Avas.s001.g2088.i1	homolog_cluster_11266	NA	SGF29 tudor-like domain	2.8e-34	152.5	Arthropoda	NA	5	F:GO:0035064; C:GO:0000124; P:GO:0006338; C:GO:1902562; P:GO:0043966	P:chromatin remodeling; F:methylated histone binding; C:H4 histone acetyltransferase complex; P:histone H3 acetylation; C:SAGA complex	K11364	NA	------	272	NA					IPR010750 (PFAM); IPR010750 (PROSITE_PROFILES)	no GO terms	no GO terms	92.2670453563491	1.77343992468658	0.360508384037524	4.91927512149617	8.68653024872841e-07	3.71695705244126e-05
Avas.s001.g2142.i1	paralog_cluster_08496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	1122	NA					no IPS match	no IPS match	no IPS match	117.536331218571	1.54553027785736	0.285636915784007	5.41082119450576	6.27363893573067e-08	3.37580524538364e-06
Avas.s001.g2156.i1	paralog_cluster_08497	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	112	NA					no IPS match	no IPS match	no IPS match	4563.37557516156	5.45322110099507	0.445549711707214	12.2393101324203	1.91654675989207e-34	1.28480503416265e-31
Avas.s001.g2179.i1	homolog_cluster_11301	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	209	NA					no IPS match	no IPS match	no IPS match	162.333256700745	1.46872948252266	0.292727245914708	5.01739931291058	5.23756347108715e-07	2.28986844256307e-05
Avas.s001.g2219.i1	homolog_cluster_11319	Ssdp	midbrain-hindbrain boundary initiation	3.1e-11	75.9	Bilateria	NA	9	P:GO:0090263; P:GO:0010628; C:GO:0005634; P:GO:0009880; F:GO:0001228; F:GO:0098847; P:GO:2000112; P:GO:0045944; F:GO:0000978	P:embryonic pattern specification; F:sequence-specific single stranded DNA binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; C:nucleus; P:regulation of cellular macromolecule biosynthetic process; P:positive regulation of canonical Wnt signaling pathway; P:positive regulation of transcription by RNA polymerase II; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:positive regulation of gene expression	NA	NA	SSBP4_HUMAN | Single-stranded D-binding protein 4 OS=Homo sapiens OX=9606 GN=SSBP4 PE=1 SV=1	256	1.2e-10	P:GO:0002244; P:GO:0008284; P:GO:0021501; P:GO:0021547; P:GO:0045944; P:GO:0048382; P:GO:0060323; P:GO:0065003; P:GO:2000744; F:GO:0003677; F:GO:0003713; F:GO:0005515; C:GO:0005667; C:GO:0005737	P:hematopoietic progenitor cell differentiation; P:positive regulation of cell population proliferation; P:prechordal plate formation; P:midbrain-hindbrain boundary initiation; P:positive regulation of transcription by R polymerase II; P:mesendoderm development; P:head morphogenesis; P:protein-containing complex assembly; P:positive regulation of anterior head development; F:D binding; F:transcription coactivator activity; F:protein binding; C:transcription regulator complex; C:cytoplasm			IPR006594 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	343.946373887961	2.19414144287732	0.3400573049604	6.45226969358249	1.10187260552636e-10	9.58271802719658e-09
Avas.s001.g2221.i1	homolog_cluster_11320	NA	NHL repeat containing protein	0.48	42.7	Cytophagia	NA	NA	NA	NA	NA	NA	------	423	NA					no IPS match	no IPS match	no IPS match	1755.73373057848	4.00956028326716	0.649990339872716	6.1686459587266	6.88772530812144e-10	5.17834637768064e-08
Avas.s001.g2247.i1	homolog_cluster_11327	DNER	Notch receptor processing	6.4e-06	60.1	Vertebrata	NA	18	F:GO:0004888; P:GO:0055002; P:GO:0007220; P:GO:0007165; P:GO:0001764; F:GO:0030276; P:GO:0007416; P:GO:0007417; C:GO:0043025; P:GO:0006897; F:GO:0005509; C:GO:0005886; C:GO:0030425; P:GO:0098657; P:GO:0048741; F:GO:0005112; C:GO:0005769; P:GO:0010001	C:early endosome; P:skeletal muscle fiber development; P:signal transduction; C:dendrite; P:import into cell; F:transmembrane signaling receptor activity; C:plasma membrane; P:striated muscle cell development; F:Notch binding; C:neuronal cell body; F:calcium ion binding; P:central nervous system development; F:clathrin binding; P:endocytosis; P:synapse assembly; P:neuron migration; P:glial cell differentiation; P:Notch receptor processing	NA	NA	FBP1_STRPU | Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2	929	1.4e-80	P:GO:0001525; P:GO:0001837; P:GO:0001889; P:GO:0002009; P:GO:0003157; P:GO:0003179; P:GO:0003203; P:GO:0003208; P:GO:0003209; P:GO:0006950; P:GO:0006955; P:GO:0007162; P:GO:0007219; P:GO:0007409; P:GO:0007420; P:GO:0007517; P:GO:0008284; P:GO:0008285; P:GO:0009605; P:GO:0009607; P:GO:0009952; P:GO:0009967; P:GO:0010605; P:GO:0014013; P:GO:0021515; P:GO:0022603; P:GO:0022612; P:GO:0030097; P:GO:0030326; P:GO:0030334; P:GO:0032835; P:GO:0035051; P:GO:0042981; P:GO:0043009; P:GO:0045165; P:GO:0045446; P:GO:0045604; P:GO:0045665; P:GO:0045685; P:GO:0045944; P:GO:0048585; P:GO:0048589; P:GO:0048608; P:GO:0048738; P:GO:0048839; P:GO:0048844; P:GO:0048863; P:GO:0050678; P:GO:0050768; P:GO:0050769; P:GO:0051049; P:GO:0051128; P:GO:0060411; P:GO:0060977; P:GO:0071310; P:GO:0072080; P:GO:2000136; F:GO:0005102; F:GO:0098772; C:GO:0005737; C:GO:0005886; C:GO:0012505; C:GO:0043231; C:GO:0120025	P:angiogenesis; P:epithelial to mesenchymal transition; P:liver development; P:morphogenesis of an epithelium; P:endocardium development; P:heart valve morphogenesis; P:endocardial cushion morphogenesis; P:cardiac ventricle morphogenesis; P:cardiac atrium morphogenesis; P:response to stress; P:immune response; P:negative regulation of cell adhesion; P:Notch sigling pathway; P:axonogenesis; P:brain development; P:muscle organ development; P:positive regulation of cell population proliferation; P:negative regulation of cell population proliferation; P:response to exterl stimulus; P:response to biotic stimulus; P:anterior/posterior pattern specification; P:positive regulation of sigl transduction; P:negative regulation of macromolecule metabolic process; P:regulation of gliogenesis; P:cell differentiation in spil cord; P:regulation of atomical structure morphogenesis; P:gland morphogenesis; P:hemopoiesis; P:embryonic limb morphogenesis; P:regulation of cell migration; P:glomerulus development; P:cardiocyte differentiation; P:regulation of apoptotic process; P:chordate embryonic development; P:cell fate commitment; P:endothelial cell differentiation; P:regulation of epidermal cell differentiation; P:negative regulation of neuron differentiation; P:regulation of glial cell differentiation; P:positive regulation of transcription by R polymerase II; P:negative regulation of response to stimulus; P:developmental growth; P:reproductive structure development; P:cardiac muscle tissue development; P:inner ear development; P:artery morphogenesis; P:stem cell differentiation; P:regulation of epithelial cell proliferation; P:negative regulation of neurogenesis; P:positive regulation of neurogenesis; P:regulation of transport; P:regulation of cellular component organization; P:cardiac septum morphogenesis; P:corory vasculature morphogenesis; P:cellular response to organic substance; P:nephron tubule development; P:regulation of cell proliferation involved in heart morphogenesis; F:sigling receptor binding; F:molecular function regulator; C:cytoplasm; C:plasma membrane; C:endomembrane system; C:intracellular membrane-bounded organelle; C:plasma membrane bounded cell projection			IPR000742 (PFAM); IPR013032 (PFAM); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES)	no GO terms	no GO terms	162.885528961052	1.42215599805784	0.230608310254847	6.16697636128639	6.96081586448493e-10	5.20895657877665e-08
Avas.s001.g2248.i1	paralog_cluster_02491	NA	diolein transacylation activity	2.2e-45	189.9	Metazoa	NA	NA	NA	NA	NA	NA	PLPL3_MOUSE | 1-acylglycerol-3-phosphate O-acyltransferase Pnpla3 OS=Mus musculus OX=10090 GN=Pnpla3 PE=1 SV=1	386	1.5e-44	P:GO:0001676; P:GO:0002021; P:GO:0006654; P:GO:0019432; P:GO:0019433; P:GO:0030154; P:GO:0036155; P:GO:0043588; P:GO:0048878; P:GO:0106342; F:GO:0003841; F:GO:0004806; F:GO:0035727; F:GO:0036042; F:GO:0106341; C:GO:0005737; C:GO:0005811; C:GO:0016020	P:long-chain fatty acid metabolic process; P:response to dietary excess; P:phosphatidic acid biosynthetic process; P:triglyceride biosynthetic process; P:triglyceride catabolic process; P:cell differentiation; P:acylglycerol acyl-chain remodeling; P:skin development; P:chemical homeostasis; P:omega-hydroxyceramide biosynthetic process; F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:triglyceride lipase activity; F:lysophosphatidic acid binding; F:long-chain fatty acyl-CoA binding; F:omega-hydroxyceramide transacylase activity; C:cytoplasm; C:lipid droplet; C:membrane	EC:2.3.1.51; EC:3.1.1.1; EC:3.1.1.3	1-acylglycerol-3-phosphate O-acyltransferase; Carboxylesterase; Triacylglycerol lipase	IPR002641 (PFAM); IPR002641 (PROSITE_PROFILES)	P:GO:0006629	P:lipid metabolic process	1183.57688892405	2.53791073599168	0.353178467671036	7.18591581397197	6.67581714734017e-13	7.78313203504028e-11
Avas.s002.g24.i1	NA	HEXA	Beta-hexosaminidase subunit alpha	0.25	43.5	Aves	EC:3.2.1.52	25	C:GO:0016020; C:GO:0043202; P:GO:0001501; P:GO:0007605; P:GO:0007628; P:GO:0065008; P:GO:0048667; P:GO:0042340; P:GO:0060395; P:GO:0030207; P:GO:0032989; F:GO:0008375; C:GO:0042582; P:GO:0006024; F:GO:0004563; P:GO:0006689; P:GO:0042552; P:GO:0019953; P:GO:0019915; P:GO:0050885; P:GO:0007040; P:GO:0046395; P:GO:0050884; F:GO:0046982; P:GO:0030214	P:hyaluronan catabolic process; P:adult walking behavior; P:lysosome organization; F:acetylglucosaminyltransferase activity; P:chondroitin sulfate catabolic process; P:keratan sulfate catabolic process; P:sensory perception of sound; P:skeletal system development; P:SMAD protein signal transduction; P:cellular component morphogenesis; C:membrane; P:myelination; P:neuromuscular process controlling posture; C:azurophil granule; P:sexual reproduction; P:glycosaminoglycan biosynthetic process; P:lipid storage; P:carboxylic acid catabolic process; F:beta-N-acetylhexosaminidase activity; F:protein heterodimerization activity; P:regulation of biological quality; P:ganglioside catabolic process; P:cell morphogenesis involved in neuron differentiation; P:neuromuscular process controlling balance; C:lysosomal lumen	K12373	map00511, map00513, map00520, map00531, map00603, map00604, map01100, map04142	------	368	NA					PS51257 (PROSITE_PROFILES)	no GO terms	no GO terms	453.151584603627	3.57335368350833	0.265345012862013	13.4668205931821	2.45199032304908e-41	2.32059248867862e-38
Avas.s002.g25.i1	paralog_cluster_08509	NA	Mannose-6-phosphate receptor	7e-12	78.2	Bilateria	NA	NA	NA	NA	NA	NA	------	285	NA					IPR018939 (PFAM); IPR044865 (PROSITE_PROFILES)	no GO terms	no GO terms	205.770034337449	1.73348165936251	0.274775279277627	6.30872494759995	2.81343596477875e-10	2.29773458057489e-08
Avas.s002.g38.i1	homolog_cluster_11333	NA	protein tyrosine phosphatase activity	1.2e-54	221.9	Metazoa	EC:3.1.3.48	NA	NA	NA	K06777	NA	PTPRA_HUMAN | Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3	906	6.3e-54	P:GO:0006464; P:GO:0007166; P:GO:0009968; P:GO:0010605; P:GO:0010977; P:GO:0016311; P:GO:0021537; P:GO:0022603; P:GO:0048522; P:GO:0050767; P:GO:0050776; P:GO:0051093; P:GO:0051241; P:GO:0051963; P:GO:0098609; F:GO:0004721; F:GO:0005515; F:GO:0097367; F:GO:1901681; C:GO:0031410; C:GO:0043005; C:GO:0098793; C:GO:0098984; C:GO:0099699	P:cellular protein modification process; P:cell surface receptor sigling pathway; P:negative regulation of sigl transduction; P:negative regulation of macromolecule metabolic process; P:negative regulation of neuron projection development; P:dephosphorylation; P:telencephalon development; P:regulation of atomical structure morphogenesis; P:positive regulation of cellular process; P:regulation of neurogenesis; P:regulation of immune response; P:negative regulation of developmental process; P:negative regulation of multicellular organismal process; P:regulation of sypse assembly; P:cell-cell adhesion; F:phosphoprotein phosphatase activity; F:protein binding; F:carbohydrate derivative binding; F:sulfur compound binding; C:cytoplasmic vesicle; C:neuron projection; C:presypse; C:neuron to neuron sypse; C:integral component of syptic membrane	EC:3.1.3	Acting on ester bonds	IPR000242 (PFAM); IPR000242 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES)	P:GO:0006470; P:GO:0016311; F:GO:0004725; F:GO:0016791	P:protein dephosphorylation; P:dephosphorylation; F:protein tyrosine phosphatase activity; F:phosphatase activity	307.355830763947	1.13919364561095	0.241293212825397	4.72120053552973	2.34456635230051e-06	9.13359032497892e-05
Avas.s002.g43.i1	paralog_cluster_08511	NA	Tetraspanin family	3.6e-07	62.4	Metazoa	NA	NA	NA	NA	K17350	NA	------	261	NA					IPR018499 (PFAM)	C:GO:0016021	C:integral component of membrane	692.537015527388	3.78576972505771	0.548538574683861	6.90155606146671	5.14359647040014e-12	5.37219716690141e-10
Avas.s002.g51.i1	paralog_cluster_02459	ATP6V1F	Subunit of the peripheral V1 complex of vacuolar ATPase essential for assembly or catalytic function. V-ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells	5.7e-40	170.2	Chordata	NA	11	F:GO:0016887; F:GO:0042625; C:GO:0033181; P:GO:0008286; P:GO:0033572; C:GO:0000221; F:GO:0022853; P:GO:0015833; P:GO:0015988; F:GO:0015078; C:GO:0005829	F:ATPase-coupled ion transmembrane transporter activity; C:plasma membrane proton-transporting V-type ATPase complex; F:proton transmembrane transporter activity; P:transferrin transport; P:energy coupled proton transmembrane transport, against electrochemical gradient; P:peptide transport; F:ATP hydrolysis activity; C:vacuolar proton-transporting V-type ATPase, V1 domain; P:insulin receptor signaling pathway; F:active ion transmembrane transporter activity; C:cytosol	K02151	map00190, map01100, map04145, map04150, map04721, map04966, map05110, map05120, map05323	VATF_MOUSE | V-type proton ATPase subunit F OS=Mus musculus OX=10090 GN=Atp6v1f PE=1 SV=2	121	1.4e-36	P:GO:0007042; P:GO:1902600; F:GO:0005515; F:GO:0046961; C:GO:0000221; C:GO:0005829; C:GO:0033181	P:lysosomal lumen acidification; P:proton transmembrane transport; F:protein binding; F:proton-transporting ATPase activity, rotatiol mechanism; C:vacuolar proton-transporting V-type ATPase, V1 domain; C:cytosol; C:plasma membrane proton-transporting V-type ATPase complex	EC:7.1.3.1	H(+)-exporting diphosphatase	IPR008218 (PFAM)	P:GO:0034220; F:GO:0046961	P:ion transmembrane transport; F:proton-transporting ATPase activity, rotatiol mechanism	1975.79466228305	1.32629090989346	0.196563170481979	6.74740291704367	1.50514880059207e-11	1.47660603980035e-09
Avas.s002.g99.i1	paralog_cluster_08518	NPC2	Domain involved in innate immunity and lipid metabolism.	1e-06	60.1	Testudines	NA	16	C:GO:0043202; P:GO:0032367; P:GO:0015914; P:GO:0033344; P:GO:0034383; F:GO:0015485; P:GO:0009615; P:GO:0046836; P:GO:0043312; P:GO:0042632; C:GO:0035578; C:GO:0005576; F:GO:0120020; F:GO:0019899; P:GO:0019747; P:GO:0015711	F:cholesterol binding; P:organic anion transport; F:cholesterol transfer activity; F:enzyme binding; C:extracellular region; P:intracellular cholesterol transport; P:response to virus; P:cholesterol efflux; P:phospholipid transport; P:glycolipid transport; P:neutrophil degranulation; P:low-density lipoprotein particle clearance; P:regulation of isoprenoid metabolic process; C:azurophil granule lumen; P:cholesterol homeostasis; C:lysosomal lumen	K13443	map04142, map04979	------	151	NA					IPR003172 (PFAM)	no GO terms	no GO terms	418.946086321562	3.04506112393239	0.62922253737686	4.83940250555364	1.3023005732557e-06	5.4001840008018e-05
Avas.s002.g134.i1	homolog_cluster_11349	Sap-r	Saposin/surfactant protein-B A-type DOMAIN	5.3e-12	79	Hymenoptera	NA	10	C:GO:0005770; C:GO:0045169; P:GO:0033227; P:GO:0006665; P:GO:0055088; C:GO:0005764; F:GO:0001664; C:GO:0005776; P:GO:0043085; F:GO:0008047	F:enzyme activator activity; P:positive regulation of catalytic activity; P:dsRNA transport; P:sphingolipid metabolic process; C:fusome; C:autophagosome; F:G protein-coupled receptor binding; C:late endosome; C:lysosome; P:lipid homeostasis	K12382	map04142	------	368	NA					IPR003119 (PFAM); IPR008139 (PROSITE_PROFILES); IPR008139 (PROSITE_PROFILES); IPR003119 (PROSITE_PROFILES)	no GO terms	no GO terms	7119.04673682847	4.31337070367154	0.7781933956853	5.54280044984584	2.97672031060133e-08	1.70435776075675e-06
Avas.s002.g1.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	125	NA					no IPS match	no IPS match	no IPS match	843.566797374856	3.88339623311706	0.79153691281183	4.90614672576899	9.28830524776951e-07	3.95091232892557e-05
Avas.s002.g149.i1	homolog_cluster_11352	NPC2	intracellular cholesterol transport	2e-13	82.4	Chordata	NA	16	C:GO:0043202; P:GO:0032367; P:GO:0015914; P:GO:0033344; P:GO:0034383; F:GO:0015485; P:GO:0009615; P:GO:0046836; P:GO:0043312; P:GO:0042632; C:GO:0035578; C:GO:0005576; F:GO:0120020; F:GO:0019899; P:GO:0019747; P:GO:0015711	F:cholesterol binding; P:organic anion transport; F:cholesterol transfer activity; F:enzyme binding; C:extracellular region; P:intracellular cholesterol transport; P:response to virus; P:cholesterol efflux; P:phospholipid transport; P:glycolipid transport; P:neutrophil degranulation; P:low-density lipoprotein particle clearance; P:regulation of isoprenoid metabolic process; C:azurophil granule lumen; P:cholesterol homeostasis; C:lysosomal lumen	K13443	map04142, map04979	NPC2_DROME | NPC intracellular cholesterol transporter 2 homolog a OS=Drosophila melanogaster OX=7227 GN=Npc2a PE=2 SV=1	153	1.4e-09	P:GO:0006694; P:GO:0007275; P:GO:0009987; P:GO:0015918; P:GO:0065008; F:GO:0008289; F:GO:0097367; C:GO:0005576	P:steroid biosynthetic process; P:multicellular organism development; P:cellular process; P:sterol transport; P:regulation of biological quality; F:lipid binding; F:carbohydrate derivative binding; C:extracellular region			IPR003172 (PFAM)	no GO terms	no GO terms	513.998609857629	2.91785392540588	0.565412160191497	5.16057865543189	2.46187699793651e-07	1.16841118052509e-05
Avas.s002.g174.i1	paralog_cluster_01234	NA	poly(A) polymerase alpha	1.2e-131	477.2	Afrotheria	NA	NA	NA	NA	NA	NA	PAPOB_MOUSE | Poly(A) polymerase beta OS=Mus musculus OX=10090 GN=Papolb PE=1 SV=2	664	6.1e-131	P:GO:0006378; P:GO:0031440; F:GO:0000287; F:GO:0004652; F:GO:0005515; F:GO:0005524; F:GO:0030145; C:GO:0005829; C:GO:0016604	P:mR polyadenylation; P:regulation of mR 3'-end processing; F:magnesium ion binding; F:polynucleotide adenylyltransferase activity; F:protein binding; F:ATP binding; F:manganese ion binding; C:cytosol; C:nuclear body	EC:2.7.7.19	Polynucleotide adenylyltransferase	IPR002934 (PFAM); IPR007012 (PFAM); IPR007010 (PFAM)	P:GO:0043631; F:GO:0003723; F:GO:0004652; F:GO:0016779	P:R polyadenylation; F:R binding; F:polynucleotide adenylyltransferase activity; F:nucleotidyltransferase activity	1168.76074147829	2.31018210769439	0.454714028048027	5.08051646792474	3.76410101053819e-07	1.7107520101285e-05
Avas.s002.g176.i1	paralog_cluster_01298	NA	AMP-activated protein kinase activity. It is involved in the biological process described with protein phosphorylation	6.2e-142	511.1	Insecta	EC:2.7.11.11	26	P:GO:0010976; P:GO:1902669; F:GO:0004679; P:GO:0050772; P:GO:0000278; P:GO:0042149; F:GO:0035174; C:GO:0031588; C:GO:0005634; P:GO:0045197; P:GO:0010770; P:GO:0045792; P:GO:0030730; C:GO:1990794; P:GO:0006629; P:GO:0001558; F:GO:0004703; P:GO:0006325; P:GO:0048813; P:GO:0045666; P:GO:0044058; P:GO:0042595; C:GO:0005768; P:GO:1904262; P:GO:0035404; P:GO:0050921	P:positive regulation of axonogenesis; P:negative regulation of cell size; P:regulation of cell growth; F:G protein-coupled receptor kinase activity; C:endosome; P:dendrite morphogenesis; P:negative regulation of TORC1 signaling; F:AMP-activated protein kinase activity; P:positive regulation of neuron projection development; P:cellular response to glucose starvation; P:sequestering of triglyceride; P:positive regulation of neuron differentiation; C:nucleotide-activated protein kinase complex; P:positive regulation of cell morphogenesis involved in differentiation; P:positive regulation of chemotaxis; P:histone-serine phosphorylation; P:chromatin organization; C:basolateral part of cell; P:behavioral response to starvation; P:regulation of digestive system process; F:histone serine kinase activity; P:positive regulation of axon guidance; P:establishment or maintenance of epithelial cell apical/basal polarity; C:nucleus; P:mitotic cell cycle; P:lipid metabolic process	K07198	map04068, map04140, map04150, map04151, map04152, map04211, map04213, map04371, map04530, map04710, map04714, map04910, map04920, map04921, map04922, map04931, map04932, map05410, map05418	AAPK1_HUMAN | 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Homo sapiens OX=9606 GN=PRKAA1 PE=1 SV=4	550	8.9e-136	P:GO:0006006; P:GO:0006694; P:GO:0008284; P:GO:0008340; P:GO:0009411; P:GO:0009631; P:GO:0010332; P:GO:0010628; P:GO:0010629; P:GO:0014850; P:GO:0015721; P:GO:0016125; P:GO:0016239; P:GO:0019395; P:GO:0031000; P:GO:0031327; P:GO:0032007; P:GO:0033135; P:GO:0034249; P:GO:0038183; P:GO:0042149; P:GO:0042752; P:GO:0045821; P:GO:0045834; P:GO:0046627; P:GO:0046890; P:GO:0048643; P:GO:0050709; P:GO:0050714; P:GO:0050995; P:GO:0055089; P:GO:0060627; P:GO:0061066; P:GO:0061744; P:GO:0061762; P:GO:0062028; P:GO:0070050; P:GO:0070301; P:GO:0070507; P:GO:0071277; P:GO:0071333; P:GO:0071361; P:GO:0071380; P:GO:0071456; P:GO:0071466; P:GO:0097009; P:GO:0120188; P:GO:1901563; P:GO:1903109; P:GO:1903944; P:GO:1903955; P:GO:1904428; P:GO:1904486; P:GO:2000758; F:GO:0003682; F:GO:0004679; F:GO:0004712; F:GO:0005524; F:GO:0008022; F:GO:0030674; F:GO:0035174; F:GO:0044877; C:GO:0005794; C:GO:0005829; C:GO:0010494; C:GO:0016324; C:GO:0016607; C:GO:0030424; C:GO:0030425; C:GO:0031588; C:GO:0043025	P:glucose metabolic process; P:steroid biosynthetic process; P:positive regulation of cell population proliferation; P:determition of adult lifespan; P:response to UV; P:cold acclimation; P:response to gamma radiation; P:positive regulation of gene expression; P:negative regulation of gene expression; P:response to muscle activity; P:bile acid and bile salt transport; P:sterol metabolic process; P:positive regulation of macroautophagy; P:fatty acid oxidation; P:response to caffeine; P:negative regulation of cellular biosynthetic process; P:negative regulation of TOR sigling; P:regulation of peptidyl-serine phosphorylation; P:negative regulation of cellular amide metabolic process; P:bile acid sigling pathway; P:cellular response to glucose starvation; P:regulation of circadian rhythm; P:positive regulation of glycolytic process; P:positive regulation of lipid metabolic process; P:negative regulation of insulin receptor sigling pathway; P:regulation of lipid biosynthetic process; P:positive regulation of skeletal muscle tissue development; P:negative regulation of protein secretion; P:positive regulation of protein secretion; P:negative regulation of lipid catabolic process; P:fatty acid homeostasis; P:regulation of vesicle-mediated transport; P:positive regulation of dauer larval development; P:motor behavior; P:CAMKK-AMPK sigling cascade; P:regulation of stress granule assembly; P:neuron cellular homeostasis; P:cellular response to hydrogen peroxide; P:regulation of microtubule cytoskeleton organization; P:cellular response to calcium ion; P:cellular response to glucose stimulus; P:cellular response to ethanol; P:cellular response to prostaglandin E stimulus; P:cellular response to hypoxia; P:cellular response to xenobiotic stimulus; P:energy homeostasis; P:regulation of bile acid secretion; P:response to camptothecin; P:positive regulation of mitochondrial transcription; P:negative regulation of hepatocyte apoptotic process; P:positive regulation of protein targeting to mitochondrion; P:negative regulation of tubulin deacetylation; P:response to 17alpha-ethynylestradiol; P:positive regulation of peptidyl-lysine acetylation; F:chromatin binding; F:AMP-activated protein kise activity; F:protein serine/threonine/tyrosine kise activity; F:ATP binding; F:protein C-terminus binding; F:protein-macromolecule adaptor activity; F:histone serine kise activity; F:protein-containing complex binding; C:Golgi apparatus; C:cytosol; C:cytoplasmic stress granule; C:apical plasma membrane; C:nuclear speck; C:axon; C:dendrite; C:nucleotide-activated protein kise complex; C:neurol cell body	EC:2.7.12.1; EC:2.7.11.11	Dual-specificity kise; cAMP-dependent protein kise	IPR000719 (PFAM); IPR032270 (PFAM); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	128.476882723125	1.18057132109832	0.232160670553387	5.08514779133032	3.67339914503313e-07	1.67425832420504e-05
Avas.s002.g243.i1	homolog_cluster_11387	NA	ubiquitin conjugating enzyme binding	6.8e-34	151.4	Metazoa	NA	NA	NA	NA	NA	NA	------	299	NA					IPR002867 (PFAM); IPR044066 (PROSITE_PROFILES)	no GO terms	no GO terms	352.480096214873	1.19513238554895	0.199263611583516	5.99774527848525	2.00076028307276e-09	1.39351654521029e-07
Avas.s002.g251.i1	paralog_cluster_03483	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	164	NA					no IPS match	no IPS match	no IPS match	507.980544251638	-3.33505610029945	0.374651955665481	-8.90174480572379	5.49755508251513e-19	1.07866053320227e-16
Avas.s002.g286.i1	paralog_cluster_08527	NA	very-low-density lipoprotein particle binding	1.4e-49	204.9	Metazoa	NA	NA	NA	NA	NA	NA	SEPR_THESR | Extracellular serine proteise OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3	814	1.2e-40	P:GO:0006508; P:GO:0023051; P:GO:0031323; P:GO:0044092; P:GO:0048261; P:GO:0048522; P:GO:0060255; F:GO:0005102; F:GO:0008233; C:GO:0005764; C:GO:0005768; C:GO:0005783; C:GO:0016020	P:proteolysis; P:regulation of sigling; P:regulation of cellular metabolic process; P:negative regulation of molecular function; P:negative regulation of receptor-mediated endocytosis; P:positive regulation of cellular process; P:regulation of macromolecule metabolic process; F:sigling receptor binding; F:peptidase activity; C:lysosome; C:endosome; C:endoplasmic reticulum; C:membrane	EC:3.4	Acting on peptide bonds (peptidases)	IPR000209 (PFAM); IPR023828 (PROSITE_PATTERNS); IPR022398 (PROSITE_PATTERNS); IPR023827 (PROSITE_PATTERNS); PS51892 (PROSITE_PROFILES)	P:GO:0006508; F:GO:0008236	P:proteolysis; F:serine-type peptidase activity	992.512867966528	2.4330112722824	0.17381260004696	13.997899298584	1.60546437629106e-44	1.84502259643906e-41
Avas.s002.g344.i1	homolog_cluster_31959	NA	Granulin a	2.8e-26	125.9	Actinopterygii	NA	NA	NA	NA	NA	NA	------	269	NA					IPR000118 (PFAM); IPR000118 (PROSITE_PATTERNS)	no GO terms	no GO terms	2848.00400849309	5.84586524785956	0.530050110361084	11.0288916719161	2.77260808424889e-28	1.08801198701172e-25
Avas.s002.g377.i1	paralog_cluster_08528	NA	Belongs to the peptidase C19 family	9.6e-23	114.4	Bilateria	NA	NA	NA	NA	NA	NA	------	312	NA					IPR006615 (PFAM); IPR006615 (PROSITE_PROFILES)	F:GO:0004843	F:thiol-dependent deubiquitise	1527.59962845904	3.58043639534598	0.7118266544914	5.02992740262613	4.90665582203528e-07	2.16876883298697e-05
Avas.s002.g391.i1	paralog_cluster_07162	loxl2	Lysyl oxidase-like 2a	2.7e-92	346.7	Actinopterygii	NA	NA	NA	NA	K00280	NA	LOXL2_XENTR | Lysyl oxidase homolog 2 OS=Xenopus tropicalis OX=8364 GN=loxl2 PE=2 SV=2	733	1e-94	P:GO:0016043; P:GO:0044237; P:GO:0048519; P:GO:0050793; P:GO:0050794; P:GO:0051239; F:GO:0016491; F:GO:0046872; C:GO:0043231	P:cellular component organization; P:cellular metabolic process; P:negative regulation of biological process; P:regulation of developmental process; P:regulation of cellular process; P:regulation of multicellular organismal process; F:oxidoreductase activity; F:metal ion binding; C:intracellular membrane-bounded organelle	EC:1	Oxidoreductases	IPR001695 (PFAM); IPR001190 (PFAM); IPR001190 (PROSITE_PATTERNS); IPR001190 (PROSITE_PATTERNS); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES)	F:GO:0005044; F:GO:0005507; F:GO:0016641; C:GO:0016020	F:scavenger receptor activity; F:copper ion binding; F:oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor; C:membrane	43.1227095845861	2.60427895526706	0.510406768382253	5.1023597581227	3.35444309003265e-07	1.54640787608983e-05
Avas.s002.g418.i1	paralog_cluster_08529	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	174	NA					no IPS match	no IPS match	no IPS match	193.573288933952	2.45669198932326	0.449259962157481	5.4683083209229	4.54351046642752e-08	2.51204604447946e-06
Avas.s002.g566.i1	paralog_cluster_00043	NA	Integrase core domain	2.1e-33	151.4	Metazoa	NA	NA	NA	NA	NA	NA	SCND3_HUMAN | SCAN domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ZBED9 PE=1 SV=1	908	1.8e-08	P:GO:0006278; P:GO:0006310; P:GO:0006508; P:GO:0008152; P:GO:0015074; P:GO:0016032; P:GO:0044826; P:GO:0045787; P:GO:0046718; P:GO:0050679; P:GO:0075713; P:GO:0090305; P:GO:0090502; F:GO:0003676; F:GO:0003677; F:GO:0003723; F:GO:0003824; F:GO:0003887; F:GO:0003964; F:GO:0004170; F:GO:0004190; F:GO:0004518; F:GO:0004519; F:GO:0004523; F:GO:0005198; F:GO:0008233; F:GO:0008270; F:GO:0016740; F:GO:0016779; F:GO:0016787; F:GO:0039660; F:GO:0046872; C:GO:0005634; C:GO:0005737; C:GO:0019013	P:R-dependent D biosynthetic process; P:D recombition; P:proteolysis; P:metabolic process; P:D integration; P:viral process; P:viral genome integration into host D; P:positive regulation of cell cycle; P:viral entry into host cell; P:positive regulation of epithelial cell proliferation; P:establishment of integrated proviral latency; P:nucleic acid phosphodiester bond hydrolysis; P:R phosphodiester bond hydrolysis, endonucleolytic; F:nucleic acid binding; F:D binding; F:R binding; F:catalytic activity; F:D-directed D polymerase activity; F:R-directed D polymerase activity; F:dUTP diphosphatase activity; F:aspartic-type endopeptidase activity; F:nuclease activity; F:endonuclease activity; F:R-D hybrid ribonuclease activity; F:structural molecule activity; F:peptidase activity; F:zinc ion binding; F:transferase activity; F:nucleotidyltransferase activity; F:hydrolase activity; F:structural constituent of virion; F:metal ion binding; C:nucleus; C:cytoplasm; C:viral nucleocapsid			IPR041588 (PFAM); IPR001584 (PFAM); IPR001584 (PROSITE_PROFILES)	P:GO:0015074	P:D integration	95.7455560218406	1.91697406859568	0.376327488048002	5.09389861085875	3.50774404691658e-07	1.60786592509518e-05
Avas.s002.g919.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	182	NA					IPR007593 (PFAM)	C:GO:0016021	C:integral component of membrane	975.820326824338	3.74824546482549	0.415367296693541	9.02393013283122	1.81459741322238e-19	3.60432812115246e-17
Avas.s002.g1028.i1	paralog_cluster_18287	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	107	NA					no IPS match	no IPS match	no IPS match	400.916865029518	1.93211505335265	0.257932319027901	7.49078308850333	6.84638856942152e-14	8.53887951111805e-12
Avas.s003.g14.i1	homolog_cluster_11458	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	293	NA					no IPS match	no IPS match	no IPS match	357.240565621078	2.01085427772013	0.395235694414782	5.08773449902486	3.62366183395107e-07	1.65628111495565e-05
Avas.s003.g15.i1	homolog_cluster_11459	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	197	NA					no IPS match	no IPS match	no IPS match	296.784524012509	1.94677896560572	0.304253929450301	6.39853351811424	1.5687630930166e-10	1.30776318153078e-08
Avas.s003.g51.i1	homolog_cluster_11470	LDB2	LIM-domain binding protein	4.4e-13	82.8	Hominidae	NA	8	P:GO:0030334; F:GO:0003712; C:GO:0005730; C:GO:0005886; F:GO:0030274; P:GO:0043549; P:GO:1903506; C:GO:0031252	C:cell leading edge; F:transcription coregulator activity; F:LIM domain binding; P:regulation of cell migration; P:regulation of kinase activity; C:nucleolus; P:regulation of nucleic acid-templated transcription; C:plasma membrane	NA	NA	------	437	NA					IPR029005 (PFAM)	no GO terms	no GO terms	322.355333968863	1.98719061560312	0.330455456240962	6.01349010304765	1.81571020911622e-09	1.27567517705113e-07
Avas.s003.g52.i1	homolog_cluster_11471	NA	Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Myosin family	0.00044	53.1	Opisthokonta	NA	NA	NA	NA	NA	NA	------	524	NA					IPR000980 (PFAM); IPR001849 (PFAM); IPR000980 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES)	no GO terms	no GO terms	450.668576147839	1.91397352956973	0.244291586037339	7.83479104056079	4.69623061868485e-15	6.86887767491096e-13
Avas.s003.g69.i1	paralog_cluster_08546	stnB	Stonin 2	3.9e-111	409.1	Metazoa	NA	13	F:GO:0097110; P:GO:0007268; P:GO:0097480; P:GO:1900242; P:GO:0046907; C:GO:0048786; C:GO:0008021; P:GO:0040017; P:GO:0098693; P:GO:0060341; P:GO:0048489; C:GO:0030139; P:GO:0098657	P:chemical synaptic transmission; P:regulation of cellular localization; P:import into cell; C:synaptic vesicle; F:scaffold protein binding; P:positive regulation of locomotion; P:establishment of synaptic vesicle localization; C:endocytic vesicle; P:intracellular transport; P:synaptic vesicle transport; P:regulation of synaptic vesicle endocytosis; C:presynaptic active zone; P:regulation of synaptic vesicle cycle	K20067	NA	STON2_HUMAN | Stonin-2 OS=Homo sapiens OX=9606 GN=STON2 PE=1 SV=1	643	3.9e-34	P:GO:0006897; P:GO:0022607; P:GO:0032879; P:GO:0050794; P:GO:0051649; P:GO:0099003; F:GO:0005515; C:GO:0012505; C:GO:0030136; C:GO:0030139; C:GO:0030659; C:GO:0045202; C:GO:0098588	P:endocytosis; P:cellular component assembly; P:regulation of localization; P:regulation of cellular process; P:establishment of localization in cell; P:vesicle-mediated transport in sypse; F:protein binding; C:endomembrane system; C:clathrin-coated vesicle; C:endocytic vesicle; C:cytoplasmic vesicle membrane; C:sypse; C:bounding membrane of organelle			IPR028565 (PFAM); IPR000293 (PROSITE_PATTERNS); IPR012320 (PROSITE_PROFILES); IPR028565 (PROSITE_PROFILES)	P:GO:0006897; P:GO:0019835; P:GO:0050829; C:GO:0016021	P:endocytosis; P:cytolysis; P:defense response to Gram-negative bacterium; C:integral component of membrane	962.939137769321	1.60609712209043	0.271115918060832	5.92402369281047	3.14158163814694e-09	2.09729904465336e-07
Avas.s003.g103.i1	paralog_cluster_00259	NA	actin filament severing	1.2e-112	413.3	Metazoa	NA	NA	NA	NA	K05768	map04666, map04810, map05203	GELS1_LUMTE | Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1	368	3.8e-98	P:GO:0030043; P:GO:0045010; P:GO:0050896; P:GO:0051014; P:GO:0051017; P:GO:0051693; F:GO:0003729; F:GO:0005509; F:GO:0051015; C:GO:0005737; C:GO:0005884	P:actin filament fragmentation; P:actin nucleation; P:response to stimulus; P:actin filament severing; P:actin filament bundle assembly; P:actin filament capping; F:mR binding; F:calcium ion binding; F:actin filament binding; C:cytoplasm; C:actin filament			IPR007123 (PFAM)	no GO terms	no GO terms	5303.47131653187	3.01312615175103	0.256364077767085	11.7533087240427	6.79068204920676e-32	3.90197441034599e-29
Avas.s003.g185.i1	paralog_cluster_00108	NA	cytochrome P450	3.4e-94	352.4	Rodentia	EC:1.14.13.194; EC:1.14.13.30	NA	NA	NA	K17726	map00590, map01100	CP4F2_HUMAN | Cytochrome P450 4F2 OS=Homo sapiens OX=9606 GN=CYP4F2 PE=1 SV=1	506	3e-90	P:GO:0000038; P:GO:0003091; P:GO:0003095; P:GO:0006805; P:GO:0006950; P:GO:0010430; P:GO:0019373; P:GO:0032304; P:GO:0032305; P:GO:0036101; P:GO:0042360; P:GO:0042361; P:GO:0042376; P:GO:0046513; P:GO:0055078; P:GO:0097267; P:GO:1905344; F:GO:0005504; F:GO:0005515; F:GO:0008392; F:GO:0018685; F:GO:0020037; F:GO:0050051; F:GO:0052869; F:GO:0052871; F:GO:0052872; F:GO:0102033; F:GO:0120319; C:GO:0005789; C:GO:0016324	P:very long-chain fatty acid metabolic process; P:rel water homeostasis; P:pressure triuresis; P:xenobiotic metabolic process; P:response to stress; P:fatty acid omega-oxidation; P:epoxygese P450 pathway; P:negative regulation of icosanoid secretion; P:positive regulation of icosanoid secretion; P:leukotriene B4 catabolic process; P:vitamin E metabolic process; P:mequinone catabolic process; P:phylloquinone catabolic process; P:ceramide biosynthetic process; P:sodium ion homeostasis; P:omega-hydroxylase P450 pathway; P:prostaglandin catabolic process; F:fatty acid binding; F:protein binding; F:arachidonic acid epoxygese activity; F:alkane 1-monooxygese activity; F:heme binding; F:leukotriene-B4 20-monooxygese activity; F:arachidonic acid omega-hydroxylase activity; F:alpha-tocopherol omega-hydroxylase activity; F:tocotrienol omega-hydroxylase activity; F:long-chain fatty acid omega-hydroxylase activity; F:long-chain fatty acid omega-1 hydroxylase activity; C:endoplasmic reticulum membrane; C:apical plasma membrane	EC:1.14.15.3; EC:1.14.14.80; EC:1.14.14.94; EC:1.14.13	Alkane 1-monooxygese; Long-chain fatty acid omega-monooxygese; Leukotriene-B(4) 20-monooxygese; Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2)	IPR001128 (PFAM); IPR017972 (PROSITE_PATTERNS)	F:GO:0004497; F:GO:0005506; F:GO:0016705; F:GO:0020037	F:monooxygese activity; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:heme binding	47.3236896646391	4.89988701356713	0.898315768881759	5.45452632949615	4.91035593608437e-08	2.6690106978264e-06
Avas.s003.g218.i1	homolog_cluster_11493	XPO4	Exportin 4	1.1e-145	524.6	Actinopterygii	NA	7	P:GO:0090087; C:GO:0005643; C:GO:0005654; F:GO:0005049; F:GO:0031267; P:GO:0046827; C:GO:0005829	P:positive regulation of protein export from nucleus; P:regulation of peptide transport; F:nuclear export signal receptor activity; F:small GTPase binding; C:nuclear pore; C:cytosol; C:nucleoplasm	NA	NA	XPO4_CHICK | Exportin-4 OS=Gallus gallus OX=9031 GN=XPO4 PE=2 SV=1	1133	4.7e-147	P:GO:0006810; C:GO:0005634; C:GO:0005737	P:transport; C:nucleus; C:cytoplasm			no IPS match	no IPS match	no IPS match	587.902378260367	3.0290027182169	0.223233064490284	13.5687906499565	6.13255046688857e-42	6.16666277886064e-39
Avas.s003.g260.i1	paralog_cluster_00840	NA	Prolyl 4-hydroxylase	1.9e-103	383.3	Actinopterygii	EC:1.14.11.2	NA	NA	NA	K00472	map00330, map01100	P4HA1_MOUSE | Prolyl 4-hydroxylase subunit alpha-1 OS=Mus musculus OX=10090 GN=P4ha1 PE=1 SV=2	536	6.3e-102	P:GO:0018401; P:GO:0030199; F:GO:0004656; F:GO:0042802; C:GO:0005654; C:GO:0005739; C:GO:0005829; C:GO:0016222	P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; P:collagen fibril organization; F:procollagen-proline 4-dioxygese activity; F:identical protein binding; C:nucleoplasm; C:mitochondrion; C:cytosol; C:procollagen-proline 4-dioxygese complex	EC:1.14.11.2	Procollagen-proline 4-dioxygese	IPR044862 (PFAM); IPR013547 (PFAM); IPR005123 (PROSITE_PROFILES)	F:GO:0004656; C:GO:0005783	F:procollagen-proline 4-dioxygese activity; C:endoplasmic reticulum	1105.27805854157	3.37009028910999	0.32576304927076	10.3452196209918	4.39906498321513e-25	1.31067697249904e-22
Avas.s003.g314.i1	homolog_cluster_11506	NA	GTP-dependent protein binding	1.9e-27	130.6	Metazoa	NA	NA	NA	NA	K07883	NA	SEC4_CANGA | Ras-related protein SEC4 OS=Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) OX=284593 GN=SEC4 PE=3 SV=1	458	1.5e-27	P:GO:0001525; P:GO:0001881; P:GO:0006887; P:GO:0006893; P:GO:0006914; P:GO:0006996; P:GO:0007107; P:GO:0010737; P:GO:0015031; P:GO:0031175; P:GO:0031321; P:GO:0032456; P:GO:0070830; P:GO:0070887; P:GO:0072659; P:GO:1902647; P:GO:1904515; P:GO:1904951; F:GO:0003924; F:GO:0005525; F:GO:0030742; F:GO:0032794; F:GO:0071532; F:GO:0080115; C:GO:0000131; C:GO:0005769; C:GO:0005777; C:GO:0005797; C:GO:0005802; C:GO:0005829; C:GO:0005923; C:GO:0016328; C:GO:0030133; C:GO:0030139; C:GO:0030424; C:GO:0031045; C:GO:0043025; C:GO:0043332; C:GO:0055038; C:GO:0062040	P:angiogenesis; P:receptor recycling; P:exocytosis; P:Golgi to plasma membrane transport; P:autophagy; P:organelle organization; P:membrane addition at site of cytokinesis; P:protein kise A sigling; P:protein transport; P:neuron projection development; P:ascospore-type prospore assembly; P:endocytic recycling; P:bicellular tight junction assembly; P:cellular response to chemical stimulus; P:protein localization to plasma membrane; P:negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; P:positive regulation of TORC2 sigling; P:positive regulation of establishment of protein localization; F:GTPase activity; F:GTP binding; F:GTP-dependent protein binding; F:GTPase activating protein binding; F:ankyrin repeat binding; F:myosin XI tail binding; C:incipient cellular bud site; C:early endosome; C:peroxisome; C:Golgi medial cister; C:trans-Golgi network; C:cytosol; C:bicellular tight junction; C:lateral plasma membrane; C:transport vesicle; C:endocytic vesicle; C:axon; C:dense core granule; C:neurol cell body; C:mating projection tip; C:recycling endosome membrane; C:fungal biofilm matrix	EC:3.6.1	Acting on acid anhydrides	IPR001806 (PFAM); IPR001806 (PROSITE_PROFILES); PS51419 (PROSITE_PROFILES)	F:GO:0003924; F:GO:0005525	F:GTPase activity; F:GTP binding	187.527643219008	1.49475719009001	0.249631781037375	5.98784811724841	2.12635482756611e-09	1.47460874227203e-07
Avas.s003.g336.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	39	NA					no IPS match	no IPS match	no IPS match	38.2280697974552	4.3836503415924	0.640298918930681	6.84625604071491	7.58077493531836e-12	7.67088603360611e-10
Avas.s003.g337.i1	NA	NA	Cysteine-rich venom protein	9.7e-30	137.9	Nematocera	NA	NA	NA	NA	NA	NA	------	371	NA					IPR002919 (PFAM)	no GO terms	no GO terms	717.386378005028	5.80756662745769	1.0509217386241	5.52616471238016	3.27306864190931e-08	1.84773338174312e-06
Avas.s003.g344.i1	paralog_cluster_08557	NA	phosphatidylglycerol phosphatidylinositol transfer protein	1.4e-17	96.3	Opisthokonta	NA	3	C:GO:0000328; P:GO:0032366; P:GO:0061024	P:membrane organization; P:intracellular sterol transport; C:fungal-type vacuole lumen	NA	NA	Y2107_DICDI | Putative phosphatidylglycerol/phosphatidylinositol transfer protein DDB_G0282107 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0282107 PE=3 SV=1	164	2e-14	P:GO:0006869; P:GO:0008150; P:GO:0015918; F:GO:0003674; F:GO:0032934; C:GO:0005575	P:lipid transport; P:biological_process; P:sterol transport; F:molecular_function; F:sterol binding; C:cellular_component			IPR003172 (PFAM)	no GO terms	no GO terms	1457.88462901455	3.29063625026986	0.624709779842576	5.26746395918292	1.38321306150139e-07	6.92816499504668e-06
Avas.s003.g364.i1	homolog_cluster_11520	EPB41L2	Erythrocyte membrane protein band 4.1-like 2	4.9e-53	215.3	Metatheria	NA	14	C:GO:0099738; P:GO:1904778; C:GO:0008091; P:GO:0031032; F:GO:0003779; F:GO:0042731; C:GO:0005654; C:GO:0005886; P:GO:0051128; P:GO:0008360; F:GO:0005200; F:GO:0030507; C:GO:0005829; C:GO:0030054	P:regulation of cell shape; C:spectrin; C:cell cortex region; P:actomyosin structure organization; P:regulation of cellular component organization; C:plasma membrane; C:cytosol; P:positive regulation of protein localization to cell cortex; F:spectrin binding; F:structural constituent of cytoskeleton; F:PH domain binding; F:actin binding; C:cell junction; C:nucleoplasm	K06107	NA	EPB41_BOVIN | Protein 4.1 OS=Bos taurus OX=9913 GN=EPB41 PE=2 SV=1	383	1.7e-53	P:GO:0002175; P:GO:0008360; P:GO:0030036; P:GO:0030913; P:GO:0032092; P:GO:0043217; P:GO:0048812; P:GO:0051924; P:GO:0061564; P:GO:0071205; P:GO:0072659; P:GO:1904478; P:GO:1904778; P:GO:1990227; F:GO:0005198; F:GO:0005545; F:GO:0008022; F:GO:0030507; F:GO:0042731; F:GO:0047485; F:GO:0051219; C:GO:0005829; C:GO:0005911; C:GO:0008180; C:GO:0014069; C:GO:0015629; C:GO:0016323; C:GO:0016604; C:GO:0030673; C:GO:0030863; C:GO:0033270; C:GO:0044224; C:GO:0045171; C:GO:0072686	P:protein localization to paranode region of axon; P:regulation of cell shape; P:actin cytoskeleton organization; P:paranodal junction assembly; P:positive regulation of protein binding; P:myelin maintence; P:neuron projection morphogenesis; P:regulation of calcium ion transport; P:axon development; P:protein localization to juxtaparanode region of axon; P:protein localization to plasma membrane; P:regulation of intestil absorption; P:positive regulation of protein localization to cell cortex; P:paranodal junction maintence; F:structural molecule activity; F:1-phosphatidylinositol binding; F:protein C-terminus binding; F:spectrin binding; F:PH domain binding; F:protein N-terminus binding; F:phosphoprotein binding; C:cytosol; C:cell-cell junction; C:COP9 siglosome; C:postsyptic density; C:actin cytoskeleton; C:basolateral plasma membrane; C:nuclear body; C:axolemma; C:cortical cytoskeleton; C:paranode region of axon; C:juxtaparanode region of axon; C:intercellular bridge; C:mitotic spindle			IPR018980 (PFAM); IPR018979 (PFAM); IPR019748 (PFAM); IPR000299 (PROSITE_PROFILES)	C:GO:0005856	C:cytoskeleton	206.131343384143	1.27683145801528	0.245297962235792	5.20522651871004	1.93760107064901e-07	9.41814611047493e-06
Avas.s003.g368.i1	homolog_cluster_11521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	383	NA					no IPS match	no IPS match	no IPS match	571.493344685629	1.25678943597747	0.24010575793695	5.23431610626971	1.65596843833858e-07	8.14766856404569e-06
Avas.s003.g379.i1	homolog_cluster_18298	ADCY10	bicarbonate binding	7.4e-200	705.3	Metazoa	EC:4.6.1.1	17	P:GO:0003351; F:GO:0071890; C:GO:0016020; F:GO:0004016; F:GO:0051117; C:GO:0030426; F:GO:0030145; P:GO:0071241; C:GO:0045177; C:GO:0043025; C:GO:0045178; C:GO:0048471; P:GO:0043065; C:GO:0030425; C:GO:0005634; P:GO:0006171; C:GO:0005829	C:basal part of cell; C:membrane; C:dendrite; C:perinuclear region of cytoplasm; F:bicarbonate binding; P:cellular response to inorganic substance; P:positive regulation of apoptotic process; F:ATPase binding; C:cytosol; F:manganese ion binding; C:neuronal cell body; P:cAMP biosynthetic process; C:growth cone; C:nucleus; F:adenylate cyclase activity; P:epithelial cilium movement involved in extracellular fluid movement; C:apical part of cell	K11265	map00230, map04024, map04371, map04713, map04714	ADCYA_HUMAN | Adenylate cyclase type 10 OS=Homo sapiens OX=9606 GN=ADCY10 PE=1 SV=3	1803	1.4e-108	P:GO:0009987; F:GO:0043167; C:GO:0005737; C:GO:0043227; C:GO:0043229; C:GO:0120025	P:cellular process; F:ion binding; C:cytoplasm; C:membrane-bounded organelle; C:intracellular organelle; C:plasma membrane bounded cell projection			IPR001054 (PFAM); IPR041664 (PFAM); IPR001054 (PROSITE_PROFILES); IPR001054 (PROSITE_PROFILES)	P:GO:0009190; P:GO:0035556	P:cyclic nucleotide biosynthetic process; P:intracellular sigl transduction	72.9650714139277	1.92603693313627	0.316240685578331	6.09041474095593	1.12618548383609e-09	7.98202566054573e-08
Avas.s003.g382.i1	paralog_cluster_07118	NA	Sulfotransferase family	3.5e-45	189.5	Metazoa	NA	NA	NA	NA	NA	NA	------	459	NA					IPR000863 (PFAM)	F:GO:0008146	F:sulfotransferase activity	151.83245931221	1.70831365852507	0.31878012009597	5.3589090123022	8.37260056894506e-08	4.37359644655055e-06
Avas.s003.g509.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	96	NA					no IPS match	no IPS match	no IPS match	238.327744328722	1.90911033540296	0.226408636368324	8.43214448894607	3.39387571806582e-17	6.06711849199566e-15
Avas.s003.g955.i1	paralog_cluster_01158	SAMHD1	dGTPase activity	3.6e-116	425.6	Vertebrata	NA	17	P:GO:0034404; P:GO:0002252; P:GO:0006203; F:GO:0003723; P:GO:0051289; F:GO:0008832; F:GO:0032567; P:GO:0060337; F:GO:0042802; F:GO:0008270; P:GO:0051607; P:GO:0090501; C:GO:0005654; C:GO:0005886; P:GO:0045088; F:GO:0004540; P:GO:0046061	P:dATP catabolic process; F:ribonuclease activity; P:defense response to virus; F:dGTPase activity; P:immune effector process; P:nucleobase-containing small molecule biosynthetic process; F:zinc ion binding; P:protein homotetramerization; F:dGTP binding; C:plasma membrane; P:regulation of innate immune response; P:dGTP catabolic process; P:RNA phosphodiester bond hydrolysis; F:RNA binding; F:identical protein binding; P:type I interferon signaling pathway; C:nucleoplasm	K12830	map03040	SAMH1_CHICK | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Gallus gallus OX=9031 GN=SAMHD1 PE=2 SV=2	574	1.1e-112	P:GO:0000724; P:GO:0006203; P:GO:0016446; P:GO:0046061; P:GO:0051289; P:GO:0051607; P:GO:0060339; P:GO:0110025; F:GO:0003697; F:GO:0003723; F:GO:0004540; F:GO:0008270; F:GO:0008832; F:GO:0032567; F:GO:0042802; C:GO:0005654; C:GO:0035861; C:GO:0097197	P:double-strand break repair via homologous recombition; P:dGTP catabolic process; P:somatic hypermutation of immunoglobulin genes; P:dATP catabolic process; P:protein homotetramerization; P:defense response to virus; P:negative regulation of type I interferon-mediated sigling pathway; P:D strand resection involved in replication fork processing; F:single-stranded D binding; F:R binding; F:ribonuclease activity; F:zinc ion binding; F:dGTPase activity; F:dGTP binding; F:identical protein binding; C:nucleoplasm; C:site of double-strand break; C:tetraspanin-enriched microdomain	EC:3.1.5.1	dGTPase	IPR006674 (PFAM)	no GO terms	no GO terms	442.224805270524	3.61901985350321	0.575847311564899	6.28468654940545	3.28515839756125e-10	2.64274567291814e-08
Avas.s003.g1012.i1	paralog_cluster_05533	NA	NA	1.8e-06	60.8	Metazoa	NA	NA	NA	NA	NA	NA	------	440	NA					IPR017981 (PROSITE_PROFILES)	P:GO:0007166; F:GO:0004888; C:GO:0016021	P:cell surface receptor sigling pathway; F:transmembrane sigling receptor activity; C:integral component of membrane	272.828718226299	1.685469515221	0.30399211066374	5.54445150415556	2.94877044638992e-08	1.69438456114169e-06
Avas.s003.g1026.i1	paralog_cluster_00028	NA	Calmodulin	6.6e-23	114	Piroplasmida	NA	NA	NA	NA	K02183	map04014, map04015, map04016, map04020, map04022, map04024, map04070, map04114, map04218, map04261, map04270, map04371, map04626, map04713, map04720, map04722, map04728, map04740, map04744, map04745, map04750, map04910, map04912, map04915, map04916, map04921, map04922, map04924, map04925, map04970, map04971, map05010, map05031, map05034, map05133, map05152, map05167, map05200, map05214, map05418	CALM_METSE | Calmodulin OS=Metridium senile OX=6116 PE=1 SV=3	164	1.7e-26	P:GO:0019722; F:GO:0005509; F:GO:0046872	P:calcium-mediated sigling; F:calcium ion binding; F:metal ion binding			IPR002048 (PFAM); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES)	F:GO:0005509	F:calcium ion binding	235.452528937956	2.71917365778085	0.250319690981901	10.862803669638	1.73343995989505e-27	6.33848079880716e-25
Avas.s003.g1049.i1	homolog_cluster_18327	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	105	NA					IPR000626 (PFAM)	F:GO:0005515	F:protein binding	658.15444478795	3.58489302085311	0.429486921131996	8.34692011436444	7.00660748047631e-17	1.19924795482323e-14
Avas.s004.g26.i1	homolog_cluster_11692	NA	smooth muscle contraction	3.1e-08	68.2	Euarchontoglires	NA	NA	NA	NA	NA	NA	------	1217	NA					IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES)	no GO terms	no GO terms	177.999375129895	2.5339062256116	0.368091666733784	6.88390000267028	5.82357616246399e-12	6.00612287678738e-10
Avas.s004.g29.i1	paralog_cluster_06217	PIK3R5	1-phosphatidylinositol-3-kinase regulator activity	7.3e-27	129.8	Metazoa	NA	15	P:GO:1903725; P:GO:0030168; P:GO:0007186; F:GO:0031683; P:GO:0043406; P:GO:0046834; P:GO:0046854; F:GO:0046934; F:GO:0046935; P:GO:0014065; P:GO:0043551; P:GO:0051897; C:GO:0005944; C:GO:0005815; C:GO:0005829	P:regulation of phosphatidylinositol 3-kinase activity; P:G protein-coupled receptor signaling pathway; P:positive regulation of protein kinase B signaling; P:lipid phosphorylation; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; C:microtubule organizing center; C:cytosol; P:platelet activation; F:1-phosphatidylinositol-3-kinase regulator activity; P:positive regulation of MAP kinase activity; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol phosphate biosynthetic process; P:regulation of phospholipid metabolic process; C:phosphatidylinositol 3-kinase complex, class IB; F:G-protein beta/gamma-subunit complex binding	K21290	map04022, map04072, map04151, map04261, map04371, map04611, map04725, map04921, map05145, map05167	------	1028	NA					IPR019522 (PFAM)	F:GO:0046935; C:GO:0005944	F:1-phosphatidylinositol-3-kise regulator activity; C:phosphatidylinositol 3-kise complex, class IB	44.4703841931024	2.19186811622356	0.420125328213111	5.2171768018512	1.8167083514409e-07	8.88420081043543e-06
Avas.s004.g76.i1	paralog_cluster_03173	PPP1R16B	protein phosphatase 1 regulatory	1.7e-08	67	Bilateria	NA	4	P:GO:0007476; P:GO:0043666; F:GO:0008157; F:GO:0017020	F:myosin phosphatase regulator activity; P:regulation of phosphoprotein phosphatase activity; F:protein phosphatase 1 binding; P:imaginal disc-derived wing morphogenesis	K17458,K17459	NA	ANK1_HUMAN | Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3	296	5.1e-13	P:GO:0006928; P:GO:0010646; P:GO:0016192; P:GO:0032414; P:GO:0033365; P:GO:0034330; P:GO:0035556; P:GO:0042221; P:GO:0043266; P:GO:0045184; P:GO:0048513; P:GO:0048523; P:GO:0048812; P:GO:0055065; P:GO:0055117; P:GO:0060341; P:GO:0061024; P:GO:0072659; P:GO:0086019; P:GO:0086070; P:GO:0098901; P:GO:1903169; P:GO:1904064; P:GO:2001257; F:GO:0008092; F:GO:0019899; C:GO:0005654; C:GO:0005856; C:GO:0005911; C:GO:0012505; C:GO:0030017; C:GO:0044304; C:GO:0045202; C:GO:0048471; C:GO:0098590	P:movement of cell or subcellular component; P:regulation of cell communication; P:vesicle-mediated transport; P:positive regulation of ion transmembrane transporter activity; P:protein localization to organelle; P:cell junction organization; P:intracellular sigl transduction; P:response to chemical; P:regulation of potassium ion transport; P:establishment of protein localization; P:animal organ development; P:negative regulation of cellular process; P:neuron projection morphogenesis; P:metal ion homeostasis; P:regulation of cardiac muscle contraction; P:regulation of cellular localization; P:membrane organization; P:protein localization to plasma membrane; P:cell-cell sigling involved in cardiac conduction; P:SA node cell to atrial cardiac muscle cell communication; P:regulation of cardiac muscle cell action potential; P:regulation of calcium ion transmembrane transport; P:positive regulation of cation transmembrane transport; P:regulation of cation channel activity; F:cytoskeletal protein binding; F:enzyme binding; C:nucleoplasm; C:cytoskeleton; C:cell-cell junction; C:endomembrane system; C:sarcomere; C:main axon; C:sypse; C:perinuclear region of cytoplasm; C:plasma membrane region			IPR002110 (PFAM); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); PS50297 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	599.723023780699	1.82130284985373	0.357215038264128	5.09861751258927	3.42143102824375e-07	1.57278296609753e-05
Avas.s004.g107.i1	paralog_cluster_08603	dscam	Down syndrome cell adhesion	1.2e-20	108.6	Actinopterygii	NA	NA	NA	NA	K06767	NA	IGDC3_MOUSE | Immunoglobulin superfamily DCC subclass member 3 OS=Mus musculus OX=10090 GN=Igdcc3 PE=2 SV=1	709	2.5e-13	C:GO:0016020	C:membrane			PF13927 (PFAM); IPR003961 (PFAM); IPR007110 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	107.662310377994	3.26325878889621	0.326338069193806	9.99962645166667	1.52972996398156e-23	4.17149582889818e-21
Avas.s004.g140.i1	paralog_cluster_00749	PYCR1	Pyrroline-5-carboxylate reductase	8.7e-60	237.3	Bilateria	EC:1.5.1.2	NA	NA	NA	K00286	map00330, map01100, map01110, map01130, map01230	P5CR1_BOVIN | Pyrroline-5-carboxylate reductase 1, mitochondrial OS=Bos taurus OX=9913 GN=PYCR1 PE=2 SV=1	276	7.3e-54	P:GO:0006561; P:GO:0051881; P:GO:1903206; F:GO:0004735; F:GO:0042802; C:GO:0005759	P:proline biosynthetic process; P:regulation of mitochondrial membrane potential; P:negative regulation of hydrogen peroxide-induced cell death; F:pyrroline-5-carboxylate reductase activity; F:identical protein binding; C:mitochondrial matrix	EC:1.5.1.2	Pyrroline-5-carboxylate reductase	IPR029036 (PFAM); IPR028939 (PFAM)	no GO terms	no GO terms	559.325733769781	3.34180383144157	0.368602572989988	9.06614352779447	1.23303988735684e-19	2.51118718325116e-17
Avas.s004.g3.i1	homolog_cluster_18334	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	193	NA					no IPS match	no IPS match	no IPS match	80.3915195750605	5.81653763882189	0.657228885563512	8.85009433788771	8.74453473535821e-19	1.67489070663307e-16
Avas.s004.g192.i1	homolog_cluster_11754	hmcn2	Hemicentin 2	5.8e-19	103.2	Actinopterygii	NA	NA	NA	NA	K17341	NA	MEGF6_HUMAN | Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4	813	1.6e-32	P:GO:0009653; P:GO:0016043; P:GO:0048513; P:GO:0048522; P:GO:0048523; P:GO:0050896; F:GO:0005515; C:GO:0031012	P:atomical structure morphogenesis; P:cellular component organization; P:animal organ development; P:positive regulation of cellular process; P:negative regulation of cellular process; P:response to stimulus; F:protein binding; C:extracellular matrix			IPR026823 (PFAM); IPR001611 (PFAM); IPR001881 (PFAM); IPR018097 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES)	F:GO:0005509; F:GO:0005515	F:calcium ion binding; F:protein binding	959.925586799937	3.86426529498759	0.271780636684045	14.2183245360483	7.05211940350384e-46	1.03146862802703e-42
Avas.s004.g252.i1	homolog_cluster_11765	EGFL7	EGF-like-domain, multiple 7	1.7e-17	97.1	Actinopterygii	NA	12	P:GO:0001938; P:GO:0001570; P:GO:0008039; C:GO:0005912; C:GO:0005615; P:GO:0044719; F:GO:0005112; P:GO:0016203; P:GO:0030336; F:GO:0005509; C:GO:0005927; P:GO:0045746	P:vasculogenesis; C:adherens junction; F:calcium ion binding; F:Notch binding; P:muscle attachment; C:extracellular space; P:synaptic target recognition; P:positive regulation of endothelial cell proliferation; P:regulation of imaginal disc-derived wing size; P:negative regulation of Notch signaling pathway; C:muscle tendon junction; P:negative regulation of cell migration	NA	NA	------	339	NA					IPR001881 (PFAM); IPR000742 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES)	F:GO:0005509	F:calcium ion binding	186.726261429064	4.36254622148649	0.520888423199045	8.37520287875441	5.5128819099489e-17	9.5372857042116e-15
Avas.s004.g254.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	120	NA					no IPS match	no IPS match	no IPS match	27.8772191147118	3.45820064824771	0.65719145533482	5.26209009593081	1.42426938777823e-07	7.09444897212506e-06
Avas.s004.g309.i1	paralog_cluster_05535	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	551	NA					no IPS match	no IPS match	no IPS match	681.725292208569	3.6026457101689	0.3899395445426	9.238985274999	2.48845872614584e-20	5.33824165932805e-18
Avas.s004.g390.i1	paralog_cluster_00507	NA	receptor-associated protein-like 2	1.2e-45	189.1	Metazoa	NA	NA	NA	NA	K08341	map04068, map04136, map04137, map04138, map04139, map04140, map04212, map04371, map04621, map04727, map05167	GBRL2_BOVIN | Gamma-aminobutyric acid receptor-associated protein-like 2 OS=Bos taurus OX=9913 GN=GABARAPL2 PE=1 SV=1	117	6.3e-39	P:GO:0000045; P:GO:0000422; P:GO:0006891; P:GO:0006995; P:GO:0015031; P:GO:0032781; P:GO:0070972; P:GO:1901799; F:GO:0000149; F:GO:0008017; F:GO:0008429; F:GO:0031625; F:GO:0048487; F:GO:0050811; F:GO:0051117; C:GO:0000139; C:GO:0000329; C:GO:0000421; C:GO:0005789; C:GO:0005829; C:GO:0033110	P:autophagosome assembly; P:autophagy of mitochondrion; P:intra-Golgi vesicle-mediated transport; P:cellular response to nitrogen starvation; P:protein transport; P:positive regulation of ATP-dependent activity; P:protein localization to endoplasmic reticulum; P:negative regulation of proteasomal protein catabolic process; F:SRE binding; F:microtubule binding; F:phosphatidylethanolamine binding; F:ubiquitin protein ligase binding; F:beta-tubulin binding; F:GABA receptor binding; F:ATPase binding; C:Golgi membrane; C:fungal-type vacuole membrane; C:autophagosome membrane; C:endoplasmic reticulum membrane; C:cytosol; C:Cvt vesicle membrane			IPR004241 (PFAM)	no GO terms	no GO terms	4480.253433677	3.49688161842242	0.421667535622869	8.29298279569229	1.10443320194327e-16	1.8509610193818e-14
Avas.s004.g671.i1	paralog_cluster_18351	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	564	NA					no IPS match	no IPS match	no IPS match	23.1351252540447	-3.14969737778509	0.652224166215564	-4.82916386870598	1.37107544472106e-06	5.62735531380538e-05
Avas.s004.g676.i1	homolog_cluster_11833	NA	zinc ion binding	7.6e-07	62	Eukaryota	NA	NA	NA	NA	NA	NA	------	418	NA					no IPS match	no IPS match	no IPS match	107.150145484901	-5.86510034081352	0.941061794926731	-6.23242848921538	4.592592069513e-10	3.60440067348267e-08
Avas.s004.g800.i1	paralog_cluster_00399	CTSB	Cathepsin B	3.1e-91	342	Cetartiodactyla	EC:3.4.22.1	39	F:GO:0030984; P:GO:0006914; P:GO:0009749; P:GO:0097067; C:GO:0009897; P:GO:0014075; P:GO:0043312; C:GO:1904813; P:GO:0042981; P:GO:0043434; C:GO:0005730; F:GO:0043621; C:GO:0048471; F:GO:0004252; F:GO:0004197; F:GO:0042277; C:GO:0005615; C:GO:0016324; P:GO:0045471; C:GO:0005739; P:GO:0051603; P:GO:0009611; C:GO:0042383; P:GO:0030574; P:GO:0009410; P:GO:0070670; P:GO:0007519; P:GO:0046718; P:GO:0071260; F:GO:0005518; P:GO:0014070; P:GO:0060548; P:GO:0009636; P:GO:0046677; P:GO:0046697; P:GO:0007283; C:GO:0036021; F:GO:0043394; P:GO:0030855	P:cellular response to thyroid hormone stimulus; C:endolysosome lumen; C:extracellular space; F:protein self-association; P:response to toxic substance; F:kininogen binding; C:perinuclear region of cytoplasm; P:proteolysis involved in cellular protein catabolic process; P:cellular response to mechanical stimulus; P:neutrophil degranulation; P:response to ethanol; P:regulation of apoptotic process; C:ficolin-1-rich granule lumen; P:response to amine; P:spermatogenesis; C:apical plasma membrane; C:nucleolus; P:negative regulation of cell death; P:epithelial cell differentiation; P:response to xenobiotic stimulus; P:collagen catabolic process; C:external side of plasma membrane; P:response to organic cyclic compound; P:autophagy; P:response to antibiotic; P:decidualization; P:skeletal muscle tissue development; F:proteoglycan binding; P:response to interleukin-4; P:response to wounding; P:viral entry into host cell; C:mitochondrion; F:serine-type endopeptidase activity; F:cysteine-type endopeptidase activity; P:response to peptide hormone; C:sarcolemma; P:response to glucose; F:peptide binding; F:collagen binding	K01363	map04140, map04142, map04210, map04612, map04621, map04924	CATB_SHEEP | Cathepsin B OS=Ovis aries OX=9940 GN=CTSB PE=1 SV=2	339	9.2e-91	P:GO:0006914; P:GO:0007283; P:GO:0007519; P:GO:0009611; P:GO:0009749; P:GO:0010466; P:GO:0014070; P:GO:0014075; P:GO:0030574; P:GO:0030855; P:GO:0042981; P:GO:0043434; P:GO:0045471; P:GO:0046697; P:GO:0051603; P:GO:0060548; P:GO:0070670; P:GO:0071260; P:GO:0097067; F:GO:0004197; F:GO:0005518; F:GO:0030984; F:GO:0042277; F:GO:0043394; F:GO:0043621; C:GO:0005615; C:GO:0005739; C:GO:0005901; C:GO:0009897; C:GO:0016324; C:GO:0036021; C:GO:0042383; C:GO:0048471; C:GO:1904090; C:GO:1904813	P:autophagy; P:spermatogenesis; P:skeletal muscle tissue development; P:response to wounding; P:response to glucose; P:negative regulation of peptidase activity; P:response to organic cyclic compound; P:response to amine; P:collagen catabolic process; P:epithelial cell differentiation; P:regulation of apoptotic process; P:response to peptide hormone; P:response to ethanol; P:decidualization; P:proteolysis involved in cellular protein catabolic process; P:negative regulation of cell death; P:response to interleukin-4; P:cellular response to mechanical stimulus; P:cellular response to thyroid hormone stimulus; F:cysteine-type endopeptidase activity; F:collagen binding; F:kininogen binding; F:peptide binding; F:proteoglycan binding; F:protein self-association; C:extracellular space; C:mitochondrion; C:caveola; C:exterl side of plasma membrane; C:apical plasma membrane; C:endolysosome lumen; C:sarcolemma; C:perinuclear region of cytoplasm; C:peptidase inhibitor complex; C:ficolin-1-rich granule lumen	EC:3.4.22	Acting on peptide bonds (peptidases)	IPR012599 (PFAM); IPR000668 (PFAM); IPR000169 (PROSITE_PATTERNS); IPR025660 (PROSITE_PATTERNS); IPR025661 (PROSITE_PATTERNS)	P:GO:0006508; P:GO:0050790; F:GO:0004197; F:GO:0008234	P:proteolysis; P:regulation of catalytic activity; F:cysteine-type endopeptidase activity; F:cysteine-type peptidase activity	469.888667112241	3.18532255305157	0.522601604780352	6.09512585479018	1.09351384785771e-09	7.80580633134442e-08
Avas.s004.g948.i1	paralog_cluster_01447	ATP6V1B2	V-type proton ATPase subunit B	1.6e-259	901.7	Metazoa	NA	20	C:GO:0016021; C:GO:0001726; C:GO:0042470; P:GO:0007035; C:GO:0033181; P:GO:0008286; P:GO:0033572; C:GO:0000221; F:GO:0016887; C:GO:0048471; P:GO:0016241; P:GO:0015833; C:GO:0043209; P:GO:0015988; F:GO:0046961; C:GO:0005769; F:GO:0008553; C:GO:0005902; C:GO:0005903; C:GO:0005829	C:early endosome; P:energy coupled proton transmembrane transport, against electrochemical gradient; P:peptide transport; F:ATP hydrolysis activity; C:vacuolar proton-transporting V-type ATPase, V1 domain; C:perinuclear region of cytoplasm; C:microvillus; C:melanosome; C:cytosol; C:myelin sheath; C:ruffle; C:plasma membrane proton-transporting V-type ATPase complex; P:transferrin transport; P:vacuolar acidification; C:brush border; C:integral component of membrane; F:P-type proton-exporting transporter activity; P:insulin receptor signaling pathway; F:proton-transporting ATPase activity, rotational mechanism; P:regulation of macroautophagy	K02147	map00190, map01100, map04145, map04150, map04721, map04966, map05110, map05120, map05323	VATB_MANSE | V-type proton ATPase subunit B OS=Manduca sexta OX=7130 GN=VHA55 PE=2 SV=1	530	1.2e-249	P:GO:0001503; P:GO:0003091; P:GO:0003096; P:GO:0006693; P:GO:0007035; P:GO:0007605; P:GO:0010468; P:GO:0016241; P:GO:0030534; P:GO:0035812; P:GO:0042048; P:GO:0042472; P:GO:0046034; P:GO:0055064; P:GO:0055074; P:GO:0055075; P:GO:0070072; P:GO:1902600; F:GO:0005515; F:GO:0005524; F:GO:0016787; F:GO:0046961; C:GO:0000221; C:GO:0001726; C:GO:0005769; C:GO:0005829; C:GO:0005902; C:GO:0005903; C:GO:0016021; C:GO:0016323; C:GO:0016324; C:GO:0016328; C:GO:0033181; C:GO:0042470; C:GO:0048471; C:GO:0098850	P:ossification; P:rel water homeostasis; P:rel sodium ion transport; P:prostaglandin metabolic process; P:vacuolar acidification; P:sensory perception of sound; P:regulation of gene expression; P:regulation of macroautophagy; P:adult behavior; P:rel sodium excretion; P:olfactory behavior; P:inner ear morphogenesis; P:ATP metabolic process; P:chloride ion homeostasis; P:calcium ion homeostasis; P:potassium ion homeostasis; P:vacuolar proton-transporting V-type ATPase complex assembly; P:proton transmembrane transport; F:protein binding; F:ATP binding; F:hydrolase activity; F:proton-transporting ATPase activity, rotatiol mechanism; C:vacuolar proton-transporting V-type ATPase, V1 domain; C:ruffle; C:early endosome; C:cytosol; C:microvillus; C:brush border; C:integral component of membrane; C:basolateral plasma membrane; C:apical plasma membrane; C:lateral plasma membrane; C:plasma membrane proton-transporting V-type ATPase complex; C:melanosome; C:perinuclear region of cytoplasm; C:extrinsic component of syptic vesicle membrane	EC:7.1.3.1; EC:3	H(+)-exporting diphosphatase; Hydrolases	IPR004100 (PFAM); IPR000194 (PFAM); IPR020003 (PROSITE_PATTERNS)	P:GO:0046034; P:GO:1902600; F:GO:0005524	P:ATP metabolic process; P:proton transmembrane transport; F:ATP binding	1499.01992499187	1.15887579639971	0.209604225869327	5.528876107308	3.22288843122756e-08	1.82581168908522e-06
Avas.s004.g978.i1	paralog_cluster_18360	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	330	NA					no IPS match	no IPS match	no IPS match	219.600065628702	3.04124934397747	0.565495326167646	5.37802737396253	7.53063687891921e-08	3.99869362194492e-06
Avas.s005.g217.i1	paralog_cluster_05538	hs6st2	6-O-sulfation enzyme which catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to position 6 of the N-sulfoglucosamine residue (GlcNS) of heparan sulfate	1e-58	234.2	Actinopterygii	NA	4	P:GO:0048048; P:GO:0001569; P:GO:0015015; F:GO:0017095	P:embryonic eye morphogenesis; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; F:heparan sulfate 6-O-sulfotransferase activity; P:branching involved in blood vessel morphogenesis	K08102	map00534	H6ST2_DANRE | Heparan-sulfate 6-O-sulfotransferase 2 OS=Danio rerio OX=7955 GN=hs6st2 PE=2 SV=2	388	2.5e-60	P:GO:0001569; P:GO:0015015; P:GO:0048048; P:GO:0048286; P:GO:0048666; P:GO:0060173; P:GO:0060716; F:GO:0005515; F:GO:0017095; F:GO:0050656; F:GO:0070492; C:GO:0016021	P:branching involved in blood vessel morphogenesis; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; P:embryonic eye morphogenesis; P:lung alveolus development; P:neuron development; P:limb development; P:labyrinthine layer blood vessel development; F:protein binding; F:heparan sulfate 6-O-sulfotransferase activity; F:3'-phosphoadenosine 5'-phosphosulfate binding; F:oligosaccharide binding; C:integral component of membrane	EC:2.8.2	Transferring sulfur-containing groups	IPR005331 (PFAM)	F:GO:0008146; C:GO:0016021	F:sulfotransferase activity; C:integral component of membrane	196.840236404845	2.6373030431165	0.409393009348276	6.44198357787029	1.17922043157322e-10	1.02002567331084e-08
Avas.s005.g234.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	27	NA					no IPS match	no IPS match	no IPS match	40.3550263239898	-2.3824611768258	0.503085943966421	-4.73569417988911	2.1830657026645e-06	8.5458258126932e-05
Avas.s005.g302.i1	homolog_cluster_11902	NA	GTPase inhibitor activity	4.3e-29	136	Chordata	NA	NA	NA	NA	NA	NA	------	431	NA					IPR035234 (PFAM); IPR019577 (PFAM)	F:GO:0005509	F:calcium ion binding	150.841135160541	4.91446601597306	0.419542046435399	11.7138819761413	1.08209267888803e-31	6.00337555538948e-29
Avas.s005.g897.i1	paralog_cluster_06231	NA	Nuclear factor (erythroid-derived 2)-like 3	0.48	41.2	Metazoa	NA	NA	NA	NA	K09040	NA	------	144	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	103.702356667387	2.79273475835647	0.50963169976452	5.47990786218142	4.25547384619188e-08	2.36907677202011e-06
Avas.s005.g900.i1	paralog_cluster_06231	cnc	regulation of odontoblast differentiation	0.00089	50.1	Opisthokonta	NA	26	P:GO:0008359; F:GO:0003700; P:GO:0051663; F:GO:0000976; P:GO:0006979; P:GO:0045995; C:GO:0005634; P:GO:0008340; P:GO:0051128; P:GO:0044087; C:GO:0005737; P:GO:2000112; P:GO:0034976; P:GO:1902875; P:GO:0008103; P:GO:0010628; P:GO:0060322; P:GO:0060465; P:GO:0007317; P:GO:1903429; P:GO:0045944; P:GO:0048813; P:GO:0060281; C:GO:0005703; P:GO:0036335; F:GO:0046982	P:response to oxidative stress; P:head development; P:regulation of pole plasm oskar mRNA localization; C:cytoplasm; P:regulation of cellular component organization; P:regulation of bicoid mRNA localization; P:oocyte microtubule cytoskeleton polarization; P:regulation of cellular component biogenesis; F:DNA-binding transcription factor activity; P:response to endoplasmic reticulum stress; P:dendrite morphogenesis; P:intestinal stem cell homeostasis; P:regulation of embryonic pattern specification; F:transcription cis-regulatory region binding; P:oocyte nucleus localization involved in oocyte dorsal/ventral axis specification; P:positive regulation of transcription by RNA polymerase II; P:regulation of oocyte development; P:positive regulation of gene expression; C:polytene chromosome puff; P:regulation of embryonic development; P:determination of adult lifespan; F:protein heterodimerization activity; P:regulation of cell maturation; P:pharynx development; C:nucleus; P:regulation of cellular macromolecule biosynthetic process	K09040,K09041	NA	------	125	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	348.116708012879	5.02189832882469	0.418012046792575	12.0137645968769	3.00831866517276e-33	1.93603356015858e-30
Avas.s005.g390.i1	paralog_cluster_00097	tbb-4	Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain	3.3e-194	684.5	Nematoda	NA	1	C:GO:0005879	C:axonemal microtubule	K07375	map04145, map04540, map05130	TBB1_DROME | Tubulin beta-1 chain OS=Drosophila melanogaster OX=7227 GN=betaTub56D PE=1 SV=2	442	3.1e-195	P:GO:0000278; P:GO:0031122; P:GO:1905789; P:GO:1905792; F:GO:0003924; F:GO:0005200; F:GO:0005525; C:GO:0005879; C:GO:0043005; C:GO:0043025	P:mitotic cell cycle; P:cytoplasmic microtubule organization; P:positive regulation of detection of mechanical stimulus involved in sensory perception of touch; P:positive regulation of mechanosensory behavior; F:GTPase activity; F:structural constituent of cytoskeleton; F:GTP binding; C:axonemal microtubule; C:neuron projection; C:neurol cell body	EC:3.6.1	Acting on acid anhydrides	IPR018316 (PFAM); IPR003008 (PFAM); IPR013838 (PROSITE_PATTERNS); IPR017975 (PROSITE_PATTERNS)	P:GO:0007017; F:GO:0003924; F:GO:0005525; C:GO:0005874	P:microtubule-based process; F:GTPase activity; F:GTP binding; C:microtubule	121.043727760837	2.63947548770354	0.402306698188901	6.5608539444804	5.35005039693623e-11	4.94695177220156e-09
Avas.s005.g418.i1	paralog_cluster_00036	NA	Rap protein signal transduction	9.1e-35	153.7	Metazoa	NA	NA	NA	NA	NA	NA	RALBA_XENLA | Ras-related protein ralB-A OS=Xenopus laevis OX=8355 GN=ralb-a PE=1 SV=1	197	4.1e-35	P:GO:0001843; P:GO:0001928; P:GO:0006935; P:GO:0007265; P:GO:0008543; P:GO:0009267; P:GO:0017157; P:GO:0030036; P:GO:0032091; P:GO:0032092; P:GO:0048070; P:GO:0051665; P:GO:0060178; P:GO:0071360; P:GO:0071902; P:GO:2000786; F:GO:0003924; F:GO:0005525; F:GO:0019003; F:GO:0031625; F:GO:0051117; C:GO:0005829; C:GO:0005886; C:GO:0005925; C:GO:0030496; C:GO:0030659	P:neural tube closure; P:regulation of exocyst assembly; P:chemotaxis; P:Ras protein sigl transduction; P:fibroblast growth factor receptor sigling pathway; P:cellular response to starvation; P:regulation of exocytosis; P:actin cytoskeleton organization; P:negative regulation of protein binding; P:positive regulation of protein binding; P:regulation of developmental pigmentation; P:membrane raft localization; P:regulation of exocyst localization; P:cellular response to exogenous dsR; P:positive regulation of protein serine/threonine kise activity; P:positive regulation of autophagosome assembly; F:GTPase activity; F:GTP binding; F:GDP binding; F:ubiquitin protein ligase binding; F:ATPase binding; C:cytosol; C:plasma membrane; C:focal adhesion; C:midbody; C:cytoplasmic vesicle membrane	EC:3.6.1	Acting on acid anhydrides	IPR001806 (PFAM); PS51419 (PROSITE_PROFILES); IPR001806 (PROSITE_PROFILES); PS51420 (PROSITE_PROFILES)	F:GO:0003924; F:GO:0005525	F:GTPase activity; F:GTP binding	261.753569994878	-1.33729508348436	0.225492702542667	-5.93054705719945	3.01927035467528e-09	2.02686205340873e-07
Avas.s005.g435.i1	homolog_cluster_11945	TRIM2	Tripartite motif-containing protein	3.9e-11	76.3	Bilateria	NA	NA	NA	NA	K11997	NA	LIN41_XENTR | E3-ubiquitin-protein ligase TRIM71 OS=Xenopus tropicalis OX=8364 GN=trim71 PE=3 SV=1	413	7.9e-20	P:GO:0009790; P:GO:0010468; P:GO:0044267; P:GO:0050794; F:GO:0005488	P:embryo development; P:regulation of gene expression; P:cellular protein metabolic process; P:regulation of cellular process; F:binding			no IPS match	no IPS match	no IPS match	26.980205646403	2.55664248163198	0.50947748670581	5.01816576462047	5.21671562779851e-07	2.28696833067167e-05
Avas.s005.g436.i1	paralog_cluster_00529	NA	chloride channel activity. It is involved in the biological process described with	5e-183	648.3	Insecta	NA	8	F:GO:0022839; C:GO:0005770; C:GO:0016020; F:GO:0015108; C:GO:0005764; P:GO:1902476; F:GO:0005247; P:GO:0050975	P:sensory perception of touch; C:membrane; F:ion gated channel activity; F:voltage-gated chloride channel activity; F:chloride transmembrane transporter activity; P:chloride transmembrane transport; C:late endosome; C:lysosome	K05016	NA	CLCN7_HUMAN | H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens OX=9606 GN=CLCN7 PE=1 SV=2	846	5e-178	P:GO:0009268; P:GO:0030321; P:GO:0034220; P:GO:0050789; F:GO:0005247; F:GO:0005515; F:GO:0022804; C:GO:0005654; C:GO:0005765; C:GO:0005768; C:GO:0034707	P:response to pH; P:transepithelial chloride transport; P:ion transmembrane transport; P:regulation of biological process; F:voltage-gated chloride channel activity; F:protein binding; F:active transmembrane transporter activity; C:nucleoplasm; C:lysosomal membrane; C:endosome; C:chloride channel complex	EC:7	Translocases	IPR000644 (PFAM); IPR001807 (PFAM); IPR000644 (PROSITE_PROFILES)	P:GO:0006821; P:GO:0055085; F:GO:0005247; C:GO:0016020	P:chloride transport; P:transmembrane transport; F:voltage-gated chloride channel activity; C:membrane	88.3851195304119	1.62099661928938	0.322234082121296	5.03049400801496	4.89217677499545e-07	2.16832595407443e-05
Avas.s005.g486.i1	paralog_cluster_00259	NA	protein secretion by the type VII secretion system	3.3e-17	95.9	Bacteria	NA	NA	NA	NA	NA	NA	------	287	NA					no IPS match	no IPS match	no IPS match	3196.39400872036	3.03618026143004	0.417761063844941	7.26774351225076	3.65542000348527e-13	4.38895913702048e-11
Avas.s005.g488.i1	homolog_cluster_11967	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	557	NA					no IPS match	no IPS match	no IPS match	67.4928893392296	1.67504864038494	0.312349823248087	5.3627327941675	8.19722218008416e-08	4.30997083841092e-06
Avas.s005.g501.i1	paralog_cluster_05022	ppkA	von Willebrand factor (vWF) type A domain	6e-13	84.3	Oscillatoriales	EC:2.7.11.1	NA	NA	NA	K11912	map02025, map03070	UNC22_CAEEL | Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3	1747	0.00068	P:GO:0006468; P:GO:0008344; P:GO:0016310; P:GO:0018105; P:GO:0018107; P:GO:0035095; P:GO:0040017; P:GO:0045989; P:GO:0051782; P:GO:0060298; P:GO:0090647; F:GO:0000166; F:GO:0004672; F:GO:0004674; F:GO:0004712; F:GO:0005516; F:GO:0005524; F:GO:0016301; F:GO:0016740; F:GO:0019901; F:GO:0046872; F:GO:0106310; C:GO:0005737; C:GO:0030017; C:GO:0031672	P:protein phosphorylation; P:adult locomotory behavior; P:phosphorylation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:behavioral response to nicotine; P:positive regulation of locomotion; P:positive regulation of striated muscle contraction; P:negative regulation of cell division; P:positive regulation of sarcomere organization; P:modulation of age-related behavioral decline; F:nucleotide binding; F:protein kise activity; F:protein serine/threonine kise activity; F:protein serine/threonine/tyrosine kise activity; F:calmodulin binding; F:ATP binding; F:kise activity; F:transferase activity; F:protein kise binding; F:metal ion binding; F:protein serine kise activity; C:cytoplasm; C:sarcomere; C:A band			IPR013098 (PFAM); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES)	no GO terms	no GO terms	2738.51282408909	2.59711046538307	0.360391692204406	7.20635497865485	5.7469467295101e-13	6.74909678329109e-11
Avas.s005.g504.i1	paralog_cluster_05022	NA	heparan sulfate proteoglycan	9e-12	79.7	Metazoa	NA	NA	NA	NA	NA	NA	------	1070	NA					IPR013098 (PFAM)	no GO terms	no GO terms	2245.64375162832	3.4400773796765	0.332601144312209	10.3429511248083	4.50448207007738e-25	1.31768385500864e-22
Avas.s005.g505.i1	paralog_cluster_05022	NA	heparan sulfate proteoglycan	7e-27	131.3	Metazoa	NA	NA	NA	NA	NA	NA	------	2861	NA					IPR013098 (PFAM); IPR008160 (PFAM); IPR007110 (PROSITE_PROFILES)	no GO terms	no GO terms	741.02322361115	3.56554238789571	0.376748993755265	9.46397322088636	2.96459254950221e-21	6.91265645346972e-19
Avas.s005.g511.i1	paralog_cluster_05022	NA	heparan sulfate proteoglycan	5.9e-13	84.3	Metazoa	NA	NA	NA	NA	NA	NA	------	1722	NA					IPR013098 (PFAM); IPR013151 (PFAM); IPR008160 (PFAM); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES)	no GO terms	no GO terms	725.605222305596	2.45272326939189	0.357986539162119	6.85143993160354	7.3110297631236e-12	7.44475682651238e-10
Avas.s005.g516.i1	paralog_cluster_00059	NA	Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain	4.1e-184	651	Actinopterygii	NA	NA	NA	NA	K07374	map04145, map04210, map04530, map04540, map05130	TBA1D_BOVIN | Tubulin alpha-1D chain OS=Bos taurus OX=9913 GN=TUBA1D PE=1 SV=1	448	1.2e-183	P:GO:0000226; P:GO:0000278; F:GO:0003924; F:GO:0005200; F:GO:0005515; F:GO:0005525; C:GO:0005737; C:GO:0005874; C:GO:0036064	P:microtubule cytoskeleton organization; P:mitotic cell cycle; F:GTPase activity; F:structural constituent of cytoskeleton; F:protein binding; F:GTP binding; C:cytoplasm; C:microtubule; C:ciliary basal body	EC:3.6.1	Acting on acid anhydrides	IPR003008 (PFAM); IPR018316 (PFAM); IPR017975 (PROSITE_PATTERNS)	P:GO:0007017; F:GO:0003924; F:GO:0005525; C:GO:0005874	P:microtubule-based process; F:GTPase activity; F:GTP binding; C:microtubule	180.80996544769	2.06847292527431	0.344417941514071	6.00570607959982	1.90501024439527e-09	1.33259607922068e-07
Avas.s005.g624.i1	paralog_cluster_00194	TAGLN3	actin binding	7.7e-31	140.6	Metazoa	NA	11	P:GO:0035626; C:GO:0005865; C:GO:0005634; P:GO:0010629; P:GO:0006939; C:GO:0043209; P:GO:0000122; F:GO:0003779; F:GO:0070594; P:GO:0007417; P:GO:2000113	C:myelin sheath; P:smooth muscle contraction; P:negative regulation of gene expression; F:juvenile hormone response element binding; C:striated muscle thin filament; P:negative regulation of transcription by RNA polymerase II; P:central nervous system development; F:actin binding; C:nucleus; P:juvenile hormone mediated signaling pathway; P:negative regulation of cellular macromolecule biosynthetic process	K20526	NA	TAGL2_MOUSE | Transgelin-2 OS=Mus musculus OX=10090 GN=Tagln2 PE=1 SV=4	190	5.6e-29	P:GO:0030855; F:GO:0005515; C:GO:0043227; C:GO:0043229	P:epithelial cell differentiation; F:protein binding; C:membrane-bounded organelle; C:intracellular organelle			IPR001715 (PFAM); IPR000557 (PFAM); IPR000557 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	530.430013082995	3.38218269237795	0.417095808353727	8.10888679444513	5.10856130574689e-16	8.38690233144508e-14
Avas.s005.g652.i1	homolog_cluster_12027	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	106	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	2338.87186536998	4.22386808016197	0.392333933780465	10.7660024190655	4.98164357259609e-27	1.66978465498955e-24
Avas.s005.g672.i1	paralog_cluster_01815	ATP6V1E1	V-type proton ATPase subunit E	9.6e-65	253.4	Metazoa	NA	17	P:GO:0007430; C:GO:0033181; P:GO:0008286; P:GO:0033572; F:GO:0051117; C:GO:0000221; F:GO:0016887; F:GO:0042625; P:GO:0016241; P:GO:0015833; C:GO:0005768; P:GO:0045176; P:GO:0015988; C:GO:0016324; F:GO:0008553; C:GO:0005902; C:GO:0005829	F:ATPase-coupled ion transmembrane transporter activity; P:energy coupled proton transmembrane transport, against electrochemical gradient; P:peptide transport; F:ATP hydrolysis activity; C:vacuolar proton-transporting V-type ATPase, V1 domain; C:endosome; F:ATPase binding; C:microvillus; P:apical protein localization; C:cytosol; C:plasma membrane proton-transporting V-type ATPase complex; P:transferrin transport; P:terminal branching, open tracheal system; F:P-type proton-exporting transporter activity; P:insulin receptor signaling pathway; C:apical plasma membrane; P:regulation of macroautophagy	K02150	map00190, map01100, map04145, map04150, map04721, map04966, map05110, map05120, map05323	VATE1_HUMAN | V-type proton ATPase subunit E 1 OS=Homo sapiens OX=9606 GN=ATP6V1E1 PE=1 SV=1	226	1.1e-63	P:GO:0016241; P:GO:0045851; P:GO:1902600; F:GO:0046961; F:GO:0051117; C:GO:0000221; C:GO:0001669; C:GO:0005768; C:GO:0005829; C:GO:0005902; C:GO:0016324	P:regulation of macroautophagy; P:pH reduction; P:proton transmembrane transport; F:proton-transporting ATPase activity, rotatiol mechanism; F:ATPase binding; C:vacuolar proton-transporting V-type ATPase, V1 domain; C:acrosomal vesicle; C:endosome; C:cytosol; C:microvillus; C:apical plasma membrane	EC:7.1.3.1	H(+)-exporting diphosphatase	IPR002842 (PFAM)	P:GO:1902600; F:GO:0046961; C:GO:0033178	P:proton transmembrane transport; F:proton-transporting ATPase activity, rotatiol mechanism; C:proton-transporting two-sector ATPase complex, catalytic domain	1525.48184972375	1.1692935967845	0.244780950341107	4.77689785563406	1.78020142713898e-06	7.05459624661062e-05
Avas.s005.g703.i1	paralog_cluster_00016	NA	cytoskeleton organization	2.4e-214	751.1	Chordata	NA	NA	NA	NA	K05692	map04015, map04145, map04210, map04390, map04391, map04510, map04520, map04530, map04611, map04670, map04714, map04745, map04810, map04919, map04921, map05100, map05110, map05130, map05131, map05132, map05164, map05205, map05225, map05410, map05412, map05414, map05416, map05418	ACTC_PISOC | Actin, cytoplasmic OS=Pisaster ochraceus OX=7612 PE=3 SV=1	376	1e-215	F:GO:0005524; C:GO:0005737; C:GO:0005856	F:ATP binding; C:cytoplasm; C:cytoskeleton			IPR004000 (PFAM); IPR004001 (PROSITE_PATTERNS); IPR004001 (PROSITE_PATTERNS); IPR020902 (PROSITE_PATTERNS)	no GO terms	no GO terms	3398.84702064086	3.3449269879839	0.287724253511274	11.6254606525648	3.05938607669696e-31	1.64074875293258e-28
Avas.s005.g756.i1	homolog_cluster_12053	feoB	Ferrous iron transport protein B	0.0044	49.7	Thermoanaerobacterales	NA	NA	NA	NA	K04759	NA	------	469	NA					IPR006703 (PFAM)	F:GO:0005525	F:GTP binding	239.414365852023	1.9833339722707	0.351860476193118	5.63670575828516	1.73333903057741e-08	1.04448283381872e-06
Avas.s005.g810.i1	paralog_cluster_00387	NA	O-acyltransferase activity. It is involved in the biological process described with lipid metabolic process	6.7e-77	294.7	Arthropoda	NA	NA	NA	NA	NA	NA	PAG15_CANLF | Phospholipase A2 group XV OS=Canis lupus familiaris OX=9615 GN=PLA2G15 PE=1 SV=1	400	3.2e-66	P:GO:0044242; P:GO:0046470; F:GO:0004623; F:GO:0008374; F:GO:0046872; C:GO:0005615; C:GO:0005773	P:cellular lipid catabolic process; P:phosphatidylcholine metabolic process; F:phospholipase A2 activity; F:O-acyltransferase activity; F:metal ion binding; C:extracellular space; C:vacuole	EC:3.1.1.1; EC:3.1.1.4; EC:2.3.1	Carboxylesterase; Phospholipase A(2); Acyltransferases	IPR003386 (PFAM)	P:GO:0006629; F:GO:0008374	P:lipid metabolic process; F:O-acyltransferase activity	95.3538211741521	-2.32642806703225	0.476408044183774	-4.88326781093318	1.04342000211126e-06	4.38318130913004e-05
Avas.s005.g816.i1	paralog_cluster_00265	NA	aspartic-type endopeptidase activity. It is involved in the biological process described with proteolysis	2.2e-93	349.4	Arthropoda	NA	NA	NA	NA	NA	NA	ASPP_AEDAE | Lysosomal aspartic protease OS=Aedes aegypti OX=7159 GN=AAEL006169 PE=1 SV=2	385	6.5e-93	P:GO:0012501; P:GO:0019886; P:GO:0031667; P:GO:0042159; P:GO:0043280; P:GO:0070265; F:GO:0004190; F:GO:0005515; F:GO:0042277; C:GO:0005576; C:GO:0005765; C:GO:0005769; C:GO:0032009; C:GO:0035580; C:GO:0043202; C:GO:0045121; C:GO:1904813	P:programmed cell death; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:response to nutrient levels; P:lipoprotein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:necrotic cell death; F:aspartic-type endopeptidase activity; F:protein binding; F:peptide binding; C:extracellular region; C:lysosomal membrane; C:early endosome; C:early phagosome; C:specific granule lumen; C:lysosomal lumen; C:membrane raft; C:ficolin-1-rich granule lumen	EC:3.4.23	Acting on peptide bonds (peptidases)	IPR033121 (PFAM); IPR001969 (PROSITE_PATTERNS); IPR001969 (PROSITE_PATTERNS); IPR033121 (PROSITE_PROFILES)	P:GO:0006508; F:GO:0004190	P:proteolysis; F:aspartic-type endopeptidase activity	594.581408623995	3.39411256639305	0.547091001592064	6.20392687234116	5.50713835322548e-10	4.21925471262118e-08
Avas.s005.g818.i1	paralog_cluster_01310	DCTD	dCMP deaminase activity	1.1e-60	239.6	Metazoa	EC:3.5.4.12	6	F:GO:0042802; P:GO:0006231; P:GO:0015949; F:GO:0004132; P:GO:0006226; C:GO:0005829	F:identical protein binding; P:dUMP biosynthetic process; P:nucleobase-containing small molecule interconversion; F:dCMP deaminase activity; C:cytosol; P:dTMP biosynthetic process	K01493	map00240, map01100	DCTD_POB | Deoxycytidylate deamise OS=Pongo abelii OX=9601 GN=DCTD PE=2 SV=1	172	2.8e-59	P:GO:0006226; P:GO:0006231; F:GO:0004132; F:GO:0008270; F:GO:0042802; C:GO:0005829	P:dUMP biosynthetic process; P:dTMP biosynthetic process; F:dCMP deamise activity; F:zinc ion binding; F:identical protein binding; C:cytosol	EC:3.5.4.12	dCMP deamise	IPR002125 (PFAM); IPR016192 (PROSITE_PATTERNS); IPR002125 (PROSITE_PROFILES)	F:GO:0008270; F:GO:0016787	F:zinc ion binding; F:hydrolase activity	143.763223910911	2.35953314514027	0.367476172568815	6.42091466406141	1.35457951589601e-10	1.14973717252922e-08
Avas.s005.g834.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	161	NA					no IPS match	no IPS match	no IPS match	1644.17702862199	-7.12197110923893	0.912911284038682	-7.80138358870056	6.12320764671973e-15	8.79609712750658e-13
Avas.s005.g852.i1	homolog_cluster_18394	ABCC4	ATP binding cassette subfamily C member 4	2.9e-116	427.2	Testudines	NA	NA	NA	NA	K05673	map01523, map02010, map04024, map04976	MRP4_HUMAN | ATP-binding cassette sub-family C member 4 OS=Homo sapiens OX=9606 GN=ABCC4 PE=1 SV=3	1332	2.3e-113	P:GO:0006869; P:GO:0010033; P:GO:0015718; P:GO:0015748; P:GO:0015849; P:GO:0016043; P:GO:0042908; P:GO:0048518; P:GO:0050794; P:GO:0051716; P:GO:0055085; P:GO:0071705; P:GO:0071715; P:GO:0140352; F:GO:0005319; F:GO:0140359; C:GO:0098590	P:lipid transport; P:response to organic substance; P:monocarboxylic acid transport; P:organophosphate ester transport; P:organic acid transport; P:cellular component organization; P:xenobiotic transport; P:positive regulation of biological process; P:regulation of cellular process; P:cellular response to stimulus; P:transmembrane transport; P:nitrogen compound transport; P:icosanoid transport; P:export from cell; F:lipid transporter activity; F:ABC-type transporter activity; C:plasma membrane region	EC:7	Translocases	IPR011527 (PFAM); IPR003439 (PFAM); IPR017871 (PROSITE_PATTERNS); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES); IPR011527 (PROSITE_PROFILES)	P:GO:0055085; F:GO:0005524; F:GO:0140359; C:GO:0016021	P:transmembrane transport; F:ATP binding; F:ABC-type transporter activity; C:integral component of membrane	22.136012857092	3.09262372741986	0.645351701147906	4.79215243706482	1.65001455509578e-06	6.636771044234e-05
Avas.s005.g861.i1	paralog_cluster_00415	SMAD9	Mothers against decapentaplegic homolog	2.9e-172	611.7	Rodentia	NA	20	P:GO:1901522; P:GO:0001880; P:GO:0010628; F:GO:0000981; P:GO:0001666; P:GO:0001657; P:GO:0060348; P:GO:0006468; P:GO:0045597; P:GO:0060395; C:GO:0005654; P:GO:0030509; C:GO:0071141; P:GO:0030902; P:GO:0051216; P:GO:0030901; P:GO:2000112; F:GO:0060089; C:GO:0005829; P:GO:0071407	C:SMAD protein complex; P:ureteric bud development; P:hindbrain development; P:response to hypoxia; P:Mullerian duct regression; F:molecular transducer activity; P:BMP signaling pathway; C:cytosol; P:bone development; F:DNA-binding transcription factor activity, RNA polymerase II-specific; P:cellular response to organic cyclic compound; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of cell differentiation; P:midbrain development; P:cartilage development; P:protein phosphorylation; P:regulation of cellular macromolecule biosynthetic process; P:SMAD protein signal transduction; C:nucleoplasm; P:positive regulation of gene expression	K16791	map04350, map04550	SMAD9_MOUSE | Mothers against decapentaplegic homolog 9 OS=Mus musculus OX=10090 GN=Smad9 PE=1 SV=2	463	6.7e-169	P:GO:0000122; P:GO:0001657; P:GO:0001666; P:GO:0001880; P:GO:0001945; P:GO:0001947; P:GO:0002051; P:GO:0003161; P:GO:0006468; P:GO:0007480; P:GO:0007488; P:GO:0008586; P:GO:0030218; P:GO:0030278; P:GO:0030707; P:GO:0030718; P:GO:0030901; P:GO:0030902; P:GO:0035019; P:GO:0035290; P:GO:0036342; P:GO:0042078; P:GO:0043049; P:GO:0045464; P:GO:0045669; P:GO:0045705; P:GO:0045887; P:GO:0048100; P:GO:0048264; P:GO:0048514; P:GO:0048922; P:GO:0051216; P:GO:0060021; P:GO:0060030; P:GO:0060037; P:GO:0060048; P:GO:0060348; P:GO:0060395; P:GO:0060799; P:GO:0071407; P:GO:1901522; P:GO:2000134; P:GO:2000223; F:GO:0000978; F:GO:0001227; F:GO:0001228; F:GO:0003713; F:GO:0017151; F:GO:0031625; F:GO:0061629; F:GO:0070411; C:GO:0000785; C:GO:0005654; C:GO:0005829; C:GO:0071144; C:GO:0090571	P:negative regulation of transcription by R polymerase II; P:ureteric bud development; P:response to hypoxia; P:Mullerian duct regression; P:lymph vessel development; P:heart looping; P:osteoblast fate commitment; P:cardiac conduction system development; P:protein phosphorylation; P:imagil disc-derived leg morphogenesis; P:histoblast morphogenesis; P:imagil disc-derived wing vein morphogenesis; P:erythrocyte differentiation; P:regulation of ossification; P:ovarian follicle cell development; P:germ-line stem cell population maintence; P:midbrain development; P:hindbrain development; P:somatic stem cell population maintence; P:trunk segmentation; P:post-al tail morphogenesis; P:germ-line stem cell division; P:otic placode formation; P:R8 cell fate specification; P:positive regulation of osteoblast differentiation; P:negative regulation of salivary gland boundary specification; P:positive regulation of syptic assembly at neuromuscular junction; P:wing disc anterior/posterior pattern formation; P:determition of ventral identity; P:blood vessel morphogenesis; P:posterior lateral line neuromast deposition; P:cartilage development; P:roof of mouth development; P:dorsal convergence; P:pharyngeal system development; P:cardiac muscle contraction; P:bone development; P:SMAD protein sigl transduction; P:transforming growth factor beta receptor sigling pathway involved in endodermal cell fate specification; P:cellular response to organic cyclic compound; P:positive regulation of transcription from R polymerase II promoter involved in cellular response to chemical stimulus; P:negative regulation of G1/S transition of mitotic cell cycle; P:regulation of BMP sigling pathway involved in heart jogging; F:R polymerase II cis-regulatory region sequence-specific D binding; F:D-binding transcription repressor activity, R polymerase II-specific; F:D-binding transcription activator activity, R polymerase II-specific; F:transcription coactivator activity; F:DEAD/H-box R helicase binding; F:ubiquitin protein ligase binding; F:R polymerase II-specific D-binding transcription factor binding; F:I-SMAD binding; C:chromatin; C:nucleoplasm; C:cytosol; C:heteromeric SMAD protein complex; C:R polymerase II transcription repressor complex			IPR003619 (PFAM); IPR001132 (PFAM); IPR013019 (PROSITE_PROFILES); IPR001132 (PROSITE_PROFILES)	P:GO:0006355; P:GO:0007179; C:GO:0005667	P:regulation of transcription, D-templated; P:transforming growth factor beta receptor sigling pathway; C:transcription regulator complex	697.605948241441	2.88247217427274	0.296621145974808	9.71768942770368	2.53467685264237e-22	6.17885089123683e-20
Avas.s005.g865.i1	paralog_cluster_00497	NA	Belongs to the sulfotransferase 1 family	1e-32	147.5	Carnivora	EC:2.8.2.3	NA	NA	NA	K16949	NA	ST3A1_MOUSE | Amine sulfotransferase OS=Mus musculus OX=10090 GN=Sult3a1 PE=2 SV=1	303	8.1e-30	P:GO:0008152; F:GO:0008146	P:metabolic process; F:sulfotransferase activity	EC:2.8.2	Transferring sulfur-containing groups	IPR000863 (PFAM)	F:GO:0008146	F:sulfotransferase activity	769.41218092053	-2.0169933125018	0.353335378551082	-5.70843859670339	1.14017296550187e-08	7.02844553331784e-07
Avas.s005.g898.i1	homolog_cluster_12108	NA	Bulb-type mannose-specific lectin	0.0033	48.5	Eukaryota	NA	NA	NA	NA	NA	NA	COMI_DICDI | Comitin OS=Dictyostelium discoideum OX=44689 GN=comA PE=1 SV=1	157	1.4e-06	P:GO:0006909; P:GO:0006972; P:GO:0009617; P:GO:0042742; P:GO:0046898; P:GO:0051017; P:GO:0051591; P:GO:0051707; F:GO:0003779; F:GO:0003785; F:GO:0005537; F:GO:0030246; F:GO:0042802; F:GO:0051015; C:GO:0000139; C:GO:0005737; C:GO:0005768; C:GO:0005794; C:GO:0005811; C:GO:0005856; C:GO:0005911; C:GO:0012505; C:GO:0016020; C:GO:0030660; C:GO:0030867; C:GO:0045335	P:phagocytosis; P:hyperosmotic response; P:response to bacterium; P:defense response to bacterium; P:response to cycloheximide; P:actin filament bundle assembly; P:response to cAMP; P:response to other organism; F:actin binding; F:actin monomer binding; F:mannose binding; F:carbohydrate binding; F:identical protein binding; F:actin filament binding; C:Golgi membrane; C:cytoplasm; C:endosome; C:Golgi apparatus; C:lipid droplet; C:cytoskeleton; C:cell-cell junction; C:endomembrane system; C:membrane; C:Golgi-associated vesicle membrane; C:rough endoplasmic reticulum membrane; C:phagocytic vesicle			IPR001480 (PROSITE_PROFILES)	no GO terms	no GO terms	139.887398004637	1.99689297464591	0.298042607246229	6.70002518464137	2.08383622801397e-11	2.03192976197071e-09
Avas.s005.g949.i1	homolog_cluster_12123	CD63	CD63 antigen	2.7e-09	69.3	Actinopterygii	NA	22	P:GO:0034613; P:GO:1901379; P:GO:1900746; C:GO:0031904; P:GO:0002576; P:GO:0043312; C:GO:0009986; C:GO:0032585; C:GO:0035577; P:GO:0045785; F:GO:0044877; C:GO:0005887; C:GO:0070062; P:GO:0007160; C:GO:0097487; P:GO:0002092; P:GO:2001046; P:GO:0030855; P:GO:0010633; P:GO:0035646; C:GO:0032991; C:GO:0031088	P:epithelial cell differentiation; C:integral component of plasma membrane; P:cell-matrix adhesion; P:platelet degranulation; P:positive regulation of receptor internalization; C:platelet dense granule membrane; P:positive regulation of cell adhesion; P:cellular protein localization; C:azurophil granule membrane; P:negative regulation of epithelial cell migration; C:endosome lumen; C:multivesicular body, internal vesicle; P:regulation of vascular endothelial growth factor signaling pathway; P:positive regulation of integrin-mediated signaling pathway; P:regulation of potassium ion transmembrane transport; C:extracellular exosome; F:protein-containing complex binding; C:cell surface; P:neutrophil degranulation; P:endosome to melanosome transport; C:protein-containing complex; C:multivesicular body membrane	K06497	map04142, map05205	------	237	NA					IPR018499 (PFAM)	C:GO:0016021	C:integral component of membrane	210.328805201896	1.81910646017499	0.359693055043108	5.05738555323783	4.25043353004122e-07	1.91555252282446e-05
Avas.s005.g1020.i1	homolog_cluster_12146	PPP1R3B	Protein phosphatase 1 regulatory	6e-16	91.7	Actinopterygii	NA	9	P:GO:0043666; P:GO:0005981; F:GO:0019888; F:GO:0019899; P:GO:0005979; C:GO:0000164; F:GO:0050196; C:GO:0042587; C:GO:0043231	C:protein phosphatase type 1 complex; P:regulation of glycogen biosynthetic process; P:regulation of phosphoprotein phosphatase activity; F:enzyme binding; C:intracellular membrane-bounded organelle; P:regulation of glycogen catabolic process; F:protein phosphatase regulator activity; C:glycogen granule; F:[phosphorylase] phosphatase activity	K07189	map04910, map04931	PPR3C_XENTR | Protein phosphatase 1 regulatory subunit 3C OS=Xenopus tropicalis OX=8364 GN=ppp1r3c PE=2 SV=1	279	3.1e-12	P:GO:0005981; P:GO:0045725; F:GO:0005515; F:GO:0050196; C:GO:0042587	P:regulation of glycogen catabolic process; P:positive regulation of glycogen biosynthetic process; F:protein binding; F:[phosphorylase] phosphatase activity; C:glycogen granule	EC:3.1.3.17	[Phosphorylase] phosphatase	IPR005036 (PFAM); IPR005036 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	195.085080247327	-2.63540407738582	0.460101979886439	-5.72786945632418	1.01699776332637e-08	6.36672257360232e-07
Avas.s005.g1236.i1	homolog_cluster_12160	ZDHHC6	protein-cysteine S-acyltransferase activity	1.4e-36	160.6	Bilateria	EC:2.3.1.225	3	P:GO:0018345; C:GO:0005783; F:GO:0016409	C:endoplasmic reticulum; F:palmitoyltransferase activity; P:protein palmitoylation	K20031	NA	ZDHC6_MOUSE | Palmitoyltransferase ZDHHC6 OS=Mus musculus OX=10090 GN=Zdhhc6 PE=1 SV=1	365	1.7e-50	P:GO:0018345; F:GO:0005488; F:GO:0019707; C:GO:0005794; C:GO:0031090	P:protein palmitoylation; F:binding; F:protein-cysteine S-acyltransferase activity; C:Golgi apparatus; C:organelle membrane	EC:2.3.1	Acyltransferases	IPR001594 (PFAM); PS50216 (PROSITE_PROFILES)	F:GO:0016409	F:palmitoyltransferase activity	131.618161569651	1.72123783892077	0.334521158178552	5.14537809295175	2.66982533378827e-07	1.26337705280352e-05
Avas.s005.g1089.i1	paralog_cluster_00194	NA	Belongs to the calponin family	6.1e-28	131	Actinopterygii	NA	NA	NA	NA	K20526	NA	MP20_DROME | Muscle-specific protein 20 OS=Drosophila melanogaster OX=7227 GN=Mp20 PE=2 SV=2	190	2.1e-23	P:GO:1901739; F:GO:0008092; C:GO:0005737; C:GO:0015629; C:GO:0030425; C:GO:0098794	P:regulation of myoblast fusion; F:cytoskeletal protein binding; C:cytoplasm; C:actin cytoskeleton; C:dendrite; C:postsypse			IPR000557 (PFAM); IPR001715 (PFAM); IPR001715 (PROSITE_PROFILES); IPR000557 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	774.257470456873	1.13087227861923	0.204508900018987	5.52969713549987	3.20784130357334e-08	1.82370878915871e-06
Avas.s005.g1140.i1	homolog_cluster_12188	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	234	NA					no IPS match	no IPS match	no IPS match	224.137715648648	3.57617418455371	0.317865936900051	11.2505738092918	2.300902746999e-29	9.49210879396587e-27
Avas.s005.g1153.i1	paralog_cluster_00940	RCN1	EF hand	6.7e-51	208	Afrotheria	NA	5	P:GO:0043687; P:GO:0043010; C:GO:0005788; P:GO:0001701; F:GO:0005509	F:calcium ion binding; C:endoplasmic reticulum lumen; P:post-translational protein modification; P:camera-type eye development; P:in utero embryonic development	NA	NA	RCN1_MOUSE | Reticulocalbin-1 OS=Mus musculus OX=10090 GN=Rcn1 PE=1 SV=1	327	2.1e-52	P:GO:0001701; P:GO:0043010; F:GO:0005515; F:GO:0046872; C:GO:0005788	P:in utero embryonic development; P:camera-type eye development; F:protein binding; F:metal ion binding; C:endoplasmic reticulum lumen			IPR002048 (PFAM); IPR018247 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES)	F:GO:0005509	F:calcium ion binding	2619.3171582785	2.7483741840778	0.504592278190868	5.4467226370004	5.1306372935683e-08	2.77935432377846e-06
Avas.s005.g1159.i1	homolog_cluster_12194	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	607	NA					IPR001849 (PROSITE_PROFILES)	no GO terms	no GO terms	719.707859315565	2.23223635520288	0.272252756096486	8.1991322593325	2.4212841865857e-16	4.01608672968839e-14
Avas.s005.g1169.i1	homolog_cluster_12196	NA	Rab subfamily of small GTPases	2e-19	102.4	Chlorophyta	NA	NA	NA	NA	K07901	map04144, map04152, map04530, map04972	RAB13_CANLF | Ras-related protein Rab-13 OS=Canis lupus familiaris OX=9615 GN=RAB13 PE=1 SV=2	166	1.7e-18	P:GO:0006996; P:GO:0016197; P:GO:0034613; P:GO:0035556; P:GO:0048513; P:GO:0051668; F:GO:0000166; C:GO:0005886; C:GO:0030139; C:GO:0030659; C:GO:0031984; C:GO:0042995; C:GO:0055037; C:GO:0098588	P:organelle organization; P:endosomal transport; P:cellular protein localization; P:intracellular sigl transduction; P:animal organ development; P:localization within membrane; F:nucleotide binding; C:plasma membrane; C:endocytic vesicle; C:cytoplasmic vesicle membrane; C:organelle subcompartment; C:cell projection; C:recycling endosome; C:bounding membrane of organelle			IPR001806 (PFAM); PS51419 (PROSITE_PROFILES)	F:GO:0003924; F:GO:0005525	F:GTPase activity; F:GTP binding	136.840528967577	2.89885990328595	0.487751310895492	5.94331545304052	2.79314177114045e-09	1.91229182790973e-07
Avas.s005.g1183.i1	paralog_cluster_06244	NA	PFAM NHL repeat containing protein	4.3e-09	68.9	Gammaproteobacteria	NA	NA	NA	NA	NA	NA	TRIM3_HUMAN | Tripartite motif-containing protein 3 OS=Homo sapiens OX=9606 GN=TRIM3 PE=1 SV=2	291	1.2e-11	P:GO:0009987; F:GO:0005515; C:GO:0005737	P:cellular process; F:protein binding; C:cytoplasm			IPR001258 (PFAM)	F:GO:0005515	F:protein binding	78.3987220185155	1.89236004349432	0.365783243162919	5.17344651201386	2.2981493226459e-07	1.09717876712314e-05
Avas.s005.g1197.i1	homolog_cluster_12200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	213	NA					no IPS match	no IPS match	no IPS match	340.090821554431	4.46309969947372	0.391309827827397	11.4055395037059	3.92337325718922e-30	1.8035186381405e-27
Avas.s005.g1224.i1	homolog_cluster_12207	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	209	NA					no IPS match	no IPS match	no IPS match	171.237141210127	2.08417023653573	0.268044645760068	7.7754593106154	7.51741403115392e-15	1.06094451181785e-12
Avas.s005.g1229.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	761	NA					no IPS match	no IPS match	no IPS match	748.510820294136	-1.07306490136077	0.1947200403331	-5.51080874636797	3.57188671389536e-08	2.00937361328191e-06
Avas.s006.g71.i1	paralog_cluster_07226	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	138	NA					IPR006629 (PFAM); IPR006629 (PROSITE_PROFILES)	no GO terms	no GO terms	129.465266899291	4.21374345773531	0.598402994384805	7.04164834948276	1.89978798519484e-12	2.12261728429165e-10
Avas.s006.g72.i1	paralog_cluster_05030	NA	Possible membrane-associated motif in LPS-induced tumor necrosis factor alpha factor (LITAF), also known as PIG7, and other animal proteins.	0.025	45.4	Diptera	NA	1	P:GO:0009631	P:cold acclimation	K19363	map04142	------	139	NA					IPR006629 (PFAM); IPR006629 (PROSITE_PROFILES)	no GO terms	no GO terms	124.054797056648	4.46516809283959	0.792149809395165	5.63677228711184	1.73266981159829e-08	1.04448283381872e-06
Avas.s006.g74.i1	paralog_cluster_05031	NA	Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog	5.7e-07	60.5	Actinopterygii	NA	NA	NA	NA	NA	NA	------	108	NA					IPR006629 (PFAM); IPR006629 (PROSITE_PROFILES)	no GO terms	no GO terms	1693.10204845081	-1.10688938614837	0.219679426526049	-5.03865748218858	4.68808591817962e-07	2.08937989854825e-05
Avas.s006.g75.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	103	NA					no IPS match	no IPS match	no IPS match	2232.16841737382	5.2454733569981	0.846939268922535	6.1934468615103	5.88625392867915e-10	4.44619434077553e-08
Avas.s006.g76.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	106	NA					no IPS match	no IPS match	no IPS match	1309.19564777616	4.39521370445106	0.548977204903975	8.00618616800283	1.18320565004974e-15	1.86633291212257e-13
Avas.s006.g84.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	18	NA					no IPS match	no IPS match	no IPS match	2001.80494672671	1.48344932627444	0.254666600257722	5.82506431849795	5.70906083508534e-09	3.70375321676161e-07
Avas.s006.g149.i1	paralog_cluster_08683	maf-S	Belongs to the bZIP family	0.76	40.8	Nematocera	NA	5	P:GO:0010628; P:GO:0060322; P:GO:2000112; F:GO:0046982; P:GO:0045944	F:protein heterodimerization activity; P:head development; P:regulation of cellular macromolecule biosynthetic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of gene expression	K09037	NA	------	176	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	184.785230294898	2.67808430326705	0.39276154161496	6.8186011600201	9.19312319949561e-12	9.18684218364503e-10
Avas.s006.g170.i1	homolog_cluster_12232	NA	Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5Bb	4e-36	160.2	Actinopterygii	NA	NA	NA	NA	K06841	map04360	SEM1A_DROME | Semaphorin-1A OS=Drosophila melanogaster OX=7227 GN=Sema1a PE=1 SV=3	810	2.9e-26	P:GO:0006928; P:GO:0006935; P:GO:0040012; P:GO:0048523; P:GO:0048583; P:GO:0048667; P:GO:0048812; P:GO:0051716; P:GO:2000026; F:GO:0005515; C:GO:0016020	P:movement of cell or subcellular component; P:chemotaxis; P:regulation of locomotion; P:negative regulation of cellular process; P:regulation of response to stimulus; P:cell morphogenesis involved in neuron differentiation; P:neuron projection morphogenesis; P:cellular response to stimulus; P:regulation of multicellular organismal development; F:protein binding; C:membrane			IPR001627 (PFAM); IPR001627 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	189.594223775914	2.17660509711408	0.269251127316797	8.08392194604676	6.27164805500479e-16	1.01923783390881e-13
Avas.s006.g234.i1	homolog_cluster_12247	PROS1	Protein S (alpha)	0.00015	55.5	Actinopterygii	NA	24	C:GO:0000139; F:GO:0004866; P:GO:0032496; P:GO:0007596; P:GO:0045807; P:GO:0002673; P:GO:0006888; P:GO:0002576; P:GO:0070613; C:GO:0005796; P:GO:0001889; C:GO:0098791; C:GO:0005886; P:GO:0050819; F:GO:0044877; C:GO:0005789; C:GO:0031093; P:GO:0030449; C:GO:0005615; P:GO:0050900; C:GO:0032991; P:GO:0050766; P:GO:2000257; P:GO:0010951	P:negative regulation of endopeptidase activity; C:Golgi apparatus subcompartment; P:liver development; P:platelet degranulation; C:extracellular space; P:regulation of complement activation; P:response to lipopolysaccharide; C:Golgi lumen; C:platelet alpha granule lumen; P:positive regulation of endocytosis; C:Golgi membrane; C:endoplasmic reticulum membrane; P:endoplasmic reticulum to Golgi vesicle-mediated transport; C:plasma membrane; P:regulation of acute inflammatory response; P:positive regulation of phagocytosis; F:protein-containing complex binding; P:blood coagulation; P:negative regulation of coagulation; F:endopeptidase inhibitor activity; C:protein-containing complex; P:regulation of protein activation cascade; P:leukocyte migration; P:regulation of protein processing	K03908	map04610	FBN1_PIG | Fibrillin-1 OS=Sus scrofa OX=9823 GN=FBN1 PE=2 SV=1	877	3.1e-42	P:GO:0007154; P:GO:0023052; P:GO:0048513; P:GO:0050794; P:GO:0051179; P:GO:0051716; F:GO:0005515; C:GO:0110165	P:cell communication; P:sigling; P:animal organ development; P:regulation of cellular process; P:localization; P:cellular response to stimulus; F:protein binding; C:cellular atomical entity			IPR001611 (PFAM); IPR026823 (PFAM); IPR001881 (PFAM); IPR000742 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR001611 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES)	F:GO:0005509; F:GO:0005515	F:calcium ion binding; F:protein binding	208.243049424111	1.82138642709558	0.380816228668237	4.78284876005732	1.72828162642199e-06	6.89983203163858e-05
Avas.s006.g361.i1	homolog_cluster_12284	NA	ribosomal protein import into nucleus	2.1e-27	131.3	Streptophyta	NA	NA	NA	NA	NA	NA	IMB_DROME | Importin subunit beta OS=Drosophila melanogaster OX=7227 GN=Fs(2)Ket PE=1 SV=2	852	1.3e-16	P:GO:0006886; P:GO:0007049; P:GO:0051170; F:GO:0005515; C:GO:0005634; C:GO:0005737; C:GO:0012505	P:intracellular protein transport; P:cell cycle; P:import into nucleus; F:protein binding; C:nucleus; C:cytoplasm; C:endomembrane system			no IPS match	no IPS match	no IPS match	237.192700338555	1.6500730970882	0.318084000434699	5.18753880997843	2.13091526334715e-07	1.02955842858836e-05
Avas.s006.g390.i1	homolog_cluster_12299	PTPRE	Protein tyrosine phosphatase, receptor type, E	3.9e-81	310.1	Testudines	EC:3.1.3.48	9	F:GO:0042803; P:GO:0033003; C:GO:0005886; C:GO:0005634; P:GO:0007185; C:GO:0005737; F:GO:0005001; P:GO:0035335; P:GO:0046627	F:transmembrane receptor protein tyrosine phosphatase activity; F:protein homodimerization activity; P:negative regulation of insulin receptor signaling pathway; P:regulation of mast cell activation; P:peptidyl-tyrosine dephosphorylation; C:cytoplasm; C:nucleus; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; C:plasma membrane	K18033	NA	PTPRA_HUMAN | Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3	1011	3e-81	P:GO:0002682; P:GO:0006470; P:GO:0007155; P:GO:0007167; P:GO:0009968; P:GO:0021543; P:GO:0030308; P:GO:0032480; P:GO:0048640; P:GO:0048679; P:GO:0050771; P:GO:0051963; P:GO:0061387; F:GO:0004725; F:GO:0005539; F:GO:0042802; F:GO:1901681; C:GO:0014069; C:GO:0030672; C:GO:0043005; C:GO:0099699	P:regulation of immune system process; P:protein dephosphorylation; P:cell adhesion; P:enzyme linked receptor protein sigling pathway; P:negative regulation of sigl transduction; P:pallium development; P:negative regulation of cell growth; P:negative regulation of type I interferon production; P:negative regulation of developmental growth; P:regulation of axon regeneration; P:negative regulation of axonogenesis; P:regulation of sypse assembly; P:regulation of extent of cell growth; F:protein tyrosine phosphatase activity; F:glycosaminoglycan binding; F:identical protein binding; F:sulfur compound binding; C:postsyptic density; C:syptic vesicle membrane; C:neuron projection; C:integral component of syptic membrane	EC:3.1.3.48	Protein-tyrosine-phosphatase	IPR000242 (PFAM); IPR016130 (PROSITE_PATTERNS); IPR000242 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES)	P:GO:0006470; P:GO:0016311; F:GO:0004725; F:GO:0016791	P:protein dephosphorylation; P:dephosphorylation; F:protein tyrosine phosphatase activity; F:phosphatase activity	648.214216126222	2.95852385738662	0.216032229987912	13.6948262652853	1.09020802916099e-42	1.16935713207808e-39
Avas.s006.g409.i1	NA	NA	collagen	1.4e-10	75.5	Metazoa	NA	NA	NA	NA	NA	NA	------	855	NA					IPR002035 (PFAM); IPR008160 (PFAM); IPR002035 (PROSITE_PROFILES)	no GO terms	no GO terms	1967.70407739259	2.76122934641807	0.256346792531269	10.7714604858232	4.69493824269516e-27	1.60716726354728e-24
Avas.s006.g410.i1	NA	NA	protein tyrosine phosphatase activity	1.7e-91	346.3	Metazoa	NA	NA	NA	NA	NA	NA	SDK_DROME | Protein sidekick OS=Drosophila melanogaster OX=7227 GN=sdk PE=1 SV=2	3498	2.4e-40	P:GO:0003008; P:GO:0006464; P:GO:0006796; P:GO:0007155; P:GO:0007507; P:GO:0009887; P:GO:0009888; P:GO:0009968; P:GO:0030239; P:GO:0031344; P:GO:0048522; P:GO:0048699; P:GO:0050793; F:GO:0004672; F:GO:0008092; F:GO:0016791; F:GO:0019899; F:GO:0043167; F:GO:0044877; C:GO:0030017; C:GO:0043005; C:GO:0043231; C:GO:0045202; C:GO:0098590	P:system process; P:cellular protein modification process; P:phosphate-containing compound metabolic process; P:cell adhesion; P:heart development; P:animal organ morphogenesis; P:tissue development; P:negative regulation of sigl transduction; P:myofibril assembly; P:regulation of cell projection organization; P:positive regulation of cellular process; P:generation of neurons; P:regulation of developmental process; F:protein kise activity; F:cytoskeletal protein binding; F:phosphatase activity; F:enzyme binding; F:ion binding; F:protein-containing complex binding; C:sarcomere; C:neuron projection; C:intracellular membrane-bounded organelle; C:sypse; C:plasma membrane region	EC:2.7.1; EC:3.1.3	Transferring phosphorus-containing groups; Acting on ester bonds	IPR003961 (PFAM); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	116.737507744148	3.46086195089418	0.350377858046275	9.87751329433924	5.21099727178273e-23	1.35225379202762e-20
Avas.s006.g439.i1	homolog_cluster_12313	NA	Tripartite motif-containing protein	0.0018	51.2	Bilateria	NA	NA	NA	NA	NA	NA	------	574	NA					IPR001258 (PFAM); IPR001258 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	213.496292235141	3.34307355246447	0.699204465953368	4.78125314589656	1.74205826887944e-06	6.93761769504984e-05
Avas.s006.g458.i1	homolog_cluster_12321	NA	protein tyrosine phosphatase activity	NA	1130.9	Opisthokonta	NA	NA	NA	NA	K16506	NA	FAT4_MOUSE | Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2	5865	6e-230	P:GO:0001736; P:GO:0001822; P:GO:0002165; P:GO:0007163; P:GO:0007165; P:GO:0007444; P:GO:0007507; P:GO:0007600; P:GO:0016477; P:GO:0030855; P:GO:0040008; P:GO:0048468; P:GO:0048518; P:GO:0048519; P:GO:0048563; P:GO:0048565; P:GO:0048592; P:GO:0048646; P:GO:0050793; P:GO:0051239; P:GO:0060113; P:GO:0060562; P:GO:0098742; P:GO:0120036; F:GO:0005515; C:GO:0005886; C:GO:0030054; C:GO:0043005; C:GO:0043227	P:establishment of plar polarity; P:kidney development; P:instar larval or pupal development; P:establishment or maintence of cell polarity; P:sigl transduction; P:imagil disc development; P:heart development; P:sensory perception; P:cell migration; P:epithelial cell differentiation; P:regulation of growth; P:cell development; P:positive regulation of biological process; P:negative regulation of biological process; P:post-embryonic animal organ morphogenesis; P:digestive tract development; P:eye morphogenesis; P:atomical structure formation involved in morphogenesis; P:regulation of developmental process; P:regulation of multicellular organismal process; P:inner ear receptor cell differentiation; P:epithelial tube morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:plasma membrane bounded cell projection organization; F:protein binding; C:plasma membrane; C:cell junction; C:neuron projection; C:membrane-bounded organelle			PF13927 (PFAM); IPR002126 (PFAM); IPR000320 (PFAM); IPR002035 (PFAM); IPR000980 (PFAM); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR000152 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR020894 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES); IPR002126 (PROSITE_PROFILES)	P:GO:0007155; P:GO:0007156; P:GO:0007267; F:GO:0005509; C:GO:0005886; C:GO:0016020	P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:cell-cell sigling; F:calcium ion binding; C:plasma membrane; C:membrane	118.408864544286	-2.04351121594258	0.382664474738601	-5.34021669332776	9.2835548912649e-08	4.80267249664183e-06
Avas.s006.g478.i1	paralog_cluster_07232	GAL3ST2	Galactose-3-O-sulfotransferase	8e-20	105.1	Metatheria	NA	NA	NA	NA	K09675	NA	G3ST1_MOUSE | Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2	425	9e-11	P:GO:0006643; P:GO:1901135; P:GO:1901564; F:GO:0016740; C:GO:0110165	P:membrane lipid metabolic process; P:carbohydrate derivative metabolic process; P:organonitrogen compound metabolic process; F:transferase activity; C:cellular atomical entity	EC:2	Transferases	IPR009729 (PFAM)	P:GO:0009247; F:GO:0001733; C:GO:0016021	P:glycolipid biosynthetic process; F:galactosylceramide sulfotransferase activity; C:integral component of membrane	102.004214876716	3.71485066528569	0.578293588450704	6.42381437296941	1.3290125524265e-10	1.13736611468032e-08
Avas.s006.g479.i1	paralog_cluster_07233	NA	collagen	3.2e-08	68.2	Metazoa	NA	NA	NA	NA	NA	NA	CO6A2_CHICK | Collagen alpha-2(VI) chain OS=Gallus gallus OX=9031 GN=COL6A2 PE=2 SV=1	1262	0.00083	P:GO:0007155; F:GO:0005518; C:GO:0005576; C:GO:0005581; C:GO:0005615; C:GO:0031012; C:GO:0032991; C:GO:0042383; C:GO:0062023	P:cell adhesion; F:collagen binding; C:extracellular region; C:collagen trimer; C:extracellular space; C:extracellular matrix; C:protein-containing complex; C:sarcolemma; C:collagen-containing extracellular matrix			IPR002035 (PFAM); IPR008160 (PFAM); IPR013098 (PFAM); IPR007110 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR002035 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES)	no GO terms	no GO terms	2654.5561693292	2.90052258224911	0.233704155448262	12.4110869003835	2.27542719184615e-35	1.66406127680058e-32
Avas.s006.g1118.i1	paralog_cluster_04600	NA	NA	9.8e-66	256.9	Bilateria	NA	NA	NA	NA	NA	NA	PRPX_HORVU | Pathogen-related protein OS=Hordeum vulgare OX=4513 PE=2 SV=2	253	3.8e-25	P:GO:0006952; P:GO:0009607	P:defense response; P:response to biotic stimulus			no IPS match	no IPS match	no IPS match	293.099220288769	3.80293120553798	0.504108709339278	7.54387126245524	4.56221525388524e-14	5.82551438252061e-12
Avas.s006.g483.i1	paralog_cluster_07233	ADAMTSL1	PLAC (protease and lacunin) domain	3.1e-31	144.1	Primates	NA	1	C:GO:0005788	C:endoplasmic reticulum lumen	NA	NA	ATS10_MOUSE | A disintegrin and metalloproteinase with thrombospondin motifs 10 OS=Mus musculus OX=10090 GN=Adamts10 PE=2 SV=3	852	6e-22	C:GO:0110165	C:cellular atomical entity			IPR013098 (PFAM); PF19030 (PFAM); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES)	no GO terms	no GO terms	4628.09355390712	6.18445706671673	0.388882335895887	15.9031575771352	6.02498615295487e-57	1.61560003691485e-53
Avas.s006.g510.i1	homolog_cluster_12334	ETV4	Ets variant gene 4	1.6e-24	120.6	Actinopterygii	NA	21	P:GO:0033600; P:GO:0010628; P:GO:0008277; P:GO:0008045; P:GO:0060762; F:GO:0001228; P:GO:0001964; P:GO:0045938; P:GO:0060159; P:GO:0051093; P:GO:0045944; F:GO:0000978; C:GO:0005730; C:GO:0005654; P:GO:0048863; P:GO:0042594; P:GO:0009792; P:GO:2000112; P:GO:0035778; P:GO:2000026; P:GO:0035108	P:regulation of G protein-coupled receptor signaling pathway; P:regulation of branching involved in mammary gland duct morphogenesis; P:negative regulation of developmental process; P:positive regulation of circadian sleep/wake cycle, sleep; P:negative regulation of mammary gland epithelial cell proliferation; P:pronephric nephron tubule epithelial cell differentiation; P:regulation of dopamine receptor signaling pathway; P:response to starvation; P:stem cell differentiation; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:startle response; P:motor neuron axon guidance; P:embryo development ending in birth or egg hatching; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:limb morphogenesis; P:regulation of cellular macromolecule biosynthetic process; P:positive regulation of transcription by RNA polymerase II; C:nucleolus; P:regulation of multicellular organismal development; C:nucleoplasm; P:positive regulation of gene expression	K15592,K15593	map05202, map05215	ETV4_DANRE | ETS translocation variant 4 OS=Danio rerio OX=7955 GN=etv4 PE=1 SV=2	380	8.9e-26	P:GO:0000122; P:GO:0007165; P:GO:0007274; P:GO:0007517; P:GO:0007626; P:GO:0007638; P:GO:0008045; P:GO:0010628; P:GO:0033600; P:GO:0034599; P:GO:0035108; P:GO:0035778; P:GO:0045618; P:GO:0045944; P:GO:0048863; P:GO:0050807; P:GO:0060762; P:GO:0071340; F:GO:0000978; F:GO:0001227; F:GO:0001228; F:GO:0005515; F:GO:0032422; C:GO:0000785; C:GO:0005654; C:GO:0005730; C:GO:0005739	P:negative regulation of transcription by R polymerase II; P:sigl transduction; P:neuromuscular syptic transmission; P:muscle organ development; P:locomotory behavior; P:mechanosensory behavior; P:motor neuron axon guidance; P:positive regulation of gene expression; P:negative regulation of mammary gland epithelial cell proliferation; P:cellular response to oxidative stress; P:limb morphogenesis; P:pronephric nephron tubule epithelial cell differentiation; P:positive regulation of keratinocyte differentiation; P:positive regulation of transcription by R polymerase II; P:stem cell differentiation; P:regulation of sypse organization; P:regulation of branching involved in mammary gland duct morphogenesis; P:skeletal muscle acetylcholine-gated channel clustering; F:R polymerase II cis-regulatory region sequence-specific D binding; F:D-binding transcription repressor activity, R polymerase II-specific; F:D-binding transcription activator activity, R polymerase II-specific; F:protein binding; F:purine-rich negative regulatory element binding; C:chromatin; C:nucleoplasm; C:nucleolus; C:mitochondrion			IPR000418 (PFAM); IPR000418 (PROSITE_PATTERNS); IPR000418 (PROSITE_PROFILES)	P:GO:0006355; F:GO:0003700; F:GO:0043565	P:regulation of transcription, D-templated; F:D-binding transcription factor activity; F:sequence-specific D binding	349.079037249176	4.27758793532344	0.611629144633465	6.99376079909812	2.67613682272444e-12	2.87042435605424e-10
Avas.s006.g527.i1	paralog_cluster_07238	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	526	NA					no IPS match	no IPS match	no IPS match	529.868407468569	2.88826421039778	0.602697018474922	4.79223245156631	1.6493564445721e-06	6.636771044234e-05
Avas.s006.g551.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	613	NA					no IPS match	no IPS match	no IPS match	180.330528658568	11.0242737072326	1.46458000370385	7.52725947326381	5.18163379366362e-14	6.56435481151606e-12
Avas.s006.g576.i1	paralog_cluster_06254	NA	heme binding	1.4e-52	214.2	Metazoa	NA	NA	NA	NA	NA	NA	CP11A_ONCMY | Cholesterol side-chain cleavage enzyme, mitochondrial OS=Oncorhynchus mykiss OX=8022 GN=cyp11a1 PE=2 SV=1	502	7.1e-39	P:GO:0006694; P:GO:0006950; P:GO:0008207; P:GO:0008211; P:GO:0008217; P:GO:0031667; P:GO:0034308; P:GO:0042180; P:GO:0043434; P:GO:0044249; P:GO:0050801; P:GO:0071310; P:GO:0071496; P:GO:0120254; F:GO:0005488; F:GO:0008395; F:GO:0016713; C:GO:0005739; C:GO:0005783; C:GO:0031090	P:steroid biosynthetic process; P:response to stress; P:C21-steroid hormone metabolic process; P:glucocorticoid metabolic process; P:regulation of blood pressure; P:response to nutrient levels; P:primary alcohol metabolic process; P:cellular ketone metabolic process; P:response to peptide hormone; P:cellular biosynthetic process; P:ion homeostasis; P:cellular response to organic substance; P:cellular response to exterl stimulus; P:olefinic compound metabolic process; F:binding; F:steroid hydroxylase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen; C:mitochondrion; C:endoplasmic reticulum; C:organelle membrane	EC:1.14.15	Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2)	IPR001128 (PFAM); IPR017972 (PROSITE_PATTERNS)	F:GO:0004497; F:GO:0005506; F:GO:0016705; F:GO:0020037	F:monooxygese activity; F:iron ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:heme binding	34.713703903114	3.81442393547706	0.808131321675218	4.72005456683691	2.35781384667486e-06	9.16301134762123e-05
Avas.s006.g611.i1	paralog_cluster_05553	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	482	NA					no IPS match	no IPS match	no IPS match	399.774820720548	4.95070204675112	1.02735711575292	4.81887161809639	1.44372411976027e-06	5.91045225517126e-05
Avas.s006.g814.i1	paralog_cluster_00707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	367	NA					no IPS match	no IPS match	no IPS match	36.22276481649	4.46047616243531	0.719770464371803	6.19708140751273	5.75197549449665e-10	4.38048327102382e-08
Avas.s006.g921.i1	paralog_cluster_11317	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	158	NA					no IPS match	no IPS match	no IPS match	1015.53556084103	2.89593528060174	0.316729412955178	9.14324708141823	6.06047205985782e-20	1.26632383079289e-17
Avas.s006.g1024.i1	paralog_cluster_06258	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	221	NA					no IPS match	no IPS match	no IPS match	6168.71928516521	3.65989163534833	0.490768632756494	7.45746853215102	8.82006187701467e-14	1.08325172167396e-11
Avas.s006.g1039.i1	paralog_cluster_06259	NA	TMEM192 family	2.7e-33	149.4	Metazoa	NA	NA	NA	NA	NA	NA	TM192_DANRE | Transmembrane protein 192 OS=Danio rerio OX=7955 GN=tmem192 PE=2 SV=1	314	1.9e-18	C:GO:0005737; C:GO:0043231	C:cytoplasm; C:intracellular membrane-bounded organelle			IPR029399 (PFAM)	no GO terms	no GO terms	119.939394043494	4.27920706237693	0.515431999774305	8.30217577537035	1.02221816998027e-16	1.73120717229606e-14
Avas.s006.g1066.i1	NA	probable collagen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	1253	NA					IPR008160 (PFAM)	no GO terms	no GO terms	16027.9368038979	6.82008891457142	0.550140394800656	12.3969971647741	2.7130109661317e-35	1.89781014930839e-32
Avas.s006.g1068.i1	NA	probable collagen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	1231	NA					IPR008160 (PFAM)	no GO terms	no GO terms	23290.3024924466	7.08412630487822	0.624631079788527	11.3412965414347	8.19216547454373e-30	3.66121528666484e-27
Avas.s006.g1071.i1	paralog_cluster_05550	NA	Belongs to the CD36 family	1.1e-55	224.6	Opisthokonta	NA	NA	NA	NA	K12384	map04142	SCRB2_HUMAN | Lysosome membrane protein 2 OS=Homo sapiens OX=9606 GN=SCARB2 PE=1 SV=2	508	3.5e-46	P:GO:0006869; P:GO:0007600; P:GO:0010033; P:GO:0043170; P:GO:0048522; P:GO:0071705; F:GO:0005515; F:GO:0008289; F:GO:0038024; C:GO:0005764; C:GO:0005886; C:GO:0031090	P:lipid transport; P:sensory perception; P:response to organic substance; P:macromolecule metabolic process; P:positive regulation of cellular process; P:nitrogen compound transport; F:protein binding; F:lipid binding; F:cargo receptor activity; C:lysosome; C:plasma membrane; C:organelle membrane			IPR002159 (PFAM)	C:GO:0016020	C:membrane	141.397562324624	2.12642986134604	0.440236377791923	4.83020024835634	1.36395806710082e-06	5.621820749826e-05
Avas.s006.g1081.i1	homolog_cluster_12391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	340	NA					IPR004827 (PFAM); IPR004827 (PROSITE_PATTERNS); IPR004827 (PROSITE_PROFILES)	P:GO:0006355; F:GO:0003700	P:regulation of transcription, D-templated; F:D-binding transcription factor activity	3221.80177939212	2.0984705870067	0.186065159850508	11.2781489489633	1.68248918499705e-29	7.12357065721515e-27
Avas.s006.g1089.i1	paralog_cluster_02178	ATP6V1H	proton-transporting ATPase activity, rotational mechanism	1e-87	330.9	Metazoa	NA	21	P:GO:0050690; P:GO:0033227; P:GO:0050790; P:GO:0007035; F:GO:0030234; C:GO:0033181; P:GO:0008286; P:GO:0033572; C:GO:0000221; P:GO:0006897; F:GO:0016887; P:GO:0044403; C:GO:0005765; P:GO:0016241; P:GO:0098657; P:GO:0008340; P:GO:0015833; P:GO:0015988; F:GO:0046961; F:GO:0008553; C:GO:0005829	P:biological process involved in symbiotic interaction; P:energy coupled proton transmembrane transport, against electrochemical gradient; P:peptide transport; P:import into cell; P:dsRNA transport; F:ATP hydrolysis activity; C:vacuolar proton-transporting V-type ATPase, V1 domain; C:cytosol; C:plasma membrane proton-transporting V-type ATPase complex; P:transferrin transport; P:determination of adult lifespan; P:vacuolar acidification; F:enzyme regulator activity; F:P-type proton-exporting transporter activity; P:endocytosis; P:regulation of defense response to virus by virus; P:insulin receptor signaling pathway; C:lysosomal membrane; P:regulation of catalytic activity; F:proton-transporting ATPase activity, rotational mechanism; P:regulation of macroautophagy	K02144	map00190, map01100, map04142, map04145, map04150, map04721, map05110, map05120, map05152, map05323	VATH_MANSE | V-type proton ATPase subunit H OS=Manduca sexta OX=7130 PE=2 SV=1	481	6e-88	P:GO:0006897; P:GO:0008340; P:GO:0033227; P:GO:0065007; P:GO:1902600; F:GO:0005515; F:GO:0046961; C:GO:0005774; C:GO:0033181	P:endocytosis; P:determition of adult lifespan; P:dsR transport; P:biological regulation; P:proton transmembrane transport; F:protein binding; F:proton-transporting ATPase activity, rotatiol mechanism; C:vacuolar membrane; C:plasma membrane proton-transporting V-type ATPase complex	EC:7.1.3.1	H(+)-exporting diphosphatase	IPR004908 (PFAM); IPR011987 (PFAM)	P:GO:1902600; F:GO:0046961; C:GO:0000221	P:proton transmembrane transport; F:proton-transporting ATPase activity, rotatiol mechanism; C:vacuolar proton-transporting V-type ATPase, V1 domain	834.875825232009	1.54027721482482	0.194388490032225	7.92370584580123	2.30534620825821e-15	3.5324490613968e-13
Avas.s006.g1096.i1	paralog_cluster_03202	NA	polyol transport	1.5e-50	206.8	Bilateria	NA	NA	NA	NA	NA	NA	AQP9_HUMAN | Aquaporin-9 OS=Homo sapiens OX=9606 GN=AQP9 PE=1 SV=2	338	1.5e-45	P:GO:0003091; P:GO:0006833; P:GO:0006863; P:GO:0006950; P:GO:0010038; P:GO:0014070; P:GO:0015791; P:GO:0015840; P:GO:0015849; P:GO:0031667; P:GO:0033993; P:GO:0036294; P:GO:0046942; P:GO:0050789; P:GO:0055085; P:GO:1901700; F:GO:0005372; F:GO:0005515; F:GO:0015166; F:GO:0015204; F:GO:0015205; F:GO:0015267; C:GO:0005886; C:GO:0016021; C:GO:0043231	P:rel water homeostasis; P:water transport; P:purine nucleobase transport; P:response to stress; P:response to metal ion; P:response to organic cyclic compound; P:polyol transport; P:urea transport; P:organic acid transport; P:response to nutrient levels; P:response to lipid; P:cellular response to decreased oxygen levels; P:carboxylic acid transport; P:regulation of biological process; P:transmembrane transport; P:response to oxygen-containing compound; F:water transmembrane transporter activity; F:protein binding; F:polyol transmembrane transporter activity; F:urea transmembrane transporter activity; F:nucleobase transmembrane transporter activity; F:channel activity; C:plasma membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle	EC:7	Translocases	IPR000425 (PFAM); IPR022357 (PROSITE_PATTERNS)	P:GO:0055085; F:GO:0015267; C:GO:0016020	P:transmembrane transport; F:channel activity; C:membrane	2846.2956797195	6.43530199110161	0.345680245419469	18.6163429249265	2.3684698201037e-77	7.62126218712969e-74
Avas.s007.g32.i1	paralog_cluster_01062	Sep-11	ATPase. Has a role at an early stage in the morphogenesis of the spore coat	2.4e-117	429.1	Mammalia	NA	4	C:GO:0001725; C:GO:0030424; P:GO:0051291; C:GO:0043197	P:protein heterooligomerization; C:dendritic spine; C:stress fiber; C:axon	K16939	map05100	SEPT8_XENTR | Septin-8 OS=Xenopus tropicalis OX=8364 GN=septin8 PE=2 SV=1	421	4e-120	P:GO:0000281; P:GO:0007283; P:GO:0030154; P:GO:0034613; P:GO:0035542; P:GO:0050807; P:GO:0060271; F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0060090; C:GO:0000776; C:GO:0001725; C:GO:0005819; C:GO:0005940; C:GO:0030496; C:GO:0030672; C:GO:0031105; C:GO:0032154; C:GO:0032173; C:GO:0043197; C:GO:0043679; C:GO:0097227; C:GO:0098978; C:GO:0098982; C:GO:0099629	P:mitotic cytokinesis; P:spermatogenesis; P:cell differentiation; P:cellular protein localization; P:regulation of SRE complex assembly; P:regulation of sypse organization; P:cilium assembly; F:GTPase activity; F:protein binding; F:GTP binding; F:molecular adaptor activity; C:kinetochore; C:stress fiber; C:spindle; C:septin ring; C:midbody; C:syptic vesicle membrane; C:septin complex; C:cleavage furrow; C:septin collar; C:dendritic spine; C:axon terminus; C:sperm annulus; C:glutamatergic sypse; C:GABA-ergic sypse; C:postsyptic specialization of symmetric sypse	EC:3.6.1	Acting on acid anhydrides	IPR030379 (PFAM); IPR030379 (PROSITE_PROFILES)	F:GO:0005525	F:GTP binding	1070.90234899194	1.05048181922527	0.218332803241187	4.81137879251624	1.49892625885898e-06	6.08995570171265e-05
Avas.s007.g127.i1	paralog_cluster_02033	NA	ATPase activity, coupled to transmembrane movement of substances	6.4e-81	307.4	Metazoa	NA	2	P:GO:0051453; C:GO:0033176	C:proton-transporting V-type ATPase complex; P:regulation of intracellular pH	K02149	map00190, map01100, map04145, map04150, map04721, map04966, map05110, map05120, map05323	VATD_SUBDO | V-type proton ATPase subunit D OS=Suberites domuncula OX=55567 GN=VATPD PE=2 SV=1	257	2e-82	P:GO:0016241; P:GO:0045851; P:GO:0051453; P:GO:0060271; P:GO:0061512; P:GO:1902600; F:GO:0005515; F:GO:0008553; F:GO:0046961; C:GO:0000221; C:GO:0005813; C:GO:0005829; C:GO:0005929; C:GO:0033181; C:GO:0035579	P:regulation of macroautophagy; P:pH reduction; P:regulation of intracellular pH; P:cilium assembly; P:protein localization to cilium; P:proton transmembrane transport; F:protein binding; F:P-type proton-exporting transporter activity; F:proton-transporting ATPase activity, rotatiol mechanism; C:vacuolar proton-transporting V-type ATPase, V1 domain; C:centrosome; C:cytosol; C:cilium; C:plasma membrane proton-transporting V-type ATPase complex; C:specific granule membrane	EC:7.1.3.1; EC:7.1.2.1	H(+)-exporting diphosphatase; P-type H(+)-exporting transporter	IPR002699 (PFAM)	F:GO:0046961	F:proton-transporting ATPase activity, rotatiol mechanism	2049.75730779393	0.969675522219457	0.183717631586941	5.27807545657684	1.30547710412567e-07	6.56369410258685e-06
Avas.s007.g145.i1	homolog_cluster_12419	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	166	NA					no IPS match	no IPS match	no IPS match	984.088371462661	1.40878706380665	0.239534403434901	5.88135584535988	4.06919260348664e-09	2.69420739907393e-07
Avas.s007.g249.i1	homolog_cluster_12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	117	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	514.831824031506	3.3636672055509	0.566473549492823	5.93790691297496	2.88683864854973e-09	1.96806555154731e-07
Avas.s007.g395.i1	homolog_cluster_12491	NA	glutathione synthase activity	7.9e-75	288.1	Chordata	NA	NA	NA	NA	NA	NA	GSHB_XENLA | Glutathione synthetase OS=Xenopus laevis OX=8355 GN=gss PE=2 SV=1	505	9.9e-65	P:GO:0010033; P:GO:0032502; P:GO:0044237; P:GO:1901564; F:GO:0000166; F:GO:0016874; F:GO:0042277; F:GO:0042802; F:GO:0043168; F:GO:0046872; C:GO:0009536	P:response to organic substance; P:developmental process; P:cellular metabolic process; P:organonitrogen compound metabolic process; F:nucleotide binding; F:ligase activity; F:peptide binding; F:identical protein binding; F:anion binding; F:metal ion binding; C:plastid	EC:6	Ligases	IPR004887 (PFAM); IPR005615 (PFAM)	P:GO:0006750; F:GO:0004363; F:GO:0005524	P:glutathione biosynthetic process; F:glutathione synthase activity; F:ATP binding	170.309189868128	1.72121116789822	0.341483428768746	5.04039441710019	4.64573379807294e-07	2.07625586325543e-05
Avas.s007.g422.i1	paralog_cluster_02403	NA	Ribose 5-phosphate isomerase A (phosphoriboisomerase A)	8.8e-70	270.4	Hymenoptera	EC:5.3.1.6	8	P:GO:0006014; F:GO:0004751; P:GO:0019682; P:GO:0019693; P:GO:0046496; P:GO:0001315; P:GO:0009052; C:GO:0043231	P:ribose phosphate metabolic process; P:glyceraldehyde-3-phosphate metabolic process; F:ribose-5-phosphate isomerase activity; P:age-dependent response to reactive oxygen species; C:intracellular membrane-bounded organelle; P:nicotinamide nucleotide metabolic process; P:D-ribose metabolic process; P:pentose-phosphate shunt, non-oxidative branch	K01807	map00030, map00710, map01100, map01110, map01120, map01130, map01200, map01230	RPIA_MOUSE | Ribose-5-phosphate isomerase OS=Mus musculus OX=10090 GN=Rpia PE=1 SV=2	260	3.8e-68	P:GO:0006014; P:GO:0008615; P:GO:0009052; P:GO:0019693; F:GO:0004751; F:GO:0042802; F:GO:0048029; C:GO:0005829; C:GO:0043231	P:D-ribose metabolic process; P:pyridoxine biosynthetic process; P:pentose-phosphate shunt, non-oxidative branch; P:ribose phosphate metabolic process; F:ribose-5-phosphate isomerase activity; F:identical protein binding; F:monosaccharide binding; C:cytosol; C:intracellular membrane-bounded organelle	EC:5.3.1.6	Ribose-5-phosphate isomerase	IPR004788 (PFAM)	P:GO:0009052; F:GO:0004751	P:pentose-phosphate shunt, non-oxidative branch; F:ribose-5-phosphate isomerase activity	149.926110310074	-2.0008094533026	0.267306812829537	-7.48506718599247	7.15105444560351e-14	8.85025499810114e-12
Avas.s007.g465.i1	paralog_cluster_00633	NA	Competence protein ComEC	2.5e-14	86.7	Eukaryota	NA	NA	NA	NA	NA	NA	------	363	NA					no IPS match	no IPS match	no IPS match	2308.08931082195	7.27644496859597	0.353492374776543	20.5844467598366	3.78331692618813e-94	3.04348930127204e-90
Avas.s007.g497.i1	paralog_cluster_00242	MAPKAPK5	kinase-activated protein kinase 5	4.3e-60	238.4	Bilateria	EC:2.7.11.1	28	F:GO:0002039; P:GO:0032147; P:GO:1900006; P:GO:0007265; P:GO:0007166; P:GO:1901796; P:GO:0006417; P:GO:0065008; P:GO:0060999; C:GO:0032156; C:GO:0005654; P:GO:1904355; P:GO:0032007; C:GO:0032991; F:GO:0005516; P:GO:0032212; F:GO:0051019; F:GO:0009931; F:GO:0004708; P:GO:0043406; P:GO:0018105; P:GO:0045666; P:GO:0046777; P:GO:0090400; F:GO:0004683; P:GO:0051973; P:GO:0050769; C:GO:0005829	F:calmodulin-dependent protein kinase activity; P:positive regulation of dendritic spine development; C:cytosol; P:protein autophosphorylation; F:p53 binding; P:regulation of signal transduction by p53 class mediator; P:positive regulation of telomerase activity; P:peptidyl-serine phosphorylation; P:positive regulation of telomere capping; C:nucleoplasm; F:calmodulin binding; P:positive regulation of neuron differentiation; P:Ras protein signal transduction; F:mitogen-activated protein kinase binding; P:positive regulation of dendrite development; P:stress-induced premature senescence; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of neurogenesis; P:cell surface receptor signaling pathway; F:calcium-dependent protein serine/threonine kinase activity; P:negative regulation of TOR signaling; C:septin cytoskeleton; F:MAP kinase kinase activity; P:positive regulation of MAP kinase activity; P:regulation of biological quality; P:activation of protein kinase activity; C:protein-containing complex; P:regulation of translation	K04442	map04010	MAPK5_MOUSE | MAP kinase-activated protein kinase 5 OS=Mus musculus OX=10090 GN=Mapkapk5 PE=1 SV=1	300	1.2e-57	P:GO:0002224; P:GO:0006417; P:GO:0006954; P:GO:0006974; P:GO:0007265; P:GO:0018105; P:GO:0032007; P:GO:0032212; P:GO:0032496; P:GO:0032675; P:GO:0032760; P:GO:0034097; P:GO:0035924; P:GO:0038066; P:GO:0044351; P:GO:0046777; P:GO:0048010; P:GO:0048839; P:GO:0051973; P:GO:0060999; P:GO:0070935; P:GO:0090400; P:GO:1904355; F:GO:0002039; F:GO:0004674; F:GO:0004712; F:GO:0051019; C:GO:0005654; C:GO:0005813; C:GO:0005829; C:GO:0032156; C:GO:0032991	P:toll-like receptor sigling pathway; P:regulation of translation; P:inflammatory response; P:cellular response to D damage stimulus; P:Ras protein sigl transduction; P:peptidyl-serine phosphorylation; P:negative regulation of TOR sigling; P:positive regulation of telomere maintence via telomerase; P:response to lipopolysaccharide; P:regulation of interleukin-6 production; P:positive regulation of tumor necrosis factor production; P:response to cytokine; P:cellular response to vascular endothelial growth factor stimulus; P:p38MAPK cascade; P:macropinocytosis; P:protein autophosphorylation; P:vascular endothelial growth factor receptor sigling pathway; P:inner ear development; P:positive regulation of telomerase activity; P:positive regulation of dendritic spine development; P:3'-UTR-mediated mR stabilization; P:stress-induced premature senescence; P:positive regulation of telomere capping; F:p53 binding; F:protein serine/threonine kise activity; F:protein serine/threonine/tyrosine kise activity; F:mitogen-activated protein kise binding; C:nucleoplasm; C:centrosome; C:cytosol; C:septin cytoskeleton; C:protein-containing complex	EC:2.7.12.1	Dual-specificity kise	IPR000719 (PFAM); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	1027.71902312899	2.20305559896302	0.414781192556664	5.31136811045756	1.08805300347633e-07	5.55736024537484e-06
Avas.s007.g499.i1	paralog_cluster_00242	MAPKAPK5	stress-induced premature senescence	2.5e-60	239.2	Metazoa	EC:2.7.11.1	28	F:GO:0002039; P:GO:0032147; P:GO:1900006; P:GO:0007265; P:GO:0007166; P:GO:1901796; P:GO:0006417; P:GO:0065008; P:GO:0060999; C:GO:0032156; C:GO:0005654; P:GO:1904355; P:GO:0032007; C:GO:0032991; F:GO:0005516; P:GO:0032212; F:GO:0051019; F:GO:0009931; F:GO:0004708; P:GO:0043406; P:GO:0018105; P:GO:0045666; P:GO:0046777; P:GO:0090400; F:GO:0004683; P:GO:0051973; P:GO:0050769; C:GO:0005829	F:calmodulin-dependent protein kinase activity; P:positive regulation of dendritic spine development; C:cytosol; P:protein autophosphorylation; F:p53 binding; P:regulation of signal transduction by p53 class mediator; P:positive regulation of telomerase activity; P:peptidyl-serine phosphorylation; P:positive regulation of telomere capping; C:nucleoplasm; F:calmodulin binding; P:positive regulation of neuron differentiation; P:Ras protein signal transduction; F:mitogen-activated protein kinase binding; P:positive regulation of dendrite development; P:stress-induced premature senescence; P:positive regulation of telomere maintenance via telomerase; P:positive regulation of neurogenesis; P:cell surface receptor signaling pathway; F:calcium-dependent protein serine/threonine kinase activity; P:negative regulation of TOR signaling; C:septin cytoskeleton; F:MAP kinase kinase activity; P:positive regulation of MAP kinase activity; P:regulation of biological quality; P:activation of protein kinase activity; C:protein-containing complex; P:regulation of translation	K04442	map04010	MAPK5_HUMAN | MAP kinase-activated protein kinase 5 OS=Homo sapiens OX=9606 GN=MAPKAPK5 PE=1 SV=2	299	6.2e-59	P:GO:0002224; P:GO:0006417; P:GO:0006954; P:GO:0006974; P:GO:0007265; P:GO:0018105; P:GO:0032007; P:GO:0032212; P:GO:0032496; P:GO:0032675; P:GO:0032760; P:GO:0034097; P:GO:0035095; P:GO:0035924; P:GO:0038066; P:GO:0044351; P:GO:0046777; P:GO:0048010; P:GO:0048691; P:GO:0048839; P:GO:0048841; P:GO:0051973; P:GO:0060999; P:GO:0090400; P:GO:1904355; P:GO:1905606; P:GO:1905870; F:GO:0002039; F:GO:0004674; F:GO:0004712; F:GO:0051019; C:GO:0005654; C:GO:0005813; C:GO:0005829; C:GO:0032156; C:GO:0032991; C:GO:0045202	P:toll-like receptor sigling pathway; P:regulation of translation; P:inflammatory response; P:cellular response to D damage stimulus; P:Ras protein sigl transduction; P:peptidyl-serine phosphorylation; P:negative regulation of TOR sigling; P:positive regulation of telomere maintence via telomerase; P:response to lipopolysaccharide; P:regulation of interleukin-6 production; P:positive regulation of tumor necrosis factor production; P:response to cytokine; P:behavioral response to nicotine; P:cellular response to vascular endothelial growth factor stimulus; P:p38MAPK cascade; P:macropinocytosis; P:protein autophosphorylation; P:vascular endothelial growth factor receptor sigling pathway; P:positive regulation of axon extension involved in regeneration; P:inner ear development; P:regulation of axon extension involved in axon guidance; P:positive regulation of telomerase activity; P:positive regulation of dendritic spine development; P:stress-induced premature senescence; P:positive regulation of telomere capping; P:regulation of presypse assembly; P:positive regulation of 3'-UTR-mediated mR stabilization; F:p53 binding; F:protein serine/threonine kise activity; F:protein serine/threonine/tyrosine kise activity; F:mitogen-activated protein kise binding; C:nucleoplasm; C:centrosome; C:cytosol; C:septin cytoskeleton; C:protein-containing complex; C:sypse	EC:2.7.12.1	Dual-specificity kise	IPR000719 (PFAM); IPR017441 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	92.1675590020562	2.14873555202695	0.404022155685041	5.318360693323	1.04706341880521e-07	5.38217359270194e-06
Avas.s007.g506.i1	paralog_cluster_06248	NA	Filamin C, gamma	4.3e-149	535.8	Bilateria	NA	1	F:GO:0003779	F:actin binding	K04437	map04010, map04510, map05132, map05205	FL_DROME | Filamin-A OS=Drosophila melanogaster OX=7227 GN=cher PE=1 SV=2	991	1.3e-140	P:GO:0000904; P:GO:0002009; P:GO:0002064; P:GO:0006950; P:GO:0007015; P:GO:0007301; P:GO:0007399; P:GO:0007610; P:GO:0009892; P:GO:0009966; P:GO:0010033; P:GO:0016477; P:GO:0016482; P:GO:0019219; P:GO:0032989; P:GO:0034330; P:GO:0034613; P:GO:0034765; P:GO:0042330; P:GO:0043467; P:GO:0044087; P:GO:0045595; P:GO:0048513; P:GO:0048523; P:GO:0048584; P:GO:0051094; P:GO:0051240; P:GO:0051495; P:GO:0055001; P:GO:0060255; P:GO:0065008; P:GO:0090257; P:GO:0120035; P:GO:0140694; P:GO:1901700; P:GO:2000026; F:GO:0005102; F:GO:0008092; F:GO:0019899; F:GO:0044877; C:GO:0005634; C:GO:0005886; C:GO:0015629; C:GO:0030017; C:GO:0030054; C:GO:0035324; C:GO:0043005; C:GO:0099738	P:cell morphogenesis involved in differentiation; P:morphogenesis of an epithelium; P:epithelial cell development; P:response to stress; P:actin filament organization; P:female germline ring cal formation; P:nervous system development; P:behavior; P:negative regulation of metabolic process; P:regulation of sigl transduction; P:response to organic substance; P:cell migration; P:cytosolic transport; P:regulation of nucleobase-containing compound metabolic process; P:cellular component morphogenesis; P:cell junction organization; P:cellular protein localization; P:regulation of ion transmembrane transport; P:taxis; P:regulation of generation of precursor metabolites and energy; P:regulation of cellular component biogenesis; P:regulation of cell differentiation; P:animal organ development; P:negative regulation of cellular process; P:positive regulation of response to stimulus; P:positive regulation of developmental process; P:positive regulation of multicellular organismal process; P:positive regulation of cytoskeleton organization; P:muscle cell development; P:regulation of macromolecule metabolic process; P:regulation of biological quality; P:regulation of muscle system process; P:regulation of plasma membrane bounded cell projection organization; P:non-membrane-bounded organelle assembly; P:response to oxygen-containing compound; P:regulation of multicellular organismal development; F:sigling receptor binding; F:cytoskeletal protein binding; F:enzyme binding; F:protein-containing complex binding; C:nucleus; C:plasma membrane; C:actin cytoskeleton; C:sarcomere; C:cell junction; C:female germline ring cal; C:neuron projection; C:cell cortex region			IPR001715 (PFAM); IPR017868 (PFAM); IPR001589 (PROSITE_PATTERNS); IPR001715 (PROSITE_PROFILES); IPR001715 (PROSITE_PROFILES); IPR017868 (PROSITE_PROFILES); IPR017868 (PROSITE_PROFILES); IPR017868 (PROSITE_PROFILES); IPR017868 (PROSITE_PROFILES); IPR017868 (PROSITE_PROFILES); IPR017868 (PROSITE_PROFILES); IPR017868 (PROSITE_PROFILES); IPR017868 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	1121.65671573429	1.16663186448817	0.209873134314337	5.55874799459016	2.7171667915317e-08	1.57253584564581e-06
Avas.s007.g595.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	297	NA					IPR008160 (PFAM)	no GO terms	no GO terms	8072.0164856375	2.65391698561583	0.264087167078954	10.0493977612414	9.24305521692939e-24	2.56399164457202e-21
Avas.s007.g679.i1	paralog_cluster_00591	NA	calcium ion transmembrane transport	3.9e-09	70.9	Eukaryota	NA	NA	NA	NA	NA	NA	------	1006	NA					IPR002110 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	72.9703770342529	-3.64368798873103	0.648921494042827	-5.61499044519329	1.96573107093534e-08	1.17135730371403e-06
Avas.s007.g759.i1	homolog_cluster_12539	fak	signal complex assembly	3.3e-06	59.3	Metazoa	EC:2.7.10.2	17	F:GO:0005102; P:GO:0007010; P:GO:0030154; C:GO:0061177; P:GO:0043407; C:GO:0061176; P:GO:0042127; F:GO:0004715; P:GO:0038083; P:GO:0042059; P:GO:0045886; C:GO:0031234; C:GO:0005622; P:GO:0045087; C:GO:0005912; P:GO:0032507; C:GO:0005925	C:type Is terminal bouton; P:negative regulation of MAP kinase activity; P:cell differentiation; C:extrinsic component of cytoplasmic side of plasma membrane; P:cytoskeleton organization; F:signaling receptor binding; C:adherens junction; P:regulation of cell population proliferation; C:focal adhesion; P:maintenance of protein location in cell; C:type Ib terminal bouton; C:intracellular anatomical structure; F:non-membrane spanning protein tyrosine kinase activity; P:negative regulation of synaptic assembly at neuromuscular junction; P:innate immune response; P:negative regulation of epidermal growth factor receptor signaling pathway; P:peptidyl-tyrosine autophosphorylation	K05725	map01522, map04012, map04062, map04151, map04360, map04370, map04510, map04670, map04810, map05100, map05146, map05165, map05200, map05202, map05205, map05222, map05418	------	279	NA					IPR005189 (PFAM)	P:GO:0006468; P:GO:0007172; F:GO:0004713; C:GO:0005925	P:protein phosphorylation; P:sigl complex assembly; F:protein tyrosine kise activity; C:focal adhesion	654.451683879292	1.9035651534611	0.207300027297207	9.18265751471395	4.20581269572592e-20	8.90359479757031e-18
Avas.s007.g766.i1	NA	COL1A1	Collagen alpha-1(I)	1.4e-18	102.8	Afrotheria	NA	58	P:GO:0010812; F:GO:0005201; P:GO:0007605; P:GO:0048706; P:GO:0007601; P:GO:0038063; P:GO:0060351; P:GO:0044344; C:GO:0005615; P:GO:2000112; P:GO:0034505; P:GO:0032964; P:GO:0034504; P:GO:0070208; P:GO:0030199; P:GO:0051591; P:GO:0031960; P:GO:0009410; P:GO:0060346; P:GO:0071260; P:GO:1902618; P:GO:0071306; P:GO:0043589; F:GO:0048407; P:GO:0071300; P:GO:0050900; C:GO:0030141; P:GO:2000026; P:GO:0030168; P:GO:0010718; P:GO:0001568; P:GO:0071230; P:GO:0042542; C:GO:0005794; P:GO:0043434; P:GO:0071356; P:GO:0001649; P:GO:0045893; P:GO:0050776; P:GO:0032355; P:GO:0010628; P:GO:0071364; P:GO:0071560; P:GO:0060325; P:GO:0055093; P:GO:0009636; C:GO:0005584; P:GO:0090263; P:GO:0046677; F:GO:0042802; P:GO:0015031; P:GO:0001957; C:GO:0005788; P:GO:0001958; P:GO:0015833; F:GO:0002020; P:GO:0044691; P:GO:0030335	P:cellular response to transforming growth factor beta stimulus; P:response to estradiol; P:blood vessel development; C:extracellular space; P:peptide transport; P:cellular response to tumor necrosis factor; P:face morphogenesis; P:protein localization to nucleus; P:positive regulation of cell migration; P:intramembranous ossification; P:osteoblast differentiation; P:cellular response to fluoride; P:collagen biosynthetic process; P:skin morphogenesis; P:cellular response to mechanical stimulus; P:cartilage development involved in endochondral bone morphogenesis; P:response to hyperoxia; P:cellular response to vitamin E; P:sensory perception of sound; F:extracellular matrix structural constituent; P:collagen fibril organization; P:response to antibiotic; P:embryonic skeletal system development; P:positive regulation of canonical Wnt signaling pathway; P:platelet activation; F:protease binding; P:bone trabecula formation; F:platelet-derived growth factor binding; P:response to hydrogen peroxide; P:cellular response to fibroblast growth factor stimulus; P:regulation of cellular macromolecule biosynthetic process; C:endoplasmic reticulum lumen; P:response to toxic substance; P:collagen-activated tyrosine kinase receptor signaling pathway; P:positive regulation of epithelial to mesenchymal transition; C:collagen type I trimer; P:negative regulation of cell-substrate adhesion; P:tooth eruption; P:cellular response to epidermal growth factor stimulus; F:identical protein binding; P:response to cAMP; P:response to corticosteroid; P:protein transport; C:secretory granule; P:protein heterotrimerization; P:cellular response to amino acid stimulus; P:regulation of multicellular organismal development; P:positive regulation of gene expression; P:leukocyte migration; P:response to xenobiotic stimulus; P:regulation of immune response; P:endochondral ossification; P:tooth mineralization; P:visual perception; P:cellular response to retinoic acid; P:response to peptide hormone; C:Golgi apparatus; P:positive regulation of transcription, DNA-templated	K06236	map04151, map04510, map04512, map04611, map04926, map04933, map04974, map05146, map05165	CO5A2_MOUSE | Collagen alpha-2(V) chain OS=Mus musculus OX=10090 GN=Col5a2 PE=1 SV=1	1535	6.3e-14	P:GO:0009987; P:GO:0048731; C:GO:0031012	P:cellular process; P:system development; C:extracellular matrix			IPR000885 (PFAM); IPR008160 (PFAM); IPR000885 (PROSITE_PROFILES)	F:GO:0005201	F:extracellular matrix structural constituent	108.127716546309	2.94376541968517	0.369949340825007	7.95721223105958	1.75958748370609e-15	2.72211567551416e-13
Avas.s007.g798.i1	paralog_cluster_00306	Mkk4	Protein tyrosine kinase	4e-65	255.8	Paraneoptera	EC:2.7.12.2	12	P:GO:0007346; P:GO:0042981; P:GO:0048082; P:GO:0007564; P:GO:0032147; F:GO:0004674; P:GO:0048666; C:GO:0030424; P:GO:0043507; P:GO:0046330; F:GO:0004708; C:GO:0005737	P:positive regulation of JUN kinase activity; F:MAP kinase kinase activity; P:activation of protein kinase activity; P:positive regulation of JNK cascade; P:regulation of apoptotic process; C:cytoplasm; P:regulation of chitin-based cuticle tanning; P:regulation of mitotic cell cycle; P:neuron development; F:protein serine/threonine kinase activity; C:axon; P:regulation of adult chitin-containing cuticle pigmentation	K04430	map04010, map04012, map04013, map04620, map04664, map04668, map04912, map04926, map05120, map05142, map05161, map05164, map05166, map05167, map05169, map05418	MP2K2_XENLA | Dual specificity mitogen-activated protein kinase kinase 2 (Fragment) OS=Xenopus laevis OX=8355 GN=map2k2 PE=1 SV=1	465	3.8e-63	P:GO:0001649; P:GO:0001817; P:GO:0006954; P:GO:0007254; P:GO:0008582; P:GO:0034393; P:GO:0035331; P:GO:0035924; P:GO:0038095; P:GO:0043406; P:GO:0043536; P:GO:0045893; P:GO:0048691; P:GO:0060048; P:GO:0060348; P:GO:0071260; P:GO:0090398; P:GO:0120163; P:GO:1900745; P:GO:2000672; F:GO:0008545; F:GO:0019211; F:GO:0031435; F:GO:0042802; F:GO:0043539; C:GO:0005654; C:GO:0005829	P:osteoblast differentiation; P:regulation of cytokine production; P:inflammatory response; P:JNK cascade; P:regulation of syptic assembly at neuromuscular junction; P:positive regulation of smooth muscle cell apoptotic process; P:negative regulation of hippo sigling; P:cellular response to vascular endothelial growth factor stimulus; P:Fc-epsilon receptor sigling pathway; P:positive regulation of MAP kise activity; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of transcription, D-templated; P:positive regulation of axon extension involved in regeneration; P:cardiac muscle contraction; P:bone development; P:cellular response to mechanical stimulus; P:cellular senescence; P:negative regulation of cold-induced thermogenesis; P:positive regulation of p38MAPK cascade; P:negative regulation of motor neuron apoptotic process; F:JUN kise kise activity; F:phosphatase activator activity; F:mitogen-activated protein kise kise kise binding; F:identical protein binding; F:protein serine/threonine kise activator activity; C:nucleoplasm; C:cytosol	EC:2.7.12.1; EC:2.7.12.2	Dual-specificity kise; Mitogen-activated protein kise kise	IPR000719 (PFAM); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	974.165176970175	2.96006953922219	0.435047216158302	6.80401903352279	1.01740088249525e-11	1.01042980237444e-09
Avas.s007.g813.i1	paralog_cluster_08747	CTBS	chitinase activity	1.3e-40	174.1	Bilateria	NA	7	F:GO:0004568; P:GO:0042178; F:GO:0008061; P:GO:0009313; C:GO:0005576; C:GO:0005764; P:GO:0006032	F:chitin binding; P:oligosaccharide catabolic process; C:extracellular region; P:chitin catabolic process; F:chitinase activity; P:xenobiotic catabolic process; C:lysosome	K12310	NA	DIAC_MOUSE | Di-N-acetylchitobiase OS=Mus musculus OX=10090 GN=Ctbs PE=1 SV=2	381	3.1e-39	P:GO:0071704; F:GO:0016798	P:organic substance metabolic process; F:hydrolase activity, acting on glycosyl bonds	EC:3.2	Glycosylases	IPR001223 (PFAM); IPR001223 (PROSITE_PROFILES)	P:GO:0005975	P:carbohydrate metabolic process	1599.83237568896	-1.5474354708216	0.234539548538287	-6.59775922852089	4.17418423113368e-11	3.92739474238069e-09
Avas.s007.g814.i1	homolog_cluster_12555	GREB1L	GREB1-like protein	1.1e-113	419.1	Afrotheria	NA	NA	NA	NA	NA	NA	GRB1L_HUMAN | GREB1-like protein OS=Homo sapiens OX=9606 GN=GREB1L PE=1 SV=2	1866	8.8e-111	P:GO:0001822; P:GO:0035295	P:kidney development; P:tube development			IPR028422 (PFAM)	no GO terms	no GO terms	131.100065034197	1.70256843559353	0.277171223068578	6.14265946061895	8.11511419081151e-10	6.0446329729614e-08
Avas.s007.g848.i1	paralog_cluster_00059	TUA1	Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain	6.3e-92	344.7	Brassicales	NA	4	P:GO:0007017; C:GO:0005886; C:GO:0005856; C:GO:0005829	C:cytoskeleton; P:microtubule-based process; C:cytosol; C:plasma membrane	K07374	map04145, map04210, map04530, map04540, map05130	TBA1_ARATH | Tubulin alpha-1 chain OS=Arabidopsis thalia OX=3702 GN=TUBA1 PE=2 SV=1	448	3.4e-93	P:GO:0007010; P:GO:0007017; P:GO:0007059; F:GO:0000166; F:GO:0005200; F:GO:0005515; C:GO:0005737; C:GO:0005813; C:GO:0005874	P:cytoskeleton organization; P:microtubule-based process; P:chromosome segregation; F:nucleotide binding; F:structural constituent of cytoskeleton; F:protein binding; C:cytoplasm; C:centrosome; C:microtubule			IPR003008 (PFAM); IPR018316 (PFAM); IPR017975 (PROSITE_PATTERNS)	P:GO:0007017; F:GO:0003924; F:GO:0005525; C:GO:0005874	P:microtubule-based process; F:GTPase activity; F:GTP binding; C:microtubule	917.34724894615	1.73350013719948	0.357572306873526	4.84797089673005	1.24730693707769e-06	5.19894334472615e-05
Avas.s007.g862.i1	paralog_cluster_08752	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	430	NA					no IPS match	no IPS match	no IPS match	616.351720734666	2.5318467807596	0.349841402242746	7.23712735121845	4.58287783374447e-13	5.46177196052702e-11
Avas.s007.g866.i1	paralog_cluster_00633	NA	Competence protein ComEC	4.8e-15	89.4	Eukaryota	NA	NA	NA	NA	NA	NA	------	450	NA					no IPS match	no IPS match	no IPS match	215.851054205509	2.54226475820378	0.300112658469199	8.47103474798846	2.43222663582667e-17	4.39686453301295e-15
Avas.s008.g47.i1	NA	RYBP	Yaf2/RYBP C-terminal binding motif	0.089	42.7	Nematocera	NA	5	F:GO:0003677; P:GO:0031146; P:GO:0043066; C:GO:0016604; P:GO:0050777	P:negative regulation of immune response; P:negative regulation of apoptotic process; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; C:nuclear body; F:DNA binding	K11468	NA	------	78	NA					IPR033774 (PFAM)	no GO terms	no GO terms	129.624040247353	2.42852934162015	0.413155265978408	5.87800650651048	4.15236601956438e-09	2.73800888888407e-07
Avas.s008.g130.i1	homolog_cluster_12616	NA	Domain of unknown function (DUF4062)	2.4e-120	440.7	Bilateria	NA	NA	NA	NA	NA	NA	Y7407_DICDI | TPR repeat-containing protein DDB_G0287407 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0287407 PE=4 SV=1	1301	1.6e-82	P:GO:0007018; P:GO:0007283; P:GO:0051179; F:GO:0005515; C:GO:0005856; C:GO:0043227; C:GO:0120025	P:microtubule-based movement; P:spermatogenesis; P:localization; F:protein binding; C:cytoskeleton; C:membrane-bounded organelle; C:plasma membrane bounded cell projection			IPR025139 (PFAM); PF13424 (PFAM); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); IPR019734 (PROSITE_PROFILES); PS50293 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	218.477219381515	1.10703522163436	0.214222705678971	5.16768387424505	2.37012750238867e-07	1.1281947155601e-05
Avas.s008.g149.i1	paralog_cluster_01318	NA	voltage-gated chloride channel activity	3.6e-167	595.5	Metazoa	NA	NA	NA	NA	K05012	NA	CLCN5_CAVPO | H(+)/Cl(-) exchange transporter 5 OS=Cavia porcellus OX=10141 GN=CLCN5 PE=2 SV=1	794	1e-161	P:GO:0006821; P:GO:0016192; P:GO:0048388; P:GO:0060249; P:GO:0098660; F:GO:0005247; F:GO:0015297; F:GO:0030165; F:GO:0042802; F:GO:0072320; C:GO:0005765; C:GO:0005769; C:GO:0005770; C:GO:0005789; C:GO:0005794; C:GO:0009897; C:GO:0010008; C:GO:0016324; C:GO:0030285; C:GO:0055037; C:GO:0060077; C:GO:0098978; C:GO:0099055	P:chloride transport; P:vesicle-mediated transport; P:endosomal lumen acidification; P:atomical structure homeostasis; P:inorganic ion transmembrane transport; F:voltage-gated chloride channel activity; F:antiporter activity; F:PDZ domain binding; F:identical protein binding; F:volume-sensitive chloride channel activity; C:lysosomal membrane; C:early endosome; C:late endosome; C:endoplasmic reticulum membrane; C:Golgi apparatus; C:exterl side of plasma membrane; C:endosome membrane; C:apical plasma membrane; C:integral component of syptic vesicle membrane; C:recycling endosome; C:inhibitory sypse; C:glutamatergic sypse; C:integral component of postsyptic membrane	EC:7	Translocases	IPR000644 (PFAM); IPR001807 (PFAM); IPR000644 (PROSITE_PROFILES)	P:GO:0006821; P:GO:0055085; F:GO:0005247; C:GO:0016020	P:chloride transport; P:transmembrane transport; F:voltage-gated chloride channel activity; C:membrane	118.942597697559	3.201851022421	0.590711466227681	5.420329899584	5.94891527016693e-08	3.21181536180254e-06
Avas.s008.g161.i1	homolog_cluster_12630	FZD7	Wnt-activated receptor activity	1.8e-12	80.9	Bilateria	NA	30	P:GO:0010976; F:GO:0004930; P:GO:1902669; P:GO:0008356; P:GO:0007367; P:GO:0007464; P:GO:0007186; P:GO:0007507; F:GO:0042813; P:GO:0035293; P:GO:0045773; P:GO:0010770; P:GO:0045198; P:GO:0016318; P:GO:0035159; P:GO:0060070; P:GO:0007435; P:GO:0002066; P:GO:0007298; P:GO:0007156; P:GO:0032231; P:GO:0045746; P:GO:0045666; F:GO:0017147; P:GO:0016360; P:GO:0035320; C:GO:0005887; P:GO:0035567; P:GO:0035206; P:GO:0050921	P:regulation of hemocyte proliferation; P:segment polarity determination; F:Wnt-activated receptor activity; P:chitin-based larval cuticle pattern formation; P:sensory organ precursor cell fate determination; P:positive regulation of axon extension; F:G protein-coupled receptor activity; P:imaginal disc-derived wing hair site selection; P:negative regulation of Notch signaling pathway; P:establishment of epithelial cell apical/basal polarity; P:border follicle cell migration; P:heart development; P:positive regulation of neuron projection development; P:columnar/cuboidal epithelial cell development; P:R3/R4 cell fate commitment; P:salivary gland morphogenesis; P:positive regulation of neuron differentiation; C:integral component of plasma membrane; P:positive regulation of cell morphogenesis involved in differentiation; P:positive regulation of chemotaxis; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:G protein-coupled receptor signaling pathway; P:non-canonical Wnt signaling pathway; P:canonical Wnt signaling pathway; P:regulation of actin filament bundle assembly; P:asymmetric cell division; F:Wnt-protein binding; P:positive regulation of axon guidance; P:ommatidial rotation; P:regulation of tube length, open tracheal system	K02235,K02432	map04150, map04310, map04390, map04550, map04916, map04934, map05165, map05166, map05200, map05205, map05217, map05224, map05225, map05226	------	483	NA					IPR000539 (PFAM); IPR017981 (PROSITE_PROFILES)	P:GO:0007166; F:GO:0004888; C:GO:0016020; C:GO:0016021	P:cell surface receptor sigling pathway; F:transmembrane sigling receptor activity; C:membrane; C:integral component of membrane	501.27690289469	2.03995596059078	0.362404390599845	5.62894935465402	1.81310620371424e-08	1.08442623463042e-06
Avas.s008.g167.i1	homolog_cluster_12633	NA	acetyltransferases and hydrolases with the alpha beta hydrolase fold	1e-58	235	Gammaproteobacteria	NA	NA	NA	NA	NA	NA	CMF_DICDI | Conditioned medium factor OS=Dictyostelium discoideum OX=44689 GN=cmfA PE=1 SV=2	667	4.4e-44	P:GO:0010468; P:GO:0031152; P:GO:0045597; C:GO:0005615	P:regulation of gene expression; P:aggregation involved in sorocarp development; P:positive regulation of cell differentiation; C:extracellular space			no IPS match	no IPS match	no IPS match	190.607032911188	3.67480965152843	0.429186442787802	8.56226871393821	1.10667893884553e-17	2.02333607353247e-15
Avas.s008.g236.i1	homolog_cluster_12660	UGCG	dihydroceramide glucosyltransferase activity	8.3e-60	238	Vertebrata	EC:2.4.1.80	8	P:GO:0008544; P:GO:0046479; C:GO:0000139; P:GO:0043066; C:GO:0098791; C:GO:0005789; P:GO:0006679; F:GO:0008120	P:glycosphingolipid catabolic process; C:Golgi apparatus subcompartment; P:negative regulation of apoptotic process; P:glucosylceramide biosynthetic process; F:ceramide glucosyltransferase activity; C:Golgi membrane; C:endoplasmic reticulum membrane; P:epidermis development	K00720	map00600, map01100	CEGTB_XENLA | Ceramide glucosyltransferase-B OS=Xenopus laevis OX=8355 GN=ugcg-b PE=2 SV=1	447	7.6e-61	P:GO:0006687; P:GO:0008544; P:GO:0030154; P:GO:0043588; P:GO:0044249; P:GO:0050794; P:GO:1901566; F:GO:0008120; C:GO:0000139; C:GO:0016021	P:glycosphingolipid metabolic process; P:epidermis development; P:cell differentiation; P:skin development; P:cellular biosynthetic process; P:regulation of cellular process; P:organonitrogen compound biosynthetic process; F:ceramide glucosyltransferase activity; C:Golgi membrane; C:integral component of membrane	EC:2.4.1.80	Ceramide glucosyltransferase	IPR025993 (PFAM)	F:GO:0016757	F:glycosyltransferase activity	971.085848313734	2.81528247608025	0.364181140679017	7.73044554375096	1.07170828179086e-14	1.46124699540111e-12
Avas.s008.g238.i1	paralog_cluster_05034	NA	Lipid phosphate phosphohydrolase	3.6e-33	149.1	Metazoa	EC:3.1.3.4	NA	NA	NA	K01080	map00561, map00564, map00565, map00600, map01100, map01110, map04072, map04666, map04975, map05231	WUN_DROME | Putative phosphatidate phosphatase OS=Drosophila melanogaster OX=7227 GN=wun PE=1 SV=2	322	1.7e-25	P:GO:0006665; P:GO:0006796; P:GO:0007165; P:GO:0008354; P:GO:0009605; P:GO:0048856; P:GO:0070887; F:GO:0042577; C:GO:0005768; C:GO:0005886; C:GO:0045177	P:sphingolipid metabolic process; P:phosphate-containing compound metabolic process; P:sigl transduction; P:germ cell migration; P:response to exterl stimulus; P:atomical structure development; P:cellular response to chemical stimulus; F:lipid phosphatase activity; C:endosome; C:plasma membrane; C:apical part of cell	EC:3.1.3	Acting on ester bonds	IPR000326 (PFAM)	no GO terms	no GO terms	260.274182057776	2.85170144402284	0.313324712415287	9.10142523403368	8.91540888107401e-20	1.8389745318923e-17
Avas.s008.g241.i1	homolog_cluster_12662	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	484	NA					no IPS match	no IPS match	no IPS match	210.146066664601	2.43468589856965	0.352818409011233	6.90067705195091	5.17552713574317e-12	5.37219716690141e-10
Avas.s008.g477.i1	paralog_cluster_04550	NA	transferase activity, transferring acyl groups other than amino-acyl groups	1.8e-21	110.2	Insecta	NA	NA	NA	NA	NA	NA	------	310	NA					IPR007130 (PFAM)	F:GO:0008374	F:O-acyltransferase activity	160.679127072789	2.29179103254532	0.373841466343329	6.13038209742251	8.76682657209789e-10	6.4406151926248e-08
Avas.s008.g483.i1	paralog_cluster_00562	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	379	NA					no IPS match	no IPS match	no IPS match	38.7445270857643	3.94576900378285	0.589450427806908	6.69397937068833	2.17182047815473e-11	2.10496504054407e-09
Avas.s008.g547.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	301	NA					no IPS match	no IPS match	no IPS match	39.3159939936598	-2.43150858826754	0.456978062275342	-5.32084314104884	1.03287431845756e-07	5.32625477873836e-06
Avas.s008.g622.i1	paralog_cluster_02141	NA	Citrate transporter	5.4e-92	345.5	Opisthokonta	NA	NA	NA	NA	NA	NA	LSI3_ORYSJ | Silicon efflux transporter LSI3 OS=Oryza sativa subsp. japonica OX=39947 GN=LSI3 PE=2 SV=1	651	8e-35	P:GO:0006726; P:GO:0007286; P:GO:0008283; P:GO:0015700; P:GO:0015828; P:GO:0030318; P:GO:0042438; P:GO:0043473; P:GO:0048066; P:GO:0055085; P:GO:0071722; F:GO:0005215; F:GO:0005302; F:GO:0005515; F:GO:0015105; F:GO:0015446; C:GO:0005737; C:GO:0005765; C:GO:0005789; C:GO:0005886; C:GO:0005887; C:GO:0010008; C:GO:0016020; C:GO:0016021; C:GO:0033162	P:eye pigment biosynthetic process; P:spermatid development; P:cell population proliferation; P:arsenite transport; P:tyrosine transport; P:melanocyte differentiation; P:melanin biosynthetic process; P:pigmentation; P:developmental pigmentation; P:transmembrane transport; P:detoxification of arsenic-containing substance; F:transporter activity; F:L-tyrosine transmembrane transporter activity; F:protein binding; F:arsenite transmembrane transporter activity; F:ATPase-coupled arsenite transmembrane transporter activity; C:cytoplasm; C:lysosomal membrane; C:endoplasmic reticulum membrane; C:plasma membrane; C:integral component of plasma membrane; C:endosome membrane; C:membrane; C:integral component of membrane; C:melanosome membrane			IPR004680 (PFAM)	P:GO:0055085; C:GO:0016021	P:transmembrane transport; C:integral component of membrane	165.07481890123	2.71567117320575	0.308835325972169	8.79326600562034	1.45273977751791e-18	2.7178058465681e-16
Avas.s008.g628.i1	paralog_cluster_08529	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	141	NA					no IPS match	no IPS match	no IPS match	731.335412228262	3.27490338907994	0.466263200430396	7.02372262288115	2.16033486880293e-12	2.36446446967146e-10
Avas.s008.g664.i1	homolog_cluster_12764	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	198	NA					no IPS match	no IPS match	no IPS match	94.4755854080829	2.19887869755343	0.394548657406393	5.57314961355589	2.50174540605639e-08	1.4530895970412e-06
Avas.s008.g719.i1	paralog_cluster_08787	TRPM2	cellular response to temperature stimulus	4.3e-80	307	Euarchontoglires	EC:3.6.1.13	35	C:GO:0070821; P:GO:0032024; P:GO:1900409; P:GO:0044849; P:GO:0033194; C:GO:0043005; P:GO:0009408; C:GO:0043025; F:GO:0005509; P:GO:0071415; F:GO:0022839; P:GO:0043312; F:GO:0015278; P:GO:0097028; P:GO:0071577; P:GO:0071236; P:GO:0070301; P:GO:0071277; F:GO:0005384; P:GO:0051489; P:GO:0051209; P:GO:2000249; C:GO:0101003; P:GO:1903223; C:GO:0035579; P:GO:0071502; P:GO:0071466; P:GO:0002407; P:GO:0001659; P:GO:0097237; P:GO:0098703; C:GO:0005765; P:GO:0035584; C:GO:0005887; P:GO:0071421	P:calcium-mediated signaling using intracellular calcium source; P:cellular response to temperature stimulus; P:calcium ion import across plasma membrane; P:positive regulation of cellular response to oxidative stress; C:specific granule membrane; C:neuronal cell body; P:estrous cycle; P:neutrophil degranulation; F:ion gated channel activity; P:temperature homeostasis; P:positive regulation of oxidative stress-induced neuron death; P:manganese ion transmembrane transport; F:manganese ion transmembrane transporter activity; P:cellular response to hydrogen peroxide; C:integral component of plasma membrane; P:dendritic cell chemotaxis; P:regulation of actin cytoskeleton reorganization; P:release of sequestered calcium ion into cytosol; P:cellular response to xenobiotic stimulus; P:response to heat; P:cellular response to purine-containing compound; P:cellular response to toxic substance; C:neuron projection; P:regulation of filopodium assembly; F:calcium ion binding; C:tertiary granule membrane; P:dendritic cell differentiation; F:calcium-release channel activity; P:cellular response to calcium ion; P:response to hydroperoxide; P:zinc ion transmembrane transport; P:positive regulation of insulin secretion; P:cellular response to antibiotic; C:lysosomal membrane; C:ficolin-1-rich granule membrane	K04977	map04621, map04921	TRPM2_HUMAN | Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens OX=9606 GN=TRPM2 PE=1 SV=2	1332	3.4e-72	P:GO:0002376; P:GO:0006950; P:GO:0007165; P:GO:0008016; P:GO:0009266; P:GO:0032879; P:GO:0042391; P:GO:0048522; P:GO:0051240; P:GO:0060402; P:GO:0070588; P:GO:0070887; F:GO:0005261; F:GO:0022836; F:GO:0043167; F:GO:0046873; F:GO:0097159; F:GO:1901363; C:GO:0005886; C:GO:0012505; C:GO:0016021; C:GO:0031090; C:GO:0031410	P:immune system process; P:response to stress; P:sigl transduction; P:regulation of heart contraction; P:response to temperature stimulus; P:regulation of localization; P:regulation of membrane potential; P:positive regulation of cellular process; P:positive regulation of multicellular organismal process; P:calcium ion transport into cytosol; P:calcium ion transmembrane transport; P:cellular response to chemical stimulus; F:cation channel activity; F:gated channel activity; F:ion binding; F:metal ion transmembrane transporter activity; F:organic cyclic compound binding; F:heterocyclic compound binding; C:plasma membrane; C:endomembrane system; C:integral component of membrane; C:organelle membrane; C:cytoplasmic vesicle	EC:7	Translocases	IPR041491 (PFAM); IPR005821 (PFAM)	P:GO:0006811; P:GO:0055085; F:GO:0005216; C:GO:0016020	P:ion transport; P:transmembrane transport; F:ion channel activity; C:membrane	89.9809565011626	2.09237717725697	0.31465685753912	6.64971103322237	2.93669004913701e-11	2.81240513098603e-09
Avas.s008.g752.i1	homolog_cluster_12794	RABGEF1	Rab guanyl-nucleotide exchange factor activity	8.6e-45	188.3	Bilateria	NA	30	P:GO:0031398; P:GO:0002792; P:GO:0032387; P:GO:0032483; P:GO:0006612; F:GO:0061630; P:GO:0018996; C:GO:0005730; C:GO:0030139; P:GO:0035214; P:GO:0046580; P:GO:0048261; F:GO:0005085; P:GO:1900235; P:GO:0007474; P:GO:0051036; P:GO:0034058; C:GO:0031901; F:GO:0031267; P:GO:0060368; P:GO:0040015; P:GO:0043305; P:GO:0043547; C:GO:0045177; P:GO:0002686; P:GO:0050728; P:GO:0001933; P:GO:0050709; P:GO:0032715; C:GO:0005829	F:guanyl-nucleotide exchange factor activity; P:negative regulation of receptor-mediated endocytosis; C:early endosome membrane; P:regulation of endosome size; P:negative regulation of inflammatory response; C:cytosol; P:negative regulation of multicellular organism growth; P:regulation of Fc receptor mediated stimulatory signaling pathway; P:negative regulation of protein phosphorylation; P:negative regulation of mast cell degranulation; F:small GTPase binding; P:negative regulation of leukocyte migration; C:apical part of cell; C:nucleolus; P:eye-antennal disc development; P:negative regulation of interleukin-6 production; P:regulation of Rab protein signal transduction; P:positive regulation of GTPase activity; C:endocytic vesicle; P:endosomal vesicle fusion; P:positive regulation of protein ubiquitination; P:negative regulation of protein secretion; P:imaginal disc-derived wing vein specification; P:negative regulation of intracellular transport; P:negative regulation of Kit signaling pathway; P:molting cycle, collagen and cuticulin-based cuticle; P:negative regulation of Ras protein signal transduction; P:negative regulation of peptide secretion; F:ubiquitin protein ligase activity; P:protein targeting to membrane	K20131,K21917	NA	RABX5_HUMAN | Rab5 GDP/GTP exchange factor OS=Homo sapiens OX=9606 GN=RABGEF1 PE=1 SV=3	510	1.4e-34	P:GO:0002682; P:GO:0006810; P:GO:0048523; P:GO:0048585; F:GO:0005515; C:GO:0005768	P:regulation of immune system process; P:transport; P:negative regulation of cellular process; P:negative regulation of response to stimulus; F:protein binding; C:endosome			IPR041545 (PFAM); IPR002653 (PFAM); IPR003123 (PFAM); IPR003123 (PROSITE_PROFILES); IPR002653 (PROSITE_PROFILES)	F:GO:0003677; F:GO:0008270	F:D binding; F:zinc ion binding	354.206936542586	1.0401355766468	0.21237552516446	4.89762450659668	9.70021713536221e-07	4.10702088133796e-05
Avas.s008.g773.i1	homolog_cluster_12802	TPD52L2	tumor protein	4.8e-10	71.6	Euarchontoglires	NA	4	F:GO:0042803; C:GO:0048471; P:GO:0042127; F:GO:0046982	F:protein homodimerization activity; F:protein heterodimerization activity; P:regulation of cell population proliferation; C:perinuclear region of cytoplasm	NA	NA	------	210	NA					IPR007327 (PFAM)	no GO terms	no GO terms	916.93746235913	-1.06184633991804	0.207692199819881	-5.1125961439039	3.17761165788591e-07	1.47758942091695e-05
Avas.s008.g781.i1	homolog_cluster_18526	ANTXR1	Anthrax toxin receptor	1.7e-55	223.8	Bilateria	NA	15	F:GO:0051015; P:GO:0031532; P:GO:0034446; F:GO:0004888; P:GO:1901202; P:GO:0007165; C:GO:0031527; P:GO:0001568; F:GO:0005518; P:GO:0022414; C:GO:0009897; P:GO:1905050; C:GO:0010008; C:GO:0031258; P:GO:0032989	P:substrate adhesion-dependent cell spreading; P:cellular component morphogenesis; P:actin cytoskeleton reorganization; P:blood vessel development; C:endosome membrane; C:external side of plasma membrane; P:signal transduction; F:transmembrane signaling receptor activity; F:actin filament binding; C:filopodium membrane; P:positive regulation of metallopeptidase activity; P:negative regulation of extracellular matrix assembly; C:lamellipodium membrane; P:reproductive process; F:collagen binding	K20909	map04621	ANTR1_HUMAN | Anthrax toxin receptor 1 OS=Homo sapiens OX=9606 GN=ANTXR1 PE=1 SV=2	464	7.7e-40	P:GO:0048856; P:GO:0050794; F:GO:0005515; F:GO:0038023; F:GO:0044877; C:GO:0005737; C:GO:0009986; C:GO:0012505; C:GO:0031253; C:GO:0043231	P:atomical structure development; P:regulation of cellular process; F:protein binding; F:sigling receptor activity; F:protein-containing complex binding; C:cytoplasm; C:cell surface; C:endomembrane system; C:cell projection membrane; C:intracellular membrane-bounded organelle			IPR008400 (PFAM); IPR002035 (PFAM); IPR002035 (PROSITE_PROFILES)	F:GO:0038023; C:GO:0016021	F:sigling receptor activity; C:integral component of membrane	231.184824132705	2.64810682655352	0.538651000250162	4.91618288153865	8.82479633674006e-07	3.76610472843e-05
Avas.s008.g879.i1	homolog_cluster_12836	NA	integrin-mediated signaling pathway	2.9e-82	313.5	Metazoa	NA	NA	NA	NA	NA	NA	ITB2_HUMAN | Integrin beta-2 OS=Homo sapiens OX=9606 GN=ITGB2 PE=1 SV=2	842	2.6e-78	P:GO:0006950; P:GO:0007155; P:GO:0007166; P:GO:0016192; P:GO:0031323; P:GO:0032879; P:GO:0032956; P:GO:0040012; P:GO:0042221; P:GO:0042592; P:GO:0042692; P:GO:0043170; P:GO:0045321; P:GO:0048513; P:GO:0048583; P:GO:0048646; P:GO:0050900; P:GO:0051094; P:GO:0051130; P:GO:0051240; F:GO:0005515; C:GO:0008305; C:GO:0043227; C:GO:0043292; C:GO:0120025	P:response to stress; P:cell adhesion; P:cell surface receptor sigling pathway; P:vesicle-mediated transport; P:regulation of cellular metabolic process; P:regulation of localization; P:regulation of actin cytoskeleton organization; P:regulation of locomotion; P:response to chemical; P:homeostatic process; P:muscle cell differentiation; P:macromolecule metabolic process; P:leukocyte activation; P:animal organ development; P:regulation of response to stimulus; P:atomical structure formation involved in morphogenesis; P:leukocyte migration; P:positive regulation of developmental process; P:positive regulation of cellular component organization; P:positive regulation of multicellular organismal process; F:protein binding; C:integrin complex; C:membrane-bounded organelle; C:contractile fiber; C:plasma membrane bounded cell projection			IPR002369 (PFAM); IPR040622 (PFAM); IPR014836 (PFAM); IPR015812 (PROSITE_PATTERNS); IPR015812 (PROSITE_PATTERNS)	no GO terms	no GO terms	703.028562467713	1.5588236670167	0.243314269979035	6.40662657044741	1.48774608863474e-10	1.24668473021064e-08
Avas.s008.g926.i1	paralog_cluster_01081	NA	Transporter	4e-42	179.5	Brassicales	NA	NA	NA	NA	NA	NA	GLPT2_ARATH | Putative glycerol-3-phosphate transporter 2 OS=Arabidopsis thalia OX=3702 GN=At4g25220 PE=2 SV=1	509	8.5e-40	P:GO:0009987; P:GO:0071702; F:GO:0022857; C:GO:0016020; C:GO:0043227	P:cellular process; P:organic substance transport; F:transmembrane transporter activity; C:membrane; C:membrane-bounded organelle	EC:7	Translocases	IPR011701 (PFAM); IPR020846 (PROSITE_PROFILES)	P:GO:0055085; F:GO:0022857	P:transmembrane transport; F:transmembrane transporter activity	106.055232263066	3.98743053172942	0.366331936513861	10.8847472313639	1.36276160916142e-27	5.09894686739489e-25
Avas.s008.g1043.i1	homolog_cluster_12854	NA	serine protease	3.1e-27	129.4	Vertebrata	NA	NA	NA	NA	K09627	NA	PRS23_BOVIN | Serine protease 23 OS=Bos taurus OX=9913 GN=PRSS23 PE=2 SV=1	329	3e-22	C:GO:0043231	C:intracellular membrane-bounded organelle			IPR001254 (PFAM); IPR018114 (PROSITE_PATTERNS)	P:GO:0006508; F:GO:0004252	P:proteolysis; F:serine-type endopeptidase activity	608.909647463074	2.44547255991042	0.321264051554974	7.61203299302833	2.69817656987796e-14	3.50088409941665e-12
Avas.s009.g158.i1	paralog_cluster_05001	NA	Sulfotransferase family	2.7e-25	123.2	Paraneoptera	EC:2.8.2.5	1	F:GO:0008146	F:sulfotransferase activity	K01017	map00532	CHSTB_HUMAN | Carbohydrate sulfotransferase 11 OS=Homo sapiens OX=9606 GN=CHST11 PE=1 SV=1	401	1.5e-23	P:GO:0001501; P:GO:0006790; P:GO:0030166; P:GO:0043009; P:GO:0048513; P:GO:0048598; P:GO:0050794; P:GO:1903510; F:GO:0008146; C:GO:0110165	P:skeletal system development; P:sulfur compound metabolic process; P:proteoglycan biosynthetic process; P:chordate embryonic development; P:animal organ development; P:embryonic morphogenesis; P:regulation of cellular process; P:mucopolysaccharide metabolic process; F:sulfotransferase activity; C:cellular atomical entity	EC:2.8.2	Transferring sulfur-containing groups	IPR005331 (PFAM)	F:GO:0008146; C:GO:0016021	F:sulfotransferase activity; C:integral component of membrane	42.4652918388553	3.10691412278994	0.536679778378448	5.78913953526874	7.0747908701941e-09	4.55305241242211e-07
Avas.s009.g271.i1	paralog_cluster_00947	NA	peptidase inhibitor activity	7.9e-30	137.5	Chordata	NA	NA	NA	NA	NA	NA	GPRL1_BOVIN | GLIPR1-like protein 1 OS=Bos taurus OX=9913 GN=GLIPR1L1 PE=1 SV=1	231	3.2e-26	P:GO:0006952; P:GO:0009725; P:GO:0051707; P:GO:1901700; C:GO:0016020	P:defense response; P:response to hormone; P:response to other organism; P:response to oxygen-containing compound; C:membrane			IPR014044 (PFAM); IPR018244 (PROSITE_PATTERNS)	C:GO:0005576	C:extracellular region	113.814565316582	4.59594602018685	0.670724332468084	6.85221304447837	7.27161511302201e-12	7.44475682651238e-10
Avas.s009.g306.i1	homolog_cluster_03549	NA	Solute carrier family 12 member	4.7e-206	724.9	Actinopterygii	NA	NA	NA	NA	K14429	NA	S12A9_XENLA | Solute carrier family 12 member 9 OS=Xenopus laevis OX=8355 GN=slc12a9 PE=2 SV=1	941	6.3e-198	P:GO:0006813; P:GO:0006821; P:GO:0006875; P:GO:0006884; P:GO:0009605; P:GO:0009628; P:GO:0030004; P:GO:0034486; P:GO:0035725; P:GO:0048589; P:GO:0055064; P:GO:0055075; P:GO:0055078; P:GO:0060603; P:GO:0070887; P:GO:0072488; P:GO:0097638; P:GO:0098659; P:GO:0098661; P:GO:1903401; P:GO:1903530; P:GO:1903826; F:GO:0005515; F:GO:0015379; F:GO:0061459; C:GO:0009925; C:GO:0031166; C:GO:0031982; C:GO:0043005; C:GO:0044297; C:GO:1990816	P:potassium ion transport; P:chloride transport; P:cellular metal ion homeostasis; P:cell volume homeostasis; P:response to exterl stimulus; P:response to abiotic stimulus; P:cellular monovalent inorganic cation homeostasis; P:vacuolar transmembrane transport; P:sodium ion transmembrane transport; P:developmental growth; P:chloride ion homeostasis; P:potassium ion homeostasis; P:sodium ion homeostasis; P:mammary gland duct morphogenesis; P:cellular response to chemical stimulus; P:ammonium transmembrane transport; P:L-arginine import across plasma membrane; P:inorganic cation import across plasma membrane; P:inorganic anion transmembrane transport; P:L-lysine transmembrane transport; P:regulation of secretion by cell; P:L-arginine transmembrane transport; F:protein binding; F:potassium:chloride symporter activity; F:L-arginine transmembrane transporter activity; C:basal plasma membrane; C:integral component of vacuolar membrane; C:vesicle; C:neuron projection; C:cell body; C:vacuole-mitochondrion membrane contact site	EC:7	Translocases	IPR004841 (PFAM); IPR018491 (PFAM)	P:GO:0006811; P:GO:0055085; F:GO:0022857; C:GO:0016020	P:ion transport; P:transmembrane transport; F:transmembrane transporter activity; C:membrane	220.457094815881	1.55611028075349	0.218960816254705	7.10679795303356	1.18766101404165e-12	1.3362432206235e-10
Avas.s009.g356.i1	homolog_cluster_12917	NA	Lysosomal-associated membrane protein 1	0.01	48.1	Actinopterygii	NA	NA	NA	NA	K06528	map04140, map04142, map04145, map05152	------	377	NA					IPR002000 (PROSITE_PROFILES)	C:GO:0016020	C:membrane	233.343447286034	2.8694252484867	0.400716519313738	7.16073610691378	8.02449917419426e-13	9.1564657598306e-11
Avas.s009.g398.i1	homolog_cluster_07291	NA	WSC domain-containing protein	2.9e-41	176	Bilateria	NA	NA	NA	NA	NA	NA	WCSD_DROME | WSCD family member CG9164 OS=Drosophila melanogaster OX=7227 GN=CG9164 PE=2 SV=1	336	7.1e-27	P:GO:0008150; F:GO:0003674; F:GO:0008146; C:GO:0005575; C:GO:0016020; C:GO:0016021	P:biological_process; F:molecular_function; F:sulfotransferase activity; C:cellular_component; C:membrane; C:integral component of membrane			IPR000863 (PFAM)	F:GO:0008146	F:sulfotransferase activity	38.5655655475748	2.32116289568169	0.465758735430287	4.98361645012908	6.24067262929014e-07	2.7136805927743e-05
Avas.s009.g501.i1	paralog_cluster_08825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	153	NA					IPR007053 (PFAM)	no GO terms	no GO terms	184.752088399592	3.33542988830259	0.2786137860881	11.9715177598854	5.01036047669882e-33	3.10044960421566e-30
Avas.s009.g502.i1	paralog_cluster_08825	pspA	Lecithin retinol acyltransferase	0.4	41.6	Spirochaetes	NA	1	C:GO:0005829	C:cytosol	K03969	NA	------	157	NA					IPR007053 (PFAM)	no GO terms	no GO terms	257.263301114427	3.89238288790674	0.638125113438661	6.09971744715057	1.06256122459826e-09	7.63194086721494e-08
Avas.s009.g527.i1	homolog_cluster_12962	SLC52A3	riboflavin transmembrane transporter activity	6.3e-37	162.2	Metazoa	NA	11	F:GO:0042910; P:GO:0035461; P:GO:0006771; F:GO:0032217; P:GO:0098656; C:GO:0005887; P:GO:0006805; P:GO:0007605; P:GO:0006855; P:GO:0032218; P:GO:0034605	C:integral component of plasma membrane; P:riboflavin transport; P:anion transmembrane transport; P:vitamin transmembrane transport; F:riboflavin transmembrane transporter activity; P:cellular response to heat; F:xenobiotic transmembrane transporter activity; P:riboflavin metabolic process; P:sensory perception of sound; P:xenobiotic transmembrane transport; P:xenobiotic metabolic process	K14620	map04977	S5A3A_DANRE | Solute carrier family 52, riboflavin transporter, member 3-A OS=Danio rerio OX=7955 GN=slc52a3a PE=2 SV=1	484	1.8e-23	C:GO:0005622; C:GO:0005886	C:intracellular atomical structure; C:plasma membrane			IPR009357 (PFAM)	P:GO:0032218; F:GO:0032217; C:GO:0005887	P:riboflavin transport; F:riboflavin transmembrane transporter activity; C:integral component of plasma membrane	71.7809432712454	2.0325906557762	0.397905968216473	5.10821856954509	3.25210333841978e-07	1.50426462477096e-05
Avas.s009.g551.i1	homolog_cluster_12965	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	153	NA					no IPS match	no IPS match	no IPS match	708.591068855345	3.22000443989356	0.433408333963394	7.42949359198414	1.09014228414343e-13	1.31874430147245e-11
Avas.s009.g555.i1	homolog_cluster_12967	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	152	NA					no IPS match	no IPS match	no IPS match	558.567605375119	1.40804576902158	0.273776808054991	5.14304253535881	2.70324387486247e-07	1.27543961004875e-05
Avas.s009.g565.i1	homolog_cluster_12972	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	188	NA					no IPS match	no IPS match	no IPS match	143.201722241709	3.43437164416977	0.529240610893166	6.48924435026593	8.6267955266638e-11	7.62618204552165e-09
Avas.s009.g581.i1	paralog_cluster_00278	NA	S-layer homology domain	0.00027	52.8	Ruminococcaceae	EC:2.7.7.6	NA	NA	NA	K03006,K13735	map00230, map00240, map01100, map03020, map05016, map05100, map05168, map05169	------	241	NA					no IPS match	no IPS match	no IPS match	1969.30186545493	2.30686180747729	0.490592464064074	4.70219576625214	2.57378548416839e-06	9.88296769803944e-05
Avas.s009.g585.i1	paralog_cluster_05040	NA	Contactin 3a, tandem duplicate 1	0.0021	50.1	Actinopterygii	NA	NA	NA	NA	K06762	NA	------	294	NA					no IPS match	no IPS match	no IPS match	381.939259353685	2.07854238430524	0.385509319783447	5.39167869008414	6.98024990498485e-08	3.73107112030901e-06
Avas.s009.g644.i1	homolog_cluster_18568	NA	Possible membrane-associated motif in LPS-induced tumor necrosis factor alpha factor (LITAF), also known as PIG7, and other animal proteins.	5.3e-05	54.3	Vertebrata	NA	NA	NA	NA	NA	NA	------	140	NA					IPR006629 (PFAM); IPR006629 (PROSITE_PROFILES)	no GO terms	no GO terms	133.573726378537	2.04833713905644	0.314673697170895	6.50940055515353	7.54512847745649e-11	6.7440873374332e-09
Avas.s010.g13.i1	paralog_cluster_11483	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	87	NA					no IPS match	no IPS match	no IPS match	1479.08908528792	5.31570143435708	0.957077939935339	5.55409461711782	2.79054307535193e-08	1.60921317345295e-06
Avas.s010.g65.i1	paralog_cluster_00340	NA	Protein tyrosine phosphatase, catalytic domain	1.4e-75	291.6	Hominidae	NA	NA	NA	NA	NA	NA	PTPRF_DANRE | Receptor-type tyrosine-protein phosphatase F OS=Danio rerio OX=7955 GN=ptprf PE=2 SV=1	1023	8.7e-68	P:GO:0001932; P:GO:0002699; P:GO:0002706; P:GO:0002822; P:GO:0006928; P:GO:0007166; P:GO:0009605; P:GO:0009967; P:GO:0009968; P:GO:0010468; P:GO:0010604; P:GO:0010605; P:GO:0010975; P:GO:0016311; P:GO:0030098; P:GO:0030155; P:GO:0040011; P:GO:0042127; P:GO:0043065; P:GO:0044092; P:GO:0045597; P:GO:0050778; P:GO:0050790; P:GO:0051179; P:GO:0051240; P:GO:0051251; P:GO:0065008; P:GO:0098609; P:GO:2000026; F:GO:0004721; F:GO:0005102; F:GO:0044877; F:GO:0097367; F:GO:1901681; C:GO:0005886; C:GO:0016021; C:GO:0030054; C:GO:0043231; C:GO:0120025	P:regulation of protein phosphorylation; P:positive regulation of immune effector process; P:regulation of lymphocyte mediated immunity; P:regulation of adaptive immune response based on somatic recombition of immune receptors built from immunoglobulin superfamily domains; P:movement of cell or subcellular component; P:cell surface receptor sigling pathway; P:response to exterl stimulus; P:positive regulation of sigl transduction; P:negative regulation of sigl transduction; P:regulation of gene expression; P:positive regulation of macromolecule metabolic process; P:negative regulation of macromolecule metabolic process; P:regulation of neuron projection development; P:dephosphorylation; P:lymphocyte differentiation; P:regulation of cell adhesion; P:locomotion; P:regulation of cell population proliferation; P:positive regulation of apoptotic process; P:negative regulation of molecular function; P:positive regulation of cell differentiation; P:positive regulation of immune response; P:regulation of catalytic activity; P:localization; P:positive regulation of multicellular organismal process; P:positive regulation of lymphocyte activation; P:regulation of biological quality; P:cell-cell adhesion; P:regulation of multicellular organismal development; F:phosphoprotein phosphatase activity; F:sigling receptor binding; F:protein-containing complex binding; F:carbohydrate derivative binding; F:sulfur compound binding; C:plasma membrane; C:integral component of membrane; C:cell junction; C:intracellular membrane-bounded organelle; C:plasma membrane bounded cell projection	EC:3.1.3	Acting on ester bonds	IPR000242 (PFAM); IPR001304 (PFAM); IPR016130 (PROSITE_PATTERNS); IPR016130 (PROSITE_PATTERNS); IPR000242 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR001304 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES)	P:GO:0006470; P:GO:0016311; F:GO:0004725; F:GO:0016791	P:protein dephosphorylation; P:dephosphorylation; F:protein tyrosine phosphatase activity; F:phosphatase activity	376.171327616932	2.11771262999499	0.428897437567106	4.93757351875913	7.91005907088597e-07	3.39373174377292e-05
Avas.s010.g299.i1	homolog_cluster_18588	MAF	Belongs to the bZIP family	0.66	40.4	Chordata	NA	18	P:GO:0010628; P:GO:0032330; C:GO:0000785; P:GO:0010629; F:GO:0001228; P:GO:0000122; P:GO:0048839; P:GO:0045944; P:GO:0001816; F:GO:0042803; P:GO:0048468; C:GO:0005654; F:GO:0003690; F:GO:0043565; C:GO:0005737; F:GO:0046982; P:GO:2000113; P:GO:0070306	C:chromatin; F:protein homodimerization activity; P:cytokine production; P:inner ear development; F:double-stranded DNA binding; P:negative regulation of transcription by RNA polymerase II; C:cytoplasm; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:negative regulation of gene expression; F:sequence-specific DNA binding; F:protein heterodimerization activity; P:cell development; P:regulation of chondrocyte differentiation; P:positive regulation of transcription by RNA polymerase II; C:nucleoplasm; P:positive regulation of gene expression; P:negative regulation of cellular macromolecule biosynthetic process; P:lens fiber cell differentiation	K09035,K09036,K09037	map04658, map05202, map05321	------	116	NA					IPR004826 (PFAM)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	894.048331928433	2.40183487261575	0.218897058086589	10.9724401671294	5.18537787883822e-28	1.98637011172924e-25
Avas.s010.g484.i1	paralog_cluster_00617	HBS1L	regulation of response to stimulus	3.6e-61	241.9	Metazoa	NA	9	F:GO:0005525; P:GO:0016441; F:GO:0005515; P:GO:0043928; P:GO:0007165; F:GO:0032550; F:GO:0003924; C:GO:0005829; P:GO:0040029	P:exonucleolytic catabolism of deadenylated mRNA; F:purine ribonucleoside binding; P:signal transduction; P:regulation of gene expression, epigenetic; F:protein binding; P:posttranscriptional gene silencing; F:GTP binding; F:GTPase activity; C:cytosol	K14416	map03015, map05134	EF1A_CALMQ | Elongation factor 1-alpha OS=Caldivirga maquilingensis (strain ATCC 700844 / DSM 13496 / JCM 10307 / IC-167) OX=397948 GN=tuf PE=3 SV=1	284	7.3e-41	P:GO:0006412; P:GO:0006414; F:GO:0000166; F:GO:0003746; F:GO:0003924; F:GO:0005525; C:GO:0005737	P:translation; P:translatiol elongation; F:nucleotide binding; F:translation elongation factor activity; F:GTPase activity; F:GTP binding; C:cytoplasm			IPR004160 (PFAM)	no GO terms	no GO terms	39.0742617092445	2.39303587680456	0.428377260346541	5.58628129529726	2.31983371116964e-08	1.36218264886891e-06
Avas.s010.g548.i1	paralog_cluster_06187	NA	Immunoglobulin	0.00038	53.5	Insecta	NA	NA	NA	NA	NA	NA	------	587	NA					IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES)	no GO terms	no GO terms	29.5869737864182	-2.84969097653835	0.556391175855794	-5.12174006382325	3.0272901322162e-07	1.4230901289863e-05
Avas.s010.g579.i1	paralog_cluster_01422	G6PD	Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis	1.2e-189	669.5	Metazoa	EC:1.1.1.363; EC:1.1.1.49	31	P:GO:0010734; P:GO:0055026; P:GO:0006695; C:GO:0009898; P:GO:0019682; P:GO:0019322; C:GO:0005634; P:GO:0045471; P:GO:0009051; P:GO:2000378; F:GO:0005536; P:GO:1904879; F:GO:0050661; P:GO:0034599; P:GO:0009410; P:GO:2000726; F:GO:0004345; P:GO:0006749; P:GO:0032094; P:GO:0043249; P:GO:0014070; P:GO:0009636; P:GO:0061052; P:GO:0046677; P:GO:0043523; F:GO:0042803; P:GO:0010041; P:GO:0046496; P:GO:0010721; P:GO:0046390; C:GO:0005829	P:pentose biosynthetic process; P:response to food; P:response to toxic substance; F:NADP binding; P:nicotinamide nucleotide metabolic process; P:ribose phosphate biosynthetic process; F:glucose-6-phosphate dehydrogenase activity; P:regulation of neuron apoptotic process; P:pentose-phosphate shunt, oxidative branch; C:cytosol; P:negative regulation of reactive oxygen species metabolic process; P:cholesterol biosynthetic process; P:response to ethanol; P:cellular response to oxidative stress; P:negative regulation of cell development; F:glucose binding; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cardiac muscle tissue development; P:response to xenobiotic stimulus; F:protein homodimerization activity; P:glyceraldehyde-3-phosphate metabolic process; P:erythrocyte maturation; P:response to organic cyclic compound; P:response to antibiotic; C:cytoplasmic side of plasma membrane; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:negative regulation of protein glutathionylation; P:negative regulation of cardiac muscle cell differentiation; P:glutathione metabolic process; P:response to iron(III) ion; C:nucleus	K00036	map00030, map00480, map01100, map01110, map01120, map01130, map01200, map05230	G6PD_HUMAN | Glucose-6-phosphate 1-dehydrogese OS=Homo sapiens OX=9606 GN=G6PD PE=1 SV=4	494	5.6e-182	P:GO:0001998; P:GO:0002033; P:GO:0006006; P:GO:0006695; P:GO:0006741; P:GO:0006749; P:GO:0009051; P:GO:0010041; P:GO:0010734; P:GO:0014070; P:GO:0019322; P:GO:0032094; P:GO:0034599; P:GO:0040014; P:GO:0043249; P:GO:0043523; P:GO:0045471; P:GO:0046390; P:GO:0061052; P:GO:1904879; P:GO:2000378; F:GO:0004345; F:GO:0005536; F:GO:0042803; F:GO:0050661; C:GO:0005634; C:GO:0005829; C:GO:0009898; C:GO:0034451	P:angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure; P:angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure; P:glucose metabolic process; P:cholesterol biosynthetic process; P:DP biosynthetic process; P:glutathione metabolic process; P:pentose-phosphate shunt, oxidative branch; P:response to iron(III) ion; P:negative regulation of protein glutathionylation; P:response to organic cyclic compound; P:pentose biosynthetic process; P:response to food; P:cellular response to oxidative stress; P:regulation of multicellular organism growth; P:erythrocyte maturation; P:regulation of neuron apoptotic process; P:response to ethanol; P:ribose phosphate biosynthetic process; P:negative regulation of cell growth involved in cardiac muscle cell development; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; P:negative regulation of reactive oxygen species metabolic process; F:glucose-6-phosphate dehydrogese activity; F:glucose binding; F:protein homodimerization activity; F:DP binding; C:nucleus; C:cytosol; C:cytoplasmic side of plasma membrane; C:centriolar satellite	EC:1.1.1.49	Glucose-6-phosphate dehydrogese (DP(+))	IPR022675 (PFAM); IPR022674 (PFAM); IPR019796 (PROSITE_PATTERNS)	P:GO:0006006; F:GO:0004345; F:GO:0016614; F:GO:0050661	P:glucose metabolic process; F:glucose-6-phosphate dehydrogese activity; F:oxidoreductase activity, acting on CH-OH group of donors; F:DP binding	790.337382145715	-1.70173526537372	0.270853648535482	-6.28285893350555	3.3240266323619e-10	2.66070967602342e-08
Avas.s010.g666.i1	paralog_cluster_06291	NA	Mannose-6-phosphate receptor	5.5e-06	59.3	Nematocera	NA	NA	NA	NA	NA	NA	------	462	NA					IPR044865 (PROSITE_PROFILES); IPR044865 (PROSITE_PROFILES)	no GO terms	no GO terms	562.406966444449	3.58125776460294	0.759173612944216	4.71731064349583	2.38982652061833e-06	9.26504069644057e-05
Avas.s010.g667.i1	paralog_cluster_06291	NA	Mannose-6-phosphate receptor	0.00018	54.3	Eukaryota	NA	NA	NA	NA	NA	NA	------	480	NA					IPR044865 (PROSITE_PROFILES); IPR044865 (PROSITE_PROFILES)	no GO terms	no GO terms	295.564888470169	3.38788580683847	0.597685610077355	5.6683409299414	1.44186844877847e-08	8.77040441732178e-07
Avas.s010.g696.i1	paralog_cluster_08854	NA	Prosaposin	1.8e-22	114.8	Bilateria	NA	NA	NA	NA	NA	NA	------	744	NA					IPR007856 (PFAM); IPR008139 (PROSITE_PROFILES); IPR008139 (PROSITE_PROFILES); IPR008139 (PROSITE_PROFILES); IPR008139 (PROSITE_PROFILES); IPR008139 (PROSITE_PROFILES); IPR008139 (PROSITE_PROFILES)	P:GO:0006629	P:lipid metabolic process	2179.23917158422	4.37600368816213	0.483516313489854	9.05037444668132	1.42478908083495e-19	2.86542894019419e-17
Avas.s011.g38.i1	paralog_cluster_08860	NA	B-Box-type zinc finger	0.68	41.6	Insecta	NA	NA	NA	NA	K10649	NA	------	267	NA					IPR013087 (PROSITE_PROFILES)	no GO terms	no GO terms	330.599782692741	3.0822621934606	0.564894510849666	5.45635005166632	4.86021338289668e-08	2.65071095313304e-06
Avas.s011.g62.i1	homolog_cluster_13159	TSPAN3	Tetraspanin family	3.7e-17	95.5	Cetartiodactyla	NA	2	P:GO:0007166; C:GO:0005887	C:integral component of plasma membrane; P:cell surface receptor signaling pathway	K17293	NA	------	252	NA					IPR018499 (PFAM)	C:GO:0016021	C:integral component of membrane	869.415342229177	2.40445874732318	0.317669221050107	7.56906425927844	3.75922177747483e-14	4.8385695342234e-12
Avas.s011.g65.i1	paralog_cluster_07148	NA	Belongs to the G-protein coupled receptor 2 family	3.9e-20	109	Metazoa	NA	NA	NA	NA	NA	NA	------	2989	NA					IPR000832 (PFAM); IPR017981 (PROSITE_PROFILES)	P:GO:0007166; P:GO:0007186; F:GO:0004888; F:GO:0004930; C:GO:0016021	P:cell surface receptor sigling pathway; P:G protein-coupled receptor sigling pathway; F:transmembrane sigling receptor activity; F:G protein-coupled receptor activity; C:integral component of membrane	544.223666766639	-3.73010616504128	0.652760562096915	-5.71435589346691	1.1012032042216e-08	6.81433013566203e-07
Avas.s011.g124.i1	homolog_cluster_13185	TGFBR1	Transforming growth factor, beta receptor 1	3.1e-82	312.8	Actinopterygii	EC:2.7.11.30	81	F:GO:0005524; P:GO:0031396; P:GO:0060037; P:GO:0001822; P:GO:0022402; P:GO:0043933; P:GO:0070723; P:GO:0060391; P:GO:0048701; P:GO:0001824; P:GO:0030307; P:GO:0048663; P:GO:0009791; P:GO:1905223; P:GO:0032924; P:GO:2000113; P:GO:0030199; F:GO:0031625; F:GO:0005114; P:GO:1902895; P:GO:0032331; P:GO:1905007; P:GO:2000826; P:GO:1902894; P:GO:0043627; P:GO:0060982; P:GO:0000122; P:GO:0001937; P:GO:0043542; P:GO:0045602; P:GO:0001938; P:GO:0046777; P:GO:0060021; C:GO:0005887; C:GO:0005768; C:GO:0005923; F:GO:0046982; P:GO:2001235; P:GO:2001237; P:GO:0030512; F:GO:0050431; P:GO:0060978; P:GO:0003222; P:GO:0032147; P:GO:0008354; F:GO:0005025; P:GO:0055024; P:GO:0060412; P:GO:0060017; P:GO:0003223; C:GO:1902554; F:GO:0044877; P:GO:0042060; C:GO:0016324; P:GO:0043393; C:GO:0016323; P:GO:0016579; P:GO:1903845; C:GO:0098802; P:GO:0009952; P:GO:0051491; P:GO:0002088; P:GO:0010628; P:GO:0008584; P:GO:0010629; P:GO:0051496; F:GO:0070411; P:GO:0043406; P:GO:0042118; P:GO:0045944; P:GO:0048538; C:GO:0009986; P:GO:0018105; P:GO:0045786; P:GO:0060043; P:GO:0051897; C:GO:0005901; P:GO:0010862; P:GO:0018107; P:GO:0030335; P:GO:1905075	P:negative regulation of cellular response to transforming growth factor beta stimulus; P:regulation of protein ubiquitination; P:thymus development; P:activin receptor signaling pathway; P:ventricular septum morphogenesis; P:positive regulation of cell migration; P:negative regulation of endothelial cell differentiation; P:pharyngeal system development; P:positive regulation of tight junction disassembly; P:neuron fate commitment; P:negative regulation of gene expression; P:protein autophosphorylation; P:negative regulation of miRNA transcription; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:lens development in camera-type eye; P:positive regulation of cell growth; C:apical plasma membrane; P:positive regulation of transcription by RNA polymerase II; P:peptidyl-serine phosphorylation; P:negative regulation of cellular macromolecule biosynthetic process; P:endothelial cell migration; C:integral component of plasma membrane; P:protein deubiquitination; P:endothelial cell activation; P:collagen fibril organization; P:anterior/posterior pattern specification; P:regulation of cardiac muscle cell proliferation; C:bicellular tight junction; P:positive regulation of apoptotic signaling pathway; P:roof of mouth development; C:plasma membrane signaling receptor complex; P:blastocyst development; P:negative regulation of chondrocyte differentiation; P:ventricular compact myocardium morphogenesis; F:protein heterodimerization activity; P:protein-containing complex organization; P:activation of protein kinase activity; P:response to cholesterol; P:coronary artery morphogenesis; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:regulation of heart morphogenesis; P:positive regulation of SMAD protein signal transduction; P:post-embryonic development; P:germ cell migration; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of protein kinase B signaling; C:endosome; P:regulation of cardiac muscle tissue development; P:cell cycle process; P:positive regulation of filopodium assembly; F:type II transforming growth factor beta receptor binding; P:positive regulation of miRNA transcription; C:serine/threonine protein kinase complex; P:regulation of protein binding; F:transforming growth factor beta receptor activity, type I; P:positive regulation of endothelial cell proliferation; P:negative regulation of cell cycle; P:peptidyl-threonine phosphorylation; F:ubiquitin protein ligase binding; P:positive regulation of stress fiber assembly; F:I-SMAD binding; P:negative regulation of endothelial cell proliferation; P:positive regulation of gene expression; P:embryonic cranial skeleton morphogenesis; P:wound healing; P:male gonad development; P:response to estrogen; P:parathyroid gland development; P:negative regulation of extrinsic apoptotic signaling pathway; P:negative regulation of transcription by RNA polymerase II; C:caveola; P:kidney development; F:protein-containing complex binding; C:basolateral plasma membrane; P:positive regulation of MAP kinase activity; C:cell surface; P:epicardium morphogenesis; F:transforming growth factor beta binding; F:ATP binding; P:ventricular trabecula myocardium morphogenesis; P:angiogenesis involved in coronary vascular morphogenesis	K04674	map04010, map04060, map04068, map04144, map04218, map04350, map04371, map04380, map04390, map04520, map04659, map04926, map04933, map05142, map05161, map05166, map05200, map05210, map05212, map05220, map05225, map05226	TGFR1_PIG | TG|F-beta receptor type-1 OS=Sus scrofa OX=9823 GN=TGFBR1 PE=2 SV=1	519	8.2e-83	P:GO:0000082; P:GO:0001666; P:GO:0001822; P:GO:0001824; P:GO:0001937; P:GO:0001938; P:GO:0001942; P:GO:0001946; P:GO:0001974; P:GO:0002088; P:GO:0003222; P:GO:0003223; P:GO:0007179; P:GO:0007417; P:GO:0007568; P:GO:0008217; P:GO:0008354; P:GO:0008584; P:GO:0009636; P:GO:0009791; P:GO:0009952; P:GO:0010628; P:GO:0010629; P:GO:0010862; P:GO:0018105; P:GO:0018107; P:GO:0030199; P:GO:0030307; P:GO:0030308; P:GO:0030324; P:GO:0030513; P:GO:0031100; P:GO:0031396; P:GO:0032331; P:GO:0032927; P:GO:0034695; P:GO:0035313; P:GO:0035912; P:GO:0038092; P:GO:0043393; P:GO:0043410; P:GO:0043537; P:GO:0043627; P:GO:0045602; P:GO:0045603; P:GO:0045648; P:GO:0045766; P:GO:0045944; P:GO:0046545; P:GO:0046777; P:GO:0048538; P:GO:0048565; P:GO:0048663; P:GO:0048701; P:GO:0051491; P:GO:0051496; P:GO:0051602; P:GO:0051895; P:GO:0051897; P:GO:0060017; P:GO:0060021; P:GO:0060037; P:GO:0060043; P:GO:0060391; P:GO:0060412; P:GO:0060836; P:GO:0060841; P:GO:0060978; P:GO:0060982; P:GO:0061154; P:GO:0061298; P:GO:0070723; P:GO:1901165; P:GO:1902894; P:GO:1902895; P:GO:1905007; P:GO:1905075; P:GO:1905223; P:GO:2000279; P:GO:2001235; P:GO:2001237; F:GO:0005025; F:GO:0005114; F:GO:0005524; F:GO:0016361; F:GO:0019901; F:GO:0031625; F:GO:0034711; F:GO:0048185; F:GO:0050431; F:GO:0070411; F:GO:0098821; C:GO:0005634; C:GO:0005768; C:GO:0005829; C:GO:0005901; C:GO:0005923; C:GO:0009986; C:GO:0016323; C:GO:0016324; C:GO:0048179; C:GO:0070021	P:G1/S transition of mitotic cell cycle; P:response to hypoxia; P:kidney development; P:blastocyst development; P:negative regulation of endothelial cell proliferation; P:positive regulation of endothelial cell proliferation; P:hair follicle development; P:lymphangiogenesis; P:blood vessel remodeling; P:lens development in camera-type eye; P:ventricular trabecula myocardium morphogenesis; P:ventricular compact myocardium morphogenesis; P:transforming growth factor beta receptor sigling pathway; P:central nervous system development; P:aging; P:regulation of blood pressure; P:germ cell migration; P:male god development; P:response to toxic substance; P:post-embryonic development; P:anterior/posterior pattern specification; P:positive regulation of gene expression; P:negative regulation of gene expression; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:collagen fibril organization; P:positive regulation of cell growth; P:negative regulation of cell growth; P:lung development; P:positive regulation of BMP sigling pathway; P:animal organ regeneration; P:regulation of protein ubiquitition; P:negative regulation of chondrocyte differentiation; P:positive regulation of activin receptor sigling pathway; P:response to prostaglandin E; P:wound healing, spreading of epidermal cells; P:dorsal aorta morphogenesis; P:nodal sigling pathway; P:regulation of protein binding; P:positive regulation of MAPK cascade; P:negative regulation of blood vessel endothelial cell migration; P:response to estrogen; P:negative regulation of endothelial cell differentiation; P:positive regulation of endothelial cell differentiation; P:positive regulation of erythrocyte differentiation; P:positive regulation of angiogenesis; P:positive regulation of transcription by R polymerase II; P:development of primary female sexual characteristics; P:protein autophosphorylation; P:thymus development; P:digestive tract development; P:neuron fate commitment; P:embryonic cranial skeleton morphogenesis; P:positive regulation of filopodium assembly; P:positive regulation of stress fiber assembly; P:response to electrical stimulus; P:negative regulation of focal adhesion assembly; P:positive regulation of protein kise B sigling; P:parathyroid gland development; P:roof of mouth development; P:pharyngeal system development; P:regulation of cardiac muscle cell proliferation; P:positive regulation of SMAD protein sigl transduction; P:ventricular septum morphogenesis; P:lymphatic endothelial cell differentiation; P:venous blood vessel development; P:angiogenesis involved in corory vascular morphogenesis; P:corory artery morphogenesis; P:endothelial tube morphogenesis; P:reti vasculature development in camera-type eye; P:response to cholesterol; P:positive regulation of trophoblast cell migration; P:negative regulation of miR transcription; P:positive regulation of miR transcription; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of tight junction disassembly; P:epicardium morphogenesis; P:negative regulation of D biosynthetic process; P:positive regulation of apoptotic sigling pathway; P:negative regulation of extrinsic apoptotic sigling pathway; F:transforming growth factor beta receptor activity, type I; F:type II transforming growth factor beta receptor binding; F:ATP binding; F:activin receptor activity, type I; F:protein kise binding; F:ubiquitin protein ligase binding; F:inhibin binding; F:activin binding; F:transforming growth factor beta binding; F:I-SMAD binding; F:BMP receptor activity; C:nucleus; C:endosome; C:cytosol; C:caveola; C:bicellular tight junction; C:cell surface; C:basolateral plasma membrane; C:apical plasma membrane; C:activin receptor complex; C:transforming growth factor beta ligand-receptor complex	EC:2.7.11.30	Receptor protein serine/threonine kise	IPR001245 (PFAM); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR003605 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0004675; F:GO:0005524; C:GO:0016020	P:protein phosphorylation; F:protein kise activity; F:transmembrane receptor protein serine/threonine kise activity; F:ATP binding; C:membrane	193.964799832689	1.42281371304813	0.26934181128553	5.28255790015388	1.27392554421856e-07	6.42513732944587e-06
Avas.s011.g181.i1	paralog_cluster_03525	NA	Ubiquitin family	3.3e-07	62.4	Peronosporales	NA	NA	NA	NA	NA	NA	------	234	NA					IPR000626 (PFAM); IPR000626 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	302.98085636069	-2.5917822703405	0.47333375075005	-5.47559151705014	4.36052528111183e-08	2.4191893533727e-06
Avas.s011.g182.i1	paralog_cluster_03525	NA	Ubiquitin family	4.2e-10	72	Peronosporales	NA	NA	NA	NA	NA	NA	------	236	NA					IPR000626 (PFAM); IPR000626 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	475.040450717744	-2.23763988560424	0.471031199872032	-4.75051310021959	2.02901148727458e-06	8.0011680928335e-05
Avas.s011.g183.i1	paralog_cluster_04236	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	265	NA					no IPS match	no IPS match	no IPS match	80.0998301554498	-2.7367256326775	0.498486437360253	-5.49007039623766	4.01773578147879e-08	2.24449135375737e-06
Avas.s011.g184.i1	paralog_cluster_03525	ZFAND4	ubiquitin	0.0029	49.3	Metazoa	NA	NA	NA	NA	K12163	NA	------	239	NA					IPR000626 (PFAM); IPR000626 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	213.249322866825	-3.450707523837	0.490957479188631	-7.02852623722065	2.08726379120316e-12	2.31599911287363e-10
Avas.s011.g185.i1	paralog_cluster_04236	NA	protein tag	0.068	44.7	Eukaryota	NA	NA	NA	NA	K02983	map03010	------	227	NA					no IPS match	no IPS match	no IPS match	28.2339803634974	-3.72807039329664	0.741437139637896	-5.0281678567078	4.95188322556822e-07	2.18276299222375e-05
Avas.s011.g416.i1	paralog_cluster_00081	NA	zinc ion binding	1.2e-09	71.2	Eukaryota	NA	NA	NA	NA	NA	NA	------	384	NA					no IPS match	no IPS match	no IPS match	403.617391790329	4.4430228147602	0.382558288328395	11.6139760928307	3.49955514548432e-31	1.81626912050636e-28
Avas.s011.g417.i1	paralog_cluster_00838	NA	lipid metabolic process	1.5e-64	253.4	Metazoa	NA	NA	NA	NA	NA	NA	AA_RABIT | N-acylethanolamine-hydrolyzing acid amidase OS=Oryctolagus cuniculus OX=9986 GN=AA PE=1 SV=2	361	2.4e-52	P:GO:0006670; P:GO:0043603; P:GO:0070291; F:GO:0047412; C:GO:0005764; C:GO:0016020	P:sphingosine metabolic process; P:cellular amide metabolic process; P:N-acylethanolamine metabolic process; F:N-(long-chain-acyl)ethanolamine deacylase activity; C:lysosome; C:membrane	EC:3.5.1.60	N-(long-chain-acyl)ethanolamine deacylase	IPR029130 (PFAM); IPR029132 (PFAM)	no GO terms	no GO terms	55.7772890186275	3.21786971502296	0.506245775360223	6.35633890027678	2.06618914654791e-10	1.70476498352868e-08
Avas.s011.g444.i1	paralog_cluster_08238	SCUBE2	Signal peptide, CUB	1.1e-13	85.5	Cercopithecoidea	NA	10	P:GO:0045778; C:GO:0009986; F:GO:0042802; P:GO:1902732; C:GO:0019897; F:GO:0097108; P:GO:0045880; C:GO:0005615; P:GO:0003413; P:GO:0045669	P:chondrocyte differentiation involved in endochondral bone morphogenesis; P:positive regulation of chondrocyte proliferation; C:extracellular space; C:extrinsic component of plasma membrane; C:cell surface; F:identical protein binding; F:hedgehog family protein binding; P:positive regulation of ossification; P:positive regulation of smoothened signaling pathway; P:positive regulation of osteoblast differentiation	NA	NA	SCUB2_DANRE | Sigl peptide, CUB and EGF-like domain-containing protein 2 OS=Danio rerio OX=7955 GN=scube2 PE=2 SV=1	719	1.3e-22	P:GO:0001756; P:GO:0001933; P:GO:0007517; P:GO:0008015; P:GO:0010628; P:GO:0010811; P:GO:0030513; P:GO:0042694; P:GO:0045669; P:GO:0045880; P:GO:0051146; P:GO:0071635; P:GO:1904188; P:GO:2000146; P:GO:2000647; F:GO:0005178; F:GO:0036122; F:GO:0042802; F:GO:0070700; C:GO:0005615; C:GO:0005886; C:GO:0009986; C:GO:0030141; C:GO:0071953	P:somitogenesis; P:negative regulation of protein phosphorylation; P:muscle organ development; P:blood circulation; P:positive regulation of gene expression; P:positive regulation of cell-substrate adhesion; P:positive regulation of BMP sigling pathway; P:muscle cell fate specification; P:positive regulation of osteoblast differentiation; P:positive regulation of smoothened sigling pathway; P:striated muscle cell differentiation; P:negative regulation of transforming growth factor beta production; P:negative regulation of transformation of host cell by virus; P:negative regulation of cell motility; P:negative regulation of stem cell proliferation; F:integrin binding; F:BMP binding; F:identical protein binding; F:BMP receptor binding; C:extracellular space; C:plasma membrane; C:cell surface; C:secretory granule; C:elastic fiber			IPR026823 (PFAM); IPR001611 (PFAM); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); PS51257 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR001611 (PROSITE_PROFILES)	F:GO:0005509; F:GO:0005515	F:calcium ion binding; F:protein binding	27.6722977059675	6.45356182845378	1.18105256643085	5.46424605634321	4.6487834366996e-08	2.55270568986553e-06
Avas.s011.g448.i1	paralog_cluster_00562	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	381	NA					no IPS match	no IPS match	no IPS match	9.55889971810053	6.78674252422538	1.4102783981192	4.81234239514442	1.4917150067834e-06	6.07600069471852e-05
Avas.s011.g507.i1	homolog_cluster_13216	NA	procollagen-proline 3-dioxygenase activity	4.3e-81	309.3	Bilateria	EC:1.14.11.7	NA	NA	NA	K08134,K19606,K22459	NA	P3H1_RAT | Prolyl 3-hydroxylase 1 OS=Rattus norvegicus OX=10116 GN=P3h1 PE=1 SV=1	652	1.3e-72	P:GO:0018126; P:GO:0048523; P:GO:0051128; F:GO:0005488; F:GO:0016491; C:GO:0005783; C:GO:0071944	P:protein hydroxylation; P:negative regulation of cellular process; P:regulation of cellular component organization; F:binding; F:oxidoreductase activity; C:endoplasmic reticulum; C:cell periphery	EC:1	Oxidoreductases	IPR044862 (PFAM); IPR005123 (PROSITE_PROFILES)	no GO terms	no GO terms	411.175998505875	1.68557147574881	0.294169194356612	5.72993878381922	1.00466884565637e-08	6.31410822568961e-07
Avas.s011.g510.i1	paralog_cluster_05046	NA	Ferritin-like	1.8e-09	72	Rhizobiaceae	NA	NA	NA	NA	NA	NA	------	1006	NA					IPR026820 (PFAM)	no GO terms	no GO terms	1321.04636733339	-3.64031343776723	0.475400336570289	-7.65736403139673	1.89788107229896e-14	2.50286955509983e-12
Avas.s011.g515.i1	paralog_cluster_05046	NA	Ferritin-like	2e-08	68.6	Rhizobiaceae	NA	NA	NA	NA	NA	NA	------	1008	NA					IPR026820 (PFAM)	no GO terms	no GO terms	91.9006350007814	-3.36351361019095	0.696398595445649	-4.82986845778821	1.36623277592266e-06	5.621820749826e-05
Avas.s011.g516.i1	paralog_cluster_05046	NA	Ferritin-like	1.7e-09	72	Rhizobiaceae	NA	NA	NA	NA	NA	NA	------	952	NA					IPR026820 (PFAM)	no GO terms	no GO terms	300.249446427855	-3.42175829036655	0.533167010994904	-6.41779821294917	1.38259345458639e-10	1.16463592098641e-08
Avas.s011.g520.i1	paralog_cluster_05046	NA	Ferritin-like	5.7e-08	67	Rhizobiaceae	NA	NA	NA	NA	NA	NA	------	1010	NA					IPR026820 (PFAM)	no GO terms	no GO terms	279.347579083102	-3.43590773882718	0.621243815662347	-5.53069125551608	3.18971309244956e-08	1.81983311859649e-06
Avas.s011.g538.i1	paralog_cluster_00041	ARF6	ADP-ribosylation factor 6	2.9e-85	321.2	Aves	NA	9	C:GO:0032587; P:GO:0035020; P:GO:0030838; C:GO:0030139; P:GO:0097178; C:GO:0005768; P:GO:0030866; C:GO:0099568; C:GO:0005938	C:endocytic vesicle; P:ruffle assembly; C:cell cortex; C:ruffle membrane; P:regulation of Rac protein signal transduction; P:positive regulation of actin filament polymerization; P:cortical actin cytoskeleton organization; C:cytoplasmic region; C:endosome	K07941	map04014, map04072, map04144, map04666	ARF6_CHICK | ADP-ribosylation factor 6 OS=Gallus gallus OX=9031 GN=ARF6 PE=2 SV=3	176	7.1e-87	P:GO:0001745; P:GO:0001889; P:GO:0006471; P:GO:0006886; P:GO:0006888; P:GO:0007112; P:GO:0007269; P:GO:0007283; P:GO:0007520; P:GO:0030838; P:GO:0030866; P:GO:0032456; P:GO:0033028; P:GO:0034143; P:GO:0035020; P:GO:0036010; P:GO:0048149; P:GO:0048261; P:GO:0048488; P:GO:0050714; P:GO:0050790; P:GO:0051489; P:GO:0051523; P:GO:0051549; P:GO:0060998; P:GO:0090162; P:GO:0097178; P:GO:0097284; P:GO:0099562; P:GO:0120183; P:GO:1903078; P:GO:1905606; P:GO:1990090; P:GO:2000009; P:GO:2000171; F:GO:0003924; F:GO:0005525; F:GO:0008047; F:GO:0019003; F:GO:0031996; F:GO:0047485; C:GO:0000139; C:GO:0000935; C:GO:0005829; C:GO:0005912; C:GO:0030139; C:GO:0031527; C:GO:0031901; C:GO:0032154; C:GO:0032587; C:GO:0051285; C:GO:0055038; C:GO:0090543; C:GO:0098793; C:GO:0098978	P:compound eye morphogenesis; P:liver development; P:protein ADP-ribosylation; P:intracellular protein transport; P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:male meiosis cytokinesis; P:neurotransmitter secretion; P:spermatogenesis; P:myoblast fusion; P:positive regulation of actin filament polymerization; P:cortical actin cytoskeleton organization; P:endocytic recycling; P:myeloid cell apoptotic process; P:regulation of toll-like receptor 4 sigling pathway; P:regulation of Rac protein sigl transduction; P:protein localization to endosome; P:behavioral response to ethanol; P:negative regulation of receptor-mediated endocytosis; P:syptic vesicle endocytosis; P:positive regulation of protein secretion; P:regulation of catalytic activity; P:regulation of filopodium assembly; P:cell growth mode switching, monopolar to bipolar; P:positive regulation of keratinocyte migration; P:regulation of dendritic spine development; P:establishment of epithelial cell polarity; P:ruffle assembly; P:hepatocyte apoptotic process; P:maintence of postsyptic density structure; P:positive regulation of focal adhesion disassembly; P:positive regulation of protein localization to plasma membrane; P:regulation of presypse assembly; P:cellular response to nerve growth factor stimulus; P:negative regulation of protein localization to cell surface; P:negative regulation of dendrite development; F:GTPase activity; F:GTP binding; F:enzyme activator activity; F:GDP binding; F:thioesterase binding; F:protein N-terminus binding; C:Golgi membrane; C:division septum; C:cytosol; C:adherens junction; C:endocytic vesicle; C:filopodium membrane; C:early endosome membrane; C:cleavage furrow; C:ruffle membrane; C:cell cortex of cell tip; C:recycling endosome membrane; C:Flemming body; C:presypse; C:glutamatergic sypse	EC:3.6.1	Acting on acid anhydrides	IPR006689 (PFAM); PS51417 (PROSITE_PROFILES)	F:GO:0003924; F:GO:0005525	F:GTPase activity; F:GTP binding	6183.48968133093	0.964768577669438	0.163660795975362	5.89492781041267	3.74845220635022e-09	2.49210113834581e-07
Avas.s011.g708.i1	homolog_cluster_18628	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	259	NA					no IPS match	no IPS match	no IPS match	334.922139150461	2.70166042360868	0.255451535096662	10.5760195278779	3.84967439394619e-26	1.21445904557255e-23
Avas.s013.g22.i1	homolog_cluster_13303	UNC13D	regulation of dense core granule exocytosis	5.2e-40	173.7	Bilateria	NA	NA	NA	NA	K15621,K19728	map05202	------	1211	NA					IPR010439 (PFAM); IPR014772 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR014770 (PROSITE_PROFILES)	no GO terms	no GO terms	613.254459810467	2.78809783512385	0.189453673289861	14.7165150546229	5.05023609725976e-49	9.02813872986803e-46
Avas.s013.g41.i2	NA	NA	Belongs to the G-protein coupled receptor 2 family	0.003	51.6	Actinopterygii	NA	NA	NA	NA	K08446	NA	SVEP1_RAT | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1	1227	6.4e-25	P:GO:0001654; P:GO:0003002; P:GO:0003179; P:GO:0003197; P:GO:0003208; P:GO:0006357; P:GO:0006955; P:GO:0007219; P:GO:0007417; P:GO:0007560; P:GO:0008284; P:GO:0008544; P:GO:0009892; P:GO:0009967; P:GO:0010033; P:GO:0010941; P:GO:0014013; P:GO:0016043; P:GO:0030155; P:GO:0030334; P:GO:0030856; P:GO:0035051; P:GO:0035114; P:GO:0035120; P:GO:0045165; P:GO:0045446; P:GO:0045596; P:GO:0045597; P:GO:0045664; P:GO:0045893; P:GO:0048514; P:GO:0048598; P:GO:0048646; P:GO:0048732; P:GO:0048738; P:GO:0048762; P:GO:0051240; P:GO:0051241; P:GO:0060976; P:GO:0061061; P:GO:0070887; P:GO:0072006; F:GO:0005515; C:GO:0005737; C:GO:0005886; C:GO:0012505; C:GO:0043231	P:eye development; P:regiolization; P:heart valve morphogenesis; P:endocardial cushion development; P:cardiac ventricle morphogenesis; P:regulation of transcription by R polymerase II; P:immune response; P:Notch sigling pathway; P:central nervous system development; P:imagil disc morphogenesis; P:positive regulation of cell population proliferation; P:epidermis development; P:negative regulation of metabolic process; P:positive regulation of sigl transduction; P:response to organic substance; P:regulation of cell death; P:regulation of gliogenesis; P:cellular component organization; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of epithelial cell differentiation; P:cardiocyte differentiation; P:imagil disc-derived appendage morphogenesis; P:post-embryonic appendage morphogenesis; P:cell fate commitment; P:endothelial cell differentiation; P:negative regulation of cell differentiation; P:positive regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription, D-templated; P:blood vessel morphogenesis; P:embryonic morphogenesis; P:atomical structure formation involved in morphogenesis; P:gland development; P:cardiac muscle tissue development; P:mesenchymal cell differentiation; P:positive regulation of multicellular organismal process; P:negative regulation of multicellular organismal process; P:corory vasculature development; P:muscle structure development; P:cellular response to chemical stimulus; P:nephron development; F:protein binding; C:cytoplasm; C:plasma membrane; C:endomembrane system; C:intracellular membrane-bounded organelle			IPR000742 (PFAM); IPR000152 (PROSITE_PATTERNS); IPR018097 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR001879 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES)	F:GO:0004930; F:GO:0005509; C:GO:0016020	F:G protein-coupled receptor activity; F:calcium ion binding; C:membrane	117.971025038672	1.65004215602166	0.344089058345083	4.79539269268728	1.62356462959727e-06	6.56319882552526e-05
Avas.s013.g53.i1	homolog_cluster_13317	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	130	NA					IPR011598 (PFAM)	F:GO:0046983	F:protein dimerization activity	2511.22459889358	1.96033955792803	0.349595630415266	5.60744868464014	2.05330862964796e-08	1.21902887610354e-06
Avas.s013.g55.i2	NA	NA	BRO family, N-terminal domain	0.68	43.1	Streptococcus suis	NA	NA	NA	NA	K07741	NA	------	773	NA					no IPS match	no IPS match	no IPS match	225.914674832592	1.50065265816664	0.312836840272111	4.79691796164848	1.61125552574065e-06	6.52984638630765e-05
Avas.s013.g64.i1	paralog_cluster_00538	NA	scavenger receptor activity	1.8e-73	285	Eukaryota	NA	NA	NA	NA	NA	NA	DMBT1_HUMAN | Deleted in malignt brain tumors 1 protein OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2	1337	1.8e-41	P:GO:0009617; P:GO:0009987; P:GO:0050789; P:GO:0098542; F:GO:0005488; C:GO:0005737; C:GO:0043231	P:response to bacterium; P:cellular process; P:regulation of biological process; P:defense response to other organism; F:binding; C:cytoplasm; C:intracellular membrane-bounded organelle			IPR001190 (PFAM); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES)	F:GO:0005044; C:GO:0016020	F:scavenger receptor activity; C:membrane	199.623218726208	-3.53727965890073	0.681615160472667	-5.18955543249331	2.10796746118343e-07	1.02153880972832e-05
Avas.s013.g65.i1	paralog_cluster_00538	NA	Belongs to the G-protein coupled receptor 2 family	3.3e-30	140.6	Metazoa	NA	NA	NA	NA	NA	NA	AGRD1_BOVIN | Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1	811	3.7e-29	P:GO:0006911; P:GO:0007155; P:GO:0007186; P:GO:0007399; P:GO:0031323; P:GO:0043277; P:GO:0048523; P:GO:0051094; P:GO:0051130; P:GO:0051241; P:GO:0065008; P:GO:2000026; F:GO:0004888; F:GO:0005515; C:GO:0005576; C:GO:0005622; C:GO:0005886; C:GO:0016021; C:GO:0043005; C:GO:0043226; C:GO:0045202	P:phagocytosis, engulfment; P:cell adhesion; P:G protein-coupled receptor sigling pathway; P:nervous system development; P:regulation of cellular metabolic process; P:apoptotic cell clearance; P:negative regulation of cellular process; P:positive regulation of developmental process; P:positive regulation of cellular component organization; P:negative regulation of multicellular organismal process; P:regulation of biological quality; P:regulation of multicellular organismal development; F:transmembrane sigling receptor activity; F:protein binding; C:extracellular region; C:intracellular atomical structure; C:plasma membrane; C:integral component of membrane; C:neuron projection; C:organelle; C:sypse			IPR000832 (PFAM); IPR000203 (PFAM); IPR017981 (PROSITE_PROFILES); IPR000203 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES)	P:GO:0007166; P:GO:0007186; F:GO:0004888; F:GO:0004930; C:GO:0016021	P:cell surface receptor sigling pathway; P:G protein-coupled receptor sigling pathway; F:transmembrane sigling receptor activity; F:G protein-coupled receptor activity; C:integral component of membrane	765.669474731688	-4.13376048699363	0.643255719200044	-6.42630972972055	1.3073888390958e-10	1.12484379851403e-08
Avas.s013.g165.i2	NA	NA	Reverse transcriptase (RNA-dependent DNA polymerase)	2.3e-64	253.4	Actinopterygii	NA	NA	NA	NA	NA	NA	RTJK_DROME | R-directed D polymerase from mobile element jockey OS=Drosophila melanogaster OX=7227 GN=pol PE=1 SV=1	544	2.5e-05	P:GO:0006278; P:GO:0006313; F:GO:0003824; F:GO:0003964; F:GO:0016740; F:GO:0016779; C:GO:0005575	P:R-dependent D biosynthetic process; P:transposition, D-mediated; F:catalytic activity; F:R-directed D polymerase activity; F:transferase activity; F:nucleotidyltransferase activity; C:cellular_component			IPR000477 (PFAM); IPR000477 (PROSITE_PROFILES)	no GO terms	no GO terms	17.8538462439861	-7.48415463024939	1.56640926853028	-4.77790497069234	1.77131053087042e-06	7.03669509411709e-05
Avas.s013.g311.i1	homolog_cluster_13340	LEMD3	LEM domain containing 3	1.5e-37	164.5	Actinopterygii	NA	17	P:GO:1903845; P:GO:0000281; P:GO:0006357; P:GO:0002044; P:GO:0035914; F:GO:0005521; P:GO:0070197; P:GO:0006998; F:GO:0031490; P:GO:0010165; P:GO:0032926; C:GO:0005639; P:GO:2000112; P:GO:1903053; P:GO:0030514; P:GO:0051726; P:GO:0030512	F:lamin binding; P:negative regulation of cellular response to transforming growth factor beta stimulus; P:response to X-ray; P:negative regulation of BMP signaling pathway; P:blood vessel endothelial cell migration involved in intussusceptive angiogenesis; P:nuclear envelope organization; P:mitotic cytokinesis; P:skeletal muscle cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of extracellular matrix organization; P:regulation of cell cycle; P:negative regulation of activin receptor signaling pathway; C:integral component of nuclear inner membrane; P:meiotic attachment of telomere to nuclear envelope; F:chromatin DNA binding; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of cellular macromolecule biosynthetic process	K19410	NA	MAN1_MOUSE | Inner nuclear membrane protein Man1 OS=Mus musculus OX=10090 GN=Lemd3 PE=1 SV=2	595	6.2e-34	P:GO:0048646; P:GO:0072359; P:GO:0090101; F:GO:0005488; C:GO:0031965	P:atomical structure formation involved in morphogenesis; P:circulatory system development; P:negative regulation of transmembrane receptor protein serine/threonine kise sigling pathway; F:binding; C:nuclear membrane			IPR018996 (PFAM)	no GO terms	no GO terms	338.535263513178	1.5187237806316	0.267946041005945	5.66802097515562	1.44456285076156e-08	8.77040441732178e-07
Avas.s013.g343.i1	paralog_cluster_11855	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	195	NA					no IPS match	no IPS match	no IPS match	352.853048561013	-7.45891038557861	1.18553592316591	-6.29159373396292	3.14222981544654e-10	2.54046912063916e-08
Avas.s013.g344.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	79	NA					no IPS match	no IPS match	no IPS match	90.6784953555035	-4.24871679176037	0.902751704444464	-4.70640683461788	2.52121126658559e-06	9.72752231848815e-05
Avas.s013.g441.i1	paralog_cluster_05584	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	566	NA					no IPS match	no IPS match	no IPS match	61.9051477016825	-6.81581797442024	1.29802642516812	-5.25090848865997	1.51350862682812e-07	7.51569144970296e-06
Avas.s013.g478.i1	homolog_cluster_13368	Abi	Abl-interactor HHR	1e-28	134.8	Paraneoptera	NA	23	C:GO:0098858; P:GO:0051491; P:GO:0002066; P:GO:0051496; P:GO:0030032; P:GO:0007528; P:GO:0060269; C:GO:0031209; P:GO:0022416; P:GO:0048846; P:GO:0021955; P:GO:0042247; C:GO:0048471; C:GO:0045180; C:GO:0031258; P:GO:0072499; P:GO:0045860; P:GO:0007030; P:GO:0008360; P:GO:0033627; P:GO:0016203; P:GO:0030866; F:GO:0045296	C:basal cortex; P:cell adhesion mediated by integrin; P:muscle attachment; C:SCAR complex; P:regulation of cell shape; P:establishment of planar polarity of follicular epithelium; P:cortical actin cytoskeleton organization; C:perinuclear region of cytoplasm; P:axon extension involved in axon guidance; P:centripetally migrating follicle cell migration; P:Golgi organization; P:photoreceptor cell axon guidance; P:positive regulation of filopodium assembly; P:central nervous system neuron axonogenesis; P:neuromuscular junction development; P:lamellipodium assembly; P:chaeta development; P:positive regulation of protein kinase activity; C:lamellipodium membrane; P:columnar/cuboidal epithelial cell development; P:positive regulation of stress fiber assembly; F:cadherin binding; C:actin-based cell projection	NA	NA	ABI2_MOUSE | Abl interactor 2 OS=Mus musculus OX=10090 GN=Abi2 PE=1 SV=1	465	2.2e-26	P:GO:0007169; P:GO:0008154; P:GO:0008285; P:GO:0010592; P:GO:0016477; P:GO:0016601; P:GO:0018108; P:GO:0045186; P:GO:0061001; P:GO:0070309; P:GO:2000601; F:GO:0008092; F:GO:0008093; F:GO:0017124; F:GO:0019900; F:GO:0031267; F:GO:0031625; F:GO:0035591; F:GO:0042802; F:GO:0070064; C:GO:0005783; C:GO:0005829; C:GO:0005884; C:GO:0005912; C:GO:0030027; C:GO:0031209; C:GO:0032433; C:GO:0043197	P:transmembrane receptor protein tyrosine kise sigling pathway; P:actin polymerization or depolymerization; P:negative regulation of cell population proliferation; P:positive regulation of lamellipodium assembly; P:cell migration; P:Rac protein sigl transduction; P:peptidyl-tyrosine phosphorylation; P:zonula adherens assembly; P:regulation of dendritic spine morphogenesis; P:lens fiber cell morphogenesis; P:positive regulation of Arp2/3 complex-mediated actin nucleation; F:cytoskeletal protein binding; F:cytoskeletal anchor activity; F:SH3 domain binding; F:kise binding; F:small GTPase binding; F:ubiquitin protein ligase binding; F:sigling adaptor activity; F:identical protein binding; F:proline-rich region binding; C:endoplasmic reticulum; C:cytosol; C:actin filament; C:adherens junction; C:lamellipodium; C:SCAR complex; C:filopodium tip; C:dendritic spine			IPR012849 (PFAM); IPR001452 (PFAM); IPR001452 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	196.299080257948	2.33153251632161	0.344650845341045	6.76491164272199	1.33390579491962e-11	1.31663867082587e-09
Avas.s013.g491.i1	homolog_cluster_13372	trio	neurotransmitter receptor localization to postsynaptic specialization membrane	1.4e-05	57.8	Chordata	EC:2.7.11.1	NA	NA	NA	K08810	NA	CNTN5_HUMAN | Contactin-5 OS=Homo sapiens OX=9606 GN=CNTN5 PE=1 SV=2	407	4.9e-06	P:GO:0007155; P:GO:0007156; P:GO:0007411; P:GO:0007420; P:GO:0007605; P:GO:0050896; P:GO:0070593; P:GO:0098609; P:GO:0099054; F:GO:0005201; F:GO:0005509; F:GO:0098632; C:GO:0005576; C:GO:0005615; C:GO:0005886; C:GO:0016020; C:GO:0030424; C:GO:0031012; C:GO:0031225; C:GO:0032154; C:GO:0062023; C:GO:0098982; C:GO:0099026	P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:axon guidance; P:brain development; P:sensory perception of sound; P:response to stimulus; P:dendrite self-avoidance; P:cell-cell adhesion; P:presypse assembly; F:extracellular matrix structural constituent; F:calcium ion binding; F:cell-cell adhesion mediator activity; C:extracellular region; C:extracellular space; C:plasma membrane; C:membrane; C:axon; C:extracellular matrix; C:anchored component of membrane; C:cleavage furrow; C:collagen-containing extracellular matrix; C:GABA-ergic sypse; C:anchored component of presyptic membrane			IPR003306 (PFAM); IPR013098 (PFAM); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR003306 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES)	no GO terms	no GO terms	158.870538131817	2.34632442310461	0.372557214308134	6.29789018436243	3.01724137479878e-10	2.45173719591604e-08
Avas.s013.g592.i1	homolog_cluster_13380	PLXNA3	Plexin A3	3.1e-214	753.1	Actinopterygii	NA	21	P:GO:1902668; C:GO:0002116; P:GO:0051495; F:GO:0017154; P:GO:0021860; P:GO:0021785; P:GO:0021766; P:GO:0021612; P:GO:0045665; F:GO:0042803; P:GO:0021637; P:GO:0060272; P:GO:0050919; P:GO:0048755; P:GO:0048843; C:GO:0005886; C:GO:0005634; P:GO:0048696; P:GO:1902287; P:GO:0010771; C:GO:0030054	P:branchiomotor neuron axon guidance; F:protein homodimerization activity; P:negative regulation of cell morphogenesis involved in differentiation; P:negative regulation of neuron differentiation; P:facial nerve structural organization; P:regulation of collateral sprouting in absence of injury; P:negative regulation of axon extension involved in axon guidance; P:hippocampus development; P:negative chemotaxis; C:plasma membrane; C:semaphorin receptor complex; P:semaphorin-plexin signaling pathway involved in axon guidance; P:trigeminal nerve structural organization; F:semaphorin receptor activity; P:branching morphogenesis of a nerve; P:positive regulation of cytoskeleton organization; P:pyramidal neuron development; C:nucleus; C:cell junction; P:embryonic skeletal joint morphogenesis; P:negative regulation of axon guidance	K06820	map04360	PLXA4_HUMAN | Plexin-A4 OS=Homo sapiens OX=9606 GN=PLX4 PE=1 SV=4	1808	6.6e-212	P:GO:0001763; P:GO:0007166; P:GO:0008045; P:GO:0021602; P:GO:0021783; P:GO:0030900; P:GO:0040012; P:GO:0043009; P:GO:0048638; P:GO:0050770; P:GO:0060429; P:GO:0061387; C:GO:0016020; C:GO:0071944	P:morphogenesis of a branching structure; P:cell surface receptor sigling pathway; P:motor neuron axon guidance; P:cranial nerve morphogenesis; P:preganglionic parasympathetic fiber development; P:forebrain development; P:regulation of locomotion; P:chordate embryonic development; P:regulation of developmental growth; P:regulation of axonogenesis; P:epithelium development; P:regulation of extent of cell growth; C:membrane; C:cell periphery			IPR002909 (PFAM); IPR002165 (PFAM); IPR013548 (PFAM); IPR001627 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	343.289795159047	2.88699401705695	0.402411031770429	7.17424173078821	7.2709041334669e-13	8.41594076283086e-11
Avas.s013.g593.i1	homolog_cluster_13381	SNAP91	Epsin N-terminal homology (ENTH) domain	1.5e-41	177.6	Hominidae	NA	42	P:GO:0010976; P:GO:0007269; F:GO:0005546; P:GO:0097480; P:GO:0050772; P:GO:0051223; F:GO:0035615; P:GO:1904006; F:GO:0005545; P:GO:1900244; P:GO:0046907; C:GO:0008021; C:GO:0043025; P:GO:0098693; P:GO:0098657; P:GO:0010770; C:GO:0014069; P:GO:2000331; P:GO:2000369; P:GO:1900275; P:GO:1905445; F:GO:0000822; C:GO:0043195; F:GO:0000149; P:GO:2000809; C:GO:0048787; C:GO:0045211; F:GO:0038024; F:GO:0032050; C:GO:0030122; F:GO:0019901; P:GO:0090087; P:GO:0045666; F:GO:0042169; C:GO:0031313; P:GO:0016185; C:GO:0098894; P:GO:0007163; C:GO:0098830; F:GO:0043274; P:GO:0051899; C:GO:0005829	P:positive regulation of axonogenesis; F:1-phosphatidylinositol binding; C:extrinsic component of presynaptic endocytic zone membrane; C:presynaptic active zone membrane; P:import into cell; C:presynaptic endosome; P:negative regulation of phospholipase C activity; F:phospholipase binding; C:synaptic vesicle; F:clathrin heavy chain binding; F:cargo receptor activity; C:AP-2 adaptor complex; P:neurotransmitter secretion; C:cytosol; C:postsynaptic density; P:positive regulation of clathrin coat assembly; P:establishment of synaptic vesicle localization; C:neuronal cell body; P:intracellular transport; P:positive regulation of neuron projection development; P:positive regulation of synaptic vesicle clustering; P:regulation of synaptic vesicle cycle; P:positive regulation of neuron differentiation; P:regulation of protein transport; F:protein kinase binding; P:positive regulation of cell morphogenesis involved in differentiation; C:extrinsic component of endosome membrane; F:inositol hexakisphosphate binding; P:synaptic vesicle budding from presynaptic endocytic zone membrane; P:positive regulation of synaptic vesicle endocytosis; P:regulation of clathrin-dependent endocytosis; P:establishment or maintenance of cell polarity; P:negative regulation of phospholipase D activity; F:SH2 domain binding; C:terminal bouton; P:regulation of peptide transport; P:regulation of terminal button organization; F:phosphatidylinositol-4,5-bisphosphate binding; F:clathrin adaptor activity; F:SNARE binding; P:membrane depolarization; C:postsynaptic membrane	K20043	NA	AP180_HUMAN | Clathrin coat assembly protein AP180 OS=Homo sapiens OX=9606 GN=SP91 PE=1 SV=2	499	1.2e-41	P:GO:0007163; P:GO:0007269; P:GO:0007270; P:GO:0007611; P:GO:0010942; P:GO:0016185; P:GO:0016188; P:GO:0030097; P:GO:0035459; P:GO:0042331; P:GO:0045893; P:GO:0048813; P:GO:0050772; P:GO:0051223; P:GO:0051899; P:GO:0090647; P:GO:0150007; P:GO:0150093; P:GO:1900244; P:GO:1900275; P:GO:1902004; P:GO:1902803; P:GO:1902961; P:GO:1902963; P:GO:1903861; P:GO:1904006; P:GO:1905445; P:GO:2000331; P:GO:2000370; P:GO:2000809; F:GO:0000149; F:GO:0000822; F:GO:0005545; F:GO:0005546; F:GO:0017124; F:GO:0019901; F:GO:0031267; F:GO:0032050; F:GO:0035615; F:GO:0042169; F:GO:0042802; F:GO:0043274; F:GO:0048156; C:GO:0005829; C:GO:0008021; C:GO:0014069; C:GO:0030132; C:GO:0030136; C:GO:0031224; C:GO:0031313; C:GO:0043025; C:GO:0043679; C:GO:0045211; C:GO:0048471; C:GO:0048787; C:GO:0070381; C:GO:0097418; C:GO:0098685; C:GO:0098688; C:GO:0098830; C:GO:0098894	P:establishment or maintence of cell polarity; P:neurotransmitter secretion; P:neuron-neuron syptic transmission; P:learning or memory; P:positive regulation of cell death; P:syptic vesicle budding from presyptic endocytic zone membrane; P:syptic vesicle maturation; P:hemopoiesis; P:vesicle cargo loading; P:phototaxis; P:positive regulation of transcription, D-templated; P:dendrite morphogenesis; P:positive regulation of axonogenesis; P:regulation of protein transport; P:membrane depolarization; P:modulation of age-related behavioral decline; P:clathrin-dependent syptic vesicle endocytosis; P:amyloid-beta clearance by transcytosis; P:positive regulation of syptic vesicle endocytosis; P:negative regulation of phospholipase C activity; P:positive regulation of amyloid-beta formation; P:regulation of syptic vesicle transport; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of dendrite extension; P:negative regulation of phospholipase D activity; P:positive regulation of clathrin coat assembly; P:regulation of termil button organization; P:positive regulation of clathrin-dependent endocytosis; P:positive regulation of syptic vesicle clustering; F:SRE binding; F:inositol hexakisphosphate binding; F:1-phosphatidylinositol binding; F:phosphatidylinositol-4,5-bisphosphate binding; F:SH3 domain binding; F:protein kise binding; F:small GTPase binding; F:clathrin heavy chain binding; F:clathrin adaptor activity; F:SH2 domain binding; F:identical protein binding; F:phospholipase binding; F:tau protein binding; C:cytosol; C:syptic vesicle; C:postsyptic density; C:clathrin coat of coated pit; C:clathrin-coated vesicle; C:intrinsic component of membrane; C:extrinsic component of endosome membrane; C:neurol cell body; C:axon terminus; C:postsyptic membrane; C:perinuclear region of cytoplasm; C:presyptic active zone membrane; C:endosome to plasma membrane transport vesicle; C:neurofibrillary tangle; C:Schaffer collateral - CA1 sypse; C:parallel fiber to Purkinje cell sypse; C:presyptic endosome; C:extrinsic component of presyptic endocytic zone membrane			IPR011417 (PFAM); IPR013809 (PROSITE_PROFILES)	F:GO:0005543	F:phospholipid binding	469.008997077177	-1.65740658477761	0.327357015713671	-5.06299393389904	4.12722990794615e-07	1.86525286485802e-05
Avas.s013.g597.i1	paralog_cluster_04237	NA	negative regulation of growth rate	3.8e-06	58.9	Bilateria	NA	2	C:GO:0005737; C:GO:0045177	C:cytoplasm; C:apical part of cell	K02599,K16681	map01522, map04320, map04330, map04390, map04391, map04658, map04919, map05020, map05165, map05200, map05206, map05224	------	245	NA					IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES)	no GO terms	no GO terms	129.745025185547	-3.10242025965993	0.329332017309218	-9.42034207608484	4.49620793917446e-21	1.00471513240803e-18
Avas.s013.g604.i1	homolog_cluster_13384	trf-1	activation of NF-kappaB-inducing kinase activity	8e-58	231.5	Bilateria	NA	2	P:GO:0050829; P:GO:0045087	P:defense response to Gram-negative bacterium; P:innate immune response	K09848	map04214, map04657, map05200, map05222	TRAF6_BOVIN | TNF receptor-associated factor 6 OS=Bos taurus OX=9913 GN=TRAF6 PE=2 SV=1	463	3.2e-38	P:GO:0001819; P:GO:0002768; P:GO:0006355; P:GO:0009653; P:GO:0016567; P:GO:0019221; P:GO:0030154; P:GO:0045860; P:GO:0048513; P:GO:0050778; P:GO:1902533; F:GO:0016740; F:GO:0019901; C:GO:0005737; C:GO:0005886; C:GO:0043229	P:positive regulation of cytokine production; P:immune response-regulating cell surface receptor sigling pathway; P:regulation of transcription, D-templated; P:atomical structure morphogenesis; P:protein ubiquitition; P:cytokine-mediated sigling pathway; P:cell differentiation; P:positive regulation of protein kise activity; P:animal organ development; P:positive regulation of immune response; P:positive regulation of intracellular sigl transduction; F:transferase activity; F:protein kise binding; C:cytoplasm; C:plasma membrane; C:intracellular organelle	EC:2	Transferases	IPR001293 (PFAM); IPR002083 (PFAM); PF13923 (PFAM); IPR017907 (PROSITE_PATTERNS); IPR001293 (PROSITE_PROFILES); IPR001293 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES); IPR002083 (PROSITE_PROFILES)	F:GO:0005515; F:GO:0008270	F:protein binding; F:zinc ion binding	513.558644809269	4.2667215125458	0.851630238776754	5.01006342690971	5.44120993929063e-07	2.37245600848908e-05
Avas.s013.g605.i1	paralog_cluster_10576	NA	It is involved in the biological process described with proteolysis	1.2e-16	93.6	Drosophilidae	NA	NA	NA	NA	NA	NA	VM3SB_TRIST | Zinc metalloproteinase-disintegrin-like stejnihagin-B OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1	219	4.9e-21	F:GO:0005488; F:GO:0008233; C:GO:0110165	F:binding; F:peptidase activity; C:cellular atomical entity	EC:3.4	Acting on peptide bonds (peptidases)	IPR001762 (PFAM); IPR006586 (PFAM); IPR001762 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES)	no GO terms	no GO terms	64.3470250899264	1.62020577864442	0.313011879187099	5.17617983973051	2.26475164282252e-07	1.08631520569162e-05
Avas.s013.g607.i1	NA	NA	coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway	6.7e-136	491.9	Eukaryota	NA	NA	NA	NA	NA	NA	ADT1_CAEEL | A disintegrin and metalloproteinase with thrombospondin motifs adt-1 OS=Caenorhabditis elegans OX=6239 GN=adt-1 PE=2 SV=1	935	1.5e-55	P:GO:0002682; P:GO:0006950; P:GO:0007507; P:GO:0007610; P:GO:0009967; P:GO:0010033; P:GO:0010468; P:GO:0016043; P:GO:0016525; P:GO:0030154; P:GO:0030335; P:GO:0031325; P:GO:0032103; P:GO:0032268; P:GO:0042127; P:GO:0048523; P:GO:0048585; P:GO:0050920; P:GO:0051094; P:GO:0051240; P:GO:0065008; P:GO:0098609; P:GO:1902531; F:GO:0005515; C:GO:0005576; C:GO:0005783; C:GO:0005886	P:regulation of immune system process; P:response to stress; P:heart development; P:behavior; P:positive regulation of sigl transduction; P:response to organic substance; P:regulation of gene expression; P:cellular component organization; P:negative regulation of angiogenesis; P:cell differentiation; P:positive regulation of cell migration; P:positive regulation of cellular metabolic process; P:positive regulation of response to exterl stimulus; P:regulation of cellular protein metabolic process; P:regulation of cell population proliferation; P:negative regulation of cellular process; P:negative regulation of response to stimulus; P:regulation of chemotaxis; P:positive regulation of developmental process; P:positive regulation of multicellular organismal process; P:regulation of biological quality; P:cell-cell adhesion; P:regulation of intracellular sigl transduction; F:protein binding; C:extracellular region; C:endoplasmic reticulum; C:plasma membrane			IPR000884 (PFAM); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES)	no GO terms	no GO terms	147.338419518419	1.47557690952097	0.248566339178033	5.93635049057909	2.91436432290697e-09	1.97013477274161e-07
Avas.s014.g12.i1	homolog_cluster_18673	LOXL4	Lysyl oxidase homolog 4	5.2e-75	289.3	Aves	NA	4	C:GO:0043235; C:GO:0005576; F:GO:0004720; P:GO:0008152	F:protein-lysine 6-oxidase activity; C:extracellular region; P:metabolic process; C:receptor complex	K00280	NA	LOXL2_RAT | Lysyl oxidase homolog 2 OS=Rattus norvegicus OX=10116 GN=Loxl2 PE=2 SV=2	736	2.2e-73	P:GO:0048519; P:GO:0048731; P:GO:0050793; P:GO:0050794; P:GO:0051239; F:GO:0005488; C:GO:0043229	P:negative regulation of biological process; P:system development; P:regulation of developmental process; P:regulation of cellular process; P:regulation of multicellular organismal process; F:binding; C:intracellular organelle			IPR001695 (PFAM); IPR001190 (PFAM); IPR001190 (PROSITE_PATTERNS); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES)	F:GO:0005044; F:GO:0005507; F:GO:0016641; C:GO:0016020	F:scavenger receptor activity; F:copper ion binding; F:oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor; C:membrane	462.220243105994	2.71355916626855	0.446743275476515	6.07409068076997	1.24692255016098e-09	8.79900741646491e-08
Avas.s014.g21.i2	NA	NA	AhpC/TSA antioxidant enzyme	2.1e-05	55.5	Actinopterygii	NA	NA	NA	NA	NA	NA	------	122	NA					no IPS match	no IPS match	no IPS match	3973.10279148845	-1.44636195750324	0.243892792745403	-5.93031856834361	3.02347500042324e-09	2.02686205340873e-07
Avas.s014.g84.i1	homolog_cluster_13418	CTBS	chitinase activity	4.5e-51	208.8	Bilateria	NA	7	F:GO:0004568; P:GO:0042178; F:GO:0008061; P:GO:0009313; C:GO:0005576; C:GO:0005764; P:GO:0006032	F:chitin binding; P:oligosaccharide catabolic process; C:extracellular region; P:chitin catabolic process; F:chitinase activity; P:xenobiotic catabolic process; C:lysosome	K12310	NA	------	377	NA					IPR001223 (PFAM); IPR001223 (PROSITE_PROFILES)	P:GO:0005975	P:carbohydrate metabolic process	103.59836538215	-1.67511236801907	0.312429276010276	-5.36157299152711	8.25003737737029e-08	4.32361079363227e-06
Avas.s014.g86.i1	homolog_cluster_13419	NA	Aristaless related homeobox	3e-23	115.5	Actinopterygii	NA	9	F:GO:0042803; P:GO:0010628; C:GO:0005634; P:GO:0042463; F:GO:0000977; F:GO:0001228; P:GO:0042052; P:GO:2000112; P:GO:0045944	F:protein homodimerization activity; P:ocellus photoreceptor cell development; C:nucleus; P:rhabdomere development; P:regulation of cellular macromolecule biosynthetic process; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; P:positive regulation of transcription by RNA polymerase II; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:positive regulation of gene expression	K09452	NA	ARX_DANRE | Aristaless-related homeobox protein OS=Danio rerio OX=7955 GN=arx PE=2 SV=1	217	1.5e-22	P:GO:0000122; P:GO:0001755; P:GO:0001843; P:GO:0003322; P:GO:0007411; P:GO:0009952; P:GO:0010628; P:GO:0010718; P:GO:0021539; P:GO:0021759; P:GO:0021794; P:GO:0021800; P:GO:0021831; P:GO:0021846; P:GO:0021853; P:GO:0030326; P:GO:0042127; P:GO:0044241; P:GO:0045944; P:GO:0046622; P:GO:0048484; P:GO:0048704; P:GO:0060021; P:GO:0072148; F:GO:0000978; F:GO:0001227; F:GO:0001228; F:GO:0003682; F:GO:0042803; C:GO:0000785; C:GO:0005667; C:GO:0005794; C:GO:0016604	P:negative regulation of transcription by R polymerase II; P:neural crest cell migration; P:neural tube closure; P:pancreatic A cell development; P:axon guidance; P:anterior/posterior pattern specification; P:positive regulation of gene expression; P:positive regulation of epithelial to mesenchymal transition; P:subthalamus development; P:globus pallidus development; P:thalamus development; P:cerebral cortex tangential migration; P:embryonic olfactory bulb interneuron precursor migration; P:cell proliferation in forebrain; P:cerebral cortex GABAergic interneuron migration; P:embryonic limb morphogenesis; P:regulation of cell population proliferation; P:lipid digestion; P:positive regulation of transcription by R polymerase II; P:positive regulation of organ growth; P:enteric nervous system development; P:embryonic skeletal system morphogenesis; P:roof of mouth development; P:epithelial cell fate commitment; F:R polymerase II cis-regulatory region sequence-specific D binding; F:D-binding transcription repressor activity, R polymerase II-specific; F:D-binding transcription activator activity, R polymerase II-specific; F:chromatin binding; F:protein homodimerization activity; C:chromatin; C:transcription regulator complex; C:Golgi apparatus; C:nuclear body			IPR001356 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES)	P:GO:0006355; F:GO:0000981; F:GO:0003677	P:regulation of transcription, D-templated; F:D-binding transcription factor activity, R polymerase II-specific; F:D binding	603.608106484464	5.25617682372572	0.419773717365604	12.5214528835016	5.69824358098614e-36	4.5839520487243e-33
Avas.s014.g146.i1	paralog_cluster_00107	NA	cysteine-type endopeptidase activity	3.2e-99	368.6	Metazoa	NA	NA	NA	NA	NA	NA	CATL1_MOUSE | Procathepsin L OS=Mus musculus OX=10090 GN=Ctsl PE=1 SV=2	355	1.2e-93	P:GO:0002250; P:GO:0006590; P:GO:0007283; P:GO:0009267; P:GO:0009749; P:GO:0010259; P:GO:0010839; P:GO:0016540; P:GO:0019064; P:GO:0019065; P:GO:0019886; P:GO:0021675; P:GO:0022617; P:GO:0030574; P:GO:0031069; P:GO:0031638; P:GO:0034230; P:GO:0034698; P:GO:0039654; P:GO:0043373; P:GO:0046697; P:GO:0048102; P:GO:0051384; P:GO:0051603; P:GO:0060008; P:GO:0060309; P:GO:0071888; P:GO:0097067; P:GO:1990834; F:GO:0001968; F:GO:0004177; F:GO:0004197; F:GO:0004252; F:GO:0005518; F:GO:0016807; F:GO:0030984; F:GO:0042277; F:GO:0042393; F:GO:0043394; F:GO:0097655; C:GO:0005615; C:GO:0005730; C:GO:0005771; C:GO:0005794; C:GO:0005902; C:GO:0009897; C:GO:0036021; C:GO:0042583; C:GO:0043005; C:GO:0043204; C:GO:0045169; C:GO:0045177; C:GO:0071682	P:adaptive immune response; P:thyroid hormone generation; P:spermatogenesis; P:cellular response to starvation; P:response to glucose; P:multicellular organism aging; P:negative regulation of keratinocyte proliferation; P:protein autoprocessing; P:fusion of virus membrane with host plasma membrane; P:receptor-mediated endocytosis of virus by host cell; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:nerve development; P:extracellular matrix disassembly; P:collagen catabolic process; P:hair follicle morphogenesis; P:zymogen activation; P:enkephalin processing; P:response to godotropin; P:fusion of virus membrane with host endosome membrane; P:CD4-positive, alpha-beta T cell lineage commitment; P:decidualization; P:autophagic cell death; P:response to glucocorticoid; P:proteolysis involved in cellular protein catabolic process; P:Sertoli cell differentiation; P:elastin catabolic process; P:macrophage apoptotic process; P:cellular response to thyroid hormone stimulus; P:response to odorant; F:fibronectin binding; F:aminopeptidase activity; F:cysteine-type endopeptidase activity; F:serine-type endopeptidase activity; F:collagen binding; F:cysteine-type carboxypeptidase activity; F:kininogen binding; F:peptide binding; F:histone binding; F:proteoglycan binding; F:serpin family protein binding; C:extracellular space; C:nucleolus; C:multivesicular body; C:Golgi apparatus; C:microvillus; C:exterl side of plasma membrane; C:endolysosome lumen; C:chromaffin granule; C:neuron projection; C:perikaryon; C:fusome; C:apical part of cell; C:endocytic vesicle lumen	EC:3.4.22; EC:3.4.11; EC:3.4.21; EC:3.4.18	Acting on peptide bonds (peptidases); Acting on peptide bonds (peptidases); Acting on peptide bonds (peptidases); Acting on peptide bonds (peptidases)	IPR000668 (PFAM); IPR013201 (PFAM); IPR000169 (PROSITE_PATTERNS); IPR025661 (PROSITE_PATTERNS)	P:GO:0006508; F:GO:0008234	P:proteolysis; F:cysteine-type peptidase activity	927.309897139113	2.76356124843565	0.495801003328943	5.5739323435821	2.4905248977539e-08	1.45181358985371e-06
Avas.s014.g154.i1	paralog_cluster_00199	ARSB	Arylsulfatase	3.4e-92	345.9	Actinopterygii	EC:3.1.6.12	28	P:GO:0010976; C:GO:0043202; F:GO:0003943; P:GO:0009268; P:GO:0007584; P:GO:0006914; P:GO:0097065; P:GO:0043436; C:GO:0005791; P:GO:0043312; C:GO:1904813; C:GO:0005794; P:GO:0061580; C:GO:0005576; P:GO:0030207; C:GO:0005739; P:GO:0010632; P:GO:0051597; P:GO:0043627; P:GO:0007417; C:GO:0009986; P:GO:0045666; C:GO:0035578; C:GO:0005788; F:GO:0004065; P:GO:0007041; P:GO:0007040; P:GO:0050769	C:endoplasmic reticulum lumen; F:N-acetylgalactosamine-4-sulfatase activity; P:anterior head development; P:lysosomal transport; C:extracellular region; P:lysosome organization; P:neutrophil degranulation; F:arylsulfatase activity; P:regulation of epithelial cell migration; P:central nervous system development; C:ficolin-1-rich granule lumen; P:positive regulation of neuron projection development; P:oxoacid metabolic process; P:chondroitin sulfate catabolic process; P:positive regulation of neuron differentiation; P:response to methylmercury; P:response to pH; P:response to estrogen; P:autophagy; C:rough endoplasmic reticulum; P:positive regulation of neurogenesis; C:cell surface; C:mitochondrion; P:response to nutrient; C:Golgi apparatus; C:azurophil granule lumen; P:colon epithelial cell migration; C:lysosomal lumen	K01135	map00531, map01100, map04142	ARSI_HUMAN | Arylsulfatase I OS=Homo sapiens OX=9606 GN=ARSI PE=1 SV=1	535	9e-101	P:GO:0006914; P:GO:0007417; P:GO:0007584; P:GO:0009268; P:GO:0010976; P:GO:0043627; P:GO:0051179; P:GO:0051597; F:GO:0005488; F:GO:0008484; C:GO:0005739; C:GO:0005764; C:GO:0005791; C:GO:0005794; C:GO:0009986; C:GO:0015629; C:GO:0031982; C:GO:0070013	P:autophagy; P:central nervous system development; P:response to nutrient; P:response to pH; P:positive regulation of neuron projection development; P:response to estrogen; P:localization; P:response to methylmercury; F:binding; F:sulfuric ester hydrolase activity; C:mitochondrion; C:lysosome; C:rough endoplasmic reticulum; C:Golgi apparatus; C:cell surface; C:actin cytoskeleton; C:vesicle; C:intracellular organelle lumen	EC:3.1.6	Acting on ester bonds	IPR000917 (PFAM); IPR024607 (PROSITE_PATTERNS)	F:GO:0008484	F:sulfuric ester hydrolase activity	114.248760718201	1.75802741771079	0.266914594372397	6.58647917639904	4.5037868760995e-11	4.21287366567238e-09
Avas.s014.g199.i1	paralog_cluster_01922	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	169	NA					no IPS match	no IPS match	no IPS match	498.137035013199	5.27325018650458	0.667572994172687	7.89913647276824	2.80842255750178e-15	4.22287014277067e-13
Avas.s014.g223.i1	paralog_cluster_06309	NA	Formyl transferase, C-terminal domain	9.2e-116	424.9	Metazoa	NA	NA	NA	NA	NA	NA	FOLD_AQUAE | Bifunctiol protein FolD OS=Aquifex aeolicus (strain VF5) OX=224324 GN=folD PE=3 SV=1	863	3.5e-54	P:GO:0044238; P:GO:0044249; P:GO:0044281; P:GO:1901566; F:GO:0016491	P:primary metabolic process; P:cellular biosynthetic process; P:small molecule metabolic process; P:organonitrogen compound biosynthetic process; F:oxidoreductase activity	EC:1	Oxidoreductases	IPR005793 (PFAM); IPR002376 (PFAM); IPR020630 (PFAM); IPR001753 (PFAM); IPR020631 (PFAM)	P:GO:0009058; F:GO:0003824; F:GO:0004488; F:GO:0016742	P:biosynthetic process; F:catalytic activity; F:methylenetetrahydrofolate dehydrogese (DP+) activity; F:hydroxymethyl-, formyl- and related transferase activity	30.7373619823345	3.81625081493079	0.551648551440669	6.91790235823947	4.58380036314632e-12	4.82018065638308e-10
Avas.s014.g458.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	435	NA					no IPS match	no IPS match	no IPS match	64.9640400649948	3.63812584089345	0.461029029920016	7.89131617487218	2.99016029156418e-15	4.45450823434964e-13
Avas.s014.g568.i1	paralog_cluster_05588	NA	Belongs to the G-protein coupled receptor 2 family	1.6e-17	98.6	Metazoa	NA	NA	NA	NA	NA	NA	AGRL1_RAT | Adhesion G protein-coupled receptor L1 OS=Rattus norvegicus OX=10116 GN=Adgrl1 PE=1 SV=1	934	2.8e-12	P:GO:0002009; P:GO:0007165; P:GO:0007399; P:GO:0048513; P:GO:0050793; P:GO:0051128; P:GO:0051179; P:GO:0098742; F:GO:0004888; F:GO:0005488; C:GO:0005886; C:GO:0016021; C:GO:0043005; C:GO:0045202	P:morphogenesis of an epithelium; P:sigl transduction; P:nervous system development; P:animal organ development; P:regulation of developmental process; P:regulation of cellular component organization; P:localization; P:cell-cell adhesion via plasma-membrane adhesion molecules; F:transmembrane sigling receptor activity; F:binding; C:plasma membrane; C:integral component of membrane; C:neuron projection; C:sypse			IPR000832 (PFAM); IPR000203 (PFAM); IPR017981 (PROSITE_PROFILES); IPR000203 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES)	P:GO:0007166; P:GO:0007186; F:GO:0004888; F:GO:0004930; C:GO:0016021	P:cell surface receptor sigling pathway; P:G protein-coupled receptor sigling pathway; F:transmembrane sigling receptor activity; F:G protein-coupled receptor activity; C:integral component of membrane	358.38960107532	-3.23050379896202	0.600294435594343	-5.38153214057956	7.38545133953969e-08	3.93458697357133e-06
Avas.s014.g618.i1	NA	Glassin	Belongs to the peptidase S10 family	0.034	46.6	Insecta	NA	3	P:GO:0033227; F:GO:0004185; P:GO:0051603	P:proteolysis involved in cellular protein catabolic process; P:dsRNA transport; F:serine-type carboxypeptidase activity	K09645	NA	------	428	NA					no IPS match	no IPS match	no IPS match	181.631873307638	4.76214408171133	0.339443888169159	14.0292526915027	1.03233658147264e-44	1.38410527160944e-41
Avas.s014.g625.i1	paralog_cluster_02847	NA	triglyceride lipase activity	9.8e-26	124.8	Bilateria	NA	NA	NA	NA	NA	NA	CXE5_ARATH | Probable carboxylesterase 5 OS=Arabidopsis thalia OX=3702 GN=CXE5 PE=2 SV=1	427	5.5e-08	F:GO:0016787	F:hydrolase activity	EC:3	Hydrolases	IPR013094 (PFAM)	F:GO:0016787	F:hydrolase activity	65.2499050643798	2.57225220749742	0.414522500044065	6.20533796651323	5.45794805712984e-10	4.20157542062976e-08
Avas.s014.g646.i1	paralog_cluster_07335	ADAMTS10	metalloendopeptidase activity	4.7e-13	84.3	Vertebrata	NA	2	C:GO:0001527; C:GO:0005576	C:extracellular region; C:microfibril	K08625	NA	------	1385	NA					IPR013098 (PFAM); PF19030 (PFAM); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES)	no GO terms	no GO terms	2775.65228927082	4.67715855599554	0.216436752733076	21.6098167105829	1.45223877573973e-103	2.33650696628765e-99
Avas.s014.g658.i1	paralog_cluster_08921	TMEM63A	Transmembrane protein 63A	1.3e-76	294.7	Actinopterygii	NA	6	P:GO:0043312; C:GO:0035579; C:GO:0070821; C:GO:0005765; C:GO:0005886; C:GO:0005815	C:tertiary granule membrane; P:neutrophil degranulation; C:specific granule membrane; C:lysosomal membrane; C:microtubule organizing center; C:plasma membrane	K21989	NA	CSCL2_HUMAN | CSC1-like protein 2 OS=Homo sapiens OX=9606 GN=TMEM63B PE=1 SV=1	778	1.3e-76	P:GO:0006811; P:GO:0050794; F:GO:0005216; F:GO:0022836; C:GO:0016020; C:GO:0043231	P:ion transport; P:regulation of cellular process; F:ion channel activity; F:gated channel activity; C:membrane; C:intracellular membrane-bounded organelle	EC:7	Translocases	IPR027815 (PFAM); IPR032880 (PFAM); IPR003864 (PFAM)	C:GO:0016020	C:membrane	31.6568056923103	2.41993933128056	0.514409829805745	4.70430227236208	2.54735605463188e-06	9.80488314903645e-05
Avas.s014.g737.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	91	NA					no IPS match	no IPS match	no IPS match	511.762870218265	-4.04173629624926	0.680751106800533	-5.93717183251461	2.89980701494948e-09	1.96856519255368e-07
Avas.s015.g146.i1	paralog_cluster_00633	NA	Competence protein ComEC	1.1e-14	87.8	Eukaryota	NA	NA	NA	NA	NA	NA	------	368	NA					no IPS match	no IPS match	no IPS match	151.762230355947	6.09603888424231	0.543121104522585	11.2240876546325	3.10575322929536e-29	1.24921159265333e-26
Avas.s015.g207.i1	paralog_cluster_13554	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	350	NA					no IPS match	no IPS match	no IPS match	134.944612090864	3.43307613580995	0.694986437052133	4.93977429310958	7.82130508665891e-07	3.36462506789452e-05
Avas.s015.g216.i1	paralog_cluster_01634	NA	N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity	1.3e-58	234.6	Metazoa	NA	NA	NA	NA	NA	NA	B4GN4_MOUSE | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1	610	2.8e-45	F:GO:0008376; C:GO:0005794	F:acetylgalactosaminyltransferase activity; C:Golgi apparatus	EC:2.4.1	Glycosyltransferases	IPR008428 (PFAM)	F:GO:0008376; C:GO:0032580	F:acetylgalactosaminyltransferase activity; C:Golgi cister membrane	142.809680689061	3.32248771343215	0.35655124010415	9.31840178837027	1.1810586024431e-20	2.56784484523069e-18
Avas.s015.g249.i1	paralog_cluster_05036	NA	glutamate reuptake	6.6e-36	158.3	Chordata	NA	NA	NA	NA	NA	NA	CLN8_HUMAN | Protein CLN8 OS=Homo sapiens OX=9606 GN=CLN8 PE=1 SV=3	352	4.1e-33	P:GO:0006644; P:GO:0006672; P:GO:0007399; P:GO:0008203; P:GO:0043170; P:GO:0050877; P:GO:0065008; F:GO:0005515; F:GO:0097001; C:GO:0005783; C:GO:0005793; C:GO:0016020	P:phospholipid metabolic process; P:ceramide metabolic process; P:nervous system development; P:cholesterol metabolic process; P:macromolecule metabolic process; P:nervous system process; P:regulation of biological quality; F:protein binding; F:ceramide binding; C:endoplasmic reticulum; C:endoplasmic reticulum-Golgi intermediate compartment; C:membrane			IPR006634 (PFAM); IPR006634 (PROSITE_PROFILES)	C:GO:0016021	C:integral component of membrane	285.503212263743	2.99327964360436	0.488548679906563	6.12688103911536	8.9618424725206e-10	6.55395834274472e-08
Avas.s015.g300.i1	paralog_cluster_08933	NA	Rap/ran-GAP	2.4e-99	371.3	Insecta	NA	NA	NA	NA	K17701,K17702	map04015	SI1L1_MOUSE | Sigl-induced proliferation-associated 1-like protein 1 OS=Mus musculus OX=10090 GN=Sipa1l1 PE=1 SV=2	1690	9.5e-96	P:GO:0001654; P:GO:0002244; P:GO:0003382; P:GO:0031532; P:GO:0048013; P:GO:0048167; P:GO:0048814; P:GO:0050770; P:GO:0051726; P:GO:0061001; P:GO:0090162; P:GO:0090630; P:GO:0098974; P:GO:0099151; F:GO:0019901; F:GO:0031625; F:GO:0046875; F:GO:0051015; C:GO:0001725; C:GO:0005654; C:GO:0005794; C:GO:0005886; C:GO:0014069; C:GO:0032991; C:GO:0043025; C:GO:0043197; C:GO:0045177; C:GO:0061689; C:GO:0098978	P:eye development; P:hematopoietic progenitor cell differentiation; P:epithelial cell morphogenesis; P:actin cytoskeleton reorganization; P:ephrin receptor sigling pathway; P:regulation of syptic plasticity; P:regulation of dendrite morphogenesis; P:regulation of axonogenesis; P:regulation of cell cycle; P:regulation of dendritic spine morphogenesis; P:establishment of epithelial cell polarity; P:activation of GTPase activity; P:postsyptic actin cytoskeleton organization; P:regulation of postsyptic density assembly; F:protein kise binding; F:ubiquitin protein ligase binding; F:ephrin receptor binding; F:actin filament binding; C:stress fiber; C:nucleoplasm; C:Golgi apparatus; C:plasma membrane; C:postsyptic density; C:protein-containing complex; C:neurol cell body; C:dendritic spine; C:apical part of cell; C:tricellular tight junction; C:glutamatergic sypse			IPR000331 (PFAM); IPR000331 (PROSITE_PROFILES)	P:GO:0051056; F:GO:0005096	P:regulation of small GTPase mediated sigl transduction; F:GTPase activator activity	138.425869414002	1.12639422412716	0.227113791772849	4.95960291682215	7.0637417646199e-07	3.05506831319811e-05
Avas.s015.g314.i1	paralog_cluster_01501	NA	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors. It is involved in the biological process described with oxidation-reduction process	5.4e-218	764.2	Arthropoda	EC:1.14.11.4	4	C:GO:0005783; C:GO:0048471; P:GO:0007295; C:GO:0005615	C:endoplasmic reticulum; C:extracellular space; C:perinuclear region of cytoplasm; P:growth of a germarium-derived egg chamber	K13647	map00310	PLOD3_RAT | Multifunctiol procollagen lysine hydroxylase and glycosyltransferase LH3 OS=Rattus norvegicus OX=10116 GN=Plod3 PE=1 SV=1	723	4.2e-194	P:GO:0001666; P:GO:0001701; P:GO:0001886; P:GO:0008104; P:GO:0017185; P:GO:0021915; P:GO:0030199; P:GO:0032870; P:GO:0032963; P:GO:0042311; P:GO:0046947; P:GO:0048730; P:GO:0070831; F:GO:0005515; F:GO:0008198; F:GO:0008475; F:GO:0031418; F:GO:0033823; F:GO:0042277; F:GO:0050211; C:GO:0005615; C:GO:0005789; C:GO:0005802; C:GO:0062023	P:response to hypoxia; P:in utero embryonic development; P:endothelial cell morphogenesis; P:protein localization; P:peptidyl-lysine hydroxylation; P:neural tube development; P:collagen fibril organization; P:cellular response to hormone stimulus; P:collagen metabolic process; P:vasodilation; P:hydroxylysine biosynthetic process; P:epidermis morphogenesis; P:basement membrane assembly; F:protein binding; F:ferrous iron binding; F:procollagen-lysine 5-dioxygese activity; F:L-ascorbic acid binding; F:procollagen glucosyltransferase activity; F:peptide binding; F:procollagen galactosyltransferase activity; C:extracellular space; C:endoplasmic reticulum membrane; C:trans-Golgi network; C:collagen-containing extracellular matrix	EC:1.14.11.4; EC:2.4.1.50; EC:2.4.1.66	Procollagen-lysine 5-dioxygese; Procollagen galactosyltransferase; Procollagen glucosyltransferase	IPR001006 (PROSITE_PATTERNS); IPR005123 (PROSITE_PROFILES)	F:GO:0008475	F:procollagen-lysine 5-dioxygese activity	1285.55837420999	3.60183793919761	0.238322603696262	15.1132871298607	1.32368432851533e-51	2.66209464518538e-48
Avas.s015.g316.i1	paralog_cluster_07343	NA	zinc ion binding	0.00075	51.2	Metazoa	NA	NA	NA	NA	NA	NA	------	234	NA					IPR033446 (PFAM)	no GO terms	no GO terms	230.563378274282	3.55571375027939	0.364746375469293	9.74845533613461	1.87296331199422e-22	4.70845417604296e-20
Avas.s015.g328.i1	homolog_cluster_13584	SEC4	GTP-binding protein	7.1e-12	77.8	Onygenales	NA	29	F:GO:0005525; P:GO:0002790; P:GO:0006893; P:GO:0023052; P:GO:0006914; C:GO:0000131; F:GO:0003924; P:GO:0009306; P:GO:0007107; C:GO:0030133; C:GO:0031521; C:GO:0005934; C:GO:0005935; C:GO:0043332; P:GO:0031321; P:GO:0006903; P:GO:0006904; F:GO:0032550; P:GO:0006886; P:GO:0072659; P:GO:0017157; C:GO:0005783; C:GO:0035974; C:GO:0005741; P:GO:0071466; C:GO:0005886; P:GO:0006906; C:GO:0005768; C:GO:0005628	P:peptide secretion; P:membrane addition at site of cytokinesis; P:signaling; C:meiotic spindle pole body; P:Golgi to plasma membrane transport; P:vesicle targeting; C:endosome; P:protein localization to plasma membrane; P:ascospore-type prospore assembly; C:transport vesicle; C:mating projection tip; F:GTP binding; F:GTPase activity; C:prospore membrane; P:vesicle fusion; C:endoplasmic reticulum; C:mitochondrial outer membrane; C:incipient cellular bud site; C:cellular bud neck; P:vesicle docking involved in exocytosis; P:regulation of exocytosis; P:autophagy; P:cellular response to xenobiotic stimulus; C:spitzenkorper; C:plasma membrane; P:protein secretion; F:purine ribonucleoside binding; C:cellular bud tip; P:intracellular protein transport	K07901,K18158	map04144, map04152, map04530, map04972	------	220	NA					IPR001806 (PFAM); PS51419 (PROSITE_PROFILES)	F:GO:0003924; F:GO:0005525	F:GTPase activity; F:GTP binding	829.897596642144	2.96774043274766	0.483328199529322	6.14021783880545	8.24083917418312e-10	6.1099936162872e-08
Avas.s015.g470.i1	paralog_cluster_07345	NA	Beta/gamma crystallins	4.8e-10	70.5	Oxalobacteraceae	NA	NA	NA	NA	NA	NA	------	94	NA					IPR001064 (PFAM); IPR001064 (PROSITE_PROFILES); IPR001064 (PROSITE_PROFILES)	no GO terms	no GO terms	165.793317800456	-4.53099361347807	0.955887170623999	-4.74009250539503	2.13620667272138e-06	8.38278759936934e-05
Avas.s015.g471.i1	paralog_cluster_07345	NA	Beta/gamma crystallins	3.1e-09	67.8	Oxalobacteraceae	NA	NA	NA	NA	NA	NA	------	94	NA					IPR001064 (PFAM); IPR001064 (PROSITE_PROFILES); IPR001064 (PROSITE_PROFILES)	no GO terms	no GO terms	281.165472313689	-5.35863336744366	1.12601440893085	-4.75893854016637	1.94613677332453e-06	7.69321733317404e-05
Avas.s015.g491.i1	paralog_cluster_00633	NA	Competence protein ComEC	6.1e-18	98.6	Eukaryota	NA	NA	NA	NA	NA	NA	------	346	NA					no IPS match	no IPS match	no IPS match	1084.94229627963	5.79200815899503	0.307376465687844	18.8433689808806	3.33074458667536e-79	1.3397087413755e-75
Avas.s015.g524.i1	paralog_cluster_07346	NA	Translation initiation factor IF-2, N-terminal region	9.7e-10	71.2	fabids	NA	NA	NA	NA	NA	NA	FAB1A_ARATH | 1-phosphatidylinositol-3-phosphate 5-kinase FAB1A OS=Arabidopsis thalia OX=3702 GN=FAB1A PE=2 SV=1	322	2.4e-08	P:GO:0016043; F:GO:0016307; C:GO:0005768	P:cellular component organization; F:phosphatidylinositol phosphate kise activity; C:endosome	EC:2.7.1	Transferring phosphorus-containing groups	IPR000306 (PFAM); IPR017455 (PROSITE_PROFILES)	F:GO:0046872	F:metal ion binding	1686.71944571686	3.88326341232886	0.462060174483379	8.40423742788624	4.30650660150666e-17	7.6139983199605e-15
Avas.s015.g549.i1	homolog_cluster_13621	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	267	NA					no IPS match	no IPS match	no IPS match	1334.01845790248	4.515884093065	0.391521941090231	11.5341788521228	8.8729783647729e-31	4.46116715346347e-28
Avas.s015.g556.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	64	NA					IPR001152 (PFAM)	P:GO:0007015; F:GO:0003785	P:actin filament organization; F:actin monomer binding	16332.5295111172	3.33358651259492	0.443283616486751	7.52021141456862	5.46877374786667e-14	6.87399225229897e-12
Avas.s016.g20.i1	homolog_cluster_13629	NA	Toll-like receptor	0.0021	51.6	Actinopterygii	NA	NA	NA	NA	NA	NA	------	860	NA					no IPS match	no IPS match	no IPS match	892.95619101654	3.26097466674896	0.496703526768439	6.56523356692253	5.19513654842527e-11	4.8314769900355e-09
Avas.s016.g32.i1	paralog_cluster_01583	NA	Calcium-binding protein	9.6e-34	149.8	Metazoa	NA	NA	NA	NA	NA	NA	AIF1_HUMAN | Allograft inflammatory factor 1 OS=Homo sapiens OX=9606 GN=AIF1 PE=1 SV=1	145	1.8e-40	P:GO:0001774; P:GO:0001934; P:GO:0006911; P:GO:0010629; P:GO:0014739; P:GO:0016601; P:GO:0021549; P:GO:0030041; P:GO:0030046; P:GO:0031668; P:GO:0032722; P:GO:0032755; P:GO:0032870; P:GO:0042102; P:GO:0043066; P:GO:0045429; P:GO:0048661; P:GO:0048662; P:GO:0048678; P:GO:0051384; P:GO:0051602; P:GO:0051764; P:GO:0071315; P:GO:0071346; P:GO:0071447; P:GO:0071672; P:GO:0071673; P:GO:0090026; P:GO:0090271; P:GO:0097178; P:GO:1900087; P:GO:2000406; F:GO:0005509; F:GO:0045504; F:GO:0051015; C:GO:0001891; C:GO:0005634; C:GO:0005829; C:GO:0005884; C:GO:0005925; C:GO:0030027; C:GO:0032587; C:GO:0036156; C:GO:0043204; C:GO:0048471	P:microglial cell activation; P:positive regulation of protein phosphorylation; P:phagocytosis, engulfment; P:negative regulation of gene expression; P:positive regulation of muscle hyperplasia; P:Rac protein sigl transduction; P:cerebellum development; P:actin filament polymerization; P:parallel actin filament bundle assembly; P:cellular response to extracellular stimulus; P:positive regulation of chemokine production; P:positive regulation of interleukin-6 production; P:cellular response to hormone stimulus; P:positive regulation of T cell proliferation; P:negative regulation of apoptotic process; P:positive regulation of nitric oxide biosynthetic process; P:positive regulation of smooth muscle cell proliferation; P:negative regulation of smooth muscle cell proliferation; P:response to axon injury; P:response to glucocorticoid; P:response to electrical stimulus; P:actin crosslink formation; P:cellular response to morphine; P:cellular response to interferon-gamma; P:cellular response to hydroperoxide; P:negative regulation of smooth muscle cell chemotaxis; P:positive regulation of smooth muscle cell chemotaxis; P:positive regulation of monocyte chemotaxis; P:positive regulation of fibroblast growth factor production; P:ruffle assembly; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of T cell migration; F:calcium ion binding; F:dynein heavy chain binding; F:actin filament binding; C:phagocytic cup; C:nucleus; C:cytosol; C:actin filament; C:focal adhesion; C:lamellipodium; C:ruffle membrane; C:inner dynein arm; C:perikaryon; C:perinuclear region of cytoplasm			IPR002048 (PFAM); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES)	F:GO:0005509	F:calcium ion binding	955.973881809478	1.65658323335129	0.210417010297768	7.87285795481557	3.46630137239876e-15	5.1164516312407e-13
Avas.s016.g82.i1	homolog_cluster_13642	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	132	NA					PS51257 (PROSITE_PROFILES)	no GO terms	no GO terms	320.108698420256	3.51423908222	0.613695132374563	5.72635971320547	1.02608536648206e-08	6.3987160702829e-07
Avas.s016.g87.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	721	NA					no IPS match	no IPS match	no IPS match	534.855609277943	-2.69551841297146	0.234853964010137	-11.4774235313955	1.71309516948948e-30	8.3521176308837e-28
Avas.s016.g93.i1	paralog_cluster_05556	NA	TNF receptor-associated factor	0.00015	53.9	Eukaryota	NA	NA	NA	NA	NA	NA	------	301	NA					no IPS match	no IPS match	no IPS match	175.288118214021	-2.9504960884574	0.381906109062205	-7.72571063527246	1.11231046030769e-14	1.50386243662945e-12
Avas.s016.g94.i1	paralog_cluster_05556	NA	activation of NF-kappaB-inducing kinase activity	2.3e-05	56.6	Metazoa	NA	NA	NA	NA	NA	NA	------	306	NA					no IPS match	no IPS match	no IPS match	30.5801126878644	-2.74262696462028	0.535747168032984	-5.11925611233737	3.06743164699539e-07	1.4346484816427e-05
Avas.s016.g112.i1	paralog_cluster_01908	SUB8	Belongs to the peptidase S8 family	1.7e-27	130.6	Sordariomycetes	EC:3.4.21.48	3	C:GO:0005622; P:GO:0043936; F:GO:0019863	F:IgE binding; C:intracellular anatomical structure; P:asexual sporulation resulting in formation of a cellular spore	K01336	map04138	ISP6_SCHPO | Sexual differentiation process putative subtilase-type proteise isp6 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=isp6 PE=2 SV=1	418	5.9e-23	P:GO:0019538; P:GO:0044248; F:GO:0008233; C:GO:0005773	P:protein metabolic process; P:cellular catabolic process; F:peptidase activity; C:vacuole	EC:3.4	Acting on peptide bonds (peptidases)	IPR000209 (PFAM); PS51892 (PROSITE_PROFILES)	P:GO:0006508; F:GO:0008236	P:proteolysis; F:serine-type peptidase activity	26.0604244883972	-5.55946372295575	1.10403880982988	-5.0355691063183	4.76431203613104e-07	2.11748663948376e-05
Avas.s016.g117.i1	paralog_cluster_01908	PCSK9	very-low-density lipoprotein particle binding	4.6e-28	132.5	Bilateria	NA	47	F:GO:0030547; F:GO:0050750; C:GO:1990667; C:GO:1990666; F:GO:0030169; P:GO:0009267; F:GO:0019871; P:GO:0001920; P:GO:0001822; P:GO:0030182; F:GO:0034189; P:GO:0009968; C:GO:0005791; C:GO:0005770; F:GO:0034185; C:GO:0005794; C:GO:0030134; P:GO:0001889; F:GO:0043621; C:GO:0048471; C:GO:0005798; P:GO:2000272; P:GO:0032805; F:GO:0004252; P:GO:0032869; C:GO:0005615; P:GO:2000650; P:GO:0008203; P:GO:0010989; P:GO:0006641; P:GO:1905601; P:GO:0043525; P:GO:0006644; P:GO:0016540; P:GO:0042157; C:GO:0031232; P:GO:0042632; P:GO:0043687; F:GO:0070326; F:GO:0034190; C:GO:0005788; P:GO:1905598; P:GO:0007041; C:GO:0005769; P:GO:1905596; C:GO:0036020; P:GO:0002092	C:endoplasmic reticulum lumen; F:low-density lipoprotein particle receptor binding; C:early endosome; P:cellular response to starvation; C:PCSK9-LDLR complex; C:extracellular space; F:protein self-association; P:negative regulation of receptor recycling; C:extrinsic component of external side of plasma membrane; P:negative regulation of signaling receptor activity; P:negative regulation of low-density lipoprotein particle receptor binding; C:perinuclear region of cytoplasm; P:lysosomal transport; C:Golgi-associated vesicle; C:late endosome; P:negative regulation of signal transduction; F:apolipoprotein receptor binding; C:PCSK9-AnxA2 complex; P:post-translational protein modification; F:very-low-density lipoprotein particle receptor binding; P:negative regulation of low-density lipoprotein receptor activity; P:negative regulation of sodium ion transmembrane transporter activity; P:neuron differentiation; P:cellular response to insulin stimulus; C:endolysosome membrane; F:sodium channel inhibitor activity; P:lipoprotein metabolic process; P:protein autoprocessing; P:liver development; P:phospholipid metabolic process; F:low-density lipoprotein particle binding; P:positive regulation of receptor internalization; C:rough endoplasmic reticulum; F:very-low-density lipoprotein particle binding; P:negative regulation of low-density lipoprotein particle clearance; F:signaling receptor inhibitor activity; P:kidney development; P:negative regulation of receptor-mediated endocytosis involved in cholesterol transport; P:positive regulation of low-density lipoprotein particle receptor catabolic process; P:positive regulation of neuron apoptotic process; F:serine-type endopeptidase activity; P:cholesterol metabolic process; C:COPII-coated ER to Golgi transport vesicle; F:apolipoprotein binding; C:Golgi apparatus; P:triglyceride metabolic process; P:cholesterol homeostasis	K13050	map04979	AQL1_THEAQ | Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2	420	9.1e-32	P:GO:0006508; P:GO:0023051; P:GO:0031323; P:GO:0044092; P:GO:0048261; P:GO:0048522; P:GO:0060255; F:GO:0005102; F:GO:0008233; C:GO:0005764; C:GO:0005768; C:GO:0005783; C:GO:0016020	P:proteolysis; P:regulation of sigling; P:regulation of cellular metabolic process; P:negative regulation of molecular function; P:negative regulation of receptor-mediated endocytosis; P:positive regulation of cellular process; P:regulation of macromolecule metabolic process; F:sigling receptor binding; F:peptidase activity; C:lysosome; C:endosome; C:endoplasmic reticulum; C:membrane	EC:3.4	Acting on peptide bonds (peptidases)	IPR000209 (PFAM); PS51892 (PROSITE_PROFILES)	P:GO:0006508; F:GO:0008236	P:proteolysis; F:serine-type peptidase activity	314.365117643556	-6.35707291417013	0.957211934631365	-6.64123866844423	3.11057874704248e-11	2.96130777876725e-09
Avas.s016.g128.i1	paralog_cluster_07347	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	219	NA					no IPS match	no IPS match	no IPS match	4951.22367026095	-2.87823625958313	0.228274910990103	-12.6086403761993	1.8922931399274e-36	1.60237391201537e-33
Avas.s016.g148.i1	homolog_cluster_13649	NA	zinc ion binding	2.2e-16	94.4	Eukaryota	NA	NA	NA	NA	NA	NA	------	664	NA					IPR000315 (PFAM); IPR017907 (PROSITE_PATTERNS); IPR001841 (PROSITE_PROFILES); IPR000315 (PROSITE_PROFILES)	F:GO:0008270	F:zinc ion binding	121.381102853785	1.90223806166338	0.318207197534526	5.97798565337913	2.25913624441362e-09	1.55996751229059e-07
Avas.s016.g150.i1	paralog_cluster_06320	NA	zinc ion binding	7.5e-21	109.4	Metazoa	NA	NA	NA	NA	NA	NA	------	750	NA					IPR017907 (PROSITE_PATTERNS); IPR001841 (PROSITE_PROFILES); IPR000315 (PROSITE_PROFILES)	F:GO:0008270	F:zinc ion binding	609.804428257802	4.81730683129408	0.598668948251934	8.04669566604422	8.50593482615148e-16	1.36851985417951e-13
Avas.s016.g155.i1	homolog_cluster_13652	NA	zinc ion binding	2.1e-15	91.3	Eukaryota	NA	NA	NA	NA	NA	NA	------	744	NA					IPR000315 (PFAM); IPR017907 (PROSITE_PATTERNS); IPR000315 (PROSITE_PROFILES); IPR001841 (PROSITE_PROFILES)	F:GO:0008270	F:zinc ion binding	661.396543847387	2.25825028898014	0.348840229612934	6.47359477857772	9.56983380100725e-11	8.41360961881998e-09
Avas.s016.g174.i1	homolog_cluster_13660	IRX5	retinal bipolar neuron differentiation	9e-19	100.9	Metazoa	EC:2.7.7.6	13	P:GO:0009954; P:GO:0009953; P:GO:0006357; P:GO:0007420; F:GO:0000981; P:GO:0008406; P:GO:0002027; P:GO:0060040; P:GO:0048701; P:GO:0042551; C:GO:0005634; C:GO:0005737; P:GO:2000112	P:regulation of heart rate; P:embryonic cranial skeleton morphogenesis; P:dorsal/ventral pattern formation; P:regulation of transcription by RNA polymerase II; P:proximal/distal pattern formation; C:cytoplasm; P:gonad development; P:retinal bipolar neuron differentiation; F:DNA-binding transcription factor activity, RNA polymerase II-specific; P:brain development; C:nucleus; P:regulation of cellular macromolecule biosynthetic process; P:neuron maturation	K03006	map00230, map00240, map01100, map03020, map05016, map05168, map05169	IRX4_HUMAN | Iroquois-class homeodomain protein IRX-4 OS=Homo sapiens OX=9606 GN=IRX4 PE=1 SV=2	255	1.2e-10	P:GO:0007346; P:GO:0007420; P:GO:0007474; P:GO:0007507; P:GO:0035310; P:GO:0039017; P:GO:0039019; P:GO:0042693; P:GO:0043009; P:GO:0045317; P:GO:0045596; P:GO:0045664; P:GO:0045892; P:GO:0045926; P:GO:0045944; P:GO:0048813; P:GO:0060993; P:GO:0072047; F:GO:0000976; F:GO:0000981; F:GO:0005515; C:GO:0005634	P:regulation of mitotic cell cycle; P:brain development; P:imagil disc-derived wing vein specification; P:heart development; P:notum cell fate specification; P:pattern specification involved in pronephros development; P:pronephric nephron development; P:muscle cell fate commitment; P:chordate embryonic development; P:equator specification; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:negative regulation of transcription, D-templated; P:negative regulation of growth; P:positive regulation of transcription by R polymerase II; P:dendrite morphogenesis; P:kidney morphogenesis; P:proximal/distal pattern formation involved in nephron development; F:transcription cis-regulatory region binding; F:D-binding transcription factor activity, R polymerase II-specific; F:protein binding; C:nucleus			IPR008422 (PFAM); IPR001356 (PROSITE_PROFILES)	P:GO:0006355; F:GO:0003677	P:regulation of transcription, D-templated; F:D binding	1129.17163220284	1.45477949005578	0.203907122381188	7.13452023189356	9.71253292425643e-13	1.10045733956593e-10
Avas.s016.g180.i1	homolog_cluster_13662	TNFAIP8	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	2.7e-20	105.5	Bilateria	NA	11	P:GO:0007435; P:GO:0043154; F:GO:0043027; P:GO:0001934; P:GO:0010506; P:GO:0043065; P:GO:0046330; C:GO:0005737; C:GO:0042995; P:GO:0070507; P:GO:0032007	P:negative regulation of TOR signaling; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; P:positive regulation of JNK cascade; C:cell projection; C:cytoplasm; P:regulation of autophagy; P:positive regulation of apoptotic process; P:regulation of microtubule cytoskeleton organization; P:salivary gland morphogenesis; P:positive regulation of protein phosphorylation	NA	NA	TFIP8_BOVIN | Tumor necrosis factor alpha-induced protein 8 OS=Bos taurus OX=9913 GN=TNFAIP8 PE=2 SV=1	189	4e-19	P:GO:0006869; P:GO:0031323; P:GO:0043065; P:GO:0043066; P:GO:0043410; P:GO:0080090; F:GO:0005515; F:GO:0043027; C:GO:0005654; C:GO:0005829	P:lipid transport; P:regulation of cellular metabolic process; P:positive regulation of apoptotic process; P:negative regulation of apoptotic process; P:positive regulation of MAPK cascade; P:regulation of primary metabolic process; F:protein binding; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; C:nucleoplasm; C:cytosol			IPR008477 (PFAM)	P:GO:0042981	P:regulation of apoptotic process	2177.01154913062	1.67731814389872	0.292570261083834	5.73304387699916	9.86441016955464e-09	6.22386255756724e-07
Avas.s016.g210.i1	paralog_cluster_05594	FRS2	optic placode formation involved in camera-type eye formation	4.2e-12	79	Bilateria	NA	38	P:GO:0055026; P:GO:0032147; P:GO:0003281; F:GO:0005168; P:GO:0008595; P:GO:0007186; F:GO:0005104; P:GO:0072089; F:GO:0019211; P:GO:0007405; P:GO:0036092; P:GO:0042981; F:GO:0046934; P:GO:0001702; F:GO:0016303; P:GO:0030900; F:GO:0005068; C:GO:0005912; P:GO:0050678; P:GO:0070307; F:GO:0005085; P:GO:0060527; P:GO:0007411; P:GO:0008543; P:GO:2000726; P:GO:0046619; F:GO:0031267; P:GO:0070372; P:GO:0043406; P:GO:0046834; P:GO:0001759; C:GO:0005887; P:GO:0051897; C:GO:0005768; P:GO:0007185; P:GO:0048011; P:GO:2000026; C:GO:0005829	F:guanyl-nucleotide exchange factor activity; P:lens fiber cell development; P:neurotrophin TRK receptor signaling pathway; F:1-phosphatidylinositol-3-kinase activity; P:positive regulation of protein kinase B signaling; C:endosome; F:fibroblast growth factor receptor binding; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; C:cytosol; F:neurotrophin TRKA receptor binding; P:stem cell proliferation; F:transmembrane receptor protein tyrosine kinase adaptor activity; C:adherens junction; P:axon guidance; P:regulation of apoptotic process; F:small GTPase binding; P:phosphatidylinositol-3-phosphate biosynthetic process; P:negative regulation of cardiac muscle tissue development; P:organ induction; P:regulation of multicellular organismal development; C:integral component of plasma membrane; P:forebrain development; P:neuroblast proliferation; P:ventricular septum development; P:regulation of ERK1 and ERK2 cascade; P:fibroblast growth factor receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; P:lipid phosphorylation; P:negative regulation of cardiac muscle cell differentiation; F:phosphatase activator activity; P:anterior/posterior axis specification, embryo; P:positive regulation of MAP kinase activity; P:activation of protein kinase activity; P:lens placode formation involved in camera-type eye formation; P:gastrulation with mouth forming second; P:regulation of epithelial cell proliferation; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	K12461	map04714, map04722, map05205	DOK1_MOUSE | Docking protein 1 OS=Mus musculus OX=10090 GN=Dok1 PE=1 SV=2	295	8.2e-11	P:GO:0007169; P:GO:0007265; F:GO:0005515; C:GO:0005634; C:GO:0005829	P:transmembrane receptor protein tyrosine kise sigling pathway; P:Ras protein sigl transduction; F:protein binding; C:nucleus; C:cytosol			IPR002404 (PFAM); IPR002404 (PROSITE_PROFILES)	no GO terms	no GO terms	2924.98881764829	3.21608570147913	0.52559643300674	6.1189260419465	9.42081126272294e-10	6.85843585547282e-08
Avas.s016.g230.i1	paralog_cluster_00294	MYL9	Myosin regulatory light polypeptide 9	6e-67	260.4	Rodentia	NA	4	C:GO:0001725; C:GO:0016460; C:GO:0030018; F:GO:0032036	C:Z disc; C:stress fiber; F:myosin heavy chain binding; C:myosin II complex	K12755	map04022, map04024, map04270, map04510, map04530, map04670, map04810, map04921	MYL9_HUMAN | Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4	171	3.2e-68	P:GO:0006937; P:GO:0008360; P:GO:0030239; F:GO:0000146; F:GO:0005509; F:GO:0008307; F:GO:0032036; F:GO:0045159; F:GO:0051015; C:GO:0001725; C:GO:0005829; C:GO:0005859; C:GO:0005903; C:GO:0005938; C:GO:0030018; C:GO:0045177; C:GO:0097513	P:regulation of muscle contraction; P:regulation of cell shape; P:myofibril assembly; F:microfilament motor activity; F:calcium ion binding; F:structural constituent of muscle; F:myosin heavy chain binding; F:myosin II binding; F:actin filament binding; C:stress fiber; C:cytosol; C:muscle myosin complex; C:brush border; C:cell cortex; C:Z disc; C:apical part of cell; C:myosin II filament	EC:5.6.1.8	Myosin ATPase	IPR002048 (PFAM); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES)	F:GO:0005509	F:calcium ion binding	1269.63509526155	1.6819705463861	0.298552370680562	5.63375377844757	1.76328723481024e-08	1.0585644895844e-06
Avas.s016.g295.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	30	NA					no IPS match	no IPS match	no IPS match	200.739343660243	1.79068451561474	0.334473349608295	5.35374348273734	8.61529723321172e-08	4.48580961764218e-06
Avas.s016.g296.i1	homolog_cluster_18734	sell	AhpC/TSA antioxidant enzyme	2.1e-13	82	Actinopterygii	NA	NA	NA	NA	NA	NA	------	121	NA					no IPS match	no IPS match	no IPS match	238.272526387299	1.77372606447252	0.347236083900213	5.10812714090578	3.25367698067184e-07	1.50426462477096e-05
Avas.s016.g336.i1	paralog_cluster_01240	NA	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity	2.1e-121	442.2	Metazoa	NA	NA	NA	NA	NA	NA	TALDO_RAT | Transaldolase OS=Rattus norvegicus OX=10116 GN=Taldo1 PE=1 SV=2	325	1.8e-120	P:GO:0005975; P:GO:0006002; P:GO:0009052; P:GO:0019682; F:GO:0004801; F:GO:0005515; F:GO:0048029; C:GO:0005829; C:GO:0043231	P:carbohydrate metabolic process; P:fructose 6-phosphate metabolic process; P:pentose-phosphate shunt, non-oxidative branch; P:glyceraldehyde-3-phosphate metabolic process; F:transaldolase activity; F:protein binding; F:monosaccharide binding; C:cytosol; C:intracellular membrane-bounded organelle	EC:2.2.1.2	Transaldolase	IPR001585 (PFAM); IPR018225 (PROSITE_PATTERNS)	P:GO:0005975	P:carbohydrate metabolic process	1452.75077216455	-1.18611070398649	0.234655732001202	-5.05468455371216	4.31102707891607e-07	1.93743337074527e-05
Avas.s016.g344.i1	paralog_cluster_07351	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	321	NA					no IPS match	no IPS match	no IPS match	82.5082210122289	2.14454348669976	0.433871955840151	4.94280272747073	7.70073961372891e-07	3.32164074116044e-05
Avas.s016.g373.i1	paralog_cluster_06258	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	219	NA					no IPS match	no IPS match	no IPS match	1748.48519126968	2.65189757345955	0.254199051108129	10.4323661394452	1.7643900112733e-25	5.39193303723144e-23
Avas.s016.g376.i1	paralog_cluster_00744	NA	Belongs to the short-chain dehydrogenases reductases (SDR) family	2e-61	242.7	Actinopterygii	NA	NA	NA	NA	NA	NA	DHR11_CHICK | Dehydrogese/reductase SDR family member 11 OS=Gallus gallus OX=9031 GN=DHRS11 PE=2 SV=1	269	3e-60	P:GO:0006694; P:GO:0006718; P:GO:0044281; F:GO:0000253; F:GO:0005515; F:GO:0047886; F:GO:0072555; F:GO:0072582; C:GO:0110165	P:steroid biosynthetic process; P:juvenile hormone biosynthetic process; P:small molecule metabolic process; F:3-keto sterol reductase activity; F:protein binding; F:farnesol dehydrogese activity; F:17-beta-ketosteroid reductase activity; F:17-beta-hydroxysteroid dehydrogese (DP+) activity; C:cellular atomical entity	EC:1.1.1.216; EC:1.1.1.62; EC:1.1.1.270	Farnesol dehydrogese; 17-beta-estradiol 17-dehydrogese; 3-beta-hydroxysteroid 3-dehydrogese	IPR002347 (PFAM)	F:GO:0016491	F:oxidoreductase activity	110.534270117816	1.77254353630241	0.306015321949713	5.79233590334308	6.94141358341975e-09	4.48515675275664e-07
Avas.s017.g11.i1	homolog_cluster_13731	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	965	NA					no IPS match	no IPS match	no IPS match	1730.88209915988	1.17226425544399	0.221388102019814	5.29506439031251	1.18974480655264e-07	6.03842403552854e-06
Avas.s018.g48.i1	paralog_cluster_01796	HAAO	Catalyzes the oxidative ring opening of 3- hydroxyanthranilate to 2-amino-3-carboxymuconate semialdehyde, which spontaneously cyclizes to quinolinate	1.7e-77	296.2	Actinopterygii	EC:1.13.11.6	15	P:GO:0009435; F:GO:0000334; C:GO:0031966; P:GO:0006805; P:GO:0006569; P:GO:0070050; F:GO:0019825; P:GO:0022900; P:GO:0046686; P:GO:0019674; P:GO:0019805; P:GO:0010043; F:GO:0008198; F:GO:0009055; C:GO:0005829	P:response to cadmium ion; F:ferrous iron binding; F:oxygen binding; P:tryptophan catabolic process; P:quinolinate biosynthetic process; F:3-hydroxyanthranilate 3,4-dioxygenase activity; P:neuron cellular homeostasis; C:mitochondrial membrane; P:NAD biosynthetic process; P:NAD metabolic process; C:cytosol; F:electron transfer activity; P:response to zinc ion; P:xenobiotic metabolic process; P:electron transport chain	K00452	map00380, map01100	3HAO_RAT | 3-hydroxyanthranilate 3,4-dioxygese OS=Rattus norvegicus OX=10116 GN=Haao PE=1 SV=2	296	2.7e-70	P:GO:0006568; P:GO:0009435; P:GO:0010043; P:GO:0019805; P:GO:0046686; P:GO:0070050; F:GO:0000334; F:GO:0005515; F:GO:0008198; F:GO:0019825; C:GO:0005829; C:GO:0031966	P:tryptophan metabolic process; P:D biosynthetic process; P:response to zinc ion; P:quinolite biosynthetic process; P:response to cadmium ion; P:neuron cellular homeostasis; F:3-hydroxyanthranilate 3,4-dioxygese activity; F:protein binding; F:ferrous iron binding; F:oxygen binding; C:cytosol; C:mitochondrial membrane	EC:1.13.11.6	3-hydroxyanthranilate 3,4-dioxygese	IPR010329 (PFAM)	F:GO:0000334; F:GO:0005506	F:3-hydroxyanthranilate 3,4-dioxygese activity; F:iron ion binding	286.95086668136	-1.83759952506022	0.322203779674044	-5.70322150447526	1.17564047662898e-08	7.21941970552813e-07
Avas.s018.g72.i1	homolog_cluster_13792	NA	Mannose-6-phosphate receptor	4.7e-15	88.6	Bilateria	NA	NA	NA	NA	NA	NA	------	259	NA					IPR018939 (PFAM)	no GO terms	no GO terms	398.064043578521	3.50856320696762	0.360084631021456	9.74371829482097	1.96239519081065e-22	4.857380957685e-20
Avas.s018.g100.i1	paralog_cluster_07232	GAL3ST3	galactosylceramide sulfotransferase activity	1.7e-23	117.5	Vertebrata	NA	10	C:GO:0016021; F:GO:0050694; P:GO:0030166; F:GO:0030246; P:GO:0009311; F:GO:0050698; P:GO:0006790; F:GO:0050656; P:GO:0030309; P:GO:0005996	P:oligosaccharide metabolic process; P:proteoglycan biosynthetic process; F:3'-phosphoadenosine 5'-phosphosulfate binding; F:carbohydrate binding; P:sulfur compound metabolic process; F:galactose 3-O-sulfotransferase activity; C:integral component of membrane; P:monosaccharide metabolic process; P:poly-N-acetyllactosamine metabolic process; F:proteoglycan sulfotransferase activity	K09676	NA	G3ST1_HUMAN | Galactosylceramide sulfotransferase OS=Homo sapiens OX=9606 GN=GAL3ST1 PE=1 SV=1	472	2.1e-16	P:GO:0006643; P:GO:0009101; F:GO:0008146; C:GO:0016020	P:membrane lipid metabolic process; P:glycoprotein biosynthetic process; F:sulfotransferase activity; C:membrane	EC:2.8.2	Transferring sulfur-containing groups	IPR009729 (PFAM)	P:GO:0009247; F:GO:0001733; C:GO:0016021	P:glycolipid biosynthetic process; F:galactosylceramide sulfotransferase activity; C:integral component of membrane	44.7773554976636	4.00351531540585	0.585452868850517	6.83832214071541	8.01260608098162e-12	8.05717620230708e-10
Avas.s018.g141.i1	homolog_cluster_13825	NA	von Willebrand factor type C domain	7.2e-44	185.7	Rhabditida	NA	1	F:GO:0005515	F:protein binding	NA	NA	KCP_XENLA | Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1	664	7e-18	P:GO:0010951; P:GO:0043086; F:GO:0004857; F:GO:0004867; F:GO:0005520; C:GO:0005576; C:GO:0016020; C:GO:0016021	P:negative regulation of endopeptidase activity; P:negative regulation of catalytic activity; F:enzyme inhibitor activity; F:serine-type endopeptidase inhibitor activity; F:insulin-like growth factor binding; C:extracellular region; C:membrane; C:integral component of membrane			IPR001007 (PFAM); IPR000867 (PFAM); IPR001007 (PROSITE_PATTERNS); IPR001007 (PROSITE_PATTERNS); IPR001007 (PROSITE_PROFILES); IPR000867 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES)	F:GO:0005515; C:GO:0005576	F:protein binding; C:extracellular region	334.015573642734	2.09429685924753	0.185203707261884	11.3080720154598	1.19690635936655e-29	5.20460173401308e-27
Avas.s018.g145.i1	NA	NA	protein tyrosine phosphatase activity	3.6e-175	625.2	Metazoa	NA	NA	NA	NA	NA	NA	PTPRF_DANRE | Receptor-type tyrosine-protein phosphatase F OS=Danio rerio OX=7955 GN=ptprf PE=2 SV=1	6726	5.9e-165	P:GO:0006796; P:GO:0007155; P:GO:0007420; P:GO:0009968; P:GO:0010977; P:GO:0048522; P:GO:0050807; P:GO:0051093; P:GO:0051241; P:GO:0051960; F:GO:0005515; F:GO:0016791; F:GO:0097367; F:GO:1901681; C:GO:0005886; C:GO:0016021; C:GO:0031410; C:GO:0042995; C:GO:0045202	P:phosphate-containing compound metabolic process; P:cell adhesion; P:brain development; P:negative regulation of sigl transduction; P:negative regulation of neuron projection development; P:positive regulation of cellular process; P:regulation of sypse organization; P:negative regulation of developmental process; P:negative regulation of multicellular organismal process; P:regulation of nervous system development; F:protein binding; F:phosphatase activity; F:carbohydrate derivative binding; F:sulfur compound binding; C:plasma membrane; C:integral component of membrane; C:cytoplasmic vesicle; C:cell projection; C:sypse	EC:3.1.3	Acting on ester bonds	IPR000242 (PFAM); IPR003961 (PFAM); IPR016130 (PROSITE_PATTERNS); IPR016130 (PROSITE_PATTERNS); IPR016130 (PROSITE_PATTERNS); IPR016130 (PROSITE_PATTERNS); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR000387 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES)	P:GO:0006470; P:GO:0016311; F:GO:0004725; F:GO:0005515; F:GO:0016791	P:protein dephosphorylation; P:dephosphorylation; F:protein tyrosine phosphatase activity; F:protein binding; F:phosphatase activity	91.5117576703591	-2.61709328150717	0.43831986279614	-5.97073850318382	2.36182037658538e-09	1.62390290764454e-07
Avas.s018.g146.i1	paralog_cluster_03557	PAK2	kinase 2	1.3e-45	190.3	Cetartiodactyla	EC:2.7.11.1	NA	NA	NA	K04410	map04010, map04012, map04014, map04360, map04510, map04660, map04810, map05211	PAK2_HUMAN | Serine/threonine-protein kinase PAK 2 OS=Homo sapiens OX=9606 GN=PAK2 PE=1 SV=3	303	7.3e-47	P:GO:0003300; P:GO:0007406; P:GO:0007409; P:GO:0010763; P:GO:0018105; P:GO:0030833; P:GO:0034333; P:GO:0043525; P:GO:0045666; P:GO:0046777; P:GO:0050731; P:GO:0051497; P:GO:0051726; P:GO:0061003; P:GO:0070830; P:GO:0071407; P:GO:0071560; P:GO:0071570; P:GO:0090017; P:GO:0150105; P:GO:2000573; P:GO:2001238; P:GO:2001271; F:GO:0004674; F:GO:0004708; F:GO:0019901; F:GO:0030296; F:GO:0031267; F:GO:0042802; C:GO:0005768; C:GO:0005829; C:GO:0005911; C:GO:0014069; C:GO:0030141; C:GO:0098978	P:cardiac muscle hypertrophy; P:negative regulation of neuroblast proliferation; P:axonogenesis; P:positive regulation of fibroblast migration; P:peptidyl-serine phosphorylation; P:regulation of actin filament polymerization; P:adherens junction assembly; P:positive regulation of neuron apoptotic process; P:positive regulation of neuron differentiation; P:protein autophosphorylation; P:positive regulation of peptidyl-tyrosine phosphorylation; P:negative regulation of stress fiber assembly; P:regulation of cell cycle; P:positive regulation of dendritic spine morphogenesis; P:bicellular tight junction assembly; P:cellular response to organic cyclic compound; P:cellular response to transforming growth factor beta stimulus; P:cement gland development; P:anterior neural plate formation; P:protein localization to cell-cell junction; P:positive regulation of D biosynthetic process; P:positive regulation of extrinsic apoptotic sigling pathway; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; F:protein serine/threonine kise activity; F:MAP kise kise activity; F:protein kise binding; F:protein tyrosine kise activator activity; F:small GTPase binding; F:identical protein binding; C:endosome; C:cytosol; C:cell-cell junction; C:postsyptic density; C:secretory granule; C:glutamatergic sypse	EC:2.7.12.1; EC:2.7.12.2	Dual-specificity kise; Mitogen-activated protein kise kise	IPR000719 (PFAM); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	4546.69525720544	2.62716124680263	0.423136753479944	6.20877582766431	5.33989314000572e-10	4.13045868892077e-08
Avas.s018.g155.i1	paralog_cluster_08971	NA	Tyrosine kinase, catalytic domain	9.3e-80	304.7	Metazoa	NA	NA	NA	NA	NA	NA	EPHA2_MOUSE | Ephrin type-A receptor 2 OS=Mus musculus OX=10090 GN=Epha2 PE=1 SV=3	575	4.9e-52	P:GO:0001501; P:GO:0001570; P:GO:0001649; P:GO:0001756; P:GO:0001771; P:GO:0002043; P:GO:0003197; P:GO:0006954; P:GO:0010717; P:GO:0010976; P:GO:0010977; P:GO:0014028; P:GO:0014719; P:GO:0016525; P:GO:0018108; P:GO:0021631; P:GO:0021915; P:GO:0021934; P:GO:0021952; P:GO:0030010; P:GO:0030316; P:GO:0031290; P:GO:0032682; P:GO:0032956; P:GO:0033598; P:GO:0036342; P:GO:0043087; P:GO:0043535; P:GO:0045806; P:GO:0046328; P:GO:0046777; P:GO:0046849; P:GO:0048013; P:GO:0048320; P:GO:0050804; P:GO:0050830; P:GO:0050965; P:GO:0051893; P:GO:0051965; P:GO:0060035; P:GO:0060326; P:GO:0060444; P:GO:0060997; P:GO:0061351; P:GO:0070121; P:GO:0070309; P:GO:0070372; P:GO:0070507; P:GO:0071300; P:GO:0071372; P:GO:0097155; P:GO:0097156; P:GO:0099560; P:GO:1901214; P:GO:1901491; P:GO:1902723; P:GO:1902725; P:GO:1903078; P:GO:1904238; F:GO:0005004; F:GO:0005005; F:GO:0008046; F:GO:0019838; F:GO:0044877; C:GO:0005576; C:GO:0005654; C:GO:0005783; C:GO:0005829; C:GO:0005887; C:GO:0009986; C:GO:0015629; C:GO:0030424; C:GO:0031256; C:GO:0031901; C:GO:0031965; C:GO:0032433; C:GO:0045121; C:GO:0098793; C:GO:0098978; C:GO:0098982	P:skeletal system development; P:vasculogenesis; P:osteoblast differentiation; P:somitogenesis; P:immunological sypse formation; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; P:endocardial cushion development; P:inflammatory response; P:regulation of epithelial to mesenchymal transition; P:positive regulation of neuron projection development; P:negative regulation of neuron projection development; P:notochord formation; P:skeletal muscle satellite cell activation; P:negative regulation of angiogenesis; P:peptidyl-tyrosine phosphorylation; P:optic nerve morphogenesis; P:neural tube development; P:hindbrain tangential cell migration; P:central nervous system projection neuron axonogenesis; P:establishment of cell polarity; P:osteoclast differentiation; P:retil ganglion cell axon guidance; P:negative regulation of chemokine production; P:regulation of actin cytoskeleton organization; P:mammary gland epithelial cell proliferation; P:post-al tail morphogenesis; P:regulation of GTPase activity; P:regulation of blood vessel endothelial cell migration; P:negative regulation of endocytosis; P:regulation of JNK cascade; P:protein autophosphorylation; P:bone remodeling; P:ephrin receptor sigling pathway; P:axial mesoderm formation; P:modulation of chemical syptic transmission; P:defense response to Gram-positive bacterium; P:detection of temperature stimulus involved in sensory perception of pain; P:regulation of focal adhesion assembly; P:positive regulation of sypse assembly; P:notochord cell development; P:cell chemotaxis; P:branching involved in mammary gland duct morphogenesis; P:dendritic spine morphogenesis; P:neural precursor cell proliferation; P:Kupffer's vesicle development; P:lens fiber cell morphogenesis; P:regulation of ERK1 and ERK2 cascade; P:regulation of microtubule cytoskeleton organization; P:cellular response to retinoic acid; P:cellular response to follicle-stimulating hormone stimulus; P:fasciculation of sensory neuron axon; P:fasciculation of motor neuron axon; P:syptic membrane adhesion; P:regulation of neuron death; P:negative regulation of lymphangiogenesis; P:negative regulation of skeletal muscle satellite cell proliferation; P:negative regulation of satellite cell differentiation; P:positive regulation of protein localization to plasma membrane; P:pericyte cell differentiation; F:GPI-linked ephrin receptor activity; F:transmembrane-ephrin receptor activity; F:axon guidance receptor activity; F:growth factor binding; F:protein-containing complex binding; C:extracellular region; C:nucleoplasm; C:endoplasmic reticulum; C:cytosol; C:integral component of plasma membrane; C:cell surface; C:actin cytoskeleton; C:axon; C:leading edge membrane; C:early endosome membrane; C:nuclear membrane; C:filopodium tip; C:membrane raft; C:presypse; C:glutamatergic sypse; C:GABA-ergic sypse	EC:2.7.10.1	Receptor protein-tyrosine kise	IPR001245 (PFAM); IPR017441 (PROSITE_PATTERNS); IPR008266 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	124.613845552945	2.11702815870754	0.316714349092811	6.68434557755751	2.3195884907358e-11	2.23472210942804e-09
Avas.s019.g65.i1	paralog_cluster_00049	NA	Ras-related C3 botulinum toxin substrate	8.6e-55	220.3	Metazoa	NA	NA	NA	NA	NA	NA	RAC1_DROME | Ras-related protein Rac1 OS=Drosophila melanogaster OX=7227 GN=Rac1 PE=1 SV=2	216	4e-55	P:GO:0001764; P:GO:0001934; P:GO:0002093; P:GO:0002433; P:GO:0002551; P:GO:0003376; P:GO:0003382; P:GO:0006954; P:GO:0006972; P:GO:0007390; P:GO:0007394; P:GO:0007422; P:GO:0007426; P:GO:0007516; P:GO:0007520; P:GO:0007613; P:GO:0008045; P:GO:0008283; P:GO:0008361; P:GO:0009611; P:GO:0010310; P:GO:0010592; P:GO:0010595; P:GO:0010764; P:GO:0014041; P:GO:0016601; P:GO:0019953; P:GO:0021799; P:GO:0021831; P:GO:0021894; P:GO:0030838; P:GO:0030865; P:GO:0031116; P:GO:0031152; P:GO:0032707; P:GO:0033630; P:GO:0035011; P:GO:0035025; P:GO:0035320; P:GO:0035774; P:GO:0043326; P:GO:0043552; P:GO:0043652; P:GO:0045216; P:GO:0045428; P:GO:0045453; P:GO:0045740; P:GO:0046425; P:GO:0048012; P:GO:0048168; P:GO:0048261; P:GO:0048532; P:GO:0048813; P:GO:0048873; P:GO:0050770; P:GO:0050829; P:GO:0050885; P:GO:0051496; P:GO:0051894; P:GO:0051932; P:GO:0060071; P:GO:0060263; P:GO:0060999; P:GO:0061344; P:GO:0071260; P:GO:0071526; P:GO:0071907; P:GO:0072659; P:GO:0090023; P:GO:0090103; P:GO:0097178; P:GO:1900026; P:GO:1902412; P:GO:1902669; P:GO:1904059; P:GO:1904948; P:GO:2000114; P:GO:2000386; F:GO:0003924; F:GO:0005525; F:GO:0019901; F:GO:0030742; F:GO:0031267; F:GO:0031996; F:GO:0042826; F:GO:0044877; F:GO:0048306; F:GO:0051022; F:GO:0051117; C:GO:0000139; C:GO:0000242; C:GO:0001891; C:GO:0005634; C:GO:0005789; C:GO:0005802; C:GO:0005829; C:GO:0005938; C:GO:0030027; C:GO:0030426; C:GO:0031143; C:GO:0031234; C:GO:0031901; C:GO:0031941; C:GO:0032587; C:GO:0036464; C:GO:0043025; C:GO:0043197; C:GO:0048471; C:GO:0055038; C:GO:0060091; C:GO:0098978; C:GO:0101003	P:neuron migration; P:positive regulation of protein phosphorylation; P:auditory receptor cell morphogenesis; P:immune response-regulating cell surface receptor sigling pathway involved in phagocytosis; P:mast cell chemotaxis; P:sphingosine-1-phosphate receptor sigling pathway; P:epithelial cell morphogenesis; P:inflammatory response; P:hyperosmotic response; P:germ-band shortening; P:dorsal closure, elongation of leading edge cells; P:peripheral nervous system development; P:tracheal outgrowth, open tracheal system; P:hemocyte development; P:myoblast fusion; P:memory; P:motor neuron axon guidance; P:cell population proliferation; P:regulation of cell size; P:response to wounding; P:regulation of hydrogen peroxide metabolic process; P:positive regulation of lamellipodium assembly; P:positive regulation of endothelial cell migration; P:negative regulation of fibroblast migration; P:regulation of neuron maturation; P:Rac protein sigl transduction; P:sexual reproduction; P:cerebral cortex radially oriented cell migration; P:embryonic olfactory bulb interneuron precursor migration; P:cerebral cortex GABAergic interneuron development; P:positive regulation of actin filament polymerization; P:cortical cytoskeleton organization; P:positive regulation of microtubule polymerization; P:aggregation involved in sorocarp development; P:negative regulation of interleukin-23 production; P:positive regulation of cell adhesion mediated by integrin; P:melanotic encapsulation of foreign target; P:positive regulation of Rho protein sigl transduction; P:imagil disc-derived wing hair site selection; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:chemotaxis to folate; P:positive regulation of phosphatidylinositol 3-kise activity; P:engulfment of apoptotic cell; P:cell-cell junction organization; P:regulation of nitric oxide biosynthetic process; P:bone resorption; P:positive regulation of D replication; P:regulation of receptor sigling pathway via JAK-STAT; P:hepatocyte growth factor receptor sigling pathway; P:regulation of neurol syptic plasticity; P:negative regulation of receptor-mediated endocytosis; P:atomical structure arrangement; P:dendrite morphogenesis; P:homeostasis of number of cells within a tissue; P:regulation of axonogenesis; P:defense response to Gram-negative bacterium; P:neuromuscular process controlling balance; P:positive regulation of stress fiber assembly; P:positive regulation of focal adhesion assembly; P:syptic transmission, GABAergic; P:Wnt sigling pathway, plar cell polarity pathway; P:regulation of respiratory burst; P:positive regulation of dendritic spine development; P:regulation of cell adhesion involved in heart morphogenesis; P:cellular response to mechanical stimulus; P:semaphorin-plexin sigling pathway; P:determition of digestive tract left/right asymmetry; P:protein localization to plasma membrane; P:positive regulation of neutrophil chemotaxis; P:cochlea morphogenesis; P:ruffle assembly; P:positive regulation of substrate adhesion-dependent cell spreading; P:regulation of mitotic cytokinesis; P:positive regulation of axon guidance; P:regulation of locomotor rhythm; P:midbrain dopaminergic neuron differentiation; P:regulation of establishment of cell polarity; P:positive regulation of ovarian follicle development; F:GTPase activity; F:GTP binding; F:protein kise binding; F:GTP-dependent protein binding; F:small GTPase binding; F:thioesterase binding; F:histone deacetylase binding; F:protein-containing complex binding; F:calcium-dependent protein binding; F:Rho GDP-dissociation inhibitor binding; F:ATPase binding; C:Golgi membrane; C:pericentriolar material; C:phagocytic cup; C:nucleus; C:endoplasmic reticulum membrane; C:trans-Golgi network; C:cytosol; C:cell cortex; C:lamellipodium; C:growth cone; C:pseudopodium; C:extrinsic component of cytoplasmic side of plasma membrane; C:early endosome membrane; C:filamentous actin; C:ruffle membrane; C:cytoplasmic ribonucleoprotein granule; C:neurol cell body; C:dendritic spine; C:perinuclear region of cytoplasm; C:recycling endosome membrane; C:kinocilium; C:glutamatergic sypse; C:ficolin-1-rich granule membrane	EC:3.6.1	Acting on acid anhydrides	IPR001806 (PFAM); PS51420 (PROSITE_PROFILES); PS51419 (PROSITE_PROFILES); IPR001806 (PROSITE_PROFILES)	F:GO:0003924; F:GO:0005525	F:GTPase activity; F:GTP binding	53.7419698469867	5.58367448495809	0.698034753384762	7.99913536952554	1.25295909468874e-15	1.95717076450942e-13
Avas.s019.g94.i1	homolog_cluster_13859	Msx3	Homeodomain	4.8e-24	118.6	Rodentia	NA	7	C:GO:0005634; P:GO:2001251; P:GO:0010629; P:GO:0035067; P:GO:1905268; P:GO:0000122; P:GO:2000113	P:negative regulation of gene expression; P:negative regulation of chromosome organization; P:negative regulation of histone acetylation; P:negative regulation of transcription by RNA polymerase II; C:nucleus; P:negative regulation of chromatin organization; P:negative regulation of cellular macromolecule biosynthetic process	K09341	map05166	MSX3_MOUSE | Homeobox protein MSX-3 OS=Mus musculus OX=10090 GN=Msx3 PE=1 SV=1	290	5.7e-25	P:GO:0000122; P:GO:0002063; P:GO:0002076; P:GO:0003148; P:GO:0003198; P:GO:0003416; P:GO:0008285; P:GO:0009952; P:GO:0023019; P:GO:0030513; P:GO:0032792; P:GO:0035067; P:GO:0035115; P:GO:0035116; P:GO:0035313; P:GO:0035880; P:GO:0043066; P:GO:0045599; P:GO:0045617; P:GO:0045669; P:GO:0048863; P:GO:0051795; P:GO:0060346; P:GO:0060364; P:GO:0060444; P:GO:0061312; P:GO:0070166; P:GO:0071392; P:GO:0090427; P:GO:2000678; P:GO:2001055; F:GO:0000978; F:GO:0001227; F:GO:0005515; C:GO:0005829; C:GO:0016607	P:negative regulation of transcription by R polymerase II; P:chondrocyte development; P:osteoblast development; P:outflow tract septum morphogenesis; P:epithelial to mesenchymal transition involved in endocardial cushion formation; P:endochondral bone growth; P:negative regulation of cell population proliferation; P:anterior/posterior pattern specification; P:sigl transduction involved in regulation of gene expression; P:positive regulation of BMP sigling pathway; P:negative regulation of CREB transcription factor activity; P:negative regulation of histone acetylation; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:wound healing, spreading of epidermal cells; P:embryonic il plate morphogenesis; P:negative regulation of apoptotic process; P:negative regulation of fat cell differentiation; P:negative regulation of keratinocyte differentiation; P:positive regulation of osteoblast differentiation; P:stem cell differentiation; P:positive regulation of timing of catagen; P:bone trabecula formation; P:frontal suture morphogenesis; P:branching involved in mammary gland duct morphogenesis; P:BMP sigling pathway involved in heart development; P:emel mineralization; P:cellular response to estradiol stimulus; P:activation of meiosis; P:negative regulation of transcription regulatory region D binding; P:positive regulation of mesenchymal cell apoptotic process; F:R polymerase II cis-regulatory region sequence-specific D binding; F:D-binding transcription repressor activity, R polymerase II-specific; F:protein binding; C:cytosol; C:nuclear speck			IPR001356 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES)	P:GO:0006355; F:GO:0000981; F:GO:0003677	P:regulation of transcription, D-templated; F:D-binding transcription factor activity, R polymerase II-specific; F:D binding	385.758271606773	3.3963610610066	0.346374908471944	9.80544773289116	1.06672872049521e-22	2.72422196572182e-20
Avas.s019.g109.i1	homolog_cluster_13865	EPB41L4A	Erythrocyte membrane protein band 4.1 like 4A	3.2e-57	230.7	Metatheria	NA	3	P:GO:0031032; C:GO:0005856; F:GO:0005200	C:cytoskeleton; F:structural constituent of cytoskeleton; P:actomyosin structure organization	NA	NA	E41LA_HUMAN | Band 4.1-like protein 4A OS=Homo sapiens OX=9606 GN=EPB41L4A PE=1 SV=2	1087	2.3e-58	P:GO:0010628; P:GO:0031032; P:GO:0031175; P:GO:0032989; P:GO:0034613; P:GO:0042060; P:GO:0042552; P:GO:0045216; P:GO:0045785; P:GO:0051549; P:GO:0099612; F:GO:0005198; F:GO:0008092; C:GO:0005634; C:GO:0005829; C:GO:0005856; C:GO:0005911; C:GO:0005938; C:GO:0044304; C:GO:0045177; C:GO:0098590	P:positive regulation of gene expression; P:actomyosin structure organization; P:neuron projection development; P:cellular component morphogenesis; P:cellular protein localization; P:wound healing; P:myelition; P:cell-cell junction organization; P:positive regulation of cell adhesion; P:positive regulation of keratinocyte migration; P:protein localization to axon; F:structural molecule activity; F:cytoskeletal protein binding; C:nucleus; C:cytosol; C:cytoskeleton; C:cell-cell junction; C:cell cortex; C:main axon; C:apical part of cell; C:plasma membrane region			IPR019748 (PFAM); IPR018980 (PFAM); IPR018979 (PFAM); IPR000299 (PROSITE_PROFILES)	C:GO:0005856	C:cytoskeleton	155.636397848835	1.36433642505931	0.266402729152186	5.1213305111447	3.0338735424346e-07	1.4230901289863e-05
Avas.s019.g115.i1	homolog_cluster_13866	NA	positive regulation of glomerular metanephric mesangial cell proliferation	1.1e-10	75.1	Chordata	NA	NA	NA	NA	K09203	map04371, map04933, map05020, map05166	EGR2_MOUSE | E3 SUMO-protein ligase EGR2 OS=Mus musculus OX=10090 GN=Egr2 PE=1 SV=3	525	7.4e-39	P:GO:0000122; P:GO:0001975; P:GO:0002931; P:GO:0006611; P:GO:0007616; P:GO:0008045; P:GO:0009749; P:GO:0014040; P:GO:0014911; P:GO:0021575; P:GO:0021612; P:GO:0021654; P:GO:0021659; P:GO:0021660; P:GO:0021665; P:GO:0021666; P:GO:0030217; P:GO:0030278; P:GO:0030509; P:GO:0031643; P:GO:0031667; P:GO:0032722; P:GO:0032731; P:GO:0032869; P:GO:0032922; P:GO:0033233; P:GO:0034465; P:GO:0035284; P:GO:0035904; P:GO:0035914; P:GO:0042060; P:GO:0042220; P:GO:0043525; P:GO:0044849; P:GO:0045444; P:GO:0045471; P:GO:0045475; P:GO:0045944; P:GO:0046886; P:GO:0048169; P:GO:0048661; P:GO:0048703; P:GO:0048709; P:GO:0048932; P:GO:0051602; P:GO:0060059; P:GO:0060086; P:GO:0060291; P:GO:0061418; P:GO:0070498; P:GO:0071236; P:GO:0071260; P:GO:0071317; P:GO:0071320; P:GO:0071372; P:GO:0071383; P:GO:0071455; P:GO:0071466; P:GO:0071480; P:GO:0071504; P:GO:0071506; P:GO:0071873; P:GO:0072303; P:GO:0090090; P:GO:0098759; P:GO:1902895; P:GO:1902949; P:GO:2000182; F:GO:0000978; F:GO:0000979; F:GO:0001228; F:GO:0008270; F:GO:0010385; F:GO:0031625; F:GO:0035035; F:GO:0044729; F:GO:0061629; F:GO:0061665; F:GO:0071837; F:GO:1990841; C:GO:0000785; C:GO:0005654; C:GO:0005737	P:negative regulation of transcription by R polymerase II; P:response to amphetamine; P:response to ischemia; P:protein export from nucleus; P:long-term memory; P:motor neuron axon guidance; P:response to glucose; P:positive regulation of Schwann cell differentiation; P:positive regulation of smooth muscle cell migration; P:hindbrain morphogenesis; P:facial nerve structural organization; P:rhombomere boundary formation; P:rhombomere 3 structural organization; P:rhombomere 3 formation; P:rhombomere 5 structural organization; P:rhombomere 5 formation; P:T cell differentiation; P:regulation of ossification; P:BMP sigling pathway; P:positive regulation of myelition; P:response to nutrient levels; P:positive regulation of chemokine production; P:positive regulation of interleukin-1 beta production; P:cellular response to insulin stimulus; P:circadian regulation of gene expression; P:regulation of protein sumoylation; P:response to carbon monoxide; P:brain segmentation; P:aorta development; P:skeletal muscle cell differentiation; P:wound healing; P:response to cocaine; P:positive regulation of neuron apoptotic process; P:estrous cycle; P:fat cell differentiation; P:response to ethanol; P:locomotor rhythm; P:positive regulation of transcription by R polymerase II; P:positive regulation of hormone biosynthetic process; P:regulation of long-term neurol syptic plasticity; P:positive regulation of smooth muscle cell proliferation; P:embryonic viscerocranium morphogenesis; P:oligodendrocyte differentiation; P:myelition of posterior lateral line nerve axons; P:response to electrical stimulus; P:embryonic reti morphogenesis in camera-type eye; P:circadian temperature homeostasis; P:long-term syptic potentiation; P:regulation of transcription from R polymerase II promoter in response to hypoxia; P:interleukin-1-mediated sigling pathway; P:cellular response to antibiotic; P:cellular response to mechanical stimulus; P:cellular response to isoquinoline alkaloid; P:cellular response to cAMP; P:cellular response to follicle-stimulating hormone stimulus; P:cellular response to steroid hormone stimulus; P:cellular response to hyperoxia; P:cellular response to xenobiotic stimulus; P:cellular response to gamma radiation; P:cellular response to heparin; P:cellular response to mycophenolic acid; P:response to norepinephrine; P:positive regulation of glomerular metanephric mesangial cell proliferation; P:negative regulation of canonical Wnt sigling pathway; P:cellular response to interleukin-8; P:positive regulation of miR transcription; P:positive regulation of tau-protein kise activity; P:regulation of progesterone biosynthetic process; F:R polymerase II cis-regulatory region sequence-specific D binding; F:R polymerase II core promoter sequence-specific D binding; F:D-binding transcription activator activity, R polymerase II-specific; F:zinc ion binding; F:double-stranded methylated D binding; F:ubiquitin protein ligase binding; F:histone acetyltransferase binding; F:hemi-methylated D-binding; F:R polymerase II-specific D-binding transcription factor binding; F:SUMO ligase activity; F:HMG box domain binding; F:promoter-specific chromatin binding; C:chromatin; C:nucleoplasm; C:cytoplasm	EC:2	Transferases	IPR013087 (PFAM); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES)	no GO terms	no GO terms	367.699947423108	3.11010349378537	0.532417264316155	5.84147754445948	5.1739853861629e-09	3.38391263731605e-07
Avas.s019.g132.i1	paralog_cluster_03585	NA	T, brachyury homolog a	3.5e-74	285.8	Actinopterygii	NA	26	P:GO:0031016; P:GO:0006357; P:GO:0003140; F:GO:0000976; P:GO:0070121; P:GO:0072045; P:GO:0042663; P:GO:0001707; P:GO:0001889; P:GO:0036342; P:GO:0048565; P:GO:0001947; P:GO:0010470; P:GO:0060034; P:GO:0035775; P:GO:2000112; P:GO:0010159; C:GO:0000228; P:GO:2000826; C:GO:0000785; P:GO:0001756; P:GO:0060028; P:GO:0035462; P:GO:0014028; P:GO:1905330; P:GO:2000223	P:regulation of heart morphogenesis; P:Kupffer's vesicle development; P:notochord formation; P:regulation of endodermal cell fate specification; P:convergent extension involved in axis elongation; P:pronephric glomerulus morphogenesis; P:regulation of BMP signaling pathway involved in heart jogging; P:post-anal tail morphogenesis; F:transcription cis-regulatory region binding; P:regulation of gastrulation; P:determination of left/right asymmetry in diencephalon; P:mesoderm formation; C:chromatin; P:notochord cell differentiation; P:digestive tract development; P:liver development; P:regulation of transcription by RNA polymerase II; P:regulation of morphogenesis of an epithelium; P:determination of left/right asymmetry in lateral mesoderm; C:nuclear chromosome; P:pancreas development; P:heart looping; P:somitogenesis; P:regulation of cellular macromolecule biosynthetic process; P:specification of animal organ position; P:convergent extension involved in nephron morphogenesis	K10172	NA	TBXTA_DANRE | T-box transcription factor T-A OS=Danio rerio OX=7955 GN=tbxta PE=1 SV=1	448	6e-74	P:GO:0000122; P:GO:0001570; P:GO:0001756; P:GO:0001839; P:GO:0001843; P:GO:0001889; P:GO:0001947; P:GO:0003140; P:GO:0003257; P:GO:0007341; P:GO:0007509; P:GO:0008284; P:GO:0008595; P:GO:0010159; P:GO:0014028; P:GO:0023019; P:GO:0031016; P:GO:0035462; P:GO:0035775; P:GO:0036342; P:GO:0042663; P:GO:0043433; P:GO:0044344; P:GO:0048565; P:GO:0048706; P:GO:0055007; P:GO:0060028; P:GO:0060034; P:GO:0060349; P:GO:0060395; P:GO:0070121; P:GO:0072045; P:GO:0090009; P:GO:2000223; F:GO:0000978; F:GO:0000981; F:GO:0051087; F:GO:0061629; C:GO:0000785; C:GO:0005654; C:GO:0005737	P:negative regulation of transcription by R polymerase II; P:vasculogenesis; P:somitogenesis; P:neural plate morphogenesis; P:neural tube closure; P:liver development; P:heart looping; P:determition of left/right asymmetry in lateral mesoderm; P:positive regulation of transcription from R polymerase II promoter involved in myocardial precursor cell differentiation; P:penetration of zo pellucida; P:mesoderm migration involved in gastrulation; P:positive regulation of cell population proliferation; P:anterior/posterior axis specification, embryo; P:specification of animal organ position; P:notochord formation; P:sigl transduction involved in regulation of gene expression; P:pancreas development; P:determition of left/right asymmetry in diencephalon; P:pronephric glomerulus morphogenesis; P:post-al tail morphogenesis; P:regulation of endodermal cell fate specification; P:negative regulation of D-binding transcription factor activity; P:cellular response to fibroblast growth factor stimulus; P:digestive tract development; P:embryonic skeletal system development; P:cardiac muscle cell differentiation; P:convergent extension involved in axis elongation; P:notochord cell differentiation; P:bone morphogenesis; P:SMAD protein sigl transduction; P:Kupffer's vesicle development; P:convergent extension involved in nephron morphogenesis; P:primitive streak formation; P:regulation of BMP sigling pathway involved in heart jogging; F:R polymerase II cis-regulatory region sequence-specific D binding; F:D-binding transcription factor activity, R polymerase II-specific; F:chaperone binding; F:R polymerase II-specific D-binding transcription factor binding; C:chromatin; C:nucleoplasm; C:cytoplasm			IPR001699 (PFAM); IPR018186 (PROSITE_PATTERNS); IPR001699 (PROSITE_PROFILES)	P:GO:0006355; F:GO:0003700; C:GO:0005634	P:regulation of transcription, D-templated; F:D-binding transcription factor activity; C:nucleus	608.268395697249	3.5003728159578	0.264103829519448	13.2537753137731	4.29064036067506e-40	3.83511737571673e-37
Avas.s019.g134.i1	homolog_cluster_13875	runt	positive regulation of CD8-positive, alpha-beta T cell differentiation	2.5e-53	216.9	Metazoa	NA	5	P:GO:0045138; C:GO:0005634; P:GO:0009792; F:GO:0046332; P:GO:0040018	P:embryo development ending in birth or egg hatching; F:SMAD binding; C:nucleus; P:nematode male tail tip morphogenesis; P:positive regulation of multicellular organism growth	K08367,K09278,K09280,K20213	map04530, map04659, map05200, map05202, map05220, map05221	RUNX1_XENLA | Runt-related transcription factor 1 OS=Xenopus laevis OX=8355 GN=runx1 PE=2 SV=2	565	2.6e-50	P:GO:0000122; P:GO:0001701; P:GO:0001889; P:GO:0001958; P:GO:0002051; P:GO:0002063; P:GO:0002076; P:GO:0002318; P:GO:0002667; P:GO:0006468; P:GO:0007366; P:GO:0007367; P:GO:0007377; P:GO:0007400; P:GO:0007411; P:GO:0007419; P:GO:0007469; P:GO:0007486; P:GO:0007540; P:GO:0008284; P:GO:0010755; P:GO:0014894; P:GO:0016360; P:GO:0030509; P:GO:0030728; P:GO:0030853; P:GO:0030854; P:GO:0031069; P:GO:0032332; P:GO:0032526; P:GO:0032729; P:GO:0032743; P:GO:0032967; P:GO:0035115; P:GO:0035165; P:GO:0035168; P:GO:0035211; P:GO:0035314; P:GO:0040036; P:GO:0042487; P:GO:0042675; P:GO:0042691; P:GO:0043371; P:GO:0043378; P:GO:0045467; P:GO:0045669; P:GO:0045766; P:GO:0045778; P:GO:0045786; P:GO:0045879; P:GO:0046672; P:GO:0048266; P:GO:0048663; P:GO:0048701; P:GO:0048863; P:GO:0048935; P:GO:0050680; P:GO:0060043; P:GO:0060216; P:GO:0061026; P:GO:0071336; P:GO:0071425; P:GO:0071560; P:GO:1901522; P:GO:1903055; P:GO:1903431; P:GO:1905203; P:GO:2000872; P:GO:2001238; F:GO:0000978; F:GO:0001222; F:GO:0001223; F:GO:0001228; F:GO:0005509; F:GO:0005524; F:GO:0019904; F:GO:0042803; F:GO:0042826; F:GO:0043425; F:GO:0046982; F:GO:0140296; F:GO:1990841; C:GO:0000785; C:GO:0005604; C:GO:0005654; C:GO:0005730; C:GO:0005829; C:GO:0016513	P:negative regulation of transcription by R polymerase II; P:in utero embryonic development; P:liver development; P:endochondral ossification; P:osteoblast fate commitment; P:chondrocyte development; P:osteoblast development; P:myeloid progenitor cell differentiation; P:regulation of T cell anergy; P:protein phosphorylation; P:periodic partitioning by pair rule gene; P:segment polarity determition; P:germ-band extension; P:neuroblast fate determition; P:axon guidance; P:ventral cord development; P:antenl development; P:imagil disc-derived female genitalia development; P:sex determition, establishment of X:A ratio; P:positive regulation of cell population proliferation; P:regulation of plasminogen activation; P:response to denervation involved in regulation of muscle adaptation; P:sensory organ precursor cell fate determition; P:BMP sigling pathway; P:ovulation; P:negative regulation of granulocyte differentiation; P:positive regulation of granulocyte differentiation; P:hair follicle morphogenesis; P:positive regulation of chondrocyte differentiation; P:response to retinoic acid; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-2 production; P:positive regulation of collagen biosynthetic process; P:embryonic forelimb morphogenesis; P:embryonic crystal cell differentiation; P:larval lymph gland hemocyte differentiation; P:spermathecum morphogenesis; P:scab formation; P:regulation of fibroblast growth factor receptor sigling pathway; P:regulation of odontogenesis of dentin-containing tooth; P:compound eye cone cell differentiation; P:positive regulation of crystal cell differentiation; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; P:R7 cell development; P:positive regulation of osteoblast differentiation; P:positive regulation of angiogenesis; P:positive regulation of ossification; P:negative regulation of cell cycle; P:negative regulation of smoothened sigling pathway; P:positive regulation of compound eye retil cell programmed cell death; P:behavioral response to pain; P:neuron fate commitment; P:embryonic cranial skeleton morphogenesis; P:stem cell differentiation; P:peripheral nervous system neuron development; P:negative regulation of epithelial cell proliferation; P:regulation of cardiac muscle cell proliferation; P:definitive hemopoiesis; P:cardiac muscle tissue regeneration; P:regulation of hair follicle cell proliferation; P:hematopoietic stem cell proliferation; P:cellular response to transforming growth factor beta stimulus; P:positive regulation of transcription from R polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of extracellular matrix organization; P:positive regulation of cell maturation; P:regulation of connective tissue replacement; P:positive regulation of progesterone secretion; P:positive regulation of extrinsic apoptotic sigling pathway; F:R polymerase II cis-regulatory region sequence-specific D binding; F:transcription corepressor binding; F:transcription coactivator binding; F:D-binding transcription activator activity, R polymerase II-specific; F:calcium ion binding; F:ATP binding; F:protein domain specific binding; F:protein homodimerization activity; F:histone deacetylase binding; F:bHLH transcription factor binding; F:protein heterodimerization activity; F:general transcription initiation factor binding; F:promoter-specific chromatin binding; C:chromatin; C:basement membrane; C:nucleoplasm; C:nucleolus; C:cytosol; C:core-binding factor complex			IPR013524 (PFAM); IPR013524 (PROSITE_PROFILES)	P:GO:0006355; F:GO:0003677; F:GO:0003700	P:regulation of transcription, D-templated; F:D binding; F:D-binding transcription factor activity	289.662710248049	1.26060511556354	0.267426000094362	4.71384650377576	2.43083806127706e-06	9.4013830692035e-05
Avas.s019.g160.i1	paralog_cluster_00041	NA	ARF-like small GTPases; ARF, ADP-ribosylation factor	1.4e-56	226.1	Metazoa	NA	NA	NA	NA	NA	NA	ARF6_CHICK | ADP-ribosylation factor 6 OS=Gallus gallus OX=9031 GN=ARF6 PE=2 SV=3	189	5.9e-47	P:GO:0001745; P:GO:0001889; P:GO:0006471; P:GO:0006886; P:GO:0007112; P:GO:0007269; P:GO:0007283; P:GO:0007520; P:GO:0030866; P:GO:0032456; P:GO:0033028; P:GO:0035020; P:GO:0036010; P:GO:0048149; P:GO:0048261; P:GO:0048488; P:GO:0050714; P:GO:0051549; P:GO:0060998; P:GO:0090162; P:GO:0097178; P:GO:0097284; P:GO:0099562; P:GO:0120183; P:GO:1903078; P:GO:1905606; P:GO:1990090; P:GO:2000009; P:GO:2000171; F:GO:0003924; F:GO:0005525; F:GO:0008047; F:GO:0019003; F:GO:0047485; C:GO:0005769; C:GO:0005794; C:GO:0005829; C:GO:0005912; C:GO:0005938; C:GO:0010008; C:GO:0032154; C:GO:0032587; C:GO:0055037; C:GO:0090543; C:GO:0098978	P:compound eye morphogenesis; P:liver development; P:protein ADP-ribosylation; P:intracellular protein transport; P:male meiosis cytokinesis; P:neurotransmitter secretion; P:spermatogenesis; P:myoblast fusion; P:cortical actin cytoskeleton organization; P:endocytic recycling; P:myeloid cell apoptotic process; P:regulation of Rac protein sigl transduction; P:protein localization to endosome; P:behavioral response to ethanol; P:negative regulation of receptor-mediated endocytosis; P:syptic vesicle endocytosis; P:positive regulation of protein secretion; P:positive regulation of keratinocyte migration; P:regulation of dendritic spine development; P:establishment of epithelial cell polarity; P:ruffle assembly; P:hepatocyte apoptotic process; P:maintence of postsyptic density structure; P:positive regulation of focal adhesion disassembly; P:positive regulation of protein localization to plasma membrane; P:regulation of presypse assembly; P:cellular response to nerve growth factor stimulus; P:negative regulation of protein localization to cell surface; P:negative regulation of dendrite development; F:GTPase activity; F:GTP binding; F:enzyme activator activity; F:GDP binding; F:protein N-terminus binding; C:early endosome; C:Golgi apparatus; C:cytosol; C:adherens junction; C:cell cortex; C:endosome membrane; C:cleavage furrow; C:ruffle membrane; C:recycling endosome; C:Flemming body; C:glutamatergic sypse	EC:3.6.1	Acting on acid anhydrides	IPR006689 (PFAM); PS51419 (PROSITE_PROFILES); PS51417 (PROSITE_PROFILES)	F:GO:0003924; F:GO:0005525	F:GTPase activity; F:GTP binding	391.391126849507	-1.20394006100519	0.248908315356801	-4.83688164165744	1.3189190882509e-06	5.4550357868557e-05
Avas.s019.g191.i1	homolog_cluster_13891	CNPY2	positive regulation of low-density lipoprotein particle receptor biosynthetic process	2.1e-05	55.8	Bilateria	NA	14	P:GO:0009888; P:GO:0002791; P:GO:0010557; P:GO:0009951; P:GO:0010988; P:GO:0007167; P:GO:0010629; F:GO:0051087; P:GO:0070613; C:GO:0005783; P:GO:0061077; P:GO:0050708; P:GO:0051247; P:GO:0031325	C:endoplasmic reticulum; P:tissue development; P:regulation of low-density lipoprotein particle clearance; P:regulation of protein secretion; P:chaperone-mediated protein folding; P:positive regulation of macromolecule biosynthetic process; P:polarity specification of dorsal/ventral axis; F:chaperone binding; P:negative regulation of gene expression; P:regulation of peptide secretion; P:enzyme linked receptor protein signaling pathway; P:positive regulation of protein metabolic process; P:positive regulation of cellular metabolic process; P:regulation of protein processing	NA	NA	------	160	NA					IPR021852 (PFAM); IPR008139 (PROSITE_PROFILES); PS51257 (PROSITE_PROFILES)	no GO terms	no GO terms	140.47397810473	1.936479265412	0.354215939796939	5.46694557710228	4.57856551291589e-08	2.52275823757889e-06
Avas.s019.g226.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	86	NA					no IPS match	no IPS match	no IPS match	7254.32863534148	-3.87943743553692	0.312185416066251	-12.4267093716948	1.87182104864265e-35	1.43408232626722e-32
Avas.s019.g225.i1	paralog_cluster_02924	NA	NAD(P)H oxidase activity	NA	1407.9	Metazoa	EC:1.6.3.1	NA	NA	NA	K13411	map04013, map04624	DUOX_DROME | Dual oxidase OS=Drosophila melanogaster OX=7227 GN=Duox PE=1 SV=2	1683	2.4e-280	P:GO:0009615; P:GO:0009886; P:GO:0009887; P:GO:0019221; P:GO:0035220; P:GO:0042303; P:GO:0042335; P:GO:0042445; P:GO:0042554; P:GO:0042742; P:GO:0050665; P:GO:0051591; P:GO:0090303; P:GO:1901564; P:GO:2000147; F:GO:0005509; F:GO:0005515; F:GO:0016174; F:GO:0097159; F:GO:1901363; C:GO:0005783; C:GO:0005829; C:GO:0005886; C:GO:0009986; C:GO:0031252; C:GO:0045177	P:response to virus; P:post-embryonic animal morphogenesis; P:animal organ morphogenesis; P:cytokine-mediated sigling pathway; P:wing disc development; P:molting cycle; P:cuticle development; P:hormone metabolic process; P:superoxide anion generation; P:defense response to bacterium; P:hydrogen peroxide biosynthetic process; P:response to cAMP; P:positive regulation of wound healing; P:organonitrogen compound metabolic process; P:positive regulation of cell motility; F:calcium ion binding; F:protein binding; F:D(P)H oxidase H2O2-forming activity; F:organic cyclic compound binding; F:heterocyclic compound binding; C:endoplasmic reticulum; C:cytosol; C:plasma membrane; C:cell surface; C:cell leading edge; C:apical part of cell	EC:1.6.3.1	D(P)H oxidase (H(2)O(2)-forming)	IPR013121 (PFAM); IPR002048 (PFAM); IPR019791 (PFAM); IPR013112 (PFAM); IPR002048 (PFAM); IPR013130 (PFAM); IPR018247 (PROSITE_PATTERNS); IPR018247 (PROSITE_PATTERNS); IPR002048 (PROSITE_PROFILES); IPR019791 (PROSITE_PROFILES); IPR017927 (PROSITE_PROFILES); IPR002048 (PROSITE_PROFILES)	F:GO:0005509; F:GO:0016491	F:calcium ion binding; F:oxidoreductase activity	4183.667111468	-3.86468099414184	0.270641341594012	-14.2797141463304	2.92799982732218e-46	4.71085892217865e-43
Avas.s019.g227.i1	paralog_cluster_06330	NA	Dual oxidase maturation factor	7.7e-67	261.2	Metazoa	NA	NA	NA	NA	K17233	NA	DOXA1_XENTR | Dual oxidase maturation factor 1 OS=Xenopus tropicalis OX=8364 GN=duoxa1 PE=2 SV=1	375	1.5e-30	P:GO:0050794; C:GO:0016020	P:regulation of cellular process; C:membrane			IPR018469 (PFAM)	P:GO:0015031; C:GO:0005789; C:GO:0016021	P:protein transport; C:endoplasmic reticulum membrane; C:integral component of membrane	5955.16694856509	-3.24862490511766	0.311417581724319	-10.4317324896366	1.77619771877224e-25	5.39193303723144e-23
Avas.s019.g241.i1	NA	NA	NA	0.33	44.3	Metazoa	NA	NA	NA	NA	NA	NA	------	828	NA					no IPS match	no IPS match	no IPS match	455.145728045563	1.06282471827131	0.17327633706203	6.13369797799244	8.58594508419035e-10	6.33666378254764e-08
Avas.s019.g265.i1	paralog_cluster_00399	NA	Belongs to the peptidase C1 family	1.5e-58	233.4	Opisthokonta	EC:3.4.22.1; EC:3.4.14.1	NA	NA	NA	K01275,K01363	map04140, map04142, map04210, map04612, map04621, map04924	CPR5_CAEEL | Cathepsin B-like cysteine proteise 5 OS=Caenorhabditis elegans OX=6239 GN=cpr-5 PE=2 SV=1	320	3.8e-46	P:GO:0006508; P:GO:0009725; P:GO:0009888; P:GO:0032501; P:GO:0044248; P:GO:0048523; P:GO:0050790; P:GO:0071478; P:GO:1901700; F:GO:0004175; F:GO:0005515; F:GO:0008234; F:GO:0044877; C:GO:0005615; C:GO:0005764; C:GO:0005886; C:GO:0031410	P:proteolysis; P:response to hormone; P:tissue development; P:multicellular organismal process; P:cellular catabolic process; P:negative regulation of cellular process; P:regulation of catalytic activity; P:cellular response to radiation; P:response to oxygen-containing compound; F:endopeptidase activity; F:protein binding; F:cysteine-type peptidase activity; F:protein-containing complex binding; C:extracellular space; C:lysosome; C:plasma membrane; C:cytoplasmic vesicle	EC:3.4	Acting on peptide bonds (peptidases)	IPR000668 (PFAM); IPR025660 (PROSITE_PATTERNS); IPR000169 (PROSITE_PATTERNS)	P:GO:0006508; F:GO:0008234	P:proteolysis; F:cysteine-type peptidase activity	556.147647367365	3.55561772358329	0.495738450036169	7.17236624135948	7.37124237229784e-13	8.47113703770714e-11
Avas.s019.g266.i1	paralog_cluster_00399	NA	Belongs to the peptidase C1 family	6.4e-25	120.6	Opisthokonta	EC:3.4.22.1; EC:3.4.14.1	NA	NA	NA	K01275,K01363	map04140, map04142, map04210, map04612, map04621, map04924	YCF2E_CAEEL | Uncharacterized peptidase C1-like protein F26E4.3 OS=Caenorhabditis elegans OX=6239 GN=F26E4.3 PE=1 SV=3	149	7.7e-26	P:GO:0006914; P:GO:0007283; P:GO:0007519; P:GO:0009611; P:GO:0009749; P:GO:0010466; P:GO:0014070; P:GO:0014075; P:GO:0030574; P:GO:0042981; P:GO:0043434; P:GO:0045471; P:GO:0046697; P:GO:0060548; P:GO:0070670; P:GO:0071260; F:GO:0004197; F:GO:0005518; F:GO:0030984; F:GO:0042277; F:GO:0043394; F:GO:0043621; C:GO:0005615; C:GO:0005739; C:GO:0005764; C:GO:0005901; C:GO:0009897; C:GO:0016324; C:GO:0042383; C:GO:0048471	P:autophagy; P:spermatogenesis; P:skeletal muscle tissue development; P:response to wounding; P:response to glucose; P:negative regulation of peptidase activity; P:response to organic cyclic compound; P:response to amine; P:collagen catabolic process; P:regulation of apoptotic process; P:response to peptide hormone; P:response to ethanol; P:decidualization; P:negative regulation of cell death; P:response to interleukin-4; P:cellular response to mechanical stimulus; F:cysteine-type endopeptidase activity; F:collagen binding; F:kininogen binding; F:peptide binding; F:proteoglycan binding; F:protein self-association; C:extracellular space; C:mitochondrion; C:lysosome; C:caveola; C:exterl side of plasma membrane; C:apical plasma membrane; C:sarcolemma; C:perinuclear region of cytoplasm	EC:3.4.22	Acting on peptide bonds (peptidases)	IPR000668 (PFAM); IPR025660 (PROSITE_PATTERNS)	P:GO:0006508; F:GO:0008234	P:proteolysis; F:cysteine-type peptidase activity	139.297083813834	2.33870510382702	0.401189770244618	5.82942357279208	5.56191626294533e-09	3.62290164998087e-07
Avas.s019.g272.i1	paralog_cluster_00837	NA	Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family	2.7e-23	116.7	Metazoa	NA	NA	NA	NA	NA	NA	GTR6_HUMAN | Solute carrier family 2, facilitated glucose transporter member 6 OS=Homo sapiens OX=9606 GN=SLC2A6 PE=1 SV=2	436	7.5e-21	P:GO:0034219; F:GO:0051119; C:GO:0005773; C:GO:0016020	P:carbohydrate transmembrane transport; F:sugar transmembrane transporter activity; C:vacuole; C:membrane	EC:7	Translocases	IPR005828 (PFAM); IPR005829 (PROSITE_PATTERNS)	P:GO:0055085; F:GO:0022857; C:GO:0016021	P:transmembrane transport; F:transmembrane transporter activity; C:integral component of membrane	12.6363769072624	7.18925052447749	1.38712576006943	5.18283974779448	2.18532793923063e-07	1.05268686270304e-05
Avas.s019.g274.i1	paralog_cluster_03500	gl	C2H2-type zinc finger	2.2e-06	60.5	Paraneoptera	NA	12	F:GO:0003677; P:GO:0035271; P:GO:0060086; P:GO:0010628; P:GO:0043153; C:GO:0005634; F:GO:0000981; P:GO:0007605; P:GO:2000112; P:GO:0010114; P:GO:0045944; P:GO:0001752	P:ring gland development; F:DNA-binding transcription factor activity, RNA polymerase II-specific; P:circadian temperature homeostasis; C:nucleus; P:compound eye photoreceptor fate commitment; P:regulation of cellular macromolecule biosynthetic process; F:DNA binding; P:positive regulation of transcription by RNA polymerase II; P:response to red light; P:sensory perception of sound; P:positive regulation of gene expression; P:entrainment of circadian clock by photoperiod	K09214	NA	GLAS_DROME | Protein glass OS=Drosophila melanogaster OX=7227 GN=gl PE=1 SV=2	406	9.1e-61	P:GO:0001752; P:GO:0007601; P:GO:0007605; P:GO:0010114; P:GO:0035271; P:GO:0043153; P:GO:0045944; P:GO:0060086; F:GO:0000978; F:GO:0000981; F:GO:0005515; F:GO:0046872; C:GO:0005654; C:GO:0005829	P:compound eye photoreceptor fate commitment; P:visual perception; P:sensory perception of sound; P:response to red light; P:ring gland development; P:entrainment of circadian clock by photoperiod; P:positive regulation of transcription by R polymerase II; P:circadian temperature homeostasis; F:R polymerase II cis-regulatory region sequence-specific D binding; F:D-binding transcription factor activity, R polymerase II-specific; F:protein binding; F:metal ion binding; C:nucleoplasm; C:cytosol			IPR013087 (PFAM); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES)	no GO terms	no GO terms	449.25127862241	2.09897969851197	0.298834138023494	7.02389530324327	2.15766515670718e-12	2.36446446967146e-10
Avas.s019.g279.i1	paralog_cluster_04256	NA	Involved in the biosynthesis of the osmoprotectant glycine betaine. Catalyzes the oxidation of choline to betaine aldehyde and betaine aldehyde to glycine betaine at the same rate	9.4e-170	603.6	Micromonosporales	NA	NA	NA	NA	NA	NA	------	562	NA					no IPS match	no IPS match	no IPS match	136.195325918513	-6.07542600586309	0.776069447233951	-7.82845662526336	4.93895279775099e-15	7.15881185252394e-13
Avas.s019.g283.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	235	NA					no IPS match	no IPS match	no IPS match	154.969920275461	-2.8450975429415	0.508917429220669	-5.59048949708471	2.26430381993713e-08	1.33726986598558e-06
Avas.s019.g391.i1	homolog_cluster_13925	NA	activation of NF-kappaB-inducing kinase activity	4.9e-35	155.6	Bilateria	NA	14	P:GO:0003384; F:GO:0005515; P:GO:0034332; P:GO:0001654; P:GO:0046529; C:GO:0045179; P:GO:0001934; P:GO:0043065; P:GO:0050829; P:GO:0045167; P:GO:0046330; P:GO:0007391; P:GO:0007370; P:GO:0032989	P:asymmetric protein localization involved in cell fate determination; P:cellular component morphogenesis; C:apical cortex; P:imaginal disc fusion, thorax closure; P:eye development; P:dorsal closure; P:adherens junction organization; P:positive regulation of JNK cascade; P:positive regulation of apoptotic process; P:defense response to Gram-negative bacterium; P:apical constriction involved in gastrulation; F:protein binding; P:ventral furrow formation; P:positive regulation of protein phosphorylation	K09848	map04214, map04657, map05200, map05222	------	405	NA					IPR001293 (PFAM); IPR001293 (PROSITE_PROFILES); IPR002083 (PROSITE_PROFILES); IPR001293 (PROSITE_PROFILES)	F:GO:0005515; F:GO:0008270	F:protein binding; F:zinc ion binding	442.547114892997	4.38552069101582	0.404150594484052	10.8512043551847	1.96814725893211e-27	7.0367824997686e-25
Avas.s020.g32.i1	paralog_cluster_01785	PSPH	phosphoserine phosphatase activity	4.5e-65	254.6	Chordata	EC:3.1.3.3	19	F:GO:0000287; P:GO:0009612; P:GO:0006564; P:GO:0007411; P:GO:0007422; P:GO:0009410; P:GO:0033574; C:GO:0043005; P:GO:0009725; F:GO:0005509; P:GO:0009636; P:GO:0046677; P:GO:0016311; F:GO:0042803; P:GO:0045433; P:GO:0048149; F:GO:0036424; C:GO:0005829; P:GO:0031667	P:response to xenobiotic stimulus; F:magnesium ion binding; F:protein homodimerization activity; P:response to toxic substance; F:L-phosphoserine phosphatase activity; P:response to antibiotic; P:behavioral response to ethanol; P:dephosphorylation; P:L-serine biosynthetic process; P:peripheral nervous system development; C:neuron projection; C:cytosol; F:calcium ion binding; P:response to nutrient levels; P:response to hormone; P:response to testosterone; P:axon guidance; P:male courtship behavior, veined wing generated song production; P:response to mechanical stimulus	K01079	map00260, map00680, map01100, map01120, map01130, map01200, map01230	SERB_BOVIN | Phosphoserine phosphatase OS=Bos taurus OX=9913 GN=PSPH PE=2 SV=1	234	1.2e-62	P:GO:0000096; P:GO:0001701; P:GO:0006564; P:GO:0009612; P:GO:0009793; P:GO:0016311; P:GO:0031667; P:GO:0033574; P:GO:0048149; P:GO:0048364; F:GO:0000287; F:GO:0036424; F:GO:0042803; C:GO:0005829; C:GO:0009507; C:GO:0043005	P:sulfur amino acid metabolic process; P:in utero embryonic development; P:L-serine biosynthetic process; P:response to mechanical stimulus; P:embryo development ending in seed dormancy; P:dephosphorylation; P:response to nutrient levels; P:response to testosterone; P:behavioral response to ethanol; P:root development; F:magnesium ion binding; F:L-phosphoserine phosphatase activity; F:protein homodimerization activity; C:cytosol; C:chloroplast; C:neuron projection	EC:3.1.3.3	Phosphoserine phosphatase	PF00702 (PFAM)	no GO terms	no GO terms	764.327144902683	2.76463667725914	0.424400686754362	6.51421348632096	7.30715110795376e-11	6.56786336178033e-09
Avas.s020.g34.i1	NA	NA	protein domain specific binding	6.8e-20	106.3	Metazoa	NA	NA	NA	NA	K21952	NA	CSKI2_HUMAN | Caskin-2 OS=Homo sapiens OX=9606 GN=CASKIN2 PE=1 SV=2	811	3.7e-13	F:GO:0005515	F:protein binding			IPR001660 (PFAM); IPR001660 (PFAM); IPR001660 (PROSITE_PROFILES); IPR001660 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	363.264785753837	0.977898868143051	0.199700542442514	4.89682629892981	9.73968592028997e-07	4.11290831421379e-05
Avas.s020.g108.i1	paralog_cluster_00446	NA	arachidonate 5-lipoxygenase activity	5.2e-163	581.6	Metazoa	EC:1.13.11.34	NA	NA	NA	K00461	map00590, map01100, map04664, map04726, map04913, map05145	LOX5_HUMAN | Polyunsaturated fatty acid 5-lipoxygese OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2	763	1.5e-109	P:GO:0001817; P:GO:0002523; P:GO:0003008; P:GO:0006665; P:GO:0008285; P:GO:0009967; P:GO:0016525; P:GO:0019370; P:GO:0031323; P:GO:0033559; P:GO:0042221; P:GO:0042759; P:GO:0045597; P:GO:0048878; P:GO:0050727; P:GO:0051046; P:GO:0051050; P:GO:0051240; P:GO:0061045; P:GO:0080135; P:GO:0120254; P:GO:2001301; F:GO:0016702; F:GO:0046872; F:GO:0050486; C:GO:0005635; C:GO:0005737; C:GO:0005886; C:GO:0031981	P:regulation of cytokine production; P:leukocyte migration involved in inflammatory response; P:system process; P:sphingolipid metabolic process; P:negative regulation of cell population proliferation; P:positive regulation of sigl transduction; P:negative regulation of angiogenesis; P:leukotriene biosynthetic process; P:regulation of cellular metabolic process; P:unsaturated fatty acid metabolic process; P:response to chemical; P:long-chain fatty acid biosynthetic process; P:positive regulation of cell differentiation; P:chemical homeostasis; P:regulation of inflammatory response; P:regulation of secretion; P:positive regulation of transport; P:positive regulation of multicellular organismal process; P:negative regulation of wound healing; P:regulation of cellular response to stress; P:olefinic compound metabolic process; P:lipoxin biosynthetic process; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:metal ion binding; F:intramolecular transferase activity, transferring hydroxy groups; C:nuclear envelope; C:cytoplasm; C:plasma membrane; C:nuclear lumen	EC:1.13.11; EC:5.4.4	Acting on single donors with incorporation of molecular oxygen (oxygeses). The oxygen incorporated need not be derived from O(2); Intramolecular transferases	IPR001024 (PFAM); IPR013819 (PFAM); IPR020834 (PROSITE_PATTERNS); IPR001024 (PROSITE_PROFILES); IPR013819 (PROSITE_PROFILES)	F:GO:0005515; F:GO:0016702; F:GO:0046872	F:protein binding; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; F:metal ion binding	326.136135443111	-4.05718035985975	0.618813933374746	-6.55638171838444	5.51290080665159e-11	5.06840349018386e-09
Avas.s020.g171.i1	paralog_cluster_01013	NA	Translation initiation factor IF-2, N-terminal region	6.1e-110	404.8	Bilateria	NA	NA	NA	NA	NA	NA	PI51A_MOUSE | Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2	535	3.8e-107	P:GO:0006661; P:GO:0006909; P:GO:0007409; P:GO:0010761; P:GO:0014066; P:GO:0016079; P:GO:0030216; P:GO:0030593; P:GO:0031532; P:GO:0034333; P:GO:0048041; P:GO:0061024; P:GO:0070527; P:GO:0072583; P:GO:0072659; P:GO:0090630; P:GO:0097178; P:GO:0099149; P:GO:1900242; F:GO:0000285; F:GO:0016308; F:GO:0019900; F:GO:0052810; F:GO:0052812; C:GO:0001931; C:GO:0005829; C:GO:0005847; C:GO:0005925; C:GO:0010008; C:GO:0014069; C:GO:0016607; C:GO:0030027; C:GO:0032587; C:GO:0098835; C:GO:0098978	P:phosphatidylinositol biosynthetic process; P:phagocytosis; P:axonogenesis; P:fibroblast migration; P:regulation of phosphatidylinositol 3-kise sigling; P:syptic vesicle exocytosis; P:keratinocyte differentiation; P:neutrophil chemotaxis; P:actin cytoskeleton reorganization; P:adherens junction assembly; P:focal adhesion assembly; P:membrane organization; P:platelet aggregation; P:clathrin-dependent endocytosis; P:protein localization to plasma membrane; P:activation of GTPase activity; P:ruffle assembly; P:regulation of postsyptic neurotransmitter receptor interlization; P:regulation of syptic vesicle endocytosis; F:1-phosphatidylinositol-3-phosphate 5-kise activity; F:1-phosphatidylinositol-4-phosphate 5-kise activity; F:kise binding; F:1-phosphatidylinositol-5-kise activity; F:phosphatidylinositol-3,4-bisphosphate 5-kise activity; C:uropod; C:cytosol; C:mR cleavage and polyadenylation specificity factor complex; C:focal adhesion; C:endosome membrane; C:postsyptic density; C:nuclear speck; C:lamellipodium; C:ruffle membrane; C:presyptic endocytic zone membrane; C:glutamatergic sypse	EC:2.7.1.150; EC:2.7.1.153; EC:2.7.1.68	1-phosphatidylinositol-3-phosphate 5-kise; Phosphatidylinositol-4,5-bisphosphate 3-kise; 1-phosphatidylinositol-4-phosphate 5-kise	IPR002498 (PFAM); IPR002498 (PROSITE_PROFILES)	P:GO:0046488; F:GO:0016307	P:phosphatidylinositol metabolic process; F:phosphatidylinositol phosphate kise activity	891.289435995389	2.03728660984849	0.273924568562189	7.43740008624299	1.02686194408362e-13	1.25160468320919e-11
Avas.s020.g267.i1	homolog_cluster_18799	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	214	NA					no IPS match	no IPS match	no IPS match	80.494781183199	-3.73811162710114	0.67925559647172	-5.5032474469377	3.72858513656393e-08	2.09021624606889e-06
Avas.s020.g283.i1	paralog_cluster_00168	prkca	Protein kinase C, alpha	4.6e-113	415.6	Actinopterygii	EC:2.7.11.13	NA	NA	NA	K02677	map01521, map04010, map04011, map04012, map04014, map04015, map04020, map04066, map04070, map04071, map04072, map04139, map04150, map04151, map04261, map04270, map04310, map04360, map04370, map04510, map04540, map04650, map04664, map04666, map04670, map04713, map04720, map04723, map04724, map04725, map04726, map04727, map04728, map04730, map04745, map04750, map04911, map04912, map04916, map04918, map04919, map04921, map04925, map04926, map04933, map04960, map04961, map04970, map04971, map04972, map05031, map05032, map05110, map05130, map05143, map05146, map05161, map05164, map05200, map05205, map05206, map05214, map05223, map05225, map05231	KPCA_RABIT | Protein kinase C alpha type OS=Oryctolagus cuniculus OX=9986 GN=PRKCA PE=2 SV=3	703	4.4e-111	P:GO:0001933; P:GO:0006355; P:GO:0006915; P:GO:0008016; P:GO:0008284; P:GO:0009653; P:GO:0009725; P:GO:0009968; P:GO:0010604; P:GO:0010608; P:GO:0010829; P:GO:0014070; P:GO:0017157; P:GO:0018105; P:GO:0018107; P:GO:0030154; P:GO:0030155; P:GO:0031325; P:GO:0032103; P:GO:0033993; P:GO:0040017; P:GO:0043269; P:GO:0043408; P:GO:0044089; P:GO:0044092; P:GO:0046777; P:GO:0048513; P:GO:0050778; P:GO:0050804; P:GO:0051094; P:GO:0051128; P:GO:0051173; P:GO:0051240; P:GO:0065008; P:GO:0070887; P:GO:0080134; P:GO:0090257; P:GO:0097305; P:GO:1902533; P:GO:2000026; F:GO:0004697; F:GO:0019899; C:GO:0001750; C:GO:0005634; C:GO:0005739; C:GO:0005829; C:GO:0005856; C:GO:0005886; C:GO:0030424; C:GO:0032991; C:GO:0036477; C:GO:0098793	P:negative regulation of protein phosphorylation; P:regulation of transcription, D-templated; P:apoptotic process; P:regulation of heart contraction; P:positive regulation of cell population proliferation; P:atomical structure morphogenesis; P:response to hormone; P:negative regulation of sigl transduction; P:positive regulation of macromolecule metabolic process; P:posttranscriptiol regulation of gene expression; P:negative regulation of glucose transmembrane transport; P:response to organic cyclic compound; P:regulation of exocytosis; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:cell differentiation; P:regulation of cell adhesion; P:positive regulation of cellular metabolic process; P:positive regulation of response to exterl stimulus; P:response to lipid; P:positive regulation of locomotion; P:regulation of ion transport; P:regulation of MAPK cascade; P:positive regulation of cellular component biogenesis; P:negative regulation of molecular function; P:protein autophosphorylation; P:animal organ development; P:positive regulation of immune response; P:modulation of chemical syptic transmission; P:positive regulation of developmental process; P:regulation of cellular component organization; P:positive regulation of nitrogen compound metabolic process; P:positive regulation of multicellular organismal process; P:regulation of biological quality; P:cellular response to chemical stimulus; P:regulation of response to stress; P:regulation of muscle system process; P:response to alcohol; P:positive regulation of intracellular sigl transduction; P:regulation of multicellular organismal development; F:protein kise C activity; F:enzyme binding; C:photoreceptor outer segment; C:nucleus; C:mitochondrion; C:cytosol; C:cytoskeleton; C:plasma membrane; C:axon; C:protein-containing complex; C:somatodendritic compartment; C:presypse	EC:2.7.11.13	Protein kise C	IPR002219 (PFAM); IPR000008 (PFAM); IPR000719 (PFAM); IPR008271 (PROSITE_PATTERNS); IPR017441 (PROSITE_PATTERNS); IPR002219 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); IPR000719 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	173.594011286237	2.46296922895629	0.463673553169986	5.31186049348247	1.08511660751081e-07	5.55736024537484e-06
Avas.s020.g319.i1	homolog_cluster_14007	KLF13	negative regulation of erythrocyte differentiation	6.7e-08	65.5	Metazoa	NA	9	P:GO:0010628; C:GO:0005634; P:GO:0008285; F:GO:0001228; P:GO:2000112; P:GO:1903707; P:GO:0045647; P:GO:0045944; F:GO:0000978	P:negative regulation of hemopoiesis; P:negative regulation of cell population proliferation; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:negative regulation of erythrocyte differentiation; C:nucleus; P:regulation of cellular macromolecule biosynthetic process; P:positive regulation of transcription by RNA polymerase II; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:positive regulation of gene expression	K09208	NA	KLF13_HUMAN | Krueppel-like factor 13 OS=Homo sapiens OX=9606 GN=KLF13 PE=1 SV=1	406	2.6e-39	P:GO:0000083; P:GO:0000122; P:GO:0007212; P:GO:0007566; P:GO:0007623; P:GO:0010839; P:GO:0043065; P:GO:0045647; P:GO:0045944; P:GO:0050847; P:GO:0071387; P:GO:0097067; P:GO:1901653; P:GO:1902070; F:GO:0000978; F:GO:0001227; F:GO:0001228; F:GO:0003682; F:GO:0005515; F:GO:0046872; C:GO:0000785; C:GO:0005829; C:GO:0005886; C:GO:0005925; C:GO:0016604	P:regulation of transcription involved in G1/S transition of mitotic cell cycle; P:negative regulation of transcription by R polymerase II; P:dopamine receptor sigling pathway; P:embryo implantation; P:circadian rhythm; P:negative regulation of keratinocyte proliferation; P:positive regulation of apoptotic process; P:negative regulation of erythrocyte differentiation; P:positive regulation of transcription by R polymerase II; P:progesterone receptor sigling pathway; P:cellular response to cortisol stimulus; P:cellular response to thyroid hormone stimulus; P:cellular response to peptide; P:positive regulation of sphingolipid mediated sigling pathway; F:R polymerase II cis-regulatory region sequence-specific D binding; F:D-binding transcription repressor activity, R polymerase II-specific; F:D-binding transcription activator activity, R polymerase II-specific; F:chromatin binding; F:protein binding; F:metal ion binding; C:chromatin; C:cytosol; C:plasma membrane; C:focal adhesion; C:nuclear body			IPR013087 (PFAM); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PATTERNS); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES); IPR013087 (PROSITE_PROFILES)	no GO terms	no GO terms	505.076712287528	2.2050587979452	0.285922420018182	7.71208776774126	1.23775958132901e-14	1.65952615866688e-12
Avas.s020.g343.i1	homolog_cluster_14013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	253	NA					no IPS match	no IPS match	no IPS match	2130.68798422361	2.77635456049915	0.271172457288965	10.2383353687747	1.33513700821943e-24	3.83589630807901e-22
Avas.s020.g391.i2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	467	NA					no IPS match	no IPS match	no IPS match	120.35474995392	2.00339374355283	0.353070166857145	5.67420850474579	1.39331345572225e-08	8.52358182095637e-07
Avas.s020.g393.i1	paralog_cluster_02480	NA	DBH-like monooxygenase protein 1	4.7e-96	359	Metazoa	NA	NA	NA	NA	NA	NA	MOXD1_DANRE | DBH-like monooxygese protein 1 homolog OS=Danio rerio OX=7955 GN=moxd1 PE=2 SV=2	647	1e-77	P:GO:0006576; P:GO:0007610; P:GO:0018958; P:GO:0019953; P:GO:0044249; P:GO:0048609; P:GO:0050789; F:GO:0004497; F:GO:0005488; C:GO:0005783; C:GO:0030054; C:GO:0031090	P:cellular biogenic amine metabolic process; P:behavior; P:phenol-containing compound metabolic process; P:sexual reproduction; P:cellular biosynthetic process; P:multicellular organismal reproductive process; P:regulation of biological process; F:monooxygese activity; F:binding; C:endoplasmic reticulum; C:cell junction; C:organelle membrane	EC:1	Oxidoreductases	IPR000323 (PFAM); IPR024548 (PFAM); PF03351 (PFAM); IPR005018 (PROSITE_PROFILES)	F:GO:0004497; F:GO:0005507; F:GO:0016715	F:monooxygese activity; F:copper ion binding; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen	125.284945682515	-1.75472777205706	0.358502242902883	-4.89460751444284	9.85021144774503e-07	4.14869246028193e-05
Avas.s020.g421.i1	paralog_cluster_08873	MICAL1	Microtubule associated monooxygenase, calponin and LIM domain containing 1	6.6e-114	419.5	Testudines	EC:1.14.13.225	16	P:GO:1903305; P:GO:0030042; C:GO:1990026; P:GO:0007596; P:GO:0007165; F:GO:0031267; F:GO:0017124; F:GO:0003779; F:GO:0071949; F:GO:0019901; C:GO:0005882; P:GO:0001933; P:GO:0043154; F:GO:0016709; P:GO:0019417; C:GO:0005829	F:protein kinase binding; P:sulfur oxidation; P:signal transduction; P:actin filament depolymerization; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; P:regulation of regulated secretory pathway; C:cytosol; C:intermediate filament; P:blood coagulation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of protein phosphorylation; C:hippocampal mossy fiber expansion; F:actin binding; F:small GTPase binding; F:FAD binding; F:SH3 domain binding	K19947	NA	MICA1_DANRE |	1467	1.2e-110	P:GO:0007015; P:GO:0032269; P:GO:0043066; F:GO:0003779; F:GO:0004497; F:GO:0019901; F:GO:0043167; C:GO:0005737; C:GO:0005856; C:GO:0030496; C:GO:0042995	P:actin filament organization; P:negative regulation of cellular protein metabolic process; P:negative regulation of apoptotic process; F:actin binding; F:monooxygese activity; F:protein kise binding; F:ion binding; C:cytoplasm; C:cytoskeleton; C:midbody; C:cell projection	EC:1	Oxidoreductases	IPR022735 (PFAM); IPR001715 (PFAM); IPR022735 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	196.55617082067	1.52035506562995	0.232747280309439	6.53221409766263	6.48044254905459e-11	5.89061243908131e-09
Avas.s020.g451.i1	paralog_cluster_01256	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	137	NA					IPR007593 (PFAM)	C:GO:0016021	C:integral component of membrane	693.383279871704	-2.69811206974924	0.4120872801594	-6.54742866294145	5.85361662386407e-11	5.3510703330312e-09
Avas.s021.g86.i1	homolog_cluster_02721	PSAT1	O-phospho-L-serine:2-oxoglutarate aminotransferase activity	8.3e-122	443.7	Metazoa	EC:2.6.1.52	5	P:GO:0006564; P:GO:0006805; P:GO:0008615; F:GO:0004648; C:GO:0005829	P:pyridoxine biosynthetic process; F:O-phospho-L-serine:2-oxoglutarate aminotransferase activity; P:L-serine biosynthetic process; P:xenobiotic metabolic process; C:cytosol	K00831	map00260, map00680, map00750, map01100, map01120, map01130, map01200, map01230	SERC_HUMAN | Phosphoserine aminotransferase OS=Homo sapiens OX=9606 GN=PSAT1 PE=1 SV=2	371	2.2e-114	P:GO:0006564; P:GO:0008615; F:GO:0004648; F:GO:0030170; F:GO:0042802; C:GO:0005829; C:GO:0009536	P:L-serine biosynthetic process; P:pyridoxine biosynthetic process; F:O-phospho-L-serine:2-oxoglutarate aminotransferase activity; F:pyridoxal phosphate binding; F:identical protein binding; C:cytosol; C:plastid	EC:2.6.1.52	Phosphoserine transamise	IPR000192 (PFAM); IPR020578 (PROSITE_PATTERNS)	no GO terms	no GO terms	539.185584389361	2.78134118162272	0.446053111374706	6.23544844929072	4.50485687215371e-10	3.55287461843535e-08
Avas.s021.g125.i1	paralog_cluster_00461	NA	glutamine biosynthetic process	1.6e-146	525.8	Metazoa	NA	NA	NA	NA	NA	NA	GL_CHICK | Glutamine synthetase OS=Gallus gallus OX=9031 GN=GLUL PE=1 SV=1	370	8.9e-140	P:GO:0006538; P:GO:0006542; P:GO:0009267; P:GO:0009749; P:GO:0010594; P:GO:0018345; P:GO:0019676; P:GO:0032024; P:GO:0042133; P:GO:0042254; P:GO:0050679; P:GO:0051968; P:GO:1903670; P:GO:1904749; F:GO:0000287; F:GO:0004356; F:GO:0005524; F:GO:0016595; F:GO:0016829; F:GO:0019706; F:GO:0030145; F:GO:0042802; F:GO:0045503; C:GO:0005739; C:GO:0005791; C:GO:0005829; C:GO:0005886; C:GO:0032991; C:GO:0043204; C:GO:0043209; C:GO:0043679; C:GO:0097386	P:glutamate catabolic process; P:glutamine biosynthetic process; P:cellular response to starvation; P:response to glucose; P:regulation of endothelial cell migration; P:protein palmitoylation; P:ammonia assimilation cycle; P:positive regulation of insulin secretion; P:neurotransmitter metabolic process; P:ribosome biogenesis; P:positive regulation of epithelial cell proliferation; P:positive regulation of syptic transmission, glutamatergic; P:regulation of sprouting angiogenesis; P:regulation of protein localization to nucleolus; F:magnesium ion binding; F:glutamate-ammonia ligase activity; F:ATP binding; F:glutamate binding; F:lyase activity; F:protein-cysteine S-palmitoyltransferase activity; F:manganese ion binding; F:identical protein binding; F:dynein light chain binding; C:mitochondrion; C:rough endoplasmic reticulum; C:cytosol; C:plasma membrane; C:protein-containing complex; C:perikaryon; C:myelin sheath; C:axon terminus; C:glial cell projection	EC:4; EC:6.3.1.2; EC:2.3.1.225	Lyases; Glutamine synthetase; Protein S-acyltransferase	IPR008147 (PFAM); IPR008146 (PFAM); IPR027302 (PROSITE_PATTERNS); IPR027303 (PROSITE_PATTERNS)	P:GO:0006542; P:GO:0006807; F:GO:0004356	P:glutamine biosynthetic process; P:nitrogen compound metabolic process; F:glutamate-ammonia ligase activity	1413.62834053304	3.11219867520616	0.444126567025969	7.00745892335728	2.42685233405987e-12	2.63821805423576e-10
Avas.s021.g141.i1	paralog_cluster_06340	NA	Ubiquitin family	4e-11	75.1	Ciliophora	NA	NA	NA	NA	K08770	map03320	------	194	NA					IPR000626 (PFAM); IPR000626 (PROSITE_PROFILES); IPR000626 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	77.1034797465151	-1.84547075778658	0.343616094083997	-5.37073434440314	7.84166564818e-08	4.15014995439369e-06
Avas.s021.g142.i1	paralog_cluster_06340	NA	ubiquitin	3.7e-12	78.6	Bilateria	NA	NA	NA	NA	K08770	map03320	------	197	NA					IPR000626 (PFAM); IPR000626 (PROSITE_PROFILES); IPR000626 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	94.0108737597094	-2.43403718136431	0.465758196949355	-5.22596745973959	1.73246828471188e-07	8.49807385144188e-06
Avas.s021.g193.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	76	NA					no IPS match	no IPS match	no IPS match	328.271180442282	-2.7465900667093	0.420889528431377	-6.52567926064978	6.76940413949975e-11	6.11870467418042e-09
Avas.s021.g213.i1	homolog_cluster_14124	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	220	NA					no IPS match	no IPS match	no IPS match	384.320681978612	-1.72662146757433	0.364772068968369	-4.73342564976939	2.20761853214364e-06	8.62096469991724e-05
Avas.s021.g244.i1	homolog_cluster_14136	NA	Belongs to the multi antimicrobial extrusion (MATE) (TC 2.A.66.1) family	3.9e-30	139.8	Streptophyta	NA	NA	NA	NA	NA	NA	S47A2_RABIT | Multidrug and toxin extrusion protein 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC47A2 PE=1 SV=1	561	2.4e-27	P:GO:0048767; P:GO:0055085; P:GO:1990961; F:GO:0015297; F:GO:0022857; F:GO:0042910; C:GO:0005774; C:GO:0005886; C:GO:0016020; C:GO:0016021; C:GO:0016324	P:root hair elongation; P:transmembrane transport; P:xenobiotic detoxification by transmembrane export across the plasma membrane; F:antiporter activity; F:transmembrane transporter activity; F:xenobiotic transmembrane transporter activity; C:vacuolar membrane; C:plasma membrane; C:membrane; C:integral component of membrane; C:apical plasma membrane			IPR002528 (PFAM)	P:GO:0055085; F:GO:0015297; F:GO:0042910; C:GO:0016020	P:transmembrane transport; F:antiporter activity; F:xenobiotic transmembrane transporter activity; C:membrane	26.2919056099331	2.59022673322398	0.515960098100727	5.02020745937279	5.16157032332356e-07	2.26897554458887e-05
Avas.s021.g253.i1	homolog_cluster_14141	TGFB1	transforming growth factor	1.2e-19	104.4	Vertebrata	NA	177	P:GO:1900126; P:GO:1903911; P:GO:0033138; P:GO:0010936; P:GO:0001666; P:GO:0002513; P:GO:0060751; P:GO:1990402; F:GO:0003823; P:GO:0007406; P:GO:0070723; P:GO:0045599; P:GO:0070168; P:GO:0019221; P:GO:0042482; P:GO:0062014; P:GO:0007492; P:GO:0045591; P:GO:0030308; P:GO:0007093; P:GO:0032967; P:GO:2000113; P:GO:0050714; P:GO:0050832; F:GO:0047485; P:GO:0010800; P:GO:1901203; P:GO:0030279; P:GO:1902895; P:GO:0002062; P:GO:0097191; P:GO:1903620; P:GO:0032570; P:GO:0045806; P:GO:0071260; P:GO:0060744; P:GO:0001933; P:GO:0042130; P:GO:0043065; C:GO:0030424; P:GO:0061035; P:GO:0045087; P:GO:1903077; P:GO:0010763; P:GO:0071549; P:GO:0030316; P:GO:0031334; P:GO:0032147; P:GO:0010716; P:GO:0008354; P:GO:0009168; P:GO:0010718; P:GO:0055025; P:GO:0031293; P:GO:0097421; P:GO:0001843; P:GO:0090190; P:GO:0006611; C:GO:0043025; P:GO:0045216; P:GO:0071677; P:GO:0032829; P:GO:0043552; C:GO:0005634; P:GO:0048565; P:GO:0032700; P:GO:0032667; P:GO:0050777; P:GO:0035307; P:GO:1903845; P:GO:0002362; P:GO:1901666; F:GO:0034714; F:GO:0034713; P:GO:2000727; P:GO:0031065; P:GO:0002248; P:GO:0055010; P:GO:0002244; P:GO:0060325; P:GO:0003179; P:GO:1903727; F:GO:0043539; P:GO:0050765; P:GO:0048298; P:GO:0046395; P:GO:0034616; P:GO:0035821; P:GO:0050921; P:GO:1903799; P:GO:2000679; P:GO:0007565; P:GO:0002793; F:GO:0005125; P:GO:0072540; P:GO:0060312; P:GO:0051280; P:GO:0043932; P:GO:0043536; P:GO:0009749; P:GO:0007568; P:GO:0006754; P:GO:0043537; P:GO:0060391; P:GO:0043011; P:GO:0030509; P:GO:0097327; F:GO:0019899; P:GO:0048146; P:GO:0007173; P:GO:0032801; P:GO:1902074; P:GO:0010575; P:GO:0030501; P:GO:0051152; P:GO:0032930; P:GO:0001570; P:GO:0007435; F:GO:0005114; P:GO:0002028; P:GO:0070374; P:GO:0000122; P:GO:1990314; P:GO:0048839; P:GO:0043029; P:GO:0045840; C:GO:0005886; P:GO:0014003; F:GO:0046982; P:GO:0030512; P:GO:0032740; P:GO:1905313; P:GO:0042307; P:GO:0043117; P:GO:0002576; P:GO:0019049; P:GO:0071479; C:GO:0005796; P:GO:0048642; P:GO:0050731; P:GO:0031536; P:GO:0030324; P:GO:0070306; P:GO:0033601; P:GO:0050680; P:GO:2000249; P:GO:0010469; P:GO:0035902; P:GO:0032355; P:GO:1903800; P:GO:2000647; P:GO:0031663; P:GO:1905269; P:GO:0061213; P:GO:0060762; P:GO:0006805; P:GO:0007219; P:GO:0033280; P:GO:0043406; P:GO:0045944; P:GO:0051092; C:GO:0031012; P:GO:0042552; C:GO:0009986; F:GO:0042803; P:GO:0048535; P:GO:0035066; P:GO:0060364; P:GO:0045662; P:GO:0051897; C:GO:0031093; P:GO:0007182; C:GO:0072562; P:GO:0007183; P:GO:0010862; P:GO:0030214; P:GO:0010742	P:negative regulation of immune response; P:response to estradiol; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; P:common-partner SMAD protein phosphorylation; P:ventricular cardiac muscle tissue morphogenesis; P:regulation of signaling receptor activity; P:ossification involved in bone remodeling; P:connective tissue replacement involved in inflammatory response wound healing; P:positive regulation of extracellular matrix assembly; P:osteoclast differentiation; P:negative regulation of neuroblast proliferation; P:cellular response to mechanical stimulus; P:positive regulation of bone mineralization; P:negative regulation of hyaluronan biosynthetic process; P:cellular response to dexamethasone stimulus; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:regulation of blood vessel remodeling; P:regulation of sodium ion transport; P:positive regulation of mesonephros development; P:salivary gland morphogenesis; P:positive regulation of protein secretion; P:aging; P:mitotic cell cycle checkpoint signaling; F:protein N-terminus binding; P:negative regulation of skeletal muscle tissue development; P:mitigation of host defenses by virus; P:positive regulation of ERK1 and ERK2 cascade; P:positive regulation of vascular endothelial growth factor production; P:liver regeneration; P:positive regulation of mammary gland epithelial cell proliferation; C:plasma membrane; P:positive regulation of NAD+ ADP-ribosyltransferase activity; F:protein heterodimerization activity; P:activation of protein kinase activity; P:mammary gland branching involved in thelarche; P:innate immune response; C:nucleus; P:response to cholesterol; P:purine ribonucleoside monophosphate biosynthetic process; P:lens fiber cell differentiation; P:positive regulation of SMAD protein signal transduction; P:hyaluronan catabolic process; P:positive regulation of epithelial to mesenchymal transition; P:positive regulation of odontogenesis; P:response to hypoxia; F:enzyme binding; P:modulation of process of another organism; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; P:positive regulation of exit from mitosis; F:type II transforming growth factor beta receptor binding; P:hematopoietic progenitor cell differentiation; P:negative regulation of small molecule metabolic process; C:neuronal cell body; P:positive regulation of miRNA transcription; P:positive regulation of chromatin organization; P:negative regulation of protein phosphorylation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:response to salt; P:negative regulation of extracellular matrix disassembly; P:branch elongation involved in mammary gland duct branching; P:positive regulation of transcription regulatory region DNA binding; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of protein-containing complex assembly; F:type III transforming growth factor beta receptor binding; P:vasculogenesis; P:positive regulation of histone deacetylation; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of phospholipid metabolic process; P:negative regulation of phagocytosis; P:digestive tract development; P:response to antineoplastic agent; P:positive regulation of chemotaxis; P:embryonic liver development; P:negative regulation of endocytosis; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of protein localization to plasma membrane; P:heart valve morphogenesis; P:positive regulation of transdifferentiation; P:positive regulation of fibroblast proliferation; P:positive regulation of interleukin-17 production; P:positive regulation of MAP kinase activity; P:macrophage derived foam cell differentiation; P:positive regulation of cardiac muscle tissue development; P:female pregnancy; P:endoderm development; P:frontal suture morphogenesis; P:lymph node development; P:positive regulation of protein dephosphorylation; P:negative regulation of cellular response to transforming growth factor beta stimulus; P:positive regulation of histone acetylation; P:inner ear development; P:response to immobilization stress; P:regulation of cartilage development; P:myeloid dendritic cell differentiation; P:face morphogenesis; P:negative regulation of cell growth; P:SMAD protein complex assembly; P:negative regulation of T cell proliferation; P:T cell homeostasis; P:extrinsic apoptotic signaling pathway; P:BMP signaling pathway; P:positive regulation of blood vessel endothelial cell migration; P:membrane protein intracellular domain proteolysis; P:response to progesterone; P:negative regulation of release of sequestered calcium ion into cytosol; P:positive regulation of protein import into nucleus; P:negative regulation of myoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:antigen binding; C:axon; P:xenobiotic metabolic process; P:negative regulation of cellular macromolecule biosynthetic process; P:negative regulation of epithelial cell proliferation; F:protein serine/threonine kinase activator activity; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of smooth muscle cell differentiation; F:cytokine activity; P:positive regulation of vascular permeability; P:positive regulation of fibroblast migration; P:defense response to fungus; P:response to vitamin D; P:regulation of actin cytoskeleton reorganization; P:epidermal growth factor receptor signaling pathway; P:receptor catabolic process; P:negative regulation of stem cell proliferation; P:lung development; F:type I transforming growth factor beta receptor binding; P:cell-cell junction organization; P:cellular response to ionizing radiation; P:positive regulation of NF-kappaB transcription factor activity; P:negative regulation of interleukin-17 production; P:response to laminar fluid shear stress; P:positive regulation of production of miRNAs involved in gene silencing by miRNA; P:Notch signaling pathway; P:cellular response to insulin-like growth factor stimulus; P:germ cell migration; P:negative regulation of blood vessel endothelial cell migration; P:positive regulation of mitotic nuclear division; P:negative regulation of macrophage cytokine production; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of protein kinase B signaling; P:positive regulation of peptide secretion; P:negative regulation of ossification; C:blood microparticle; P:positive regulation of isotype switching to IgA isotypes; P:protein export from nucleus; P:positive regulation of superoxide anion generation; P:regulation of interleukin-23 production; P:cytokine-mediated signaling pathway; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of regulatory T cell differentiation; F:protein homodimerization activity; P:oligodendrocyte development; P:neural tube closure; P:CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment; P:myelination; P:platelet degranulation; P:T-helper 17 cell lineage commitment; P:transforming growth factor beta receptor signaling pathway involved in heart development; C:Golgi lumen; C:platelet alpha granule lumen; P:positive regulation of receptor clustering; P:positive regulation of peptidyl-threonine phosphorylation; P:positive regulation of apoptotic process; P:carboxylic acid catabolic process; P:chondrocyte differentiation; P:positive regulation of collagen biosynthetic process; P:ATP biosynthetic process; P:tolerance induction to self antigen; P:positive regulation of mononuclear cell migration; C:cell surface; P:negative regulation of fat cell differentiation; P:response to glucose; C:extracellular matrix; P:negative regulation of biomineral tissue development	K13375	map04010, map04060, map04068, map04110, map04218, map04350, map04380, map04390, map04659, map04672, map04926, map04932, map04933, map05140, map05142, map05144, map05145, map05146, map05152, map05161, map05166, map05200, map05205, map05210, map05211, map05212, map05220, map05225, map05226, map05321, map05323, map05410, map05414	TGFB2_XENLA | Transforming growth factor beta-2 proprotein OS=Xenopus laevis OX=8355 GN=tgfb2 PE=1 SV=1	365	4.8e-21	P:GO:0001502; P:GO:0001666; P:GO:0001756; P:GO:0001822; P:GO:0001843; P:GO:0003148; P:GO:0003149; P:GO:0003181; P:GO:0003184; P:GO:0003215; P:GO:0003222; P:GO:0003289; P:GO:0003407; P:GO:0007411; P:GO:0007435; P:GO:0007519; P:GO:0007565; P:GO:0007568; P:GO:0008284; P:GO:0008347; P:GO:0008584; P:GO:0008585; P:GO:0009314; P:GO:0009409; P:GO:0009410; P:GO:0009615; P:GO:0010628; P:GO:0010634; P:GO:0010693; P:GO:0010862; P:GO:0010936; P:GO:0014068; P:GO:0016525; P:GO:0030097; P:GO:0030199; P:GO:0030307; P:GO:0030308; P:GO:0030324; P:GO:0030326; P:GO:0030512; P:GO:0030593; P:GO:0030856; P:GO:0030878; P:GO:0030902; P:GO:0031016; P:GO:0032147; P:GO:0032355; P:GO:0032526; P:GO:0032570; P:GO:0032874; P:GO:0032909; P:GO:0032956; P:GO:0033280; P:GO:0033630; P:GO:0034097; P:GO:0034616; P:GO:0035910; P:GO:0042060; P:GO:0043066; P:GO:0043525; P:GO:0043627; P:GO:0045216; P:GO:0045726; P:GO:0045747; P:GO:0045778; P:GO:0045787; P:GO:0045823; P:GO:0046580; P:GO:0048103; P:GO:0048536; P:GO:0048566; P:GO:0048663; P:GO:0048702; P:GO:0048839; P:GO:0050680; P:GO:0050714; P:GO:0050777; P:GO:0050778; P:GO:0051280; P:GO:0051795; P:GO:0051891; P:GO:0060038; P:GO:0060364; P:GO:0060395; P:GO:0060416; P:GO:0061037; P:GO:0061626; P:GO:0062009; P:GO:0070237; P:GO:1902256; P:GO:1902895; P:GO:1904426; P:GO:1905006; P:GO:1905007; P:GO:2001241; F:GO:0001540; F:GO:0005114; F:GO:0034714; F:GO:0042803; F:GO:0044877; F:GO:0047485; F:GO:0048018; C:GO:0005604; C:GO:0005615; C:GO:0005634; C:GO:0005768; C:GO:0005802; C:GO:0009986; C:GO:0030141; C:GO:0030315; C:GO:0030424; C:GO:0043025; C:GO:0099126	P:cartilage condensation; P:response to hypoxia; P:somitogenesis; P:kidney development; P:neural tube closure; P:outflow tract septum morphogenesis; P:membranous septum morphogenesis; P:atrioventricular valve morphogenesis; P:pulmory valve morphogenesis; P:cardiac right ventricle morphogenesis; P:ventricular trabecula myocardium morphogenesis; P:atrial septum primum morphogenesis; P:neural reti development; P:axon guidance; P:salivary gland morphogenesis; P:skeletal muscle tissue development; P:female pregncy; P:aging; P:positive regulation of cell population proliferation; P:glial cell migration; P:male god development; P:female god development; P:response to radiation; P:response to cold; P:response to xenobiotic stimulus; P:response to virus; P:positive regulation of gene expression; P:positive regulation of epithelial cell migration; P:negative regulation of alkaline phosphatase activity; P:positive regulation of pathway-restricted SMAD protein phosphorylation; P:negative regulation of macrophage cytokine production; P:positive regulation of phosphatidylinositol 3-kise sigling; P:negative regulation of angiogenesis; P:hemopoiesis; P:collagen fibril organization; P:positive regulation of cell growth; P:negative regulation of cell growth; P:lung development; P:embryonic limb morphogenesis; P:negative regulation of transforming growth factor beta receptor sigling pathway; P:neutrophil chemotaxis; P:regulation of epithelial cell differentiation; P:thyroid gland development; P:hindbrain development; P:pancreas development; P:activation of protein kise activity; P:response to estradiol; P:response to retinoic acid; P:response to progesterone; P:positive regulation of stress-activated MAPK cascade; P:regulation of transforming growth factor beta2 production; P:regulation of actin cytoskeleton organization; P:response to vitamin D; P:positive regulation of cell adhesion mediated by integrin; P:response to cytokine; P:response to lamir fluid shear stress; P:ascending aorta morphogenesis; P:wound healing; P:negative regulation of apoptotic process; P:positive regulation of neuron apoptotic process; P:response to estrogen; P:cell-cell junction organization; P:positive regulation of integrin biosynthetic process; P:positive regulation of Notch sigling pathway; P:positive regulation of ossification; P:positive regulation of cell cycle; P:positive regulation of heart contraction; P:negative regulation of Ras protein sigl transduction; P:somatic stem cell division; P:spleen development; P:embryonic digestive tract development; P:neuron fate commitment; P:embryonic neurocranium morphogenesis; P:inner ear development; P:negative regulation of epithelial cell proliferation; P:positive regulation of protein secretion; P:negative regulation of immune response; P:positive regulation of immune response; P:negative regulation of release of sequestered calcium ion into cytosol; P:positive regulation of timing of catagen; P:positive regulation of cardioblast differentiation; P:cardiac muscle cell proliferation; P:frontal suture morphogenesis; P:SMAD protein sigl transduction; P:response to growth hormone; P:negative regulation of cartilage development; P:pharyngeal arch artery morphogenesis; P:secondary palate development; P:positive regulation of activation-induced cell death of T cells; P:regulation of apoptotic process involved in outflow tract morphogenesis; P:positive regulation of miR transcription; P:positive regulation of GTP binding; P:negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; P:positive regulation of extrinsic apoptotic sigling pathway in absence of ligand; F:amyloid-beta binding; F:type II transforming growth factor beta receptor binding; F:type III transforming growth factor beta receptor binding; F:protein homodimerization activity; F:protein-containing complex binding; F:protein N-terminus binding; F:receptor ligand activity; C:basement membrane; C:extracellular space; C:nucleus; C:endosome; C:trans-Golgi network; C:cell surface; C:secretory granule; C:T-tubule; C:axon; C:neurol cell body; C:transforming growth factor beta complex			IPR001839 (PFAM); IPR017948 (PROSITE_PATTERNS); IPR001839 (PROSITE_PROFILES)	F:GO:0008083	F:growth factor activity	142.382996454458	1.86893562657237	0.390543834107122	4.78546955131222	1.70588047559195e-06	6.8273410377609e-05
Avas.s021.g260.i1	homolog_cluster_18813	NA	NHL repeat containing protein	4.8e-14	85.9	Cytophagia	NA	NA	NA	NA	NA	NA	LIN41_RAT | E3-ubiquitin-protein ligase TRIM71 OS=Rattus norvegicus OX=10116 GN=Trim71 PE=3 SV=1	405	2.6e-15	P:GO:0010608; P:GO:0010629; P:GO:0044267; P:GO:0050794; P:GO:0051246; F:GO:0005488	P:posttranscriptiol regulation of gene expression; P:negative regulation of gene expression; P:cellular protein metabolic process; P:regulation of cellular process; P:regulation of protein metabolic process; F:binding			IPR001258 (PFAM); IPR001258 (PROSITE_PROFILES); IPR001258 (PROSITE_PROFILES); IPR001258 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	92.0887265989185	1.49526584132311	0.304798429271811	4.9057531067185	9.30695364946729e-07	3.95091232892557e-05
Avas.s021.g264.i1	homolog_cluster_14145	ATP6V1G1	proton-exporting ATPase activity, phosphorylative mechanism	0.024	45.4	Metazoa	NA	10	C:GO:0016471; P:GO:0007430; P:GO:0009168; C:GO:0033181; P:GO:0043068; P:GO:0006805; P:GO:0015988; P:GO:0001700; F:GO:0015078; P:GO:0006754	P:ATP biosynthetic process; P:embryonic development via the syncytial blastoderm; C:plasma membrane proton-transporting V-type ATPase complex; F:proton transmembrane transporter activity; P:energy coupled proton transmembrane transport, against electrochemical gradient; P:positive regulation of programmed cell death; P:terminal branching, open tracheal system; C:vacuolar proton-transporting V-type ATPase complex; P:purine ribonucleoside monophosphate biosynthetic process; P:xenobiotic metabolic process	K02152	map00190, map01100, map04145, map04150, map04721, map04966, map05110, map05120, map05323	------	134	NA					IPR005124 (PFAM)	P:GO:1902600; F:GO:0046961; C:GO:0016471	P:proton transmembrane transport; F:proton-transporting ATPase activity, rotatiol mechanism; C:vacuolar proton-transporting V-type ATPase complex	1410.25552780621	3.63264735917138	0.318392422493781	11.4093398665678	3.75568685005242e-30	1.77721310972039e-27
Avas.s021.g335.i1	paralog_cluster_01167	PRKD3	Belongs to the protein kinase superfamily. CAMK Ser Thr protein kinase family	1.2e-159	570.9	Actinopterygii	EC:2.7.11.13	7	C:GO:0005654; P:GO:0089700; F:GO:0004697; P:GO:0030148; P:GO:0006468; P:GO:0007205; C:GO:0005829	P:protein kinase D signaling; P:protein kinase C-activating G protein-coupled receptor signaling pathway; F:protein kinase C activity; P:sphingolipid biosynthetic process; P:protein phosphorylation; C:cytosol; C:nucleoplasm	K06070	map04015, map04925	KPCD3_HUMAN | Serine/threonine-protein kinase D3 OS=Homo sapiens OX=9606 GN=PRKD3 PE=1 SV=1	1023	8.2e-159	P:GO:0002376; P:GO:0006468; P:GO:0007275; P:GO:0010557; P:GO:0018193; P:GO:0031328; P:GO:0031401; P:GO:0034599; P:GO:0035924; P:GO:0042327; P:GO:0043085; P:GO:0045935; P:GO:0048010; P:GO:0048523; P:GO:0050678; P:GO:0051049; P:GO:0051091; P:GO:0051094; P:GO:0051128; P:GO:0051240; P:GO:0065008; P:GO:0098542; P:GO:1902533; P:GO:2001028; F:GO:0004697; F:GO:0042802; C:GO:0005634; C:GO:0005794; C:GO:0005886	P:immune system process; P:protein phosphorylation; P:multicellular organism development; P:positive regulation of macromolecule biosynthetic process; P:peptidyl-amino acid modification; P:positive regulation of cellular biosynthetic process; P:positive regulation of protein modification process; P:cellular response to oxidative stress; P:cellular response to vascular endothelial growth factor stimulus; P:positive regulation of phosphorylation; P:positive regulation of catalytic activity; P:positive regulation of nucleobase-containing compound metabolic process; P:vascular endothelial growth factor receptor sigling pathway; P:negative regulation of cellular process; P:regulation of epithelial cell proliferation; P:regulation of transport; P:positive regulation of D-binding transcription factor activity; P:positive regulation of developmental process; P:regulation of cellular component organization; P:positive regulation of multicellular organismal process; P:regulation of biological quality; P:defense response to other organism; P:positive regulation of intracellular sigl transduction; P:positive regulation of endothelial cell chemotaxis; F:protein kise C activity; F:identical protein binding; C:nucleus; C:Golgi apparatus; C:plasma membrane	EC:2.7.11.13	Protein kise C	IPR000719 (PFAM); IPR002219 (PFAM); IPR017441 (PROSITE_PATTERNS); IPR002219 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES); IPR002219 (PROSITE_PROFILES)	P:GO:0006468; F:GO:0004672; F:GO:0005524	P:protein phosphorylation; F:protein kise activity; F:ATP binding	365.565086443352	1.22481093837819	0.219292977373967	5.58527205497094	2.33334651998149e-08	1.36513498763571e-06
Avas.s021.g425.i1	homolog_cluster_14197	NA	scavenger receptor activity	0.00012	54.7	Eukaryota	NA	NA	NA	NA	K13912	map04970	------	427	NA					IPR017448 (PFAM); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR001190 (PROSITE_PROFILES)	F:GO:0005044; C:GO:0016020	F:scavenger receptor activity; C:membrane	188.742192974018	4.0895894355143	0.409480952556373	9.98725193438951	1.73320073599039e-23	4.64757777355822e-21
Avas.s021.g443.i1	paralog_cluster_07374	NA	Calcium ion binding	0.67	42.7	Drosophilidae	NA	NA	NA	NA	K04550	map04979, map05010, map05144	CUE_DROMO | Protein cueball OS=Drosophila mojavensis OX=7230 GN=cue PE=3 SV=1	587	6.2e-10	P:GO:0007283; P:GO:0030154; P:GO:0045938; P:GO:0048477; P:GO:0070328; F:GO:0003674; C:GO:0005575; C:GO:0005886; C:GO:0016020; C:GO:0016021	P:spermatogenesis; P:cell differentiation; P:positive regulation of circadian sleep/wake cycle, sleep; P:oogenesis; P:triglyceride homeostasis; F:molecular_function; C:cellular_component; C:plasma membrane; C:membrane; C:integral component of membrane			IPR013111 (PFAM); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PATTERNS); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES); IPR000742 (PROSITE_PROFILES)	no GO terms	no GO terms	98.443787694827	3.3614656682775	0.380113772191124	8.84331459210411	9.2920131562876e-19	1.75881411378248e-16
Avas.s021.g449.i1	paralog_cluster_00374	XDH	Xanthine dehydrogenase	NA	1089.3	Aves	EC:1.17.1.4; EC:1.17.3.2	11	F:GO:0004854; F:GO:0004855; P:GO:0009115; P:GO:0072522; F:GO:0051537; F:GO:0043546; F:GO:0070674; P:GO:0034418; F:GO:0016903; F:GO:0050660; C:GO:0005829	P:urate biosynthetic process; F:hypoxanthine dehydrogenase activity; F:flavin adenine dinucleotide binding; P:xanthine catabolic process; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors; P:purine-containing compound biosynthetic process; F:xanthine dehydrogenase activity; F:xanthine oxidase activity; F:2 iron, 2 sulfur cluster binding; C:cytosol; F:molybdopterin cofactor binding	K00106	map00230, map00232, map00983, map01100, map01110, map01120, map04146	XDH_CHICK | Xanthine dehydrogese/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1	1312	0	P:GO:0000255; P:GO:0001933; P:GO:0001937; P:GO:0006147; P:GO:0006148; P:GO:0006149; P:GO:0006154; P:GO:0006157; P:GO:0006161; P:GO:0006196; P:GO:0006204; P:GO:0006206; P:GO:0006525; P:GO:0006568; P:GO:0006650; P:GO:0006919; P:GO:0007595; P:GO:0008340; P:GO:0009114; P:GO:0009115; P:GO:0009408; P:GO:0010044; P:GO:0010629; P:GO:0016226; P:GO:0032496; P:GO:0034465; P:GO:0042542; P:GO:0045602; P:GO:0046038; P:GO:0046055; P:GO:0046059; P:GO:0051898; P:GO:0071347; P:GO:0071356; P:GO:0097184; P:GO:1900745; P:GO:1900747; P:GO:2000379; P:GO:2001213; F:GO:0004854; F:GO:0004855; F:GO:0030151; F:GO:0042803; F:GO:0043546; F:GO:0050421; F:GO:0051537; F:GO:0070674; F:GO:0070675; F:GO:0071949; C:GO:0002197; C:GO:0005615; C:GO:0005777; C:GO:0005829; C:GO:0016529	P:allantoin metabolic process; P:negative regulation of protein phosphorylation; P:negative regulation of endothelial cell proliferation; P:guanine catabolic process; P:inosine catabolic process; P:deoxyinosine catabolic process; P:adenosine catabolic process; P:deoxyadenosine catabolic process; P:deoxyguanosine catabolic process; P:AMP catabolic process; P:IMP catabolic process; P:pyrimidine nucleobase metabolic process; P:arginine metabolic process; P:tryptophan metabolic process; P:glycerophospholipid metabolic process; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:lactation; P:determition of adult lifespan; P:hypoxanthine catabolic process; P:xanthine catabolic process; P:response to heat; P:response to aluminum ion; P:negative regulation of gene expression; P:iron-sulfur cluster assembly; P:response to lipopolysaccharide; P:response to carbon monoxide; P:response to hydrogen peroxide; P:negative regulation of endothelial cell differentiation; P:GMP catabolic process; P:dGMP catabolic process; P:dAMP catabolic process; P:negative regulation of protein kise B sigling; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:response to azide; P:positive regulation of p38MAPK cascade; P:negative regulation of vascular endothelial growth factor sigling pathway; P:positive regulation of reactive oxygen species metabolic process; P:negative regulation of vasculogenesis; F:xanthine dehydrogese activity; F:xanthine oxidase activity; F:molybdenum ion binding; F:protein homodimerization activity; F:molybdopterin cofactor binding; F:nitrite reductase (NO-forming) activity; F:2 iron, 2 sulfur cluster binding; F:hypoxanthine dehydrogese activity; F:hypoxanthine oxidase activity; F:FAD binding; C:xanthine dehydrogese complex; C:extracellular space; C:peroxisome; C:cytosol; C:sarcoplasmic reticulum	EC:1.7.2.1; EC:1.17.1.4; EC:1.17.3.2	Nitrite reductase (NO-forming); Xanthine dehydrogese; Xanthine oxidase	IPR002888 (PFAM); IPR001041 (PFAM); IPR000674 (PFAM); IPR005107 (PFAM); IPR002346 (PFAM); IPR008274 (PFAM); IPR006058 (PROSITE_PATTERNS); IPR001041 (PROSITE_PROFILES); IPR016166 (PROSITE_PROFILES)	F:GO:0016491; F:GO:0046872; F:GO:0051536; F:GO:0051537; F:GO:0071949	F:oxidoreductase activity; F:metal ion binding; F:iron-sulfur cluster binding; F:2 iron, 2 sulfur cluster binding; F:FAD binding	1108.56698998339	-2.19562439556628	0.232469905230065	-9.44476831697149	3.56191425345788e-21	8.07149836956111e-19
Avas.s021.g485.i1	paralog_cluster_00540	ABCG2	glucuronoside metabolic process	6e-115	421.8	Rodentia	NA	37	C:GO:0016021; F:GO:0005524; F:GO:0008559; P:GO:0006879; P:GO:0060136; F:GO:0015232; P:GO:0071392; P:GO:0006855; P:GO:0060359; P:GO:0001101; P:GO:0007568; F:GO:0016887; P:GO:0019389; P:GO:0043278; P:GO:0097744; P:GO:0072347; F:GO:0008092; P:GO:0072521; P:GO:0097327; C:GO:0005634; P:GO:0015747; C:GO:0016324; P:GO:0032868; P:GO:0010039; P:GO:0015886; P:GO:0051593; C:GO:0043235; P:GO:1904612; P:GO:0032496; P:GO:0033344; P:GO:1904479; P:GO:0046618; P:GO:0046415; P:GO:0019752; F:GO:0042803; P:GO:0071466; P:GO:0071549	P:xenobiotic export; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:response to lipopolysaccharide; F:ATP hydrolysis activity; P:urate transport; P:cholesterol efflux; P:response to iron ion; P:response to folic acid; P:cellular response to dexamethasone stimulus; P:embryonic process involved in female pregnancy; P:carboxylic acid metabolic process; P:cellular iron ion homeostasis; P:glucuronoside metabolic process; C:integral component of membrane; C:apical plasma membrane; P:response to insulin; P:response to ammonium ion; F:cytoskeletal protein binding; P:aging; F:protein homodimerization activity; P:response to antineoplastic agent; P:response to anesthetic; P:response to morphine; P:cellular response to xenobiotic stimulus; P:heme transport; P:response to acid chemical; P:negative regulation of intestinal absorption; F:ABC-type xenobiotic transporter activity; P:cellular response to estradiol stimulus; P:purine-containing compound metabolic process; C:nucleus; P:urate metabolic process; F:ATP binding; P:renal urate salt excretion; C:receptor complex; P:xenobiotic transmembrane transport; F:heme transmembrane transporter activity	K05681	map01523, map02010, map04976	ABCG2_MOUSE | Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Mus musculus OX=10090 GN=Abcg2 PE=1 SV=1	664	2e-113	P:GO:0007568; P:GO:0010039; P:GO:0015747; P:GO:0015878; P:GO:0019389; P:GO:0032218; P:GO:0032496; P:GO:0032868; P:GO:0043278; P:GO:0046415; P:GO:0051593; P:GO:0060136; P:GO:0065003; P:GO:0070633; P:GO:0071392; P:GO:0071549; P:GO:0097744; P:GO:1904479; P:GO:1904612; P:GO:1990748; P:GO:1990961; P:GO:1990962; F:GO:0008092; F:GO:0008559; F:GO:0015143; F:GO:0015225; F:GO:0015562; F:GO:0032217; F:GO:0042803; C:GO:0005654; C:GO:0005737; C:GO:0031526; C:GO:0045121; C:GO:0098591	P:aging; P:response to iron ion; P:urate transport; P:biotin transport; P:glucuronoside metabolic process; P:riboflavin transport; P:response to lipopolysaccharide; P:response to insulin; P:response to morphine; P:urate metabolic process; P:response to folic acid; P:embryonic process involved in female pregncy; P:protein-containing complex assembly; P:transepithelial transport; P:cellular response to estradiol stimulus; P:cellular response to dexamethasone stimulus; P:rel urate salt excretion; P:negative regulation of intestil absorption; P:response to 2,3,7,8-tetrachlorodibenzodioxine; P:cellular detoxification; P:xenobiotic detoxification by transmembrane export across the plasma membrane; P:xenobiotic transport across blood-brain barrier; F:cytoskeletal protein binding; F:ABC-type xenobiotic transporter activity; F:urate transmembrane transporter activity; F:biotin transmembrane transporter activity; F:efflux transmembrane transporter activity; F:riboflavin transmembrane transporter activity; F:protein homodimerization activity; C:nucleoplasm; C:cytoplasm; C:brush border membrane; C:membrane raft; C:exterl side of apical plasma membrane	EC:7.6.2.2	ABC-type xenobiotic transporter	IPR003439 (PFAM); IPR013525 (PFAM); IPR043926 (PFAM); IPR003439 (PROSITE_PROFILES)	F:GO:0005524; F:GO:0140359; C:GO:0016020	F:ATP binding; F:ABC-type transporter activity; C:membrane	49.6921755734815	2.3261883390359	0.402987374853118	5.77236033730276	7.81687284937706e-09	4.97097499105247e-07
Avas.s021.g541.i1	paralog_cluster_00218	NA	Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin- like GTPase superfamily. Septin GTPase family	1.4e-122	446.4	Actinopterygii	NA	NA	NA	NA	K16944	NA	SEPT7_XENLA | Septin-7 OS=Xenopus laevis OX=8355 GN=septin7 PE=2 SV=1	421	1.6e-116	P:GO:0000281; P:GO:0001764; P:GO:0007349; P:GO:0007476; P:GO:0016476; P:GO:0017157; P:GO:0030317; P:GO:0030865; P:GO:0031270; P:GO:0031398; P:GO:0034613; P:GO:0045572; P:GO:0048515; P:GO:0048668; P:GO:0060031; P:GO:0060997; P:GO:0061484; P:GO:1902857; P:GO:2001244; F:GO:0000287; F:GO:0003779; F:GO:0003924; F:GO:0005198; F:GO:0005525; F:GO:0008017; F:GO:0031625; F:GO:0042803; F:GO:0060090; C:GO:0000775; C:GO:0001725; C:GO:0005654; C:GO:0005741; C:GO:0005829; C:GO:0005930; C:GO:0005940; C:GO:0008021; C:GO:0015630; C:GO:0016324; C:GO:0030425; C:GO:0031105; C:GO:0032154; C:GO:0032160; C:GO:0042734; C:GO:0043204; C:GO:0043679; C:GO:0045171; C:GO:0070938; C:GO:0097227; C:GO:0097730; C:GO:0098978	P:mitotic cytokinesis; P:neuron migration; P:cellularization; P:imagil disc-derived wing morphogenesis; P:regulation of embryonic cell shape; P:regulation of exocytosis; P:flagellated sperm motility; P:cortical cytoskeleton organization; P:pseudopodium retraction; P:positive regulation of protein ubiquitition; P:cellular protein localization; P:positive regulation of imagil disc growth; P:spermatid differentiation; P:collateral sprouting; P:mediolateral intercalation; P:dendritic spine morphogenesis; P:hematopoietic stem cell homeostasis; P:positive regulation of non-motile cilium assembly; P:positive regulation of intrinsic apoptotic sigling pathway; F:magnesium ion binding; F:actin binding; F:GTPase activity; F:structural molecule activity; F:GTP binding; F:microtubule binding; F:ubiquitin protein ligase binding; F:protein homodimerization activity; F:molecular adaptor activity; C:chromosome, centromeric region; C:stress fiber; C:nucleoplasm; C:mitochondrial outer membrane; C:cytosol; C:axoneme; C:septin ring; C:syptic vesicle; C:microtubule cytoskeleton; C:apical plasma membrane; C:dendrite; C:septin complex; C:cleavage furrow; C:septin filament array; C:presyptic membrane; C:perikaryon; C:axon terminus; C:intercellular bridge; C:contractile ring; C:sperm annulus; C:non-motile cilium; C:glutamatergic sypse	EC:3.6.1	Acting on acid anhydrides	IPR030379 (PFAM); IPR030379 (PROSITE_PROFILES)	F:GO:0005525	F:GTP binding	915.546397244555	1.00050675449253	0.185534350529182	5.39256882425748	6.94574822766607e-08	3.72500477449731e-06
Avas.s022.g9.i1	paralog_cluster_00592	NA	carbohydrate binding. It is involved in the biological process described with mannose metabolic process	4.4e-263	914.4	Metazoa	NA	NA	NA	NA	NA	NA	MA2B1_CAVPO | Lysosomal alpha-mannosidase OS=Cavia porcellus OX=10141 GN=MAN2B1 PE=1 SV=1	981	4.5e-247	P:GO:0006013; P:GO:0006517; P:GO:0007611; F:GO:0004559; F:GO:0008270; F:GO:0030246; C:GO:0005615; C:GO:0005654; C:GO:0032009; C:GO:0035578; C:GO:0043202	P:mannose metabolic process; P:protein deglycosylation; P:learning or memory; F:alpha-mannosidase activity; F:zinc ion binding; F:carbohydrate binding; C:extracellular space; C:nucleoplasm; C:early phagosome; C:azurophil granule lumen; C:lysosomal lumen	EC:3.2.1.24	Alpha-mannosidase	IPR041147 (PFAM); IPR011682 (PFAM); IPR015341 (PFAM); IPR000602 (PFAM)	P:GO:0006013; F:GO:0004559	P:mannose metabolic process; F:alpha-mannosidase activity	23.5595510925216	2.98049072206817	0.582637252442673	5.11551691824138	3.12882899880766e-07	1.45912260179178e-05
Avas.s022.g60.i1	homolog_cluster_14225	CRIM1	Cysteine-rich motor neuron 1 protein	1.1e-18	100.9	Afrotheria	NA	7	C:GO:0016021; P:GO:0048009; P:GO:0007399; C:GO:0005576; F:GO:0030165; F:GO:0005010; P:GO:0018108	P:nervous system development; F:insulin-like growth factor-activated receptor activity; P:insulin-like growth factor receptor signaling pathway; C:extracellular region; F:PDZ domain binding; C:integral component of membrane; P:peptidyl-tyrosine phosphorylation	NA	NA	------	309	NA					IPR001007 (PFAM); IPR001007 (PROSITE_PATTERNS); IPR001007 (PROSITE_PATTERNS); IPR001007 (PROSITE_PROFILES); IPR001007 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	454.530126060035	2.34154678915954	0.247596222408216	9.45711839374911	3.16546265899536e-21	7.2755898172252e-19
Avas.s022.g173.i1	homolog_cluster_14244	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	404	NA					no IPS match	no IPS match	no IPS match	465.928270089348	1.37211862672825	0.215022310592575	6.38128491386246	1.7560823870606e-10	1.45637162502155e-08
Avas.s022.g181.i1	paralog_cluster_09049	GAL3ST1	galactose-3-O-sulfotransferase 1	2.3e-27	130.2	Metazoa	EC:2.8.2.11	8	P:GO:0042552; C:GO:0000139; P:GO:0006487; P:GO:0006682; C:GO:0098791; C:GO:0005887; P:GO:0007283; F:GO:0001733	C:integral component of plasma membrane; C:Golgi apparatus subcompartment; F:galactosylceramide sulfotransferase activity; P:myelination; P:galactosylceramide biosynthetic process; P:protein N-linked glycosylation; P:spermatogenesis; C:Golgi membrane	K01019	map00565, map00600, map01100	G3ST2_PIG | Galactose-3-O-sulfotransferase 2 OS=Sus scrofa OX=9823 GN=GAL3ST2 PE=2 SV=1	424	1.5e-18	P:GO:0006664; P:GO:0006665; P:GO:0009100; P:GO:0044249; P:GO:1901137; P:GO:1901566; F:GO:0005488; F:GO:0008146; C:GO:0016020; C:GO:0043227	P:glycolipid metabolic process; P:sphingolipid metabolic process; P:glycoprotein metabolic process; P:cellular biosynthetic process; P:carbohydrate derivative biosynthetic process; P:organonitrogen compound biosynthetic process; F:binding; F:sulfotransferase activity; C:membrane; C:membrane-bounded organelle	EC:2.8.2	Transferring sulfur-containing groups	IPR009729 (PFAM)	P:GO:0009247; F:GO:0001733; C:GO:0016021	P:glycolipid biosynthetic process; F:galactosylceramide sulfotransferase activity; C:integral component of membrane	155.006611660496	1.94074347855992	0.370749152781632	5.23465384613568	1.65294344577358e-07	8.14766856404569e-06
Avas.s022.g268.i1	paralog_cluster_00838	NA	lipid metabolic process	1.7e-68	266.5	Bilateria	NA	NA	NA	NA	NA	NA	AA_RAT | N-acylethanolamine-hydrolyzing acid amidase OS=Rattus norvegicus OX=10116 GN=aa PE=1 SV=1	358	1.6e-56	P:GO:0006665; P:GO:0070291; F:GO:0047412; C:GO:0005764; C:GO:0016020	P:sphingolipid metabolic process; P:N-acylethanolamine metabolic process; F:N-(long-chain-acyl)ethanolamine deacylase activity; C:lysosome; C:membrane	EC:3.5.1.60	N-(long-chain-acyl)ethanolamine deacylase	IPR029132 (PFAM); IPR029130 (PFAM)	no GO terms	no GO terms	161.190477189379	-2.0562945017554	0.330523367482271	-6.2213286685871	4.92962276645075e-10	3.85013110142845e-08
Avas.s022.g309.i1	homolog_cluster_14298	Fim	Calcium ion binding	0.0046	50.1	Arthropoda	NA	6	F:GO:0051015; C:GO:0032432; P:GO:0051639; C:GO:0005884; P:GO:0051017; P:GO:0051764	P:actin filament network formation; P:actin filament bundle assembly; P:actin crosslink formation; C:actin filament; F:actin filament binding; C:actin filament bundle	K17336	NA	------	643	NA					no IPS match	no IPS match	no IPS match	534.290835684156	1.47668458013962	0.311467659258518	4.7410526783263	2.1261063850392e-06	8.36355149850751e-05
Avas.s022.g447.i1	homolog_cluster_14318	NA	positive regulation of natural killer cell degranulation	4.3e-09	68.9	Chordata	NA	NA	NA	NA	NA	NA	------	289	NA					IPR002000 (PROSITE_PROFILES)	C:GO:0016020	C:membrane	434.628517464878	-2.02540559012211	0.332322778790924	-6.09469383197582	1.09647102423012e-09	7.80580633134442e-08
Avas.s023.g62.i1	paralog_cluster_00633	NA	Competence protein ComEC	2.4e-25	123.2	Eukaryota	NA	NA	NA	NA	NA	NA	------	360	NA					no IPS match	no IPS match	no IPS match	404.831391888117	6.52601489550485	0.688931314226705	9.47266405335343	2.7279586082675e-21	6.45443030123762e-19
Avas.s023.g120.i1	homolog_cluster_14369	NA	amine dehydrogenase activity	3e-13	82.8	Bacteria	NA	NA	NA	NA	NA	NA	------	297	NA					IPR001258 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	592.228565853421	1.53604105092556	0.274777708916575	5.59012249203925	2.26909486863114e-08	1.33726986598558e-06
Avas.s023.g132.i1	homolog_cluster_14375	NA	zinc ion binding. It is involved in the biological process described with positive regulation of JNK cascade	7.9e-30	138.3	Insecta	NA	14	P:GO:0003384; F:GO:0005515; P:GO:0034332; P:GO:0001654; P:GO:0046529; C:GO:0045179; P:GO:0001934; P:GO:0043065; P:GO:0050829; P:GO:0045167; P:GO:0046330; P:GO:0007391; P:GO:0007370; P:GO:0032989	P:asymmetric protein localization involved in cell fate determination; P:cellular component morphogenesis; C:apical cortex; P:imaginal disc fusion, thorax closure; P:eye development; P:dorsal closure; P:adherens junction organization; P:positive regulation of JNK cascade; P:positive regulation of apoptotic process; P:defense response to Gram-negative bacterium; P:apical constriction involved in gastrulation; F:protein binding; P:ventral furrow formation; P:positive regulation of protein phosphorylation	K09848,K09849	map04064, map04214, map04217, map04621, map04657, map04668, map05168, map05169, map05200, map05203, map05222	------	394	NA					IPR001293 (PFAM); IPR001293 (PROSITE_PROFILES); IPR002083 (PROSITE_PROFILES); IPR001293 (PROSITE_PROFILES)	F:GO:0005515; F:GO:0008270	F:protein binding; F:zinc ion binding	333.863941261234	2.33960337530731	0.295330869706477	7.92197367526324	2.33769811944265e-15	3.54822877770875e-13
Avas.s023.g159.i1	homolog_cluster_14383	NA	negative regulation of cardiac chamber formation	1.4e-45	191.4	Chordata	NA	NA	NA	NA	K10176	map04013	TBX4_CANLF | T-box transcription factor TBX4 OS=Canis lupus familiaris OX=9615 GN=TBX4 PE=2 SV=1	714	3.2e-45	P:GO:0001525; P:GO:0001707; P:GO:0001947; P:GO:0003146; P:GO:0003167; P:GO:0003190; P:GO:0003197; P:GO:0003218; P:GO:0003281; P:GO:0003294; P:GO:0003342; P:GO:0003344; P:GO:0007517; P:GO:0009880; P:GO:0009952; P:GO:0010719; P:GO:0021554; P:GO:0030177; P:GO:0030324; P:GO:0030336; P:GO:0035115; P:GO:0035116; P:GO:0035118; P:GO:0036302; P:GO:0045944; P:GO:0048705; P:GO:0051891; P:GO:0060042; P:GO:0060044; P:GO:0060045; P:GO:0060174; P:GO:0060371; P:GO:0060413; P:GO:0060928; P:GO:0060929; P:GO:0060980; P:GO:0061026; P:GO:0072513; P:GO:0086019; P:GO:0086054; P:GO:1901846; P:GO:1903598; P:GO:1903781; P:GO:1990401; F:GO:0000978; F:GO:0001228; F:GO:0030274; F:GO:0051087; F:GO:0061629; F:GO:0097110; C:GO:0001725; C:GO:0005737; C:GO:0005884; C:GO:0017053; C:GO:0032993; C:GO:0071339	P:angiogenesis; P:mesoderm formation; P:heart looping; P:heart jogging; P:atrioventricular bundle cell differentiation; P:atrioventricular valve formation; P:endocardial cushion development; P:cardiac left ventricle formation; P:ventricular septum development; P:atrial ventricular junction remodeling; P:proepicardium development; P:pericardium morphogenesis; P:muscle organ development; P:embryonic pattern specification; P:anterior/posterior pattern specification; P:negative regulation of epithelial to mesenchymal transition; P:optic nerve development; P:positive regulation of Wnt sigling pathway; P:lung development; P:negative regulation of cell migration; P:embryonic forelimb morphogenesis; P:embryonic hindlimb morphogenesis; P:embryonic pectoral fin morphogenesis; P:atrioventricular cal development; P:positive regulation of transcription by R polymerase II; P:skeletal system morphogenesis; P:positive regulation of cardioblast differentiation; P:reti morphogenesis in camera-type eye; P:negative regulation of cardiac muscle cell proliferation; P:positive regulation of cardiac muscle cell proliferation; P:limb bud formation; P:regulation of atrial cardiac muscle cell membrane depolarization; P:atrial septum morphogenesis; P:atrioventricular node cell development; P:atrioventricular node cell fate commitment; P:cell migration involved in corory vasculogenesis; P:cardiac muscle tissue regeneration; P:positive regulation of secondary heart field cardioblast proliferation; P:cell-cell sigling involved in cardiac conduction; P:bundle of His cell to Purkinje myocyte communication by electrical coupling; P:positive regulation of cell communication by electrical coupling involved in cardiac conduction; P:positive regulation of gap junction assembly; P:positive regulation of cardiac conduction; P:embryonic lung development; F:R polymerase II cis-regulatory region sequence-specific D binding; F:D-binding transcription activator activity, R polymerase II-specific; F:LIM domain binding; F:chaperone binding; F:R polymerase II-specific D-binding transcription factor binding; F:scaffold protein binding; C:stress fiber; C:cytoplasm; C:actin filament; C:transcription repressor complex; C:protein-D complex; C:MLL1 complex			IPR001699 (PFAM); IPR001699 (PROSITE_PROFILES)	P:GO:0006355; F:GO:0003700	P:regulation of transcription, D-templated; F:D-binding transcription factor activity	354.252001589262	2.69996104539305	0.348094231598959	7.75640846730172	8.73683151120606e-15	1.20142634345123e-12
Avas.s023.g164.i1	paralog_cluster_06287	NA	electron carrier activity. It is involved in the biological process described with cell redox homeostasis	3.1e-26	126.3	Drosophilidae	NA	NA	NA	NA	K17479	NA	------	397	NA					IPR006993 (PFAM); PS51354 (PROSITE_PROFILES)	no GO terms	no GO terms	144.974341164406	4.03694921136347	0.529395324306586	7.62558531594732	2.42929582168157e-14	3.1776374369947e-12
Avas.s023.g273.i1	paralog_cluster_00043	NA	Integrase core domain	3e-26	127.5	Metazoa	NA	NA	NA	NA	NA	NA	------	862	NA					IPR041588 (PFAM); IPR001584 (PROSITE_PROFILES)	P:GO:0015074	P:D integration	26.8258776455215	4.02347589757514	0.763900241398799	5.26701744485332	1.38658035204489e-07	6.92816499504668e-06
Avas.s023.g294.i1	homolog_cluster_14407	NA	BEN	0.00046	52.4	Testudines	NA	NA	NA	NA	NA	NA	------	316	NA					no IPS match	no IPS match	no IPS match	662.493651665034	5.15562935435549	0.53411437686097	9.65266912427166	4.78926424782935e-22	1.15006675348248e-19
Avas.s025.g22.i1	homolog_cluster_14424	NA	NA	4.1e-06	58.9	Metazoa	NA	NA	NA	NA	NA	NA	------	269	NA					no IPS match	no IPS match	no IPS match	1038.36918131601	1.9975671697457	0.383365430632162	5.21060849553324	1.88222269475527e-07	9.17669119270227e-06
Avas.s025.g111.i1	paralog_cluster_08718	NA	Protein tyrosine phosphatase, receptor type, D, b	1.8e-11	77.8	Actinopterygii	NA	NA	NA	NA	NA	NA	------	577	NA					IPR003961 (PFAM); IPR003961 (PROSITE_PROFILES); IPR003961 (PROSITE_PROFILES)	F:GO:0005515	F:protein binding	63.4025722514614	3.09145606827763	0.612541945501379	5.04692958740516	4.48966717339435e-07	2.01209624380896e-05
Avas.s042.g7.i1	paralog_cluster_00043	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	577	NA					no IPS match	no IPS match	no IPS match	174.559338941065	1.92220227997144	0.290367415415329	6.61989664791419	3.59450092497984e-11	3.40187796364709e-09
Avas.s047.g7.i1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	661	NA					no IPS match	no IPS match	no IPS match	110.005434201843	2.73627434556229	0.500883169409009	5.46289935992623	4.68420188057137e-08	2.56340558015349e-06
Avas.s053.g3.i1	paralog_cluster_09079	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	------	127	NA					no IPS match	no IPS match	no IPS match	374.294857703548	4.3580763001905	0.463729058119154	9.39789349812689	5.56663323371161e-21	1.22687071366008e-18
Avas.s053.g5.i1	paralog_cluster_01505	CPEB1	negative regulation of cytoplasmic translation	2.2e-111	409.5	Mammalia	NA	30	P:GO:0010976; C:GO:0016020; C:GO:1990124; P:GO:1900365; C:GO:0030426; P:GO:0071230; C:GO:0043025; C:GO:0005654; P:GO:0071456; C:GO:0048471; P:GO:0008285; P:GO:0048168; P:GO:0051028; P:GO:0007130; P:GO:0032869; C:GO:0005813; C:GO:0014069; F:GO:0008135; F:GO:0043022; P:GO:2000766; F:GO:0035925; P:GO:0051770; F:GO:0000900; P:GO:0045727; P:GO:0045666; P:GO:0071222; P:GO:0050769; P:GO:0030335; C:GO:0072687; C:GO:0005829	C:meiotic spindle; P:negative regulation of cell population proliferation; C:messenger ribonucleoprotein complex; F:mRNA 3'-UTR AU-rich region binding; C:perinuclear region of cytoplasm; P:positive regulation of cell migration; F:translation factor activity, RNA binding; P:positive regulation of translation; F:translation repressor activity, mRNA regulatory element binding; P:synaptonemal complex assembly; C:cytosol; P:positive regulation of nitric-oxide synthase biosynthetic process; C:postsynaptic density; P:regulation of neuronal synaptic plasticity; C:neuronal cell body; C:centrosome; P:cellular response to hypoxia; P:positive regulation of neuron projection development; P:cellular response to amino acid stimulus; P:cellular response to insulin stimulus; C:nucleoplasm; P:positive regulation of neuron differentiation; P:positive regulation of mRNA polyadenylation; C:membrane; P:negative regulation of cytoplasmic translation; F:ribosome binding; P:cellular response to lipopolysaccharide; P:positive regulation of neurogenesis; C:growth cone; P:mRNA transport	K02602	map04114, map04320, map04914	CPEB1_POB | Cytoplasmic polyadenylation element-binding protein 1 OS=Pongo abelii OX=9601 GN=CPEB1 PE=2 SV=1	467	4.9e-111	P:GO:0007130; P:GO:0008285; P:GO:0010976; P:GO:0030335; P:GO:0032869; P:GO:0032880; P:GO:0045727; P:GO:0048168; P:GO:0051028; P:GO:0051770; P:GO:0071222; P:GO:0071230; P:GO:0071456; P:GO:0099547; P:GO:1900365; P:GO:2000766; F:GO:0000900; F:GO:0008135; F:GO:0008494; F:GO:0035925; F:GO:0042802; F:GO:0043022; F:GO:0046872; C:GO:0000922; C:GO:0000932; C:GO:0005654; C:GO:0005813; C:GO:0005829; C:GO:0014069; C:GO:0016020; C:GO:0030425; C:GO:0030426; C:GO:0043025; C:GO:0048471; C:GO:0071598; C:GO:0072687; C:GO:0099154; C:GO:1990124	P:syptonemal complex assembly; P:negative regulation of cell population proliferation; P:positive regulation of neuron projection development; P:positive regulation of cell migration; P:cellular response to insulin stimulus; P:regulation of protein localization; P:positive regulation of translation; P:regulation of neurol syptic plasticity; P:mR transport; P:positive regulation of nitric-oxide synthase biosynthetic process; P:cellular response to lipopolysaccharide; P:cellular response to amino acid stimulus; P:cellular response to hypoxia; P:regulation of translation at sypse, modulating syptic transmission; P:positive regulation of mR polyadenylation; P:negative regulation of cytoplasmic translation; F:translation repressor activity, mR regulatory element binding; F:translation factor activity, R binding; F:translation activator activity; F:mR 3'-UTR AU-rich region binding; F:identical protein binding; F:ribosome binding; F:metal ion binding; C:spindle pole; C:P-body; C:nucleoplasm; C:centrosome; C:cytosol; C:postsyptic density; C:membrane; C:dendrite; C:growth cone; C:neurol cell body; C:perinuclear region of cytoplasm; C:neurol ribonucleoprotein granule; C:meiotic spindle; C:serotonergic sypse; C:messenger ribonucleoprotein complex			IPR032296 (PFAM); IPR000504 (PFAM); IPR000504 (PROSITE_PROFILES)	F:GO:0003723	F:R binding	365.440679016707	2.10892969998414	0.40245613955747	5.24014791351691	1.60447939007338e-07	7.94291350981251e-06
Avas.s064.g4.i1	paralog_cluster_09080	NA	Src homology 3 domains	0.00087	51.2	Arthropoda	NA	6	C:GO:0016327; P:GO:0035331; F:GO:0045296; P:GO:0090251; P:GO:0090163; C:GO:0045179	P:establishment of epithelial cell planar polarity; P:negative regulation of hippo signaling; C:apical cortex; C:apicolateral plasma membrane; F:cadherin binding; P:protein localization involved in establishment of planar polarity	NA	NA	------	272	NA					IPR001452 (PFAM)	F:GO:0005515	F:protein binding	144.849051487554	1.91181443938178	0.333341044185717	5.73531064574405	9.73337808226466e-09	6.1653669277778e-07
